commit 7ab24fe976be5c798004246aa079a429e568689b
Author: davidlagorce <david.lagorce@inserm.fr>
Date:   Mon Jun 30 11:46:37 2025 +0200

    JULY 2025

diff --git a/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml b/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml
old mode 100644
new mode 100755
index c186125..e1f16e9
--- a/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml	
+++ b/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml	
@@ -1,5 +1,5 @@
-<?xml version="1.0" encoding="ISO-8859-1"?>
-<JDBOR date="2024-12-03 07:34:24" version="1.3.29 / 4.1.7 [2023-08-02] (orientdb version)" copyright="Orphanet (c) 2024" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
+<?xml version="1.0" encoding="UTF-8"?>
+<JDBOR date="2025-06-24 07:39:17" version="1.3.42 / 4.1.8 [2025-03-03]" copyright="Orphanet (c) 2025" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
   <Availability> 
     <Licence>
       <FullName lang="en">Creative Commons Attribution 4.0 International</FullName>
@@ -7,7 +7,7 @@
       <LegalCode>https://creativecommons.org/licenses/by/4.0/legalcode</LegalCode>
     </Licence>
   </Availability>
-  <DisorderList count="6150">
+  <DisorderList count="6317">
     <Disorder id="17601">
       <OrphaCode>166024</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=166024</ExpertLink>
@@ -542,7 +542,7 @@
     <Disorder id="6">
       <OrphaCode>585</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=585</ExpertLink>
-      <Name lang="nl">Multipele sulfatasedeficiëntie</Name>
+      <Name lang="nl">Multipele sulfatasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -591,7 +591,7 @@
     <Disorder id="7">
       <OrphaCode>118</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=118</ExpertLink>
-      <Name lang="nl">Bèta-mannosidose</Name>
+      <Name lang="nl">BÃ¨ta-mannosidose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -1334,7 +1334,7 @@
     <Disorder id="14">
       <OrphaCode>365</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=365</ExpertLink>
-      <Name lang="nl">Glycogeenstapelingsziekte door zure-maltasedeficiëntie</Name>
+      <Name lang="nl">Glycogeenstapelingsziekte door zure-maltasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -1735,7 +1735,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="59">
           <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
@@ -1755,6 +1755,25 @@
             <Name lang="nl">Not yet validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17880">
+          <Source>29143597[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.035</ValMoy>
+          <PrevalenceGeographic id="25293">
+            <Name lang="nl">Spain</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="17617">
@@ -2169,7 +2188,7 @@
     <Disorder id="18">
       <OrphaCode>369</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=369</ExpertLink>
-      <Name lang="nl">Glycogeenstapelingsziekte door hepatische glycogeenfosforylasedeficiëntie</Name>
+      <Name lang="nl">Glycogeenstapelingsziekte door hepatische glycogeenfosforylasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -2309,7 +2328,7 @@
     <Disorder id="17620">
       <OrphaCode>166108</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=166108</ExpertLink>
-      <Name lang="nl">Intellectuele achterstand, Birk-Barel-type</Name>
+      <Name lang="nl">Syndroom van Birk-Barel</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -2496,7 +2515,7 @@
     <Disorder id="17622">
       <OrphaCode>166119</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=166119</ExpertLink>
-      <Name lang="nl">Geïsoleerde osteopoikilose</Name>
+      <Name lang="nl">GeÃ¯soleerde osteopoikilose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -4027,55 +4046,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="17634">
-      <OrphaCode>166305</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=166305</ExpertLink>
-      <Name lang="nl">Goedaardige infantiele epileptische aanvallen geassocieerd met milde gastro-enteritis</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="12663">
-          <Source>24125788[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Geval(len)/Gezinnen</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Geval(len)</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>100.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="12664">
-          <Source>ORPHANET_24125788[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="32">
       <OrphaCode>2912</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2912</ExpertLink>
@@ -4311,6 +4281,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="17639">
+      <OrphaCode>166409</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=166409</ExpertLink>
+      <Name lang="nl">Fotosensitieve epilepsie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17919">
+          <Source>27986877[PMID]_28532712[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>30.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="39">
       <OrphaCode>801</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=801</ExpertLink>
@@ -4489,6 +4491,87 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="17643">
+      <OrphaCode>166421</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=166421</ExpertLink>
+      <Name lang="nl">Orgasme-geÃ¯nduceerde epileptische aanvallen</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17833">
+          <Source>17201724[PMID]_27057393[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>7.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17834">
+          <Source>17201724[PMID]_27057393[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="17642">
+      <OrphaCode>166418</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=166418</ExpertLink>
+      <Name lang="nl">VoedingsgeÃ¯nduceerde reflexepilepsie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17837">
+          <Source>Source: 33080481[PMID]_27986877[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.5</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="40">
       <OrphaCode>584</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=584</ExpertLink>
@@ -4692,6 +4775,87 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="17640">
+      <OrphaCode>166412</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=166412</ExpertLink>
+      <Name lang="nl">Heet water-reflexepilepsie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17846">
+          <Source>27986877[PMID]_29403278[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>4.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="17647">
+      <OrphaCode>166433</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=166433</ExpertLink>
+      <Name lang="nl">Leesepilepsie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17868">
+          <Source>37437391[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>101.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17869">
+          <Source>37437391[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="44">
       <OrphaCode>881</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=881</ExpertLink>
@@ -5142,6 +5306,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="17644">
+      <OrphaCode>166424</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=166424</ExpertLink>
+      <Name lang="nl">GedachtengeÃ¯nduceerde epileptische aanvallen</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17867">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="45">
       <OrphaCode>95</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=95</ExpertLink>
@@ -5481,7 +5677,7 @@
     <Disorder id="51">
       <OrphaCode>848</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=848</ExpertLink>
-      <Name lang="nl">Bèta-thalassemie</Name>
+      <Name lang="nl">BÃ¨ta-thalassemie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -7451,7 +7647,7 @@
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="8299">
-          <Source>Dr Véronique PINGAULT[EXPERT]</Source>
+          <Source>Dr VÃ©ronique PINGAULT[EXPERT]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
           </PrevalenceType>
@@ -7577,6 +7773,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="17549">
+      <OrphaCode>163931</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=163931</ExpertLink>
+      <Name lang="nl">Acrodermatitis continua van Hallopeau</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17862">
+          <Source>34532894[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>6.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="77">
       <OrphaCode>273</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=273</ExpertLink>
@@ -8382,7 +8610,7 @@
     <Disorder id="17555">
       <OrphaCode>163961</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=163961</ExpertLink>
-      <Name lang="nl">X-gebonden cerebraal-cerebellair-coloboomsyndroom</Name>
+      <Name lang="nl">X-linked cerebral-cerebellar-coloboma syndrome</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -8428,6 +8656,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="17567">
+      <OrphaCode>164726</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=164726</ExpertLink>
+      <Name lang="nl">Acute myeloÃ¯de leukemie en myelodysplastische syndromen gerelateerd aan bestraling</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17835">
+          <Source>22585703[PMID]_39256810[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.3</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="94">
       <OrphaCode>324</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=324</ExpertLink>
@@ -9172,7 +9432,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="307">
           <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
@@ -9192,6 +9452,25 @@
             <Name lang="nl">Not yet validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17741">
+          <Source>27861775[PMID]</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.7</ValMoy>
+          <PrevalenceGeographic id="25006">
+            <Name lang="nl">Norway</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="101">
@@ -9404,6 +9683,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="17568">
+      <OrphaCode>164736</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=164736</ExpertLink>
+      <Name lang="nl">Familiaal geavanceerde slaapfase-syndroom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17849">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="110">
       <OrphaCode>138</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=138</ExpertLink>
@@ -9620,55 +9931,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="17579">
-      <OrphaCode>165805</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=165805</ExpertLink>
-      <Name lang="nl">Familiale mesiale temporaalkwabepilepsie met febriele epileptische aanvallen</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="12553">
-          <Source>21922598[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Geval(len)/Gezinnen</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Geval(len)</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>4.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="12554">
-          <Source>ORPHANET_21922598[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="106">
       <OrphaCode>803</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=803</ExpertLink>
@@ -10312,7 +10574,7 @@
     <Disorder id="104">
       <OrphaCode>100</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100</ExpertLink>
-      <Name lang="nl">Ataxie-teleangiëctasie</Name>
+      <Name lang="nl">Ataxie-teleangiÃ«ctasie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -11336,6 +11598,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="17588">
+      <OrphaCode>165955</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=165955</ExpertLink>
+      <Name lang="nl">Wondmyiasis</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17901">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>23.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17902">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="117">
       <OrphaCode>501</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=501</ExpertLink>
@@ -11402,16 +11713,48 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="11338">
-          <Source>ORPHANET_25217339[PMID]</Source>
+        <Prevalence id="17830">
+          <Source>29489177[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.02</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="17589">
+      <OrphaCode>165958</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=165958</ExpertLink>
+      <Name lang="nl">Cavitaire myiasis</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17855">
+          <Source>28822697[PMID]_ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
           <PrevalenceQualification id="23704">
             <Name lang="nl">Class only</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
           </PrevalenceClass>
           <ValMoy>0.0</ValMoy>
           <PrevalenceGeographic id="23844">
@@ -12772,6 +13115,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="17597">
+      <OrphaCode>166002</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=166002</ExpertLink>
+      <Name lang="nl">Multipele epifysaire dysplasie door collageen 9-anomalie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17931">
+          <Source>11565064[PMID]_11200990[PMID]_10655510[PMID]_20358595[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>59.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17932">
+          <Source>11565064[PMID]_11200990[PMID]_10655510[PMID]_20358595[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="123">
       <OrphaCode>534</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=534</ExpertLink>
@@ -13406,6 +13798,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="17595">
+      <OrphaCode>165991</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=165991</ExpertLink>
+      <Name lang="nl">InspanningsgeÃ¯nduceerd hyperinsulinisme</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17852">
+          <Source>17701893[PMID]_1358043[PMID]_11207177[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>17.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17853">
+          <Source>17701893[PMID]_1358043[PMID]_11207177[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="121">
       <OrphaCode>652</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=652</ExpertLink>
@@ -16891,7 +17332,7 @@
     <Disorder id="149">
       <OrphaCode>96</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=96</ExpertLink>
-      <Name lang="nl">Ataxie met vitamine E-deficiëntie</Name>
+      <Name lang="nl">Ataxie met vitamine E-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -17131,7 +17572,7 @@
     <Disorder id="171">
       <OrphaCode>631</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=631</ExpertLink>
-      <Name lang="nl">Niet-verworven geïsoleerde groeihormoondeficiëntie</Name>
+      <Name lang="nl">Niet-verworven geÃ¯soleerde groeihormoondeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -17163,7 +17604,7 @@
     <Disorder id="170">
       <OrphaCode>276</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=276</ExpertLink>
-      <Name lang="nl">Ernstige gecombineerde T-B+ immuundeficiëntie als gevolg van gammaketendeficiëntie</Name>
+      <Name lang="nl">Ernstige gecombineerde T-B+ immuundeficiÃ«ntie als gevolg van gammaketendeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -17352,7 +17793,7 @@
     <Disorder id="168">
       <OrphaCode>664</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=664</ExpertLink>
-      <Name lang="nl">Ornithinetranscarbamylasedeficiëntie</Name>
+      <Name lang="nl">OrnithinetranscarbamylasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -17596,7 +18037,7 @@
     <Disorder id="173">
       <OrphaCode>394</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=394</ExpertLink>
-      <Name lang="nl">Homocystinurie door deficiëntie van cystathionine-bèta-synthase</Name>
+      <Name lang="nl">Homocystinurie door deficiÃ«ntie van cystathionine-bÃ¨ta-synthase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -17829,7 +18270,7 @@
     <Disorder id="172">
       <OrphaCode>508</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=508</ExpertLink>
-      <Name lang="nl">Leprechaunisme</Name>
+      <Name lang="nl">Syndroom van Donohue</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -17931,7 +18372,7 @@
     <Disorder id="17507">
       <OrphaCode>163596</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=163596</ExpertLink>
-      <Name lang="nl">Hb - Hydrops foetalis van Bart</Name>
+      <Name lang="nl">Hb-Bart's hydrops foetalis</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -17952,7 +18393,7 @@
           </PrevalenceClass>
           <ValMoy>275.0</ValMoy>
           <PrevalenceGeographic id="23830">
-            <Name lang="nl">Zuid-Oost Azië</Name>
+            <Name lang="nl">Zuid-Oost AziÃ«</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
@@ -18327,6 +18768,70 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="17531">
+      <OrphaCode>163717</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=163717</ExpertLink>
+      <Name lang="nl">Goedaardige familiale mesiale temporaalkwabepilepsie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17940">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="17529">
+      <OrphaCode>163708</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=163708</ExpertLink>
+      <Name lang="nl">Cryptogene epileptische spasmen met late aanvang</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17872">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="185">
       <OrphaCode>636</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=636</ExpertLink>
@@ -18533,7 +19038,7 @@
     <Disorder id="17528">
       <OrphaCode>163703</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=163703</ExpertLink>
-      <Name lang="nl">Febriele infectie-gerelateerde epilepsie-syndroom</Name>
+      <Name lang="nl">Febriele-infectiegerelateerd epilepsiesyndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -18633,7 +19138,7 @@
     <Disorder id="17533">
       <OrphaCode>163727</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=163727</ExpertLink>
-      <Name lang="nl">Rolandische epilepsie - paroxysmale inspanningsgeïnduceerde dystonie - schrijfkramp-syndroom</Name>
+      <Name lang="nl">Rolandische epilepsie - paroxysmale inspanningsgeÃ¯nduceerde dystonie - schrijfkramp-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -18679,6 +19184,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="17532">
+      <OrphaCode>163721</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=163721</ExpertLink>
+      <Name lang="nl">Rolandische epilepsie - spraakdyspraxie-syndroom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17870">
+          <Source>16497722[PMID]_23933820[PMID]_24995671[PMID]_18248446[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>277.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17871">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="17522">
       <OrphaCode>163684</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=163684</ExpertLink>
@@ -20036,7 +20590,7 @@
     <Disorder id="201">
       <OrphaCode>281</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=281</ExpertLink>
-      <Name lang="nl">Monosomie 5p</Name>
+      <Name lang="nl">Monosomie 5p-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -20106,7 +20660,7 @@
     <Disorder id="203">
       <OrphaCode>752</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=752</ExpertLink>
-      <Name lang="nl">46,XY-geslachtsontwikkelingsstoornis door deficiëntie van 17-bèta-hydroxysteroïde-dehydrogenase 3</Name>
+      <Name lang="nl">46,XY-geslachtsontwikkelingsstoornis door deficiÃ«ntie van 17-bÃ¨ta-hydroxysteroÃ¯de-dehydrogenase 3</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -20714,7 +21268,7 @@
     <Disorder id="194">
       <OrphaCode>60</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=60</ExpertLink>
-      <Name lang="nl">Deficiëntie van alfa-1-antitrypsine</Name>
+      <Name lang="nl">DeficiÃ«ntie van alfa-1-antitrypsine</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -20899,7 +21453,7 @@
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="767">
-          <Source>ORPHANET_Dr Véronique PINGAULT[EXPERT]</Source>
+          <Source>ORPHANET_Dr VÃ©ronique PINGAULT[EXPERT]</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -21001,7 +21555,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="11365">
-          <Source>ORPHANET_Dr Véronique PINGAULT[EXPERT]</Source>
+          <Source>ORPHANET_Dr VÃ©ronique PINGAULT[EXPERT]</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -21024,7 +21578,7 @@
     <Disorder id="212">
       <OrphaCode>682</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=682</ExpertLink>
-      <Name lang="nl">Hyperkaliëmische periodieke paralyse</Name>
+      <Name lang="nl">HyperkaliÃ«mische periodieke paralyse</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -21815,7 +22369,7 @@
     <Disorder id="211">
       <OrphaCode>681</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=681</ExpertLink>
-      <Name lang="nl">Hypokaliëmische periodieke paralyse</Name>
+      <Name lang="nl">HypokaliÃ«mische periodieke paralyse</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -21968,7 +22522,7 @@
     <Disorder id="236">
       <OrphaCode>774</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=774</ExpertLink>
-      <Name lang="nl">Erfelijke hemorragische teleangiëctasie</Name>
+      <Name lang="nl">Erfelijke hemorragische teleangiÃ«ctasie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -22534,18 +23088,18 @@
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
+          <ValMoy>0.4</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
       </PrevalenceList>
@@ -22553,7 +23107,7 @@
     <Disorder id="255">
       <OrphaCode>53</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=53</ExpertLink>
-      <Name lang="nl">Osteopetrose van Albers-Schönberg</Name>
+      <Name lang="nl">Osteopetrose van Albers-SchÃ¶nberg</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -22642,7 +23196,7 @@
     <Disorder id="252">
       <OrphaCode>14</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=14</ExpertLink>
-      <Name lang="nl">Abètalipoproteïnemie</Name>
+      <Name lang="nl">AbÃ¨talipoproteÃ¯nemie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -22799,7 +23353,7 @@
     <Disorder id="249">
       <OrphaCode>167</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=167</ExpertLink>
-      <Name lang="nl">Syndroom van Chédiak-Higashi</Name>
+      <Name lang="nl">Syndroom van ChÃ©diak-Higashi</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -23089,11 +23643,11 @@
       <OrphaCode>201</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=201</ExpertLink>
       <Name lang="nl">Syndroom van Cowden</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="793">
@@ -23394,7 +23948,7 @@
     <Disorder id="277">
       <OrphaCode>2443</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2443</ExpertLink>
-      <Name lang="nl">Stoornis van mitochondriale oxidatieve fosforylatie door anomalieën van nucleair DNA</Name>
+      <Name lang="nl">Stoornis van mitochondriale oxidatieve fosforylatie door anomalieÃ«n van nucleair DNA</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -24005,7 +24559,7 @@
     <Disorder id="257">
       <OrphaCode>1646</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1646</ExpertLink>
-      <Name lang="nl">Chromosoom Y-microdeletie</Name>
+      <Name lang="nl">Chromosoom Y-microdeletiesyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -24056,7 +24610,7 @@
     <Disorder id="17863">
       <OrphaCode>169464</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=169464</ExpertLink>
-      <Name lang="nl">Primaire CD59-deficiëntie</Name>
+      <Name lang="nl">Primaire CD59-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -26291,7 +26845,7 @@
     <Disorder id="17815">
       <OrphaCode>169079</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=169079</ExpertLink>
-      <Name lang="nl">Cernunnos-XLF-deficiëntie</Name>
+      <Name lang="nl">Cernunnos-XLF-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -26337,10 +26891,61 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="341">
+      <OrphaCode>1716</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1716</ExpertLink>
+      <Name lang="nl">Distale duplicatie 18q-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17754">
+          <Source>36064004[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.4</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18067">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="340">
       <OrphaCode>1715</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1715</ExpertLink>
-      <Name lang="nl">Trisomie 18p</Name>
+      <Name lang="nl">Trisomie 18p-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -26389,7 +26994,7 @@
     <Disorder id="339">
       <OrphaCode>3380</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3380</ExpertLink>
-      <Name lang="nl">Trisomie 18</Name>
+      <Name lang="nl">Trisomie 18-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -27034,7 +27639,7 @@
     <Disorder id="337">
       <OrphaCode>3378</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3378</ExpertLink>
-      <Name lang="nl">Trisomie 13</Name>
+      <Name lang="nl">Trisomie 13-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -27446,7 +28051,7 @@
     <Disorder id="17820">
       <OrphaCode>169100</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=169100</ExpertLink>
-      <Name lang="nl">Immuundeficiëntie door CD25-deficiëntie</Name>
+      <Name lang="nl">ImmuundeficiÃ«ntie door CD25-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -27544,7 +28149,7 @@
     <Disorder id="17818">
       <OrphaCode>169090</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=169090</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door CRAC-kanaaldisfunctie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door CRAC-kanaaldisfunctie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -27593,7 +28198,7 @@
     <Disorder id="346">
       <OrphaCode>236</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=236</ExpertLink>
-      <Name lang="nl">Trisomie 9p</Name>
+      <Name lang="nl">Trisomie 9p-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -27642,7 +28247,7 @@
     <Disorder id="17819">
       <OrphaCode>169095</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=169095</ExpertLink>
-      <Name lang="nl">Ernstige gecombineerde immuundeficiëntie door FOXN1-deficiëntie</Name>
+      <Name lang="nl">Ernstige gecombineerde immuundeficiÃ«ntie door FOXN1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -27755,7 +28360,7 @@
     <Disorder id="17797">
       <OrphaCode>168816</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=168816</ExpertLink>
-      <Name lang="nl">Peritoneaal cystisch mesothelioom</Name>
+      <Name lang="nl">Peritoneale inclusiecyste</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -27804,7 +28409,7 @@
     <Disorder id="324">
       <OrphaCode>753</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=753</ExpertLink>
-      <Name lang="nl">46,XY-geslachtsontwikkelingsstoornis door deficiëntie van 5-alfa-reductase 2</Name>
+      <Name lang="nl">46,XY-geslachtsontwikkelingsstoornis door deficiÃ«ntie van 5-alfa-reductase 2</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -27836,7 +28441,7 @@
     <Disorder id="325">
       <OrphaCode>868</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=868</ExpertLink>
-      <Name lang="nl">Triosefosfaatisomerasedeficiëntie</Name>
+      <Name lang="nl">TriosefosfaatisomerasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -28193,7 +28798,7 @@
     <Disorder id="334">
       <OrphaCode>1642</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1642</ExpertLink>
-      <Name lang="nl">Distale deletie 9p</Name>
+      <Name lang="nl">Distale deletie 9p-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -28392,6 +28997,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="332">
+      <OrphaCode>1636</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1636</ExpertLink>
+      <Name lang="nl">Distale monosomie 7q36-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17752">
+          <Source>15844773[PMID]_10521829[PMID]_39624702[PMID]_38847723[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>30.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17753">
+          <Source>15844773[PMID]_10521829[PMID]_39624702[PMID]_38847723[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="17805">
       <OrphaCode>168956</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=168956</ExpertLink>
@@ -28484,7 +29138,7 @@
     <Disorder id="330">
       <OrphaCode>1600</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1600</ExpertLink>
-      <Name lang="nl">Monosomie 18q</Name>
+      <Name lang="nl">Monosomie 18q-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -28535,7 +29189,7 @@
     <Disorder id="328">
       <OrphaCode>1598</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1598</ExpertLink>
-      <Name lang="nl">Monosomie 18p</Name>
+      <Name lang="nl">Monosomie 18p-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -28684,7 +29338,7 @@
     <Disorder id="369">
       <OrphaCode>2609</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2609</ExpertLink>
-      <Name lang="nl">Geïsoleerde complex I-deficiëntie</Name>
+      <Name lang="nl">GeÃ¯soleerde complex I-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -28716,7 +29370,7 @@
     <Disorder id="370">
       <OrphaCode>626</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=626</ExpertLink>
-      <Name lang="nl">Grote congenitale melanocytaire naevus</Name>
+      <Name lang="nl">Grote/reuze congenitale melanocytaire naevus</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -28797,7 +29451,7 @@
     <Disorder id="378">
       <OrphaCode>11</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=11</ExpertLink>
-      <Name lang="nl">Pentasomie X</Name>
+      <Name lang="nl">Pentasomie X-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -28829,7 +29483,7 @@
     <Disorder id="17829">
       <OrphaCode>169154</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=169154</ExpertLink>
-      <Name lang="nl">Ernstige gecombineerde T- B+ immuundeficiëntie door IL-7R-alfa-deficiëntie</Name>
+      <Name lang="nl">Ernstige gecombineerde T- B+ immuundeficiÃ«ntie door IL-7R-alfa-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -28988,7 +29642,7 @@
     <Disorder id="17831">
       <OrphaCode>169160</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=169160</ExpertLink>
-      <Name lang="nl">Ernstige gecombineerde T- B+ immuundeficiëntie door CD3-delta/CD3-epsilon/CD3-zeta</Name>
+      <Name lang="nl">Ernstige gecombineerde T- B+ immuundeficiÃ«ntie door CD3-delta/CD3-epsilon/CD3-zeta</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -29071,7 +29725,7 @@
     <Disorder id="17830">
       <OrphaCode>169157</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=169157</ExpertLink>
-      <Name lang="nl">Ernstige gecombineerde T- B+ immuundeficiëntie door CD45-deficiëntie</Name>
+      <Name lang="nl">Ernstige gecombineerde T- B+ immuundeficiÃ«ntie door CD45-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -29121,11 +29775,11 @@
       <OrphaCode>1947</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1947</ExpertLink>
       <Name lang="nl">Progressieve epilepsie - intellectuele achterstand-syndroom, Fins type</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="989">
@@ -29464,7 +30118,7 @@
     <Disorder id="361">
       <OrphaCode>3307</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3307</ExpertLink>
-      <Name lang="nl">Tetrasomie 18p</Name>
+      <Name lang="nl">Tetrasomie 18p-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -30205,7 +30859,7 @@
     <Disorder id="412">
       <OrphaCode>1006</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1006</ExpertLink>
-      <Name lang="nl">Alopecie met antilichaamdeficiëntie</Name>
+      <Name lang="nl">Alopecie met antilichaamdeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -30254,7 +30908,7 @@
     <Disorder id="413">
       <OrphaCode>1046</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1046</ExpertLink>
-      <Name lang="nl">Letale hemolytische anemie - genitale anomalieën-syndroom</Name>
+      <Name lang="nl">Letale hemolytische anemie - genitale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -30303,7 +30957,7 @@
     <Disorder id="402">
       <OrphaCode>22</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=22</ExpertLink>
-      <Name lang="nl">Succinyl-semialdehyde-dehydrogenasedeficiëntie</Name>
+      <Name lang="nl">Succinyl-semialdehyde-dehydrogenasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -30972,7 +31626,7 @@
     <Disorder id="390">
       <OrphaCode>9</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=9</ExpertLink>
-      <Name lang="nl">Tetrasomie X</Name>
+      <Name lang="nl">Tetrasomie X-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -31021,7 +31675,7 @@
     <Disorder id="17785">
       <OrphaCode>168615</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=168615</ExpertLink>
-      <Name lang="nl">Hereditaire persistentie van alfa-foetoproteïne</Name>
+      <Name lang="nl">Hereditaire persistentie van alfa-foetoproteÃ¯ne</Name>
       <DisorderType id="21408">
         <Name lang="nl">Biologische anomalie</Name>
       </DisorderType>
@@ -31070,7 +31724,7 @@
     <Disorder id="17784">
       <OrphaCode>168612</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=168612</ExpertLink>
-      <Name lang="nl">Congenitale deficiëntie van alfa-foetoproteïne</Name>
+      <Name lang="nl">Congenitale deficiÃ«ntie van alfa-foetoproteÃ¯ne</Name>
       <DisorderType id="21408">
         <Name lang="nl">Biologische anomalie</Name>
       </DisorderType>
@@ -31417,7 +32071,7 @@
     <Disorder id="447">
       <OrphaCode>200</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=200</ExpertLink>
-      <Name lang="nl">Geïsoleerde agenesie van corpus callosum</Name>
+      <Name lang="nl">GeÃ¯soleerde agenesie van corpus callosum</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -31783,7 +32437,7 @@
     <Disorder id="17778">
       <OrphaCode>168588</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=168588</ExpertLink>
-      <Name lang="nl">Hyperandrogenisme door cortisonereductasedeficiëntie</Name>
+      <Name lang="nl">Hyperandrogenisme door cortisonereductasedeficiÃ«ntie</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -31881,7 +32535,7 @@
     <Disorder id="17780">
       <OrphaCode>168598</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=168598</ExpertLink>
-      <Name lang="nl">Deficiëntie van methionine-adenosyltransferase I/III</Name>
+      <Name lang="nl">DeficiÃ«ntie van methionine-adenosyltransferase I/III</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -32077,7 +32731,7 @@
     <Disorder id="424">
       <OrphaCode>1154</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1154</ExpertLink>
-      <Name lang="nl">Artrogrypose - oculomotorische beperkingen - elektroretinale anomalieën-syndroom</Name>
+      <Name lang="nl">Artrogrypose - oculomotorische beperkingen - elektroretinale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -32158,7 +32812,7 @@
     <Disorder id="17771">
       <OrphaCode>168558</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=168558</ExpertLink>
-      <Name lang="nl">46,XY-geslachtsontwikkelingsstoornis - adrenale insufficiëntie door CYP11A1-deficiëntie</Name>
+      <Name lang="nl">46,XY-geslachtsontwikkelingsstoornis - adrenale insufficiÃ«ntie door CYP11A1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -32383,7 +33037,7 @@
     <Disorder id="17773">
       <OrphaCode>168566</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=168566</ExpertLink>
-      <Name lang="nl">Fatale mitochondriale ziekte door gecombineerde oxidatieve fosforylatiedeficiëntie type 3</Name>
+      <Name lang="nl">Fatale mitochondriale ziekte door gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 3</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -32847,7 +33501,7 @@
     <Disorder id="17764">
       <OrphaCode>168454</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=168454</ExpertLink>
-      <Name lang="nl">Spondylo-epimetafysaire dysplasie, Geneviève-type</Name>
+      <Name lang="nl">Spondylo-epimetafysaire dysplasie, GeneviÃ¨ve-type</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -33109,7 +33763,7 @@
     <Disorder id="476">
       <OrphaCode>1770</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1770</ExpertLink>
-      <Name lang="nl">Gonadale dysgenesie, XY-type - geassocieerde anomalieën-syndroom</Name>
+      <Name lang="nl">Gonadale dysgenesie, XY-type - geassocieerde anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -33341,7 +33995,7 @@
     <Disorder id="470">
       <OrphaCode>1672</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1672</ExpertLink>
-      <Name lang="nl">Diëncefaal syndroom</Name>
+      <Name lang="nl">DiÃ«ncefaal syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -33373,7 +34027,7 @@
     <Disorder id="468">
       <OrphaCode>833</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=833</ExpertLink>
-      <Name lang="nl">Encefalopathie door sulfietoxidasedeficiëntie</Name>
+      <Name lang="nl">Encefalopathie door sulfietoxidasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -33422,7 +34076,7 @@
     <Disorder id="17684">
       <OrphaCode>167714</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=167714</ExpertLink>
-      <Name lang="nl">Niet-geclassificeerde acute myeloïde leukemie</Name>
+      <Name lang="nl">Niet-geclassificeerde acute myeloÃ¯de leukemie</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -33503,7 +34157,7 @@
     <Disorder id="467">
       <OrphaCode>765</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=765</ExpertLink>
-      <Name lang="nl">Pyruvaatdehydrogenasedeficiëntie</Name>
+      <Name lang="nl">PyruvaatdehydrogenasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -33554,7 +34208,7 @@
     <Disorder id="465">
       <OrphaCode>395</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=395</ExpertLink>
-      <Name lang="nl">Homocystinurie als gevolg van methyleentetrahydrofolaat reductasedeficiëntie</Name>
+      <Name lang="nl">Homocystinurie als gevolg van methyleentetrahydrofolaat reductasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -33586,7 +34240,7 @@
     <Disorder id="463">
       <OrphaCode>408</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=408</ExpertLink>
-      <Name lang="nl">Geïsoleerde glycerolkinasedeficiëntie</Name>
+      <Name lang="nl">GeÃ¯soleerde glycerolkinasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -33618,7 +34272,7 @@
     <Disorder id="462">
       <OrphaCode>148</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=148</ExpertLink>
-      <Name lang="nl">Meervoudige carboxylasedeficiëntie</Name>
+      <Name lang="nl">Meervoudige carboxylasedeficiÃ«ntie</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -33650,7 +34304,7 @@
     <Disorder id="461">
       <OrphaCode>147</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=147</ExpertLink>
-      <Name lang="nl">Deficiëntie van carbamoylfosfaatsynthetase 1</Name>
+      <Name lang="nl">DeficiÃ«ntie van carbamoylfosfaatsynthetase 1</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -33847,7 +34501,7 @@
     <Disorder id="458">
       <OrphaCode>45</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=45</ExpertLink>
-      <Name lang="nl">Adenosinemonofosfaatdeaminasedeficiëntie</Name>
+      <Name lang="nl">AdenosinemonofosfaatdeaminasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -33896,7 +34550,7 @@
     <Disorder id="457">
       <OrphaCode>226</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=226</ExpertLink>
-      <Name lang="nl">Deficiëntie van dihydrobiopteridinereductase</Name>
+      <Name lang="nl">DeficiÃ«ntie van dihydrobiopteridinereductase</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -33945,7 +34599,7 @@
     <Disorder id="456">
       <OrphaCode>217</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=217</ExpertLink>
-      <Name lang="nl">Geïsoleerde Dandy-Walker malformatie</Name>
+      <Name lang="nl">GeÃ¯soleerde Dandy-Walker malformatie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -34145,7 +34799,7 @@
     <Disorder id="508">
       <OrphaCode>417</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=417</ExpertLink>
-      <Name lang="nl">Neonatale ernstige primaire hyperparathyreoïdie</Name>
+      <Name lang="nl">Neonatale ernstige primaire hyperparathyreoÃ¯die</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -34744,7 +35398,7 @@
     <Disorder id="505">
       <OrphaCode>2135</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2135</ExpertLink>
-      <Name lang="nl">Syndroom van Hennekam-Beemer</Name>
+      <Name lang="nl">Cutane mastocytose - doofheid - microtie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -36480,7 +37134,7 @@
     <Disorder id="486">
       <OrphaCode>1885</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1885</ExpertLink>
-      <Name lang="nl">Geïsoleerde ectopia lentis</Name>
+      <Name lang="nl">GeÃ¯soleerde ectopia lentis</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -37972,7 +38626,7 @@
     <Disorder id="557">
       <OrphaCode>884</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=884</ExpertLink>
-      <Name lang="nl">Tetrasomie 12p</Name>
+      <Name lang="nl">Syndroom van Pallister-Killian</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -38153,7 +38807,7 @@
     <Disorder id="567">
       <OrphaCode>2971</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2971</ExpertLink>
-      <Name lang="nl">Peroxisomale acyl-CoA-oxidasedeficiëntie</Name>
+      <Name lang="nl">Peroxisomale acyl-CoA-oxidasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -38482,7 +39136,7 @@
     <Disorder id="562">
       <OrphaCode>718</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=718</ExpertLink>
-      <Name lang="nl">Geïsoleerd syndroom van Pierre Robin</Name>
+      <Name lang="nl">GeÃ¯soleerde Pierre Robin sequentie</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -39647,7 +40301,7 @@
     <Disorder id="515">
       <OrphaCode>2300</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2300</ExpertLink>
-      <Name lang="nl">Multipele intestinale atresie</Name>
+      <Name lang="nl">GeÃ¯soleerde multipele intestinale atresie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -39957,6 +40611,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="18133">
+      <OrphaCode>180247</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=180247</ExpertLink>
+      <Name lang="nl">Vaginaal carcinoom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17929">
+          <Source>38924674[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.36</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="532">
       <OrphaCode>506</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=506</ExpertLink>
@@ -40046,10 +40732,61 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="535">
+      <OrphaCode>2430</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2430</ExpertLink>
+      <Name lang="nl">Congenitale macroglossie</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17758">
+          <Source>29570380[PMID]</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>4.6</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18068">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="534">
       <OrphaCode>2414</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2414</ExpertLink>
-      <Name lang="nl">Congenitale pulmonale lymfangiëctasie</Name>
+      <Name lang="nl">Congenitale pulmonale lymfangiÃ«ctasie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -40095,6 +40832,57 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="529">
+      <OrphaCode>2373</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2373</ExpertLink>
+      <Name lang="nl">Congenitale laryngomalacie</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17757">
+          <Source>31334986[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>40.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18069">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="18128">
       <OrphaCode>180234</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=180234</ExpertLink>
@@ -40162,7 +40950,7 @@
     <Disorder id="530">
       <OrphaCode>2374</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2374</ExpertLink>
-      <Name lang="nl">Geïsoleerd congenitaal web van larynx</Name>
+      <Name lang="nl">GeÃ¯soleerd congenitaal web van larynx</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -41310,7 +42098,7 @@
       </DisorderGroup>
       <PrevalenceList count="103">
         <Prevalence id="1506">
-          <Source>11641035[PMID]_17616847[PMID]_[EXPERT]_Haute Autorité de Santé 2010[INST]</Source>
+          <Source>11641035[PMID]_17616847[PMID]_[EXPERT]_Haute AutoritÃ© de SantÃ© 2010[INST]</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -43513,7 +44301,7 @@
     <Disorder id="635">
       <OrphaCode>154</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=154</ExpertLink>
-      <Name lang="nl">Familiale geïsoleerde gedilateerde cardiomyopathie</Name>
+      <Name lang="nl">Familiale geÃ¯soleerde gedilateerde cardiomyopathie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -43799,7 +44587,7 @@
     <Disorder id="632">
       <OrphaCode>69</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=69</ExpertLink>
-      <Name lang="nl">Amyloïdose</Name>
+      <Name lang="nl">AmyloÃ¯dose</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -44375,7 +45163,7 @@
     <Disorder id="582">
       <OrphaCode>3151</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3151</ExpertLink>
-      <Name lang="nl">Multipele sclerose - ichthyosis - factor VIII-deficiëntie-syndroom</Name>
+      <Name lang="nl">Multipele sclerose - ichthyosis - factor VIII-deficiÃ«ntie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -44957,7 +45745,7 @@
     <Disorder id="586">
       <OrphaCode>816</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=816</ExpertLink>
-      <Name lang="nl">Syndroom van Sjögren-Larsson</Name>
+      <Name lang="nl">Syndroom van SjÃ¶gren-Larsson</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -46501,7 +47289,7 @@
     <Disorder id="677">
       <OrphaCode>715</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=715</ExpertLink>
-      <Name lang="nl">Glycogeenstapelingsziekte door deficiëntie van fosforylasekinase in spier</Name>
+      <Name lang="nl">Glycogeenstapelingsziekte door deficiÃ«ntie van fosforylasekinase in spier</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -46599,7 +47387,7 @@
     <Disorder id="676">
       <OrphaCode>348</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=348</ExpertLink>
-      <Name lang="nl">Fructose-1,6-bisfosfatasedeficiëntie</Name>
+      <Name lang="nl">Fructose-1,6-bisfosfatasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -46797,7 +47585,7 @@
     <Disorder id="673">
       <OrphaCode>3137</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3137</ExpertLink>
-      <Name lang="nl">Deficiëntie van alfa-N-acetylgalactosaminidase</Name>
+      <Name lang="nl">DeficiÃ«ntie van alfa-N-acetylgalactosaminidase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -46846,7 +47634,7 @@
     <Disorder id="703">
       <OrphaCode>117</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=117</ExpertLink>
-      <Name lang="nl">Ziekte van Behçet</Name>
+      <Name lang="nl">Ziekte van BehÃ§et</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -48640,7 +49428,7 @@
     <Disorder id="18039">
       <OrphaCode>178517</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=178517</ExpertLink>
-      <Name lang="nl">Gelokaliseerde pagetoïde reticulose</Name>
+      <Name lang="nl">Gelokaliseerde pagetoÃ¯de reticulose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -49974,7 +50762,7 @@
     <Disorder id="17999">
       <OrphaCode>178029</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=178029</ExpertLink>
-      <Name lang="nl">Deficiëntie van arginine-vasopressine</Name>
+      <Name lang="nl">DeficiÃ«ntie van arginine-vasopressine</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -50412,7 +51200,7 @@
     <Disorder id="650">
       <OrphaCode>216</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=216</ExpertLink>
-      <Name lang="nl">Neuronale ceroïdlipofuscinose</Name>
+      <Name lang="nl">Neuronale ceroÃ¯dlipofuscinose</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -51034,7 +51822,7 @@
     <Disorder id="17991">
       <OrphaCode>177107</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=177107</ExpertLink>
-      <Name lang="nl">Syndromale hypothyreoïdie</Name>
+      <Name lang="nl">Syndromale hypothyreoÃ¯die</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -51422,7 +52210,7 @@
     <Disorder id="18015">
       <OrphaCode>178333</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=178333</ExpertLink>
-      <Name lang="nl">Åland eiland-oogziekte</Name>
+      <Name lang="nl">Ãland eiland-oogziekte</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -51471,7 +52259,7 @@
     <Disorder id="671">
       <OrphaCode>760</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=760</ExpertLink>
-      <Name lang="nl">Deficiëntie van purinenucleosidefosforylase</Name>
+      <Name lang="nl">DeficiÃ«ntie van purinenucleosidefosforylase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -53059,7 +53847,7 @@
     <Disorder id="747">
       <OrphaCode>375</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=375</ExpertLink>
-      <Name lang="nl">Antiglomerulair basaal membraanziekte</Name>
+      <Name lang="nl">Antiglomerulaire-basaalmembraanziekte</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -54833,7 +55621,7 @@
     <Disorder id="739">
       <OrphaCode>713</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=713</ExpertLink>
-      <Name lang="nl">Glycogeenstapelingsziekte als gevolg van fosfoglyceraatkinase 1-deficiëntie</Name>
+      <Name lang="nl">Glycogeenstapelingsziekte als gevolg van fosfoglyceraatkinase 1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -54914,7 +55702,7 @@
     <Disorder id="738">
       <OrphaCode>57</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=57</ExpertLink>
-      <Name lang="nl">Glycogeenstapelingsziekte door aldolase A-deficiëntie</Name>
+      <Name lang="nl">Glycogeenstapelingsziekte door aldolase A-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -55039,10 +55827,59 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="741">
+      <OrphaCode>755</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=755</ExpertLink>
+      <Name lang="nl">Hypoplasie van Leydigcellen</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17759">
+          <Source>39162678[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>70.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17760">
+          <Source>39162678[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="17957">
       <OrphaCode>171929</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=171929</ExpertLink>
-      <Name lang="nl">Trisomie 10p</Name>
+      <Name lang="nl">Trisomie 10p-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -55123,7 +55960,7 @@
     <Disorder id="763">
       <OrphaCode>46</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=46</ExpertLink>
-      <Name lang="nl">Deficiëntie van adenylosuccinaatlyase</Name>
+      <Name lang="nl">DeficiÃ«ntie van adenylosuccinaatlyase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -55172,7 +56009,7 @@
     <Disorder id="760">
       <OrphaCode>442</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=442</ExpertLink>
-      <Name lang="nl">Congenitale hypothyreoïdie</Name>
+      <Name lang="nl">Congenitale hypothyreoÃ¯die</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -58015,7 +58852,7 @@
     <Disorder id="713">
       <OrphaCode>134</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=134</ExpertLink>
-      <Name lang="nl">Bèta-ketothiolasedeficiëntie</Name>
+      <Name lang="nl">BÃ¨ta-ketothiolasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -58204,7 +59041,7 @@
     <Disorder id="17931">
       <OrphaCode>171706</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=171706</ExpertLink>
-      <Name lang="nl">Kleine gestalte - vertraagde botleeftijd door deficiëntie in schildklierhormoonmetabolisme</Name>
+      <Name lang="nl">Kleine gestalte - vertraagde botleeftijd door deficiÃ«ntie in schildklierhormoonmetabolisme</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -58236,7 +59073,7 @@
     <Disorder id="17934">
       <OrphaCode>171719</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=171719</ExpertLink>
-      <Name lang="nl">Cutis laxa - marfanoïd-syndroom</Name>
+      <Name lang="nl">Cutis laxa - marfanoÃ¯d-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -58385,7 +59222,7 @@
     <Disorder id="17923">
       <OrphaCode>171673</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=171673</ExpertLink>
-      <Name lang="nl">Limbale stamceldeficiëntie</Name>
+      <Name lang="nl">Limbale stamceldeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -58726,7 +59563,7 @@
     <Disorder id="711">
       <OrphaCode>32</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=32</ExpertLink>
-      <Name lang="nl">Deficiëntie van glutathionsynthetase</Name>
+      <Name lang="nl">DeficiÃ«ntie van glutathionsynthetase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -59562,7 +60399,7 @@
     <Disorder id="735">
       <OrphaCode>797</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=797</ExpertLink>
-      <Name lang="nl">Sarcoïdose</Name>
+      <Name lang="nl">SarcoÃ¯dose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -60268,7 +61105,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="1846">
-          <Source>Haute Autorité de Santé 2009[INST]_ORPHANET_16821272[PMID]</Source>
+          <Source>Haute AutoritÃ© de SantÃ© 2009[INST]_ORPHANET_16821272[PMID]</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -62609,7 +63446,7 @@
     <Disorder id="18421">
       <OrphaCode>200418</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=200418</ExpertLink>
-      <Name lang="nl">Immuundeficiëntie met factor I-anomalie</Name>
+      <Name lang="nl">ImmuundeficiÃ«ntie met factor I-anomalie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -63154,7 +63991,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="2194">
           <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
@@ -63174,12 +64011,31 @@
             <Name lang="nl">Not yet validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17824">
+          <Source>39144879[PMID]_23225563[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>3.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25965">
+            <Name lang="nl">Not yet validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="829">
       <OrphaCode>330</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=330</ExpertLink>
-      <Name lang="nl">Congenitale factor XII-deficiëntie</Name>
+      <Name lang="nl">Congenitale factor XII-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -63208,6 +64064,57 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="828">
+      <OrphaCode>1482</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1482</ExpertLink>
+      <Name lang="nl">Gonokokken-conjunctivitis</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17769">
+          <Source>31855399[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>30.0</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18070">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="831">
       <OrphaCode>1959</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1959</ExpertLink>
@@ -63577,6 +64484,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="18405">
+      <OrphaCode>199340</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=199340</ExpertLink>
+      <Name lang="nl">Spierdystrofie, Selcen-type</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="8622">
+          <Source>22734908[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>12.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="8623">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="804">
       <OrphaCode>293</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=293</ExpertLink>
@@ -63647,59 +64603,10 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="18405">
-      <OrphaCode>199340</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=199340</ExpertLink>
-      <Name lang="nl">Spierdystrofie, Selcen-type</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="8622">
-          <Source>22734908[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Geval(len)/Gezinnen</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Geval(len)</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>12.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8623">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="18404">
       <OrphaCode>199337</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=199337</ExpertLink>
-      <Name lang="nl">Pancreasinsufficiëntie - anemie - hyperostose-syndroom</Name>
+      <Name lang="nl">PancreasinsufficiÃ«ntie - anemie - hyperostose-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -64322,7 +65229,7 @@
     <Disorder id="18401">
       <OrphaCode>199326</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=199326</ExpertLink>
-      <Name lang="nl">Geïsoleerde autosomaal dominante hypomagnesiëmie, Glaudemans-type</Name>
+      <Name lang="nl">GeÃ¯soleerde autosomaal dominante hypomagnesiÃ«mie, Glaudemans-type</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -65765,7 +66672,7 @@
     <Disorder id="18389">
       <OrphaCode>199285</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=199285</ExpertLink>
-      <Name lang="nl">Hereditaire hypercarotenemie en vitamine A-deficiëntie</Name>
+      <Name lang="nl">Hereditaire hypercarotenemie en vitamine A-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -65829,7 +66736,7 @@
     <Disorder id="787">
       <OrphaCode>2102</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2102</ExpertLink>
-      <Name lang="nl">GTP-cyclohydrolase I-deficiëntie</Name>
+      <Name lang="nl">GTP-cyclohydrolase I-deficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -66129,9 +67036,28 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="8612">
-          <Source>25077648[PMID]_[EXPERT]</Source>
+      <PrevalenceList count="4">
+        <Prevalence id="8613">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17736">
+          <Source>25077648[PMID]_26963284[PMID]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
           </PrevalenceType>
@@ -66139,7 +67065,7 @@
             <Name lang="nl">Geval(len)</Name>
           </PrevalenceQualification>
           <PrevalenceClass/>
-          <ValMoy>246.0</ValMoy>
+          <ValMoy>264.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -66147,20 +67073,39 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="8613">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
+        <Prevalence id="17737">
+          <Source>29691480[PMID]</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
+          <ValMoy>0.018</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17738">
+          <Source>32778765[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.04</ValMoy>
+          <PrevalenceGeographic id="25006">
+            <Name lang="nl">Norway</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
@@ -66301,7 +67246,7 @@
     <Disorder id="18394">
       <OrphaCode>199302</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=199302</ExpertLink>
-      <Name lang="nl">Geïsoleerde gespleten lip</Name>
+      <Name lang="nl">GeÃ¯soleerde gespleten lip</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -66613,7 +67558,7 @@
     <Disorder id="774">
       <OrphaCode>1675</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1675</ExpertLink>
-      <Name lang="nl">Deficiëntie van dihydropyrimidine-dehydrogenase</Name>
+      <Name lang="nl">DeficiÃ«ntie van dihydropyrimidine-dehydrogenase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -66677,7 +67622,7 @@
     <Disorder id="775">
       <OrphaCode>976</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=976</ExpertLink>
-      <Name lang="nl">Adeninefosforibosyltransferasedeficiëntie</Name>
+      <Name lang="nl">AdeninefosforibosyltransferasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -66855,7 +67800,7 @@
     <Disorder id="770">
       <OrphaCode>415</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=415</ExpertLink>
-      <Name lang="nl">Hyperornithinemie - hyperammoniëmie - homocitrullinurie-syndroom</Name>
+      <Name lang="nl">Hyperornithinemie - hyperammoniÃ«mie - homocitrullinurie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -66942,7 +67887,7 @@
     <Disorder id="771">
       <OrphaCode>13</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=13</ExpertLink>
-      <Name lang="nl">Deficiëntie van 6-pyruvoyl-tetrahydropterinesynthase</Name>
+      <Name lang="nl">DeficiÃ«ntie van 6-pyruvoyl-tetrahydropterinesynthase</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -67050,7 +67995,7 @@
     <Disorder id="782">
       <OrphaCode>2494</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2494</ExpertLink>
-      <Name lang="nl">Ziekte van Ménétrier</Name>
+      <Name lang="nl">Ziekte van MÃ©nÃ©trier</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -67437,7 +68382,7 @@
     <Disorder id="18381">
       <OrphaCode>199247</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=199247</ExpertLink>
-      <Name lang="nl">Deficiëntie van corticosteroïdbindend globuline</Name>
+      <Name lang="nl">DeficiÃ«ntie van corticosteroÃ¯dbindend globuline</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -68522,209 +69467,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="894">
-      <OrphaCode>3451</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3451</ExpertLink>
-      <Name lang="nl">Infantiele epileptische spasmen-syndroom</Name>
-      <DisorderType id="21422">
-        <Name lang="nl">Klinisch syndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="10">
-        <Prevalence id="2478">
-          <Source>European Medicines Agency 2017[INST]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>6.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2479">
-          <Source>ORPHANET_11701251[PMID]_8082625[PMID]_7555969[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>3.5</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2480">
-          <Source>[EXPERT]_ORPHANET</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>3.7</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2481">
-          <Source>11701251[PMID]_8082625[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>2.5</ValMoy>
-          <PrevalenceGeographic id="24362">
-            <Name lang="nl">Finland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2482">
-          <Source>11701251[PMID]_8082625[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>2.5</ValMoy>
-          <PrevalenceGeographic id="24551">
-            <Name lang="nl">Iceland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2483">
-          <Source>7555969[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>4.5</ValMoy>
-          <PrevalenceGeographic id="25335">
-            <Name lang="nl">Sweden</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2484">
-          <Source>10368073[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>2.9</ValMoy>
-          <PrevalenceGeographic id="25482">
-            <Name lang="nl">United States</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2485">
-          <Source>11701260[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>31.0</ValMoy>
-          <PrevalenceGeographic id="25244">
-            <Name lang="nl">Singapore</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2486">
-          <Source>11701256[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>25.0</ValMoy>
-          <PrevalenceGeographic id="24670">
-            <Name lang="nl">Korea, Republic of</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2487">
-          <Source>11701258[PMID]_17633081[PMID]_ORPHANET</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>3.25</ValMoy>
-          <PrevalenceGeographic id="24621">
-            <Name lang="nl">Japan</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="864">
       <OrphaCode>3299</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3299</ExpertLink>
@@ -69229,7 +69971,7 @@
     <Disorder id="866">
       <OrphaCode>770</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=770</ExpertLink>
-      <Name lang="nl">Rabiës</Name>
+      <Name lang="nl">RabiÃ«s</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -69521,7 +70263,7 @@
     <Disorder id="870">
       <OrphaCode>267</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=267</ExpertLink>
-      <Name lang="nl">Calpaïne-3-gerelateerde limb-girdle-spierdystrofie R1</Name>
+      <Name lang="nl">CalpaÃ¯ne-3-gerelateerde limb-girdle-spierdystrofie R1</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -73279,6 +74021,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="857">
+      <OrphaCode>2587</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2587</ExpertLink>
+      <Name lang="nl">DeficiÃ«ntie van myeloperoxidase</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17793">
+          <Source>29262241[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>18.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17794">
+          <Source>29262241[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="863">
       <OrphaCode>3389</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3389</ExpertLink>
@@ -74624,7 +75415,7 @@
     <Disorder id="834">
       <OrphaCode>2103</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2103</ExpertLink>
-      <Name lang="nl">Syndroom van Guillain-Barré</Name>
+      <Name lang="nl">Syndroom van Guillain-BarrÃ©</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -75019,10 +75810,42 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="838">
+      <OrphaCode>2312</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2312</ExpertLink>
+      <Name lang="nl">Voorbijgaande familiale neonatale hyperbilirubinemie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17778">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23781">
+            <Name lang="nl">Nog niet gedocumenteerd</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="18311">
       <OrphaCode>183707</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=183707</ExpertLink>
-      <Name lang="nl">Infantiele LAD-achtige ziekte door RAC2-deficiëntie</Name>
+      <Name lang="nl">Infantiele LAD-achtige ziekte door RAC2-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -75071,7 +75894,7 @@
     <Disorder id="839">
       <OrphaCode>2314</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2314</ExpertLink>
-      <Name lang="nl">Autosomaal dominant hyper-IgE-syndroom door STAT3-deficiëntie</Name>
+      <Name lang="nl">Autosomaal dominant hyper-IgE-syndroom door STAT3-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -75122,7 +75945,7 @@
     <Disorder id="18309">
       <OrphaCode>183678</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=183678</ExpertLink>
-      <Name lang="nl">Syndroom van Hermansky-Pudlak door deficiëntie van AP-3</Name>
+      <Name lang="nl">Syndroom van Hermansky-Pudlak door deficiÃ«ntie van AP-3</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -75621,7 +76444,7 @@
     <Disorder id="18308">
       <OrphaCode>183675</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=183675</ExpertLink>
-      <Name lang="nl">Recidiverende infecties geassocieerd met zeldzame deficiëntie van immunoglobuline-isotypes</Name>
+      <Name lang="nl">Recidiverende infecties geassocieerd met zeldzame deficiÃ«ntie van immunoglobuline-isotypes</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -76398,27 +77221,29 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="18313">
-      <OrphaCode>183713</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=183713</ExpertLink>
-      <Name lang="nl">Vatbaarheid voor bacteriële infectie door deficiëntie van TLR-signaalweg</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+    <Disorder id="840">
+      <OrphaCode>2372</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2372</ExpertLink>
+      <Name lang="nl">Laryngocele</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
-        <Prevalence id="8599">
-          <Source>[EXPERT]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Geval(len)/Gezinnen</Name>
+        <Prevalence id="18063">
+          <Source>32487170[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
           </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Geval(len)</Name>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>24.0</ValMoy>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.4</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -76426,7 +77251,7 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="8600">
+        <Prevalence id="18064">
           <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
@@ -76450,14 +77275,14 @@
     <Disorder id="841">
       <OrphaCode>2380</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2380</ExpertLink>
-      <Name lang="nl">Ziekte van Legg-Calvé-Perthes</Name>
+      <Name lang="nl">Ziekte van Legg-CalvÃ©-Perthes</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="2251">
           <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
@@ -76477,6 +77302,25 @@
             <Name lang="nl">Not yet validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="18090">
+          <Source>22223709[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>2.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="846">
@@ -76943,7 +77787,7 @@
     <Disorder id="18303">
       <OrphaCode>183660</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=183660</ExpertLink>
-      <Name lang="nl">Ernstige gecombineerde immuundeficiëntie</Name>
+      <Name lang="nl">Ernstige gecombineerde immuundeficiÃ«ntie</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -77136,7 +77980,7 @@
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="2544">
-          <Source>Dr Véronique PINGAULT[EXPERT]</Source>
+          <Source>Dr VÃ©ronique PINGAULT[EXPERT]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
           </PrevalenceType>
@@ -77241,55 +78085,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="950">
-      <OrphaCode>844</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=844</ExpertLink>
-      <Name lang="nl">Syndroom van Lown-Ganong-Levine</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="2540">
-          <Source>836114[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Geval(len)/Gezinnen</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Geval(len)</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>12.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="2541">
-          <Source>ORPHANET_836114[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="946">
       <OrphaCode>3027</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3027</ExpertLink>
@@ -77693,7 +78488,7 @@
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="2525">
-          <Source>27616609[PMID]</Source>
+          <Source>27616609[PMID]_ORPHANET</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
           </PrevalenceType>
@@ -77701,7 +78496,7 @@
             <Name lang="nl">Geval(len)</Name>
           </PrevalenceQualification>
           <PrevalenceClass/>
-          <ValMoy>196.0</ValMoy>
+          <ValMoy>424.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -77765,7 +78560,7 @@
     <Disorder id="926">
       <OrphaCode>326</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=326</ExpertLink>
-      <Name lang="nl">Congenitale factor V-deficiëntie</Name>
+      <Name lang="nl">Congenitale factor V-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -77846,7 +78641,7 @@
     <Disorder id="924">
       <OrphaCode>650</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=650</ExpertLink>
-      <Name lang="nl">LCAT-deficiëntie</Name>
+      <Name lang="nl">LCAT-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -78086,7 +78881,7 @@
     <Disorder id="921">
       <OrphaCode>180</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=180</ExpertLink>
-      <Name lang="nl">Choroïderemie</Name>
+      <Name lang="nl">ChoroÃ¯deremie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -78239,7 +79034,7 @@
     <Disorder id="916">
       <OrphaCode>327</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=327</ExpertLink>
-      <Name lang="nl">Congenitale factor VII-deficiëntie</Name>
+      <Name lang="nl">Congenitale factor VII-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -78586,7 +79381,7 @@
     <Disorder id="901">
       <OrphaCode>157</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=157</ExpertLink>
-      <Name lang="nl">Deficiëntie van carnitinepalmitoyltransferase II</Name>
+      <Name lang="nl">DeficiÃ«ntie van carnitinepalmitoyltransferase II</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -78771,7 +79566,7 @@
     <Disorder id="18232">
       <OrphaCode>183435</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=183435</ExpertLink>
-      <Name lang="nl">Overgeërfde ichthyosis</Name>
+      <Name lang="nl">OvergeÃ«rfde ichthyosis</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -79011,7 +79806,7 @@
     <Disorder id="1009">
       <OrphaCode>113</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=113</ExpertLink>
-      <Name lang="nl">Syndroom van Bazex-Dupré-Christol</Name>
+      <Name lang="nl">Syndroom van Bazex-DuprÃ©-Christol</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -79550,7 +80345,7 @@
     <Disorder id="993">
       <OrphaCode>275</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=275</ExpertLink>
-      <Name lang="nl">Ernstige gecombineerde immuundeficiëntie door DCLRE1C-deficiëntie</Name>
+      <Name lang="nl">Ernstige gecombineerde immuundeficiÃ«ntie door DCLRE1C-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -79582,7 +80377,7 @@
     <Disorder id="18210">
       <OrphaCode>182090</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=182090</ExpertLink>
-      <Name lang="nl">Pulmonale arteriële hypertensie</Name>
+      <Name lang="nl">Pulmonale arteriÃ«le hypertensie</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -79823,7 +80618,7 @@
     <Disorder id="18211">
       <OrphaCode>182095</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=182095</ExpertLink>
-      <Name lang="nl">Interstitiële longziekte</Name>
+      <Name lang="nl">InterstitiÃ«le longziekte</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -80169,7 +80964,7 @@
     <Disorder id="990">
       <OrphaCode>1949</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1949</ExpertLink>
-      <Name lang="nl">Goedaardige familiale neonatale epilepsie</Name>
+      <Name lang="nl">Zelflimiterende neonatale epilepsie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -80250,7 +81045,7 @@
     <Disorder id="988">
       <OrphaCode>1473</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1473</ExpertLink>
-      <Name lang="nl">Uveaal coloboom - gespleten lip en verhemelte - intellectuele achterstand</Name>
+      <Name lang="nl">Coloboom van uvea - gespleten lip en gehemelte - intellectuele achterstand</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -80853,7 +81648,7 @@
     <Disorder id="1096">
       <OrphaCode>1597</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1597</ExpertLink>
-      <Name lang="nl">Distale deletie 17q</Name>
+      <Name lang="nl">Distale deletie 17q-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -80885,7 +81680,7 @@
     <Disorder id="1092">
       <OrphaCode>1590</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1590</ExpertLink>
-      <Name lang="nl">Distale deletie 13q</Name>
+      <Name lang="nl">Distale deletie 13q-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -80934,7 +81729,7 @@
     <Disorder id="1090">
       <OrphaCode>1587</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1587</ExpertLink>
-      <Name lang="nl">Monosomie 13q14</Name>
+      <Name lang="nl">Monosomie 13q14-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -81034,7 +81829,7 @@
     <Disorder id="1114">
       <OrphaCode>1620</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1620</ExpertLink>
-      <Name lang="nl">Distale deletie 3p</Name>
+      <Name lang="nl">Distale deletie 3p-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -81080,10 +81875,59 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="1132">
+      <OrphaCode>1643</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1643</ExpertLink>
+      <Name lang="nl">Xp22.3-microdeletiesyndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17775">
+          <Source>12657015[PMID]_32670353[PMID]_1519653[PMID]_17591464[PMID]_18925676[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>6.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17776">
+          <Source>12657015[PMID]_32670353[PMID]_1519653[PMID]_17591464[PMID]_18925676[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="1121">
       <OrphaCode>1627</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1627</ExpertLink>
-      <Name lang="nl">Deletie 5q35</Name>
+      <Name lang="nl">Deletie 5q35-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -81132,7 +81976,7 @@
     <Disorder id="1150">
       <OrphaCode>1699</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1699</ExpertLink>
-      <Name lang="nl">Trisomie 12p</Name>
+      <Name lang="nl">Trisomie 12p-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -81197,6 +82041,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="1149">
+      <OrphaCode>1695</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1695</ExpertLink>
+      <Name lang="nl">Niet-distale duplicatie 10q-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17779">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23781">
+            <Name lang="nl">Nog niet gedocumenteerd</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="1032">
       <OrphaCode>500</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=500</ExpertLink>
@@ -81383,7 +82259,7 @@
     <Disorder id="1025">
       <OrphaCode>657</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=657</ExpertLink>
-      <Name lang="nl">Congenitaal geïsoleerd hyperinsulinisme</Name>
+      <Name lang="nl">Congenitaal geÃ¯soleerd hyperinsulinisme</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -82708,7 +83584,7 @@
     <Disorder id="1043">
       <OrphaCode>240</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=240</ExpertLink>
-      <Name lang="nl">Dyschondrosteose van Léri-Weill</Name>
+      <Name lang="nl">Dyschondrosteose van LÃ©ri-Weill</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -84292,10 +85168,42 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="1086">
+      <OrphaCode>1581</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1581</ExpertLink>
+      <Name lang="nl">Niet-distale deletie 10q-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17770">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23781">
+            <Name lang="nl">Nog niet gedocumenteerd</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="1085">
       <OrphaCode>1580</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1580</ExpertLink>
-      <Name lang="nl">Distale deletie 10p</Name>
+      <Name lang="nl">Distale deletie 10p-syndroom</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -84655,7 +85563,7 @@
     <Disorder id="1231">
       <OrphaCode>3375</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3375</ExpertLink>
-      <Name lang="nl">Trisomie X</Name>
+      <Name lang="nl">Trisomie X-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -84687,7 +85595,7 @@
     <Disorder id="1230">
       <OrphaCode>3310</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3310</ExpertLink>
-      <Name lang="nl">Tetrasomie 9p</Name>
+      <Name lang="nl">Tetrasomie 9p-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -84765,6 +85673,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="1227">
+      <OrphaCode>3305</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3305</ExpertLink>
+      <Name lang="nl">TetraploÃ¯diesyndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17786">
+          <Source>26789424[PMID]_37981762[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>12.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17787">
+          <Source>26789424[PMID]_37981762[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="1226">
       <OrphaCode>3176</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3176</ExpertLink>
@@ -84819,7 +85776,7 @@
     <Disorder id="1236">
       <OrphaCode>1708</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1708</ExpertLink>
-      <Name lang="nl">Mozaïektrisomie 16</Name>
+      <Name lang="nl">MozaÃ¯ektrisomie 16-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -84868,7 +85825,7 @@
     <Disorder id="1237">
       <OrphaCode>1711</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1711</ExpertLink>
-      <Name lang="nl">Mozaïektrisomie 17</Name>
+      <Name lang="nl">MozaÃ¯ektrisomie 17-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -84917,7 +85874,7 @@
     <Disorder id="1232">
       <OrphaCode>3376</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3376</ExpertLink>
-      <Name lang="nl">Triploïdie</Name>
+      <Name lang="nl">TriploÃ¯diesyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -84968,7 +85925,7 @@
     <Disorder id="1233">
       <OrphaCode>1692</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1692</ExpertLink>
-      <Name lang="nl">Mozaïektrisomie 1</Name>
+      <Name lang="nl">MozaÃ¯ektrisomie 1-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -85017,7 +85974,7 @@
     <Disorder id="1234">
       <OrphaCode>1698</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1698</ExpertLink>
-      <Name lang="nl">Mozaïektrisomie 12</Name>
+      <Name lang="nl">MozaÃ¯ektrisomie 12-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -85049,7 +86006,7 @@
     <Disorder id="1235">
       <OrphaCode>1706</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1706</ExpertLink>
-      <Name lang="nl">Mozaïektrisomie 15</Name>
+      <Name lang="nl">MozaÃ¯ektrisomie 15-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -85260,7 +86217,7 @@
     <Disorder id="1255">
       <OrphaCode>931</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=931</ExpertLink>
-      <Name lang="nl">Geïsoleerde acheiropodie</Name>
+      <Name lang="nl">GeÃ¯soleerde acheiropodie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -85671,7 +86628,7 @@
     <Disorder id="1258">
       <OrphaCode>935</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=935</ExpertLink>
-      <Name lang="nl">Skeletdysplasie met korte ledematen en met ernstige gecombineerde immuundeficiëntie</Name>
+      <Name lang="nl">Skeletdysplasie met korte ledematen en met ernstige gecombineerde immuundeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -86166,6 +87123,153 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="1153">
+      <OrphaCode>1702</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1702</ExpertLink>
+      <Name lang="nl">Niet-distale duplicatie 13q-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17780">
+          <Source>10674161[PMID]_10674161[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>2.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17781">
+          <Source>10674161[PMID]_10674161[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="1154">
+      <OrphaCode>1703</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1703</ExpertLink>
+      <Name lang="nl">MozaÃ¯ektrisomie 14-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17755">
+          <Source>30181735[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>50.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17756">
+          <Source>30181735[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="1156">
+      <OrphaCode>1705</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1705</ExpertLink>
+      <Name lang="nl">Distale duplicatie 14q-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17788">
+          <Source>6500567[PMID]_3612709[PMID]_27590390[PMID]_1524416[PMID]_ 2227953[PMID]_6196971[PMID]_18434272[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>25.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17789">
+          <Source>6500567[PMID]_3612709[PMID]_27590390[PMID]_1524416[PMID]_ 2227953[PMID]_6196971[PMID]_18434272[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="1160">
       <OrphaCode>1713</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1713</ExpertLink>
@@ -86218,7 +87322,7 @@
     <Disorder id="1174">
       <OrphaCode>1738</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1738</ExpertLink>
-      <Name lang="nl">Trisomie 4p</Name>
+      <Name lang="nl">Trisomie 4p-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -86267,7 +87371,7 @@
     <Disorder id="1178">
       <OrphaCode>1742</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1742</ExpertLink>
-      <Name lang="nl">Trisomie 5p</Name>
+      <Name lang="nl">Trisomie 5p-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -86316,7 +87420,7 @@
     <Disorder id="1181">
       <OrphaCode>1745</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1745</ExpertLink>
-      <Name lang="nl">Distale duplicatie 6p</Name>
+      <Name lang="nl">Distale duplicatie 6p-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -86365,7 +87469,7 @@
     <Disorder id="1186">
       <OrphaCode>1752</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1752</ExpertLink>
-      <Name lang="nl">Trisomie 8q</Name>
+      <Name lang="nl">Trisomie 8q-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -86646,7 +87750,7 @@
     <Disorder id="1201">
       <OrphaCode>1951</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1951</ExpertLink>
-      <Name lang="nl">Epilepsie - teleangiëctasie-syndroom</Name>
+      <Name lang="nl">Epilepsie - teleangiÃ«ctasie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -86776,7 +87880,7 @@
     <Disorder id="1215">
       <OrphaCode>156</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=156</ExpertLink>
-      <Name lang="nl">Carnitinepalmitoyltransferase 1A-deficiëntie</Name>
+      <Name lang="nl">Carnitinepalmitoyltransferase 1A-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -87429,10 +88533,59 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="1353">
+      <OrphaCode>1055</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1055</ExpertLink>
+      <Name lang="nl">Congenitaal linkerventrikelaneurysma</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17881">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17882">
+          <Source>25782048[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>809.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="1351">
       <OrphaCode>1052</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1052</ExpertLink>
-      <Name lang="nl">Variabele aneuploïdie-mozaïek-syndroom</Name>
+      <Name lang="nl">Variabele aneuploÃ¯die-mozaÃ¯ek-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -87806,7 +88959,7 @@
     <Disorder id="1401">
       <OrphaCode>1121</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1121</ExpertLink>
-      <Name lang="nl">Radiale deficiëntie - tibiale hypoplasie-syndroom</Name>
+      <Name lang="nl">Radiale deficiÃ«ntie - tibiale hypoplasie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -87838,7 +88991,7 @@
     <Disorder id="1400">
       <OrphaCode>1120</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1120</ExpertLink>
-      <Name lang="nl">Longagenesie - hartdefect - duimanomalieën-syndroom</Name>
+      <Name lang="nl">Longagenesie - hartdefect - duimanomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -87936,7 +89089,7 @@
     <Disorder id="1397">
       <OrphaCode>1116</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1116</ExpertLink>
-      <Name lang="nl">Aplasia cutis congenita - intestinale lymfangiëctasie-syndroom</Name>
+      <Name lang="nl">Aplasia cutis congenita - intestinale lymfangiÃ«ctasie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -88230,7 +89383,7 @@
     <Disorder id="1388">
       <OrphaCode>1106</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1106</ExpertLink>
-      <Name lang="nl">Microftalmie met ledemaatanomalieën</Name>
+      <Name lang="nl">Microftalmie met ledemaatanomalieÃ«n</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -88590,7 +89743,7 @@
     <Disorder id="1309">
       <OrphaCode>51</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=51</ExpertLink>
-      <Name lang="nl">Syndroom van Aicardi-Goutières</Name>
+      <Name lang="nl">Syndroom van Aicardi-GoutiÃ¨res</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -88785,6 +89938,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="1303">
+      <OrphaCode>988</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=988</ExpertLink>
+      <Name lang="nl">Hemimelie van tibia - polysyndactylie - trifalangeale duim-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17784">
+          <Source>10869115[PMID]_2333896[PMID]_39273297[PMID]_24965254[PMID]_24478176[PMID]_24777739[PMID]_2837505[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>94.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17785">
+          <Source>10869115[PMID]_2333896[PMID]_39273297[PMID]_24965254[PMID]_24478176[PMID]_24777739[PMID]_2837505[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="1300">
       <OrphaCode>983</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=983</ExpertLink>
@@ -89062,10 +90264,59 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="1292">
+      <OrphaCode>972</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=972</ExpertLink>
+      <Name lang="nl">Erfelijke continue spiervezelactiviteit</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17782">
+          <Source>6703941[PMID]_17136396[PMID]_1170284[PMID]_9528033[PMID]_889293[PMID]_3504247[PMID]_1647493[PMID]_17136396[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>34.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17783">
+          <Source>6703941[PMID]_17136396[PMID]_1170284[PMID]_9528033[PMID]_889293[PMID]_3504247[PMID]_1647493[PMID]_17136396[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="1293">
       <OrphaCode>973</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=973</ExpertLink>
-      <Name lang="nl">Geïsoleerde afwezigheid/hypoplasie van vingers exclusief duim, unilateraal</Name>
+      <Name lang="nl">GeÃ¯soleerde afwezigheid/hypoplasie van vingers exclusief duim, unilateraal</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -89610,7 +90861,7 @@
     <Disorder id="1342">
       <OrphaCode>1035</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1035</ExpertLink>
-      <Name lang="nl">Bèta-mercaptolactaat-cysteïne-disulfidurie</Name>
+      <Name lang="nl">BÃ¨ta-mercaptolactaat-cysteÃ¯ne-disulfidurie</Name>
       <DisorderType id="21408">
         <Name lang="nl">Biologische anomalie</Name>
       </DisorderType>
@@ -89757,7 +91008,7 @@
     <Disorder id="1328">
       <OrphaCode>64</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=64</ExpertLink>
-      <Name lang="nl">Syndroom van Alström</Name>
+      <Name lang="nl">Syndroom van AlstrÃ¶m</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -89919,7 +91170,7 @@
     <Disorder id="16887">
       <OrphaCode>139406</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=139406</ExpertLink>
-      <Name lang="nl">Encefalopathie door deficiëntie van prosaposine</Name>
+      <Name lang="nl">Encefalopathie door deficiÃ«ntie van prosaposine</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -90590,7 +91841,7 @@
     <Disorder id="1500">
       <OrphaCode>1262</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1262</ExpertLink>
-      <Name lang="nl">Syndroom van Böök</Name>
+      <Name lang="nl">Syndroom van BÃ¶Ã¶k</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -90953,11 +92204,11 @@
       <OrphaCode>109</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=109</ExpertLink>
       <Name lang="nl">Syndroom van Bannayan-Riley-Ruvalcaba</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="2984">
@@ -91212,7 +92463,7 @@
     <Disorder id="1480">
       <OrphaCode>1236</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1236</ExpertLink>
-      <Name lang="nl">Ernstige microbrachycefalie - intellectuele achterstand - athetoïde cerebrale parese-syndroom</Name>
+      <Name lang="nl">Ernstige microbrachycefalie - intellectuele achterstand - athetoÃ¯de cerebrale parese-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -91261,7 +92512,7 @@
     <Disorder id="16693">
       <OrphaCode>137622</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=137622</ExpertLink>
-      <Name lang="nl">Refractaire diarree - choane atresie - ooganomalieën-syndroom</Name>
+      <Name lang="nl">Refractaire diarree - choane atresie - ooganomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -91359,7 +92610,7 @@
     <Disorder id="16695">
       <OrphaCode>137628</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=137628</ExpertLink>
-      <Name lang="nl">Hartanomalieën - heterotaxie-syndroom</Name>
+      <Name lang="nl">HartanomalieÃ«n - heterotaxie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -91457,7 +92708,7 @@
     <Disorder id="16694">
       <OrphaCode>137625</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=137625</ExpertLink>
-      <Name lang="nl">Glycogeenstapelingsziekte door deficiëntie van glycogeensynthase in spier en hart</Name>
+      <Name lang="nl">Glycogeenstapelingsziekte door deficiÃ«ntie van glycogeensynthase in spier en hart</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -91605,11 +92856,11 @@
       <OrphaCode>137667</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=137667</ExpertLink>
       <Name lang="nl">Capillaire malformatie-arterioveneuze malformatie</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
+      <DisorderType id="21436">
+        <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36540">
+        <Name lang="nl">Groep van aandoeningen</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="8075">
@@ -91751,7 +93002,7 @@
     <Disorder id="16696">
       <OrphaCode>137631</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=137631</ExpertLink>
-      <Name lang="nl">Longfibrose - immuundeficiëntie - 46,XX gonadale dysgenesie-syndroom</Name>
+      <Name lang="nl">Longfibrose - immuundeficiÃ«ntie - 46,XX gonadale dysgenesie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -92011,7 +93262,7 @@
     <Disorder id="1511">
       <OrphaCode>1276</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1276</ExpertLink>
-      <Name lang="nl">Brachydactylie - arteriële hypertensie-syndroom</Name>
+      <Name lang="nl">Brachydactylie - arteriÃ«le hypertensie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -92475,7 +93726,7 @@
     <Disorder id="16721">
       <OrphaCode>137817</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=137817</ExpertLink>
-      <Name lang="nl">Arachnoïditis</Name>
+      <Name lang="nl">ArachnoÃ¯ditis</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -92803,7 +94054,7 @@
     <Disorder id="1438">
       <OrphaCode>1180</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1180</ExpertLink>
-      <Name lang="nl">Ataxie - hypogonadisme - choroïdale dystrofie-syndroom</Name>
+      <Name lang="nl">Ataxie - hypogonadisme - choroÃ¯dale dystrofie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -92965,7 +94216,7 @@
     <Disorder id="16706">
       <OrphaCode>137681</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=137681</ExpertLink>
-      <Name lang="nl">Hepato-encefalopathie door gecombineerde oxidatieve fosforylatiedeficiëntie type 1</Name>
+      <Name lang="nl">Hepato-encefalopathie door gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 1</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -93063,7 +94314,7 @@
     <Disorder id="16704">
       <OrphaCode>137675</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=137675</ExpertLink>
-      <Name lang="nl">Histiocytoïde cardiomyopathie</Name>
+      <Name lang="nl">HistiocytoÃ¯de cardiomyopathie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -93210,7 +94461,7 @@
     <Disorder id="16710">
       <OrphaCode>137698</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=137698</ExpertLink>
-      <Name lang="nl">Cytomegalovirusziekte met risico voor patiënten met verminderde celgemedieerde immuniteit</Name>
+      <Name lang="nl">Cytomegalovirusziekte met risico voor patiÃ«nten met verminderde celgemedieerde immuniteit</Name>
       <DisorderType id="21429">
         <Name lang="nl">Particulaire klinische situatie binnen een ziekte of syndroom</Name>
       </DisorderType>
@@ -93242,7 +94493,7 @@
     <Disorder id="16711">
       <OrphaCode>137754</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=137754</ExpertLink>
-      <Name lang="nl">Deficiëntie van aminoacylase 1</Name>
+      <Name lang="nl">DeficiÃ«ntie van aminoacylase 1</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -93568,7 +94819,7 @@
     <Disorder id="16718">
       <OrphaCode>137807</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=137807</ExpertLink>
-      <Name lang="nl">Primaire cutane amyloïdose</Name>
+      <Name lang="nl">Primaire cutane amyloÃ¯dose</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -93619,7 +94870,7 @@
     <Disorder id="1423">
       <OrphaCode>1159</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1159</ExpertLink>
-      <Name lang="nl">Progressieve pseudoreumatoïde artropathie op kinderleeftijd</Name>
+      <Name lang="nl">Progressieve pseudoreumatoÃ¯de dysplasie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -94454,7 +95705,7 @@
     <Disorder id="16742">
       <OrphaCode>137908</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=137908</ExpertLink>
-      <Name lang="nl">Hypotonie met melkzuuracidemie en hyperammoniëmie</Name>
+      <Name lang="nl">Hypotonie met melkzuuracidemie en hyperammoniÃ«mie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -95997,7 +97248,7 @@
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="3129">
-          <Source>25574826[PMID]_20503327[PMID]</Source>
+          <Source>25574826[PMID]_20503327[PMID]_ORPHANET</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
           </PrevalenceType>
@@ -96005,7 +97256,7 @@
             <Name lang="nl">Geval(len)</Name>
           </PrevalenceQualification>
           <PrevalenceClass/>
-          <ValMoy>12.0</ValMoy>
+          <ValMoy>26.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -96204,6 +97455,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="1634">
+      <OrphaCode>1429</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1429</ExpertLink>
+      <Name lang="nl">Goedaardige erfelijke chorea</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17766">
+          <Source>26196025[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.02</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="1632">
       <OrphaCode>1426</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1426</ExpertLink>
@@ -96288,7 +97571,7 @@
     <Disorder id="1633">
       <OrphaCode>1427</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1427</ExpertLink>
-      <Name lang="nl">Otospondylomega-epifysaire dysplasie</Name>
+      <Name lang="nl">Autosomaal recessieve otospondylomega-epifysaire dysplasie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -96435,7 +97718,7 @@
     <Disorder id="1637">
       <OrphaCode>1433</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1433</ExpertLink>
-      <Name lang="nl">Choroïdale atrofie - alopecie-syndroom</Name>
+      <Name lang="nl">ChoroÃ¯dale atrofie - alopecie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -97236,7 +98519,7 @@
     <Disorder id="1605">
       <OrphaCode>1398</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1398</ExpertLink>
-      <Name lang="nl">Geïsoleerde cerebellaire agenesie</Name>
+      <Name lang="nl">GeÃ¯soleerde cerebellaire agenesie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -97383,7 +98666,7 @@
     <Disorder id="17048">
       <OrphaCode>141152</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=141152</ExpertLink>
-      <Name lang="nl">Geïsoleerde congenitale hypoglossie/aglossie</Name>
+      <Name lang="nl">GeÃ¯soleerde congenitale hypoglossie/aglossie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -98113,7 +99396,7 @@
     <Disorder id="1569">
       <OrphaCode>1361</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1361</ExpertLink>
-      <Name lang="nl">Carnosinasedeficiëntie</Name>
+      <Name lang="nl">CarnosinasedeficiÃ«ntie</Name>
       <DisorderType id="21408">
         <Name lang="nl">Biologische anomalie</Name>
       </DisorderType>
@@ -98262,7 +99545,7 @@
     <Disorder id="1596">
       <OrphaCode>1390</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1390</ExpertLink>
-      <Name lang="nl">Nachtblindheid - skeletale anomalieën - dysmorfie-syndroom</Name>
+      <Name lang="nl">Nachtblindheid - skeletale anomalieÃ«n - dysmorfie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -98311,7 +99594,7 @@
     <Disorder id="17149">
       <OrphaCode>157820</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=157820</ExpertLink>
-      <Name lang="nl">Koudegeïnduceerd zweten-syndroom</Name>
+      <Name lang="nl">KoudegeÃ¯nduceerd zweten-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -98607,7 +99890,7 @@
     <Disorder id="17144">
       <OrphaCode>157791</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=157791</ExpertLink>
-      <Name lang="nl">Epithelioïd hemangio-endothelioom</Name>
+      <Name lang="nl">EpithelioÃ¯d hemangio-endothelioom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -99011,6 +100294,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="1544">
+      <OrphaCode>1321</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1321</ExpertLink>
+      <Name lang="nl">Camptodactylie - hyperplasie van fibreus weefsel - skeletanomalieÃ«n-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17767">
+          <Source>5046631[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>3.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17768">
+          <Source>5046631[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="1546">
       <OrphaCode>1323</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1323</ExpertLink>
@@ -99348,7 +100680,7 @@
     <Disorder id="1537">
       <OrphaCode>1307</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1307</ExpertLink>
-      <Name lang="nl">Distale ledemaatdeficiënties - micrognathie-syndroom</Name>
+      <Name lang="nl">Distale ledemaatdeficiÃ«nties - micrognathie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -99397,7 +100729,7 @@
     <Disorder id="1539">
       <OrphaCode>1313</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1313</ExpertLink>
-      <Name lang="nl">Infantiel choroïdo-cerebrale calcificatie-syndroom</Name>
+      <Name lang="nl">Infantiel choroÃ¯do-cerebrale calcificatie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -99590,6 +100922,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="1561">
+      <OrphaCode>1342</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1342</ExpertLink>
+      <Name lang="nl">Hart-handsyndroom type 3</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17773">
+          <Source>7450756[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>4.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17774">
+          <Source>7450756[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="1563">
       <OrphaCode>1345</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1345</ExpertLink>
@@ -99759,7 +101140,7 @@
     <Disorder id="1553">
       <OrphaCode>2856</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2856</ExpertLink>
-      <Name lang="nl">Persisterende gang van Müller-syndroom</Name>
+      <Name lang="nl">Persisterende gang van MÃ¼ller-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -99910,7 +101291,7 @@
     <Disorder id="1762">
       <OrphaCode>1682</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1682</ExpertLink>
-      <Name lang="nl">Arteriële dissectie - lentiginose-syndroom</Name>
+      <Name lang="nl">ArteriÃ«le dissectie - lentiginose-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -100415,7 +101796,7 @@
     <Disorder id="1789">
       <OrphaCode>1788</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1788</ExpertLink>
-      <Name lang="nl">Acrofaciale dysostose, Rodríguez-type</Name>
+      <Name lang="nl">Acrofaciale dysostose, RodrÃ­guez-type</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -100464,7 +101845,7 @@
     <Disorder id="1729">
       <OrphaCode>859</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=859</ExpertLink>
-      <Name lang="nl">Transcobalaminedeficiëntie</Name>
+      <Name lang="nl">TranscobalaminedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -100522,7 +101903,7 @@
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="8145">
-          <Source>ORPHANET</Source>
+          <Source>39951964[PMID]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
           </PrevalenceType>
@@ -100530,7 +101911,7 @@
             <Name lang="nl">Geval(len)</Name>
           </PrevalenceQualification>
           <PrevalenceClass/>
-          <ValMoy>19.0</ValMoy>
+          <ValMoy>216.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -100562,7 +101943,7 @@
     <Disorder id="1728">
       <OrphaCode>3196</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3196</ExpertLink>
-      <Name lang="nl">Steroïdedehydrogenasedeficiëntie - dentale anomalieën-syndroom</Name>
+      <Name lang="nl">SteroÃ¯dedehydrogenasedeficiÃ«ntie - dentale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -101005,7 +102386,7 @@
     <Disorder id="1737">
       <OrphaCode>1596</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1596</ExpertLink>
-      <Name lang="nl">Distale deletie 15q</Name>
+      <Name lang="nl">Distale deletie 15q-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -101054,7 +102435,7 @@
     <Disorder id="16904">
       <OrphaCode>139471</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=139471</ExpertLink>
-      <Name lang="nl">Microftalmie met anomalieën van hersenen en digitus</Name>
+      <Name lang="nl">Microftalmie met anomalieÃ«n van hersenen en digitus</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -101350,7 +102731,7 @@
     <Disorder id="16908">
       <OrphaCode>139485</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=139485</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve ataxie door ubiquinondeficiëntie</Name>
+      <Name lang="nl">Autosomaal recessieve ataxie door ubiquinondeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -101872,7 +103253,7 @@
     <Disorder id="1750">
       <OrphaCode>1661</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1661</ExpertLink>
-      <Name lang="nl">X-gebonden corneaal dermoïd</Name>
+      <Name lang="nl">X-gebonden corneaal dermoÃ¯d</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -102065,6 +103446,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="1753">
+      <OrphaCode>1665</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1665</ExpertLink>
+      <Name lang="nl">Sporadische foetale hersendisruptiesequentie</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17795">
+          <Source>11760023[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>20.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17796">
+          <Source>11760023[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="16920">
       <OrphaCode>139564</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=139564</ExpertLink>
@@ -102749,7 +104179,7 @@
     <Disorder id="1696">
       <OrphaCode>1532</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1532</ExpertLink>
-      <Name lang="nl">Syndroom van Gómez-López-Hernández</Name>
+      <Name lang="nl">Syndroom van GÃ³mez-LÃ³pez-HernÃ¡ndez</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -103075,7 +104505,7 @@
     <Disorder id="17003">
       <OrphaCode>140941</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=140941</ExpertLink>
-      <Name lang="nl">Kleine gestalte door primaire deficiëntie van zuurlabiele subeenheid</Name>
+      <Name lang="nl">Kleine gestalte door primaire deficiÃ«ntie van zuurlabiele subeenheid</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -103156,7 +104586,7 @@
     <Disorder id="17000">
       <OrphaCode>140927</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=140927</ExpertLink>
-      <Name lang="nl">Goedaardige familiale neonatale-infantiele insulten</Name>
+      <Name lang="nl">Zelflimiterende neonatale-infantiele epilepsie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -103599,7 +105029,7 @@
     <Disorder id="1726">
       <OrphaCode>382</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=382</ExpertLink>
-      <Name lang="nl">Guanidinoacetaat-methyltransferasedeficiëntie</Name>
+      <Name lang="nl">Guanidinoacetaat-methyltransferasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -103648,7 +105078,7 @@
     <Disorder id="1727">
       <OrphaCode>742</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=742</ExpertLink>
-      <Name lang="nl">Prolidasedeficiëntie</Name>
+      <Name lang="nl">ProlidasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -103716,7 +105146,7 @@
     <Disorder id="1725">
       <OrphaCode>1979</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1979</ExpertLink>
-      <Name lang="nl">Lipodystrofie door deficiëntie van peptidische groeifactoren</Name>
+      <Name lang="nl">Lipodystrofie door deficiÃ«ntie van peptidische groeifactoren</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -103863,7 +105293,7 @@
     <Disorder id="1723">
       <OrphaCode>1551</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1551</ExpertLink>
-      <Name lang="nl">Familiale goedaardige koperdeficiëntie</Name>
+      <Name lang="nl">Familiale goedaardige koperdeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -104091,7 +105521,7 @@
     <Disorder id="16962">
       <OrphaCode>140286</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=140286</ExpertLink>
-      <Name lang="nl">Secundaire hypoparathyreoïdie door verminderde parathormoonsecretie</Name>
+      <Name lang="nl">Secundaire hypoparathyreoÃ¯die door verminderde parathormoonsecretie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -104474,7 +105904,7 @@
     <Disorder id="1684">
       <OrphaCode>1517</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1517</ExpertLink>
-      <Name lang="nl">Syndroom van Cantú</Name>
+      <Name lang="nl">Syndroom van CantÃº</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -104800,7 +106230,7 @@
     <Disorder id="1683">
       <OrphaCode>1516</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1516</ExpertLink>
-      <Name lang="nl">Niet-syndromale bilambdoïde en sagittale craniosynostose</Name>
+      <Name lang="nl">Niet-syndromale bilambdoÃ¯de en sagittale craniosynostose</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -105181,7 +106611,7 @@
     <Disorder id="1913">
       <OrphaCode>1969</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1969</ExpertLink>
-      <Name lang="nl">Faciale dysmorfie - anorexie - cachexie - oog- en huidanomalieën-syndroom</Name>
+      <Name lang="nl">Faciale dysmorfie - anorexie - cachexie - oog- en huidanomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -105852,7 +107282,7 @@
     <Disorder id="1889">
       <OrphaCode>2209</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2209</ExpertLink>
-      <Name lang="nl">Maternale fenylketonurie</Name>
+      <Name lang="nl">Maternale fenylketonurie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -106146,7 +107576,7 @@
     <Disorder id="1875">
       <OrphaCode>1912</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1912</ExpertLink>
-      <Name lang="nl">Foetaal hydantoïnesyndroom</Name>
+      <Name lang="nl">Foetaal hydantoÃ¯nesyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -106210,7 +107640,7 @@
     <Disorder id="1873">
       <OrphaCode>1911</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1911</ExpertLink>
-      <Name lang="nl">Cocaïne-embryofoetopathie</Name>
+      <Name lang="nl">CocaÃ¯ne-embryofoetopathie</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -106274,7 +107704,7 @@
     <Disorder id="1879">
       <OrphaCode>1916</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1916</ExpertLink>
-      <Name lang="nl">Diëthylstilbestrolsyndroom</Name>
+      <Name lang="nl">DiÃ«thylstilbestrolsyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -107091,7 +108521,7 @@
     <Disorder id="1850">
       <OrphaCode>1882</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1882</ExpertLink>
-      <Name lang="nl">Hypohidrotische ectodermale dysplasie - hypothyreoïdie - ciliaire dyskinesie-syndroom</Name>
+      <Name lang="nl">Hypohidrotische ectodermale dysplasie - hypothyreoÃ¯die - ciliaire dyskinesie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -108458,6 +109888,57 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2033">
+      <OrphaCode>2128</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2128</ExpertLink>
+      <Name lang="nl">GeÃ¯soleerde hemihyperplasie</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17797">
+          <Source>30645194[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>5.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18071">
+          <Source>30645194[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>5.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2035">
       <OrphaCode>2130</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2130</ExpertLink>
@@ -108610,7 +110091,7 @@
     <Disorder id="2038">
       <OrphaCode>2139</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2139</ExpertLink>
-      <Name lang="nl">Syndroom van Hernández-Aguirre Negrete</Name>
+      <Name lang="nl">Syndroom van HernÃ¡ndez-Aguirre Negrete</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -108642,7 +110123,7 @@
     <Disorder id="2040">
       <OrphaCode>2141</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2141</ExpertLink>
-      <Name lang="nl">Diafragmadefect - ledemaatdeficiëntie - schedeldefect-syndroom</Name>
+      <Name lang="nl">Diafragmadefect - ledemaatdeficiÃ«ntie - schedeldefect-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -109326,7 +110807,7 @@
     <Disorder id="2027">
       <OrphaCode>2994</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2994</ExpertLink>
-      <Name lang="nl">Kleine gestalte - craniofaciale anomalieën - genitale hypoplasie-syndroom</Name>
+      <Name lang="nl">Kleine gestalte - craniofaciale anomalieÃ«n - genitale hypoplasie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -109474,8 +110955,8 @@
       <OrphaCode>2123</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2123</ExpertLink>
       <Name lang="nl">Diffuse neonatale hemangiomatose</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
@@ -109949,11 +111430,11 @@
       <OrphaCode>2095</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2095</ExpertLink>
       <Name lang="nl">Syndroom van Gorlin-Chaudhry-Moss</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="3427">
@@ -109997,7 +111478,7 @@
     <Disorder id="17176">
       <OrphaCode>158014</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=158014</ExpertLink>
-      <Name lang="nl">Ziekte van Rosaï-Dorfman</Name>
+      <Name lang="nl">Ziekte van RosaÃ¯-Dorfman</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -110241,55 +111722,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="17180">
-      <OrphaCode>158029</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=158029</ExpertLink>
-      <Name lang="nl">Sea-blue histiocytose</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="8259">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Geval(len)/Gezinnen</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Geval(len)</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>60.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8260">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="1987">
       <OrphaCode>2069</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2069</ExpertLink>
@@ -112306,7 +113738,7 @@
     <Disorder id="1942">
       <OrphaCode>2006</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2006</ExpertLink>
-      <Name lang="nl">Mediane lip-/mandibulaspleet</Name>
+      <Name lang="nl">Mediane schisis van lip/mandibula</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -113072,6 +114504,57 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="1927">
+      <OrphaCode>1987</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1987</ExpertLink>
+      <Name lang="nl">GeÃ¯soleerde agenesie/hypoplasie van femur</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17792">
+          <Source>26408260[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.6</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18072">
+          <Source>26408260[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.6</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="1926">
       <OrphaCode>1986</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1986</ExpertLink>
@@ -113329,7 +114812,7 @@
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="11832">
-          <Source>25210574[PMID]</Source>
+          <Source>30070764[PMID]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
           </PrevalenceType>
@@ -113337,7 +114820,7 @@
             <Name lang="nl">Geval(len)</Name>
           </PrevalenceQualification>
           <PrevalenceClass/>
-          <ValMoy>62.0</ValMoy>
+          <ValMoy>68.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -113369,7 +114852,7 @@
     <Disorder id="2200">
       <OrphaCode>2348</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2348</ExpertLink>
-      <Name lang="nl">Familiale partiële lipodystrofie, Dunnigan-type</Name>
+      <Name lang="nl">Familiale partiÃ«le lipodystrofie, Dunnigan-type</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -113401,7 +114884,7 @@
     <Disorder id="19545">
       <OrphaCode>247775</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=247775</ExpertLink>
-      <Name lang="nl">Syndroom van Mayer-Rokitansky-Küster-Hauser type 1</Name>
+      <Name lang="nl">Syndroom van Mayer-Rokitansky-KÃ¼ster-Hauser type 1</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -113430,6 +114913,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="19544">
+      <OrphaCode>247768</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=247768</ExpertLink>
+      <Name lang="nl">MÃ¼lleriaanse aplasie en hyperandrogenisme</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="9086">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25965">
+            <Name lang="nl">Not yet validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2201">
       <OrphaCode>2351</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2351</ExpertLink>
@@ -113479,38 +114994,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="19544">
-      <OrphaCode>247768</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=247768</ExpertLink>
-      <Name lang="nl">Mülleriaanse aplasie en hyperandrogenisme</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="9086">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="2202">
       <OrphaCode>2353</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2353</ExpertLink>
@@ -113661,7 +115144,7 @@
     <Disorder id="19551">
       <OrphaCode>247815</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=247815</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve ataxie door PEX10-deficiëntie</Name>
+      <Name lang="nl">Autosomaal recessieve ataxie door PEX10-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -114130,7 +115613,7 @@
     <Disorder id="19529">
       <OrphaCode>247598</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=247598</ExpertLink>
-      <Name lang="nl">Neonatale intrahepatische cholestase door deficiëntie van citrine</Name>
+      <Name lang="nl">Neonatale intrahepatische cholestase door deficiÃ«ntie van citrine</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -115088,7 +116571,7 @@
     <Disorder id="19527">
       <OrphaCode>247582</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=247582</ExpertLink>
-      <Name lang="nl">Citrinedeficiëntie</Name>
+      <Name lang="nl">CitrinedeficiÃ«ntie</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -115739,6 +117222,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2218">
+      <OrphaCode>2387</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2387</ExpertLink>
+      <Name lang="nl">Leukonychia totalis</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17790">
+          <Source>29805369[PMID]_19401242[PMID]_30003652[PMID]_36987828[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>44.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17791">
+          <Source>29805369[PMID]_19401242[PMID]_30003652[PMID]_36987828[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2217">
       <OrphaCode>2386</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2386</ExpertLink>
@@ -115872,7 +117404,7 @@
     <Disorder id="2222">
       <OrphaCode>2391</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2391</ExpertLink>
-      <Name lang="nl">Congenitaal kort costocoracoïd ligament</Name>
+      <Name lang="nl">Congenitaal kort costocoracoÃ¯d ligament</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -116363,6 +117895,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2270">
+      <OrphaCode>2456</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2456</ExpertLink>
+      <Name lang="nl">Familiale surnumeraire tepels</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17813">
+          <Source>9809822[PMID]_1638072[PMID]_28361071[PMID]_20465693[PMID]_8603338[PMID]_11421419[PMID]_12514363[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>46.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17814">
+          <Source>9809822[PMID]_1638072[PMID]_28361071[PMID]_20465693[PMID]_8603338[PMID]_11421419[PMID]_12514363[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2271">
       <OrphaCode>2457</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2457</ExpertLink>
@@ -116577,7 +118158,7 @@
     <Disorder id="2261">
       <OrphaCode>2440</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2440</ExpertLink>
-      <Name lang="nl">Geïsoleerde gespleten hand-gespleten voet malformatie</Name>
+      <Name lang="nl">GeÃ¯soleerde gespleten hand-gespleten voet malformatie</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -116895,10 +118476,59 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2259">
+      <OrphaCode>2438</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2438</ExpertLink>
+      <Name lang="nl">Hand-voet-genitaal syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17771">
+          <Source>29177010[PMID]_33520218[PMID]_29638102[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>33.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17772">
+          <Source>29177010[PMID]_33520218[PMID]_29638102[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="19468">
       <OrphaCode>243343</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=243343</ExpertLink>
-      <Name lang="nl">Deficiëntie van dimethylglycinedehydrogenase</Name>
+      <Name lang="nl">DeficiÃ«ntie van dimethylglycinedehydrogenase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -117730,6 +119360,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2291">
+      <OrphaCode>2479</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2479</ExpertLink>
+      <Name lang="nl">Megalocornea - intellectuele achterstand-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17809">
+          <Source>24032289[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>40.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17810">
+          <Source>24032289[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2288">
       <OrphaCode>2475</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2475</ExpertLink>
@@ -118046,7 +119725,7 @@
     <Disorder id="2278">
       <OrphaCode>2464</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2464</ExpertLink>
-      <Name lang="nl">Marfanoïd syndroom, De Silva-type</Name>
+      <Name lang="nl">MarfanoÃ¯d syndroom, De Silva-type</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -118095,7 +119774,7 @@
     <Disorder id="2277">
       <OrphaCode>559</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=559</ExpertLink>
-      <Name lang="nl">Syndroom van Marinesco-Sjögren</Name>
+      <Name lang="nl">Syndroom van Marinesco-SjÃ¶gren</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -118144,7 +119823,7 @@
     <Disorder id="2276">
       <OrphaCode>2463</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2463</ExpertLink>
-      <Name lang="nl">Marfanoïde habitus - autosomaal recessieve intellectuele achterstand-syndroom</Name>
+      <Name lang="nl">MarfanoÃ¯de habitus - autosomaal recessieve intellectuele achterstand-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -118361,7 +120040,7 @@
     <Disorder id="2065">
       <OrphaCode>2172</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2172</ExpertLink>
-      <Name lang="nl">Microcefalie - glomerulonefritis - marfanoïde habitus-syndroom</Name>
+      <Name lang="nl">Microcefalie - glomerulonefritis - marfanoÃ¯de habitus-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -118490,38 +120169,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="2069">
-      <OrphaCode>2176</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2176</ExpertLink>
-      <Name lang="nl">Infantiele systemische hyalinose</Name>
-      <DisorderType id="21450">
-        <Name lang="nl">Klinisch subtype</Name>
-      </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="nl">Subtype van aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="3473">
-          <Source>ORPHANET_25754064[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="19668">
       <OrphaCode>251643</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251643</ExpertLink>
@@ -118573,6 +120220,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2069">
+      <OrphaCode>2176</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2176</ExpertLink>
+      <Name lang="nl">Infantiele systemische hyalinose</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
+      </DisorderType>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="3473">
+          <Source>ORPHANET_25754064[PMID]</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="19669">
       <OrphaCode>251646</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251646</ExpertLink>
@@ -118922,6 +120601,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="19675">
+      <OrphaCode>251674</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251674</ExpertLink>
+      <Name lang="nl">ChordoÃ¯d glioom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17860">
+          <Source>25648470[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>80.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17861">
+          <Source>25648470[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="19676">
       <OrphaCode>251679</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251679</ExpertLink>
@@ -119065,7 +120793,7 @@
     <Disorder id="2078">
       <OrphaCode>2196</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2196</ExpertLink>
-      <Name lang="nl">Primaire hypomagnesiëmie met hypercalciurie en nefrocalcinose met ernstige oculaire betrokkenheid</Name>
+      <Name lang="nl">Primaire hypomagnesiÃ«mie met hypercalciurie en nefrocalcinose met ernstige oculaire betrokkenheid</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -119859,10 +121587,59 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="19662">
+      <OrphaCode>251623</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251623</ExpertLink>
+      <Name lang="nl">PituÃ¯cytoom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17831">
+          <Source>33971477[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>171.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17832">
+          <Source>33971477[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2063">
       <OrphaCode>2169</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2169</ExpertLink>
-      <Name lang="nl">Methylcobalaminedeficiëntie type cblE</Name>
+      <Name lang="nl">MethylcobalaminedeficiÃ«ntie type cblE</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -120009,7 +121786,7 @@
     <Disorder id="2103">
       <OrphaCode>1051</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1051</ExpertLink>
-      <Name lang="nl">Ramos-Arroyosyndroom</Name>
+      <Name lang="nl">Syndroom van Ramos-Arroyo</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -120136,10 +121913,42 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="19701">
+      <OrphaCode>251937</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251937</ExpertLink>
+      <Name lang="nl">Gangliocytoom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17888">
+          <Source>18798534[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2107">
       <OrphaCode>2232</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2232</ExpertLink>
-      <Name lang="nl">Primair hypergonadotroop hypogonadisme - partiële alopecie-syndroom</Name>
+      <Name lang="nl">Primair hypergonadotroop hypogonadisme - partiÃ«le alopecie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -120188,7 +121997,7 @@
     <Disorder id="2105">
       <OrphaCode>2230</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2230</ExpertLink>
-      <Name lang="nl">Hypogonadotroop hypogonadisme - frontopariëtale alopecie-syndroom</Name>
+      <Name lang="nl">Hypogonadotroop hypogonadisme - frontopariÃ«tale alopecie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -120286,7 +122095,7 @@
     <Disorder id="2111">
       <OrphaCode>2238</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2238</ExpertLink>
-      <Name lang="nl">Familiale geïsoleerde hypoparathyreoïdie</Name>
+      <Name lang="nl">Familiale geÃ¯soleerde hypoparathyreoÃ¯die</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -120335,7 +122144,7 @@
     <Disorder id="2110">
       <OrphaCode>2237</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2237</ExpertLink>
-      <Name lang="nl">Hypoparathyreoïdie - sensorineurale doofheid - nierziekte-syndroom</Name>
+      <Name lang="nl">HypoparathyreoÃ¯die - sensorineurale doofheid - nierziekte-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -120433,7 +122242,7 @@
     <Disorder id="2108">
       <OrphaCode>2234</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2234</ExpertLink>
-      <Name lang="nl">Mannelijk hypergonadotroop hypogonadisme - intellectuele achterstand - skeletanomalieën-syndroom</Name>
+      <Name lang="nl">Mannelijk hypergonadotroop hypogonadisme - intellectuele achterstand - skeletanomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -120479,6 +122288,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2082">
+      <OrphaCode>2199</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2199</ExpertLink>
+      <Name lang="nl">Epidermolytische palmoplantaire keratodermie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17804">
+          <Source>9856842[PMID]</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>4.4</ValMoy>
+          <PrevalenceGeographic id="24586">
+            <Name lang="nl">Ireland</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="19682">
       <OrphaCode>251863</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251863</ExpertLink>
@@ -120511,6 +122352,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2083">
+      <OrphaCode>2200</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2200</ExpertLink>
+      <Name lang="nl">Focale palmoplantaire en gingivale keratodermie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17805">
+          <Source>33262878[PMID]_15761417[PMID]_36179229[PMID]_17624145[PMID]_6212891[PMID]_6447853[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>17.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17806">
+          <Source>33262878[PMID]_15761417[PMID]_36179229[PMID]_17624145[PMID]_6212891[PMID]_6447853[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2080">
       <OrphaCode>2198</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2198</ExpertLink>
@@ -120560,6 +122450,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2081">
+      <OrphaCode>495</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=495</ExpertLink>
+      <Name lang="nl">Palmoplantaire keratoderma transgrediens en progrediens</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17798">
+          <Source>8274799[PMID]_10738633[PMID]_16227096[PMID]_32864403_Iranian Journal of Dermatology[OTHER]_International Journal of Advances in Medicine(IJAM)[OTHER]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>21.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17799">
+          <Source>8274799[PMID]_10738633[PMID]_16227096[PMID]_32864403_Iranian Journal of Dermatology[OTHER]_International Journal of Advances in Medicine (IJAM)[OTHER]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2087">
       <OrphaCode>2206</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2206</ExpertLink>
@@ -120658,6 +122597,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="19685">
+      <OrphaCode>251877</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251877</ExpertLink>
+      <Name lang="nl">Ganglioneuroblastoom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17938">
+          <Source>NCDB National Cancer Database[REG]_36171902[PMID]_36405824[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>425.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17939">
+          <Source>NCDB National Cancer Database[REG]_36171902[PMID]_36405824[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2085">
       <OrphaCode>2202</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2202</ExpertLink>
@@ -121069,6 +123057,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2093">
+      <OrphaCode>2216</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2216</ExpertLink>
+      <Name lang="nl">Geboortedefecten geÃ¯nduceerd door maternale hyperthermie</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17815">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="19604">
       <OrphaCode>251019</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251019</ExpertLink>
@@ -121381,7 +123401,7 @@
     <Disorder id="19601">
       <OrphaCode>251004</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251004</ExpertLink>
-      <Name lang="nl">Paternale uniparentale disomie van chromosoom 1</Name>
+      <Name lang="nl">Paternale uniparentale disomie van chromosoom 1-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -121413,7 +123433,7 @@
     <Disorder id="19602">
       <OrphaCode>251009</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251009</ExpertLink>
-      <Name lang="nl">Maternale uniparentale disomie van chromosoom 1</Name>
+      <Name lang="nl">Maternale uniparentale disomie van chromosoom 1-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -121673,7 +123693,7 @@
     <Disorder id="2140">
       <OrphaCode>2272</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2272</ExpertLink>
-      <Name lang="nl">Ichthyosis - orale en digitale anomalieën-syndroom</Name>
+      <Name lang="nl">Ichthyosis - orale en digitale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -122308,7 +124328,7 @@
     <Disorder id="2112">
       <OrphaCode>2239</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2239</ExpertLink>
-      <Name lang="nl">Familiale geïsoleerde hypoparathyreoïdie door agenesie van bijschildklier</Name>
+      <Name lang="nl">Familiale geÃ¯soleerde hypoparathyreoÃ¯die door agenesie van bijschildklier</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -122455,7 +124475,7 @@
     <Disorder id="2124">
       <OrphaCode>2256</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2256</ExpertLink>
-      <Name lang="nl">Fibulo-ulnaire hypoplasie - nieranomalieën-syndroom</Name>
+      <Name lang="nl">Fibulo-ulnaire hypoplasie - nieranomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -122501,6 +124521,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2125">
+      <OrphaCode>2257</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2257</ExpertLink>
+      <Name lang="nl">Primaire pulmonale hypoplasie</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="18073">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="19596">
       <OrphaCode>250977</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=250977</ExpertLink>
@@ -122683,7 +124735,7 @@
     <Disorder id="19593">
       <OrphaCode>250923</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=250923</ExpertLink>
-      <Name lang="nl">Geïsoleerde aniridie</Name>
+      <Name lang="nl">GeÃ¯soleerde aniridie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -123019,7 +125071,7 @@
     <Disorder id="2167">
       <OrphaCode>2306</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2306</ExpertLink>
-      <Name lang="nl">Isotretinoïne-achtig syndroom</Name>
+      <Name lang="nl">IsotretinoÃ¯ne-achtig syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -123117,7 +125169,7 @@
     <Disorder id="2166">
       <OrphaCode>2305</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2305</ExpertLink>
-      <Name lang="nl">Isotretinoïnesyndroom</Name>
+      <Name lang="nl">IsotretinoÃ¯nesyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -123150,11 +125202,11 @@
       <OrphaCode>251370</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251370</ExpertLink>
       <Name lang="nl">Sikkelcel - hemoglobine D-ziekte-syndroom</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="9153">
@@ -123182,11 +125234,11 @@
       <OrphaCode>251375</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251375</ExpertLink>
       <Name lang="nl">Sikkelcel - hemoglobine E-ziekte-syndroom</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="9154">
@@ -123213,7 +125265,7 @@
     <Disorder id="19634">
       <OrphaCode>251359</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251359</ExpertLink>
-      <Name lang="nl">Sikkelcelziekte - bèta-thalassemie-syndroom</Name>
+      <Name lang="nl">Sikkelcelziekte - bÃ¨ta-thalassemie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -123490,7 +125542,7 @@
     <Disorder id="19642">
       <OrphaCode>251510</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251510</ExpertLink>
-      <Name lang="nl">46,XY partiële gonadale dysgenesie</Name>
+      <Name lang="nl">46,XY partiÃ«le gonadale dysgenesie</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -123767,7 +125819,7 @@
     <Disorder id="19623">
       <OrphaCode>251295</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251295</ExpertLink>
-      <Name lang="nl">Gepigmenteerde paraveneuze retinochoroïdale atrofie</Name>
+      <Name lang="nl">Gepigmenteerde paraveneuze retinochoroÃ¯dale atrofie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -124188,10 +126240,59 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2158">
+      <OrphaCode>2291</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2291</ExpertLink>
+      <Name lang="nl">Congenitale velofaryngeale incompetentie</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17807">
+          <Source>7296935[PMID]_12887789[PMID]_11903361[PMID]_14986834[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>37.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17808">
+          <Source>7296935[PMID]_12887789[PMID]_11903361[PMID]_14986834[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="19631">
       <OrphaCode>251347</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251347</ExpertLink>
-      <Name lang="nl">Ataxie-teleangiëctasie-achtige aandoening</Name>
+      <Name lang="nl">Ataxie-teleangiÃ«ctasie-achtige aandoening</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -124320,6 +126421,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2154">
+      <OrphaCode>2287</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2287</ExpertLink>
+      <Name lang="nl">Gefuseerde mandibulaire snijtanden</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17777">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2152">
       <OrphaCode>2285</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2285</ExpertLink>
@@ -124387,7 +126520,7 @@
     <Disorder id="19624">
       <OrphaCode>251304</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251304</ExpertLink>
-      <Name lang="nl">Infantiele panniculitis met uveïtis en systemische granulomatose</Name>
+      <Name lang="nl">Infantiele panniculitis met uveÃ¯tis en systemische granulomatose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -124583,7 +126716,7 @@
     <Disorder id="2446">
       <OrphaCode>2678</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2678</ExpertLink>
-      <Name lang="nl">Familiale geïsoleerde café-au-lait maculae</Name>
+      <Name lang="nl">Familiale geÃ¯soleerde cafÃ©-au-lait maculae</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -124612,10 +126745,42 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="19788">
+      <OrphaCode>254851</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=254851</ExpertLink>
+      <Name lang="nl">Mitochondriaal DNA-gerelateerde dystonie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17987">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2435">
       <OrphaCode>2668</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2668</ExpertLink>
-      <Name lang="nl">Nefropathie - doofheid - hyperparathyreoïdie-syndroom</Name>
+      <Name lang="nl">Nefropathie - doofheid - hyperparathyreoÃ¯die-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -124958,7 +127123,7 @@
     <Disorder id="19803">
       <OrphaCode>254930</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=254930</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 7</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 7</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -125007,7 +127172,7 @@
     <Disorder id="19802">
       <OrphaCode>254925</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=254925</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 4</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 4</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -125105,7 +127270,7 @@
     <Disorder id="19801">
       <OrphaCode>254920</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=254920</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 2</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 2</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -125186,7 +127351,7 @@
     <Disorder id="19807">
       <OrphaCode>255182</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=255182</ExpertLink>
-      <Name lang="nl">Pyruvaatdehydrogenase E3-bindend proteïnedeficiëntie</Name>
+      <Name lang="nl">Pyruvaatdehydrogenase E3-bindend proteÃ¯nedeficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -125267,7 +127432,7 @@
     <Disorder id="19806">
       <OrphaCode>255138</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=255138</ExpertLink>
-      <Name lang="nl">Pyruvaatdehydrogenase E1-bèta-deficiëntie</Name>
+      <Name lang="nl">Pyruvaatdehydrogenase E1-bÃ¨ta-deficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -127047,6 +129212,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="19718">
+      <OrphaCode>252050</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=252050</ExpertLink>
+      <Name lang="nl">Primair melanoom van centraal zenuwstelsel</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="18062">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.007</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2503">
       <OrphaCode>2743</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2743</ExpertLink>
@@ -127096,6 +129293,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="19719">
+      <OrphaCode>252054</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=252054</ExpertLink>
+      <Name lang="nl">Hemangioblastoom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17951">
+          <Source>39163468[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.14</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2501">
       <OrphaCode>2741</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2741</ExpertLink>
@@ -127831,6 +130060,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2516">
+      <OrphaCode>2762</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2762</ExpertLink>
+      <Name lang="nl">Progressieve ossale heteroplasie</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17820">
+          <Source>25894639[PMID]_18553568[PMID]_12605446[PMID]_11092390[PMID]_10998448[PMID]_7671486[PMID]_3126297[PMID]_37003989[PMID]_32832452[PMID]_35035755[PMID]_36936194[PMID]_39678607[PMID]_36483469[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>78.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17821">
+          <Source>25894639[PMID]_18553568[PMID]_12605446[PMID]_11092390[PMID]_10998448[PMID]_7671486[PMID]_3126297[PMID]_37003989[PMID]_32832452[PMID]_35035755[PMID]_36936194[PMID]_39678607[PMID]_36483469[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="19733">
       <OrphaCode>252212</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=252212</ExpertLink>
@@ -127929,10 +130207,108 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="19732">
+      <OrphaCode>252206</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=252206</ExpertLink>
+      <Name lang="nl">Melanoom en tumor van zenuwstelsel-syndroom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17875">
+          <Source>8414022[PMID]_8635060[PMID]_37585199[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>49.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17876">
+          <Source>8414022[PMID]_8635060[PMID]_37585199[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="19731">
+      <OrphaCode>252202</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=252202</ExpertLink>
+      <Name lang="nl">Constitutionele 'mismatch repair'-deficiÃ«ntie-syndroom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18016">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>200.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18017">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2514">
       <OrphaCode>2759</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2759</ExpertLink>
-      <Name lang="nl">Ongeperforeerde orofarynx - costovertebrale anomalieën-syndroom</Name>
+      <Name lang="nl">Ongeperforeerde orofarynx - costovertebrale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -128214,6 +130590,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2540">
+      <OrphaCode>2792</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2792</ExpertLink>
+      <Name lang="nl">Otofaciocervicaal syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17885">
+          <Source>8558563[PMID]_11409867[PMID]_16441263[PMID]_31379922[PMID]_28657137[PMID]_29681087[PMID]_23851939[PMID]_ 37689091[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>18.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17886">
+          <Source>8558563[PMID]_11409867[PMID]_16441263[PMID]_31379922[PMID]_28657137[PMID]_29681087[PMID]_23851939[PMID]_ 37689091[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="19757">
       <OrphaCode>254519</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=254519</ExpertLink>
@@ -129420,6 +131845,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2553">
+      <OrphaCode>2809</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2809</ExpertLink>
+      <Name lang="nl">Familiale recurrente perifere facialisparalyse</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17920">
+          <Source>38435234[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>5.6</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2554">
       <OrphaCode>2812</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2812</ExpertLink>
@@ -129472,7 +131929,7 @@
     <Disorder id="2548">
       <OrphaCode>2805</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2805</ExpertLink>
-      <Name lang="nl">Partiële pancreatische agenesie</Name>
+      <Name lang="nl">PartiÃ«le pancreatische agenesie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -129521,7 +131978,7 @@
     <Disorder id="19765">
       <OrphaCode>254698</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=254698</ExpertLink>
-      <Name lang="nl">Epithelioïde trofoblasttumor</Name>
+      <Name lang="nl">EpithelioÃ¯de trofoblasttumor</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -129589,7 +132046,7 @@
     <Disorder id="19764">
       <OrphaCode>254693</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=254693</ExpertLink>
-      <Name lang="nl">Partiële mola hydatidosa</Name>
+      <Name lang="nl">PartiÃ«le mola hydatidosa</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -129935,10 +132392,61 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2550">
+      <OrphaCode>2807</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2807</ExpertLink>
+      <Name lang="nl">Papilloom van plexus choroideus</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17836">
+          <Source>23172371[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.003</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18074">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2551">
       <OrphaCode>678</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=678</ExpertLink>
-      <Name lang="nl">Syndroom van Papillon-Lefèvre</Name>
+      <Name lang="nl">Syndroom van Papillon-LefÃ¨vre</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -130189,7 +132697,7 @@
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
-        <Prevalence id="3853">
+        <Prevalence id="17828">
           <Source>10594887[PMID]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
@@ -130206,7 +132714,7 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="3854">
+        <Prevalence id="17829">
           <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
@@ -130230,7 +132738,7 @@
     <Disorder id="2304">
       <OrphaCode>2491</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2491</ExpertLink>
-      <Name lang="nl">Anomalieën van gang van Müller - ledemaatanomalieën-syndroom</Name>
+      <Name lang="nl">AnomalieÃ«n van gang van MÃ¼ller - ledemaatanomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -130521,6 +133029,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2312">
+      <OrphaCode>2500</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2500</ExpertLink>
+      <Name lang="nl">Acrogerie</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17762">
+          <Source>36353018[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>51.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17763">
+          <Source>36353018[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2313">
       <OrphaCode>2501</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2501</ExpertLink>
@@ -130619,6 +133176,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2317">
+      <OrphaCode>2505</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2505</ExpertLink>
+      <Name lang="nl">Meervoudige goedaardige circumferentiÃ«le huidplooien op ledematen</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17816">
+          <Source>29696100[PMID]_39583440[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>32.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17817">
+          <Source>29696100[PMID]_39583440[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2323">
       <OrphaCode>2511</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2511</ExpertLink>
@@ -130720,7 +133326,7 @@
     <Disorder id="2320">
       <OrphaCode>2508</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2508</ExpertLink>
-      <Name lang="nl">Agenesie van corpus callosum - abnormale genitaliën-syndroom</Name>
+      <Name lang="nl">Agenesie van corpus callosum - abnormale genitaliÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -130850,7 +133456,7 @@
     <Disorder id="2324">
       <OrphaCode>2513</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2513</ExpertLink>
-      <Name lang="nl">Microcefalie - albinisme - digitale anomalieën-syndroom</Name>
+      <Name lang="nl">Microcefalie - albinisme - digitale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -130997,7 +133603,7 @@
     <Disorder id="2333">
       <OrphaCode>2523</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2523</ExpertLink>
-      <Name lang="nl">Microcefalie - hersendefect - spasticiteit - hypernatriëmie-syndroom</Name>
+      <Name lang="nl">Microcefalie - hersendefect - spasticiteit - hypernatriÃ«mie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -131288,6 +133894,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2353">
+      <OrphaCode>2549</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2549</ExpertLink>
+      <Name lang="nl">Oculo-auriculo-vertebraal spectrum met radiale defecten</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17801">
+          <Source>17290277[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>40.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17802">
+          <Source>17290277[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2355">
       <OrphaCode>2551</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2551</ExpertLink>
@@ -132241,6 +134896,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2383">
+      <OrphaCode>2585</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2585</ExpertLink>
+      <Name lang="nl">Ataxie - pancytopenie-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17764">
+          <Source>28202457[PMID]_283689[PMID]_6947857[PMID]_27259050[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>25.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17765">
+          <Source>28202457[PMID]_283689[PMID]_6947857[PMID]_27259050[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="19853">
       <OrphaCode>261144</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=261144</ExpertLink>
@@ -132342,7 +135046,7 @@
     <Disorder id="2378">
       <OrphaCode>2578</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2578</ExpertLink>
-      <Name lang="nl">Syndroom van Mayer-Rokitansky-Küster-Hauser type 2</Name>
+      <Name lang="nl">Syndroom van Mayer-Rokitansky-KÃ¼ster-Hauser type 2</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -132607,55 +135311,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="19863">
-      <OrphaCode>261243</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=261243</ExpertLink>
-      <Name lang="nl">16p13.11-microduplicatiesyndroom</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="9245">
-          <Source>27378146[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Geval(len)/Gezinnen</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Geval(len)</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>162.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="9246">
-          <Source>ORPHANET_27378146[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="2390">
       <OrphaCode>2608</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2608</ExpertLink>
@@ -132705,6 +135360,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="19863">
+      <OrphaCode>261243</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=261243</ExpertLink>
+      <Name lang="nl">16p13.11-microduplicatiesyndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="9245">
+          <Source>27378146[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>162.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="9246">
+          <Source>ORPHANET_27378146[PMID]</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="19860">
       <OrphaCode>261222</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=261222</ExpertLink>
@@ -132786,6 +135490,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2388">
+      <OrphaCode>2593</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2593</ExpertLink>
+      <Name lang="nl">Myopathie met tubulaire aggregaten</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17822">
+          <Source>6176692[PMID]_66818785[PMID]_6681878[PMID]_16758596[PMID]_1484321[PMID]_9447609[PMID]_8836987[PMID]_11547948[PMID]_15452313[PMID]_25227914[PMID]_27882542[PMID]_23332920[PMID]_24570283[PMID]_25326555[PMID]_37923376[PMID]_35666680[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>60.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17823">
+          <Source>6176692[PMID]_66818785[PMID]_6681878[PMID]_16758596[PMID]_1484321[PMID]_9447609[PMID]_8836987[PMID]_11547948[PMID]_15452313[PMID]_25227914[PMID]_27882542[PMID]_23332920[PMID]_24570283[PMID]_25326555[PMID]_37923376[PMID]_35666680[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="19861">
       <OrphaCode>261229</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=261229</ExpertLink>
@@ -132933,10 +135686,10 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="19859">
-      <OrphaCode>261211</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=261211</ExpertLink>
-      <Name lang="nl">16p11.2p12.2-microdeletiesyndroom</Name>
+    <Disorder id="2386">
+      <OrphaCode>2589</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2589</ExpertLink>
+      <Name lang="nl">Myoclonus - cerebellaire ataxie - doofheid-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -132944,8 +135697,8 @@
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
-        <Prevalence id="9238">
-          <Source>24259393[PMID]</Source>
+        <Prevalence id="3738">
+          <Source>5698045[PMID]_6537856[PMID]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
           </PrevalenceType>
@@ -132953,7 +135706,7 @@
             <Name lang="nl">Geval(len)</Name>
           </PrevalenceQualification>
           <PrevalenceClass/>
-          <ValMoy>8.0</ValMoy>
+          <ValMoy>4.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -132961,8 +135714,8 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="9239">
-          <Source>ORPHANET_24259393[PMID]</Source>
+        <Prevalence id="3739">
+          <Source>ORPHANET_5698045[PMID]_6537856[PMID]</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -132982,10 +135735,10 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="2386">
-      <OrphaCode>2589</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2589</ExpertLink>
-      <Name lang="nl">Myoclonus - cerebellaire ataxie - doofheid-syndroom</Name>
+    <Disorder id="19859">
+      <OrphaCode>261211</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=261211</ExpertLink>
+      <Name lang="nl">16p11.2p12.2-microdeletiesyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -132993,8 +135746,8 @@
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
-        <Prevalence id="3738">
-          <Source>5698045[PMID]_6537856[PMID]</Source>
+        <Prevalence id="9238">
+          <Source>24259393[PMID]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
           </PrevalenceType>
@@ -133002,7 +135755,7 @@
             <Name lang="nl">Geval(len)</Name>
           </PrevalenceQualification>
           <PrevalenceClass/>
-          <ValMoy>4.0</ValMoy>
+          <ValMoy>8.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -133010,8 +135763,40 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="3739">
-          <Source>ORPHANET_5698045[PMID]_6537856[PMID]</Source>
+        <Prevalence id="9239">
+          <Source>ORPHANET_24259393[PMID]</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="2385">
+      <OrphaCode>2588</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2588</ExpertLink>
+      <Name lang="nl">Syndroom van Myhre</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="3737">
+          <Source>ORPHANET_28406602[PMID]</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -133080,38 +135865,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="2385">
-      <OrphaCode>2588</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2588</ExpertLink>
-      <Name lang="nl">Syndroom van Myhre</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="3737">
-          <Source>ORPHANET_28406602[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="19857">
       <OrphaCode>261197</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=261197</ExpertLink>
@@ -133313,7 +136066,7 @@
     <Disorder id="19869">
       <OrphaCode>261290</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=261290</ExpertLink>
-      <Name lang="nl">Trisomie 17p</Name>
+      <Name lang="nl">Trisomie 17p-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -133726,7 +136479,7 @@
     <Disorder id="19877">
       <OrphaCode>261344</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=261344</ExpertLink>
-      <Name lang="nl">Trisomie 1q</Name>
+      <Name lang="nl">Trisomie 1q-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -133905,7 +136658,7 @@
     <Disorder id="19873">
       <OrphaCode>261318</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=261318</ExpertLink>
-      <Name lang="nl">Trisomie 20p</Name>
+      <Name lang="nl">Trisomie 20p-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -134099,7 +136852,7 @@
     <Disorder id="19885">
       <OrphaCode>261524</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=261524</ExpertLink>
-      <Name lang="nl">Paternale uniparentale disomie van chromosoom X</Name>
+      <Name lang="nl">Paternale uniparentale disomie van chromosoom X-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -134128,10 +136881,59 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2413">
+      <OrphaCode>2639</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2639</ExpertLink>
+      <Name lang="nl">Fibula-aplasie - complexe brachydactylie-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17811">
+          <Source>37064338[PMID]_2624264[PMID]_2363425[PMID]_16222676[PMID]_18629880[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>16.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17812">
+          <Source>37064338[PMID]_2624264[PMID]_2363425[PMID]_16222676[PMID]_18629880[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="19884">
       <OrphaCode>261519</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=261519</ExpertLink>
-      <Name lang="nl">Maternale uniparentale disomie van chromosoom X</Name>
+      <Name lang="nl">Maternale uniparentale disomie van chromosoom X-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -134437,6 +137239,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2410">
+      <OrphaCode>2633</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2633</ExpertLink>
+      <Name lang="nl">Mesomele dysplasie, Nievergelt-type</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17818">
+          <Source>29245094[PMID]_11977180[PMID]_6059604[PMID]_39035397[PMID]_18085094[PMID]_675214[PMID]_2717950[PMID]_17702012[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>19.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17819">
+          <Source>29245094[PMID]_11977180[PMID]_6059604[PMID]_39035397[PMID]_18085094[PMID]_675214[PMID]_2717950[PMID]_17702012[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="19882">
       <OrphaCode>261501</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=261501</ExpertLink>
@@ -134862,7 +137713,7 @@
     <Disorder id="2747">
       <OrphaCode>3057</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3057</ExpertLink>
-      <Name lang="nl">Monoamineoxidase A-deficiëntie</Name>
+      <Name lang="nl">Monoamineoxidase A-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -134943,7 +137794,7 @@
     <Disorder id="2741">
       <OrphaCode>3052</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3052</ExpertLink>
-      <Name lang="nl">X-gebonden intellectuele achterstand - convulsies - psoriasis-syndroom</Name>
+      <Name lang="nl">X-gebonden intellectuele achterstand - stuipen - psoriasis-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -136238,7 +139089,7 @@
     <Disorder id="20057">
       <OrphaCode>263458</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=263458</ExpertLink>
-      <Name lang="nl">Hyperinsulinisme door INSR-deficiëntie</Name>
+      <Name lang="nl">Hyperinsulinisme door INSR-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -136287,7 +139138,7 @@
     <Disorder id="20056">
       <OrphaCode>263455</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=263455</ExpertLink>
-      <Name lang="nl">Congenitaal hyperinsulinisme door HNF4A-deficiëntie</Name>
+      <Name lang="nl">Congenitaal hyperinsulinisme door HNF4A-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -136730,7 +139581,7 @@
     <Disorder id="2711">
       <OrphaCode>3016</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3016</ExpertLink>
-      <Name lang="nl">Afwezige radius - anogenitale anomalieën-syndroom</Name>
+      <Name lang="nl">Afwezige radius - anogenitale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -137654,7 +140505,7 @@
     <Disorder id="20039">
       <OrphaCode>263297</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=263297</ExpertLink>
-      <Name lang="nl">Glycogeenstapelingsziekte met ernstige cardiomyopathie door deficiëntie van glycogenine</Name>
+      <Name lang="nl">Glycogeenstapelingsziekte met ernstige cardiomyopathie door deficiÃ«ntie van glycogenine</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -137801,7 +140652,7 @@
     <Disorder id="2690">
       <OrphaCode>2988</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2988</ExpertLink>
-      <Name lang="nl">Pterygium colli - intellectuele achterstand - digitale anomalieën-syndroom</Name>
+      <Name lang="nl">Pterygium colli - intellectuele achterstand - digitale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -137899,7 +140750,7 @@
     <Disorder id="2814">
       <OrphaCode>3145</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3145</ExpertLink>
-      <Name lang="nl">Resistentie voor arginine-vasopressine - intracraniële calcificatie - kleine gestalte - faciale dysmorfie-syndroom</Name>
+      <Name lang="nl">Resistentie voor arginine-vasopressine - intracraniÃ«le calcificatie - kleine gestalte - faciale dysmorfie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -138178,7 +141029,7 @@
     <Disorder id="20021">
       <OrphaCode>262941</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=262941</ExpertLink>
-      <Name lang="nl">Partiële trisomie van de lange arm van chromosoom 14</Name>
+      <Name lang="nl">PartiÃ«le trisomie van de lange arm van chromosoom 14-syndroom</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -138317,7 +141168,7 @@
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="4049">
-          <Source>29642415[PMID]</Source>
+          <Source>20301415[PMID]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
           </PrevalenceType>
@@ -138325,7 +141176,7 @@
             <Name lang="nl">Geval(len)</Name>
           </PrevalenceQualification>
           <PrevalenceClass/>
-          <ValMoy>400.0</ValMoy>
+          <ValMoy>500.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -138334,15 +141185,15 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="4050">
-          <Source>ORPHANET_29642415[PMID]</Source>
+          <Source>20301415[PMID]_ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
           <PrevalenceQualification id="23704">
             <Name lang="nl">Class only</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
           </PrevalenceClass>
           <ValMoy>0.0</ValMoy>
           <PrevalenceGeographic id="23844">
@@ -138386,6 +141237,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2789">
+      <OrphaCode>3115</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3115</ExpertLink>
+      <Name lang="nl">Syndroom van Roussy-LÃ©vy</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17841">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2776">
       <OrphaCode>3101</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3101</ExpertLink>
@@ -138585,7 +141468,7 @@
     <Disorder id="2783">
       <OrphaCode>3109</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3109</ExpertLink>
-      <Name lang="nl">Syndroom van Mayer-Rokitansky-Küster-Hauser</Name>
+      <Name lang="nl">Syndroom van Mayer-Rokitansky-KÃ¼ster-Hauser</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -138636,7 +141519,7 @@
     <Disorder id="2769">
       <OrphaCode>3086</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3086</ExpertLink>
-      <Name lang="nl">Autosomaal dominante vitreoretinochoroïdopathie</Name>
+      <Name lang="nl">Autosomaal dominante vitreoretinochoroÃ¯dopathie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -139401,7 +142284,7 @@
     <Disorder id="20208">
       <OrphaCode>268826</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=268826</ExpertLink>
-      <Name lang="nl">Pariëtale encefalocele</Name>
+      <Name lang="nl">PariÃ«tale encefalocele</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -139462,38 +142345,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="20223">
-      <OrphaCode>268920</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=268920</ExpertLink>
-      <Name lang="nl">Geïsoleerde megalencefalie</Name>
-      <DisorderType id="21450">
-        <Name lang="nl">Klinisch subtype</Name>
-      </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="nl">Subtype van aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="9403">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="20220">
       <OrphaCode>268882</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=268882</ExpertLink>
@@ -139578,7 +142429,7 @@
     <Disorder id="2619">
       <OrphaCode>2891</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2891</ExpertLink>
-      <Name lang="nl">Pili torti - ontwikkelingsachterstand - neurologische anomalieën-syndroom</Name>
+      <Name lang="nl">Pili torti - ontwikkelingsachterstand - neurologische anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -139789,7 +142640,7 @@
     <Disorder id="20217">
       <OrphaCode>268868</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=268868</ExpertLink>
-      <Name lang="nl">Geïsoleerde amyelie</Name>
+      <Name lang="nl">GeÃ¯soleerde amyelie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -140016,6 +142867,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2606">
+      <OrphaCode>2875</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2875</ExpertLink>
+      <Name lang="nl">Phakomatosis pigmentovascularis</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18044">
+          <Source>18045734[PMID]_31148861[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>248.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18045">
+          <Source>18045734[PMID]_31148861[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="20207">
       <OrphaCode>268823</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=268823</ExpertLink>
@@ -140245,7 +143145,7 @@
     <Disorder id="20203">
       <OrphaCode>268810</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=268810</ExpertLink>
-      <Name lang="nl">Geïsoleerde posterieure meningocele</Name>
+      <Name lang="nl">GeÃ¯soleerde posterieure meningocele</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -140586,7 +143486,7 @@
     <Disorder id="2582">
       <OrphaCode>2847</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2847</ExpertLink>
-      <Name lang="nl">Pericardiaal en diafragmatisch defect</Name>
+      <Name lang="nl">Pericard- en diafragmadefect</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -140855,7 +143755,7 @@
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="3900">
-          <Source>Haute Autorité de Santé[OTHER]</Source>
+          <Source>Haute AutoritÃ© de SantÃ©[OTHER]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
           </PrevalenceType>
@@ -142205,11 +145105,11 @@
       <OrphaCode>2969</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2969</ExpertLink>
       <Name lang="nl">Proteus-achtig syndroom</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="3980">
@@ -142233,6 +145133,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2674">
+      <OrphaCode>2964</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2964</ExpertLink>
+      <Name lang="nl">Autosomaal dominante prognathie</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17878">
+          <Source>18074368[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23725">
+            <Name lang="nl">Familie/Gezinnen</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>55.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17879">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2673">
       <OrphaCode>2962</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2962</ExpertLink>
@@ -142415,7 +145364,7 @@
     <Disorder id="2681">
       <OrphaCode>2975</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2975</ExpertLink>
-      <Name lang="nl">46,XX-geslachtsontwikkelingsstoornis - skeletanomalieën-syndroom</Name>
+      <Name lang="nl">46,XX-geslachtsontwikkelingsstoornis - skeletanomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -142932,7 +145881,7 @@
     <Disorder id="2663">
       <OrphaCode>2951</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2951</ExpertLink>
-      <Name lang="nl">Afwezige duim - kleine gestalte - immuundeficiëntie-syndroom</Name>
+      <Name lang="nl">Afwezige duim - kleine gestalte - immuundeficiÃ«ntie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -143030,7 +145979,7 @@
     <Disorder id="20132">
       <OrphaCode>264978</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=264978</ExpertLink>
-      <Name lang="nl">Interstitiële longziekte gerelateerd aan medicatie of radiatie</Name>
+      <Name lang="nl">InterstitiÃ«le longziekte gerelateerd aan medicatie of radiatie</Name>
       <DisorderType id="21429">
         <Name lang="nl">Particulaire klinische situatie binnen een ziekte of syndroom</Name>
       </DisorderType>
@@ -143358,7 +146307,7 @@
     <Disorder id="2641">
       <OrphaCode>2924</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2924</ExpertLink>
-      <Name lang="nl">Geïsoleerde polycystische leverziekte</Name>
+      <Name lang="nl">GeÃ¯soleerde polycystische leverziekte</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -143802,6 +146751,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2625">
+      <OrphaCode>2899</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2899</ExpertLink>
+      <Name lang="nl">Brachyolmie - amelogenesis imperfecta-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17863">
+          <Source>8721563[PMID]_19213025[PMID]_19344874[PMID]_25899461[PMID]_ 25669657[PMID]_26511208[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>15.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17864">
+          <Source>8721563[PMID]_19213025[PMID]_19344874[PMID]_25899461[PMID]_ 25669657[PMID]_26511208[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2626">
       <OrphaCode>2900</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2900</ExpertLink>
@@ -144026,7 +147024,7 @@
     <Disorder id="20103">
       <OrphaCode>264580</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=264580</ExpertLink>
-      <Name lang="nl">Glycogeenstapelingsziekte door hepatische fosforylasekinasedeficiëntie</Name>
+      <Name lang="nl">Glycogeenstapelingsziekte door hepatische fosforylasekinasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -144077,7 +147075,7 @@
     <Disorder id="2634">
       <OrphaCode>2916</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2916</ExpertLink>
-      <Name lang="nl">Postaxiale polydactylie - dentale en vertebrale anomalieën-syndroom</Name>
+      <Name lang="nl">Postaxiale polydactylie - dentale en vertebrale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -144224,7 +147222,7 @@
     <Disorder id="20108">
       <OrphaCode>264675</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=264675</ExpertLink>
-      <Name lang="nl">Erfelijke pulmonale alveolaire proteïnose</Name>
+      <Name lang="nl">Erfelijke pulmonale alveolaire proteÃ¯nose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -144305,7 +147303,7 @@
     <Disorder id="20111">
       <OrphaCode>264691</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=264691</ExpertLink>
-      <Name lang="nl">Geïsoleerde pulmonale capillaritis</Name>
+      <Name lang="nl">GeÃ¯soleerde pulmonale capillaritis</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -144469,7 +147467,7 @@
     <Disorder id="20332">
       <OrphaCode>275803</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=275803</ExpertLink>
-      <Name lang="nl">Pulmonale arteriële hypertensie geassocieerd met congenitale hartziekte</Name>
+      <Name lang="nl">Pulmonale arteriÃ«le hypertensie geassocieerd met congenitale hartziekte</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -144653,7 +147651,7 @@
     <Disorder id="20333">
       <OrphaCode>275808</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=275808</ExpertLink>
-      <Name lang="nl">Pulmonale arteriële hypertensie geassocieerd met HIV-infectie</Name>
+      <Name lang="nl">Pulmonale arteriÃ«le hypertensie geassocieerd met HIV-infectie</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -144685,7 +147683,7 @@
     <Disorder id="20334">
       <OrphaCode>275813</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=275813</ExpertLink>
-      <Name lang="nl">Pulmonale arteriële hypertensie geassocieerd met portale hypertensie</Name>
+      <Name lang="nl">Pulmonale arteriÃ«le hypertensie geassocieerd met portale hypertensie</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -144714,6 +147712,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2991">
+      <OrphaCode>1717</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1717</ExpertLink>
+      <Name lang="nl">Distale duplicatie 19q-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17839">
+          <Source>25606462[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>36.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17840">
+          <Source>25606462[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2990">
       <OrphaCode>3377</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3377</ExpertLink>
@@ -144749,7 +147796,7 @@
     <Disorder id="20335">
       <OrphaCode>275823</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=275823</ExpertLink>
-      <Name lang="nl">Pulmonale arteriële hypertensie geassocieerd met schistosomiase</Name>
+      <Name lang="nl">Pulmonale arteriÃ«le hypertensie geassocieerd met schistosomiase</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -144781,7 +147828,7 @@
     <Disorder id="2985">
       <OrphaCode>3368</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3368</ExpertLink>
-      <Name lang="nl">Trigonocefalie - gespleten neus - acrale anomalieën-syndroom</Name>
+      <Name lang="nl">Trigonocefalie - gespleten neus - acrale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -144830,7 +147877,7 @@
     <Disorder id="20328">
       <OrphaCode>275777</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=275777</ExpertLink>
-      <Name lang="nl">Hereditaire pulmonale arteriële hypertensie</Name>
+      <Name lang="nl">Hereditaire pulmonale arteriÃ«le hypertensie</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -144900,7 +147947,7 @@
     <Disorder id="20329">
       <OrphaCode>275786</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=275786</ExpertLink>
-      <Name lang="nl">Medicatie- of toxinegeïnduceerde pulmonale arteriële hypertensie</Name>
+      <Name lang="nl">Medicatie- of toxinegeÃ¯nduceerde pulmonale arteriÃ«le hypertensie</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -144932,7 +147979,7 @@
     <Disorder id="20330">
       <OrphaCode>275791</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=275791</ExpertLink>
-      <Name lang="nl">Pulmonale arteriële hypertensie geassocieerd met andere ziekte</Name>
+      <Name lang="nl">Pulmonale arteriÃ«le hypertensie geassocieerd met andere ziekte</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -145013,7 +148060,7 @@
     <Disorder id="20331">
       <OrphaCode>275798</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=275798</ExpertLink>
-      <Name lang="nl">Pulmonale arteriële hypertensie geassocieerd met bindweefselziekte</Name>
+      <Name lang="nl">Pulmonale arteriÃ«le hypertensie geassocieerd met bindweefselziekte</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -145227,7 +148274,7 @@
     <Disorder id="20326">
       <OrphaCode>275761</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=275761</ExpertLink>
-      <Name lang="nl">Deficiëntie van lysosomale zure lipase</Name>
+      <Name lang="nl">DeficiÃ«ntie van lysosomale zure lipase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -145378,7 +148425,7 @@
     <Disorder id="20327">
       <OrphaCode>275766</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=275766</ExpertLink>
-      <Name lang="nl">Idiopathische pulmonale arteriële hypertensie</Name>
+      <Name lang="nl">Idiopathische pulmonale arteriÃ«le hypertensie</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -146560,7 +149607,7 @@
     <Disorder id="20346">
       <OrphaCode>276066</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=276066</ExpertLink>
-      <Name lang="nl">Deficiëntie van galzuur-CoA-ligase en defect van amidatie</Name>
+      <Name lang="nl">DeficiÃ«ntie van galzuur-CoA-ligase en defect van amidatie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -147073,7 +150120,7 @@
     <Disorder id="2998">
       <OrphaCode>3387</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3387</ExpertLink>
-      <Name lang="nl">Geïsoleerde anterieure cervicale hypertrichose</Name>
+      <Name lang="nl">GeÃ¯soleerde anterieure cervicale hypertrichose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -147572,7 +150619,7 @@
     <Disorder id="2992">
       <OrphaCode>1723</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1723</ExpertLink>
-      <Name lang="nl">Mozaïektrisomie 2</Name>
+      <Name lang="nl">MozaÃ¯ektrisomie 2-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -147621,7 +150668,7 @@
     <Disorder id="20336">
       <OrphaCode>275828</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=275828</ExpertLink>
-      <Name lang="nl">Pulmonale arteriële hypertensie geassocieerd met chronische hemolytische anemie</Name>
+      <Name lang="nl">Pulmonale arteriÃ«le hypertensie geassocieerd met chronische hemolytische anemie</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -147653,7 +150700,7 @@
     <Disorder id="2993">
       <OrphaCode>1724</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1724</ExpertLink>
-      <Name lang="nl">Mozaïektrisomie 20</Name>
+      <Name lang="nl">MozaÃ¯ektrisomie 20-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -147685,7 +150732,7 @@
     <Disorder id="2994">
       <OrphaCode>1747</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1747</ExpertLink>
-      <Name lang="nl">Mozaïektrisomie 7</Name>
+      <Name lang="nl">MozaÃ¯ektrisomie 7-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -147766,7 +150813,7 @@
     <Disorder id="2953">
       <OrphaCode>3328</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3328</ExpertLink>
-      <Name lang="nl">Afwezige tibia - polydactylie - arachnoïdale cyste-syndroom</Name>
+      <Name lang="nl">Afwezige tibia - polydactylie - arachnoÃ¯dale cyste-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -148369,7 +151416,7 @@
     <Disorder id="20315">
       <OrphaCode>275517</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=275517</ExpertLink>
-      <Name lang="nl">Auto-immuun lymfoproliferatief syndroom-recidiverende virale infecties door CASP8-deficiëntie</Name>
+      <Name lang="nl">Auto-immuun lymfoproliferatief syndroom-recidiverende virale infecties door CASP8-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -148565,7 +151612,7 @@
     <Disorder id="2967">
       <OrphaCode>3347</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3347</ExpertLink>
-      <Name lang="nl">Syndroom van Mounier-Kühn</Name>
+      <Name lang="nl">Syndroom van Mounier-KÃ¼hn</Name>
       <DisorderType id="21422">
         <Name lang="nl">Klinisch syndroom</Name>
       </DisorderType>
@@ -148614,7 +151661,7 @@
     <Disorder id="2964">
       <OrphaCode>3341</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3341</ExpertLink>
-      <Name lang="nl">Torticollis - keloïden - cryptorchidie - renale dysplasie-syndroom</Name>
+      <Name lang="nl">Torticollis - keloÃ¯den - cryptorchidie - renale dysplasie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -148663,7 +151710,7 @@
     <Disorder id="2965">
       <OrphaCode>3342</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3342</ExpertLink>
-      <Name lang="nl">Arteriële tortuositeitsyndroom</Name>
+      <Name lang="nl">ArteriÃ«le tortuositeitsyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -148761,7 +151808,7 @@
     <Disorder id="20307">
       <OrphaCode>271861</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=271861</ExpertLink>
-      <Name lang="nl">Hereditaire ATTR-amyloïdose</Name>
+      <Name lang="nl">Hereditaire ATTR-amyloÃ¯dose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -149997,8 +153044,8 @@
       <OrphaCode>3465</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3465</ExpertLink>
       <Name lang="nl">Syndroom van Worster-Drought</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
@@ -150109,7 +153156,7 @@
     <Disorder id="3069">
       <OrphaCode>3200</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3200</ExpertLink>
-      <Name lang="nl">Artrogrypose - ectodermale dysplasie - andere anomalieën-syndroom</Name>
+      <Name lang="nl">Artrogrypose - ectodermale dysplasie - andere anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -150320,7 +153367,7 @@
     <Disorder id="20234">
       <OrphaCode>268980</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=268980</ExpertLink>
-      <Name lang="nl">Geïsoleerde focale corticale dysplasie type Ib</Name>
+      <Name lang="nl">GeÃ¯soleerde focale corticale dysplasie type Ib</Name>
       <DisorderType id="21457">
         <Name lang="nl">Histopathologisch subtype</Name>
       </DisorderType>
@@ -150352,7 +153399,7 @@
     <Disorder id="20235">
       <OrphaCode>268987</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=268987</ExpertLink>
-      <Name lang="nl">Geïsoleerde focale corticale dysplasie type Ic</Name>
+      <Name lang="nl">GeÃ¯soleerde focale corticale dysplasie type Ic</Name>
       <DisorderType id="21457">
         <Name lang="nl">Histopathologisch subtype</Name>
       </DisorderType>
@@ -150433,7 +153480,7 @@
     <Disorder id="20233">
       <OrphaCode>268973</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=268973</ExpertLink>
-      <Name lang="nl">Geïsoleerde focale corticale dysplasie type Ia</Name>
+      <Name lang="nl">GeÃ¯soleerde focale corticale dysplasie type Ia</Name>
       <DisorderType id="21457">
         <Name lang="nl">Histopathologisch subtype</Name>
       </DisorderType>
@@ -150465,7 +153512,7 @@
     <Disorder id="20238">
       <OrphaCode>269008</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=269008</ExpertLink>
-      <Name lang="nl">Geïsoleerde focale corticale dysplasie type IIb</Name>
+      <Name lang="nl">GeÃ¯soleerde focale corticale dysplasie type IIb</Name>
       <DisorderType id="21457">
         <Name lang="nl">Histopathologisch subtype</Name>
       </DisorderType>
@@ -150546,7 +153593,7 @@
     <Disorder id="20236">
       <OrphaCode>268994</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=268994</ExpertLink>
-      <Name lang="nl">Geïsoleerde focale corticale dysplasie type II</Name>
+      <Name lang="nl">GeÃ¯soleerde focale corticale dysplasie type II</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -150627,7 +153674,7 @@
     <Disorder id="20237">
       <OrphaCode>269001</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=269001</ExpertLink>
-      <Name lang="nl">Geïsoleerde focale corticale dysplasie type IIa</Name>
+      <Name lang="nl">GeÃ¯soleerde focale corticale dysplasie type IIa</Name>
       <DisorderType id="21457">
         <Name lang="nl">Histopathologisch subtype</Name>
       </DisorderType>
@@ -150853,7 +153900,7 @@
     <Disorder id="20225">
       <OrphaCode>268936</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=268936</ExpertLink>
-      <Name lang="nl">Geïsoleerde arhinencefalie</Name>
+      <Name lang="nl">GeÃ¯soleerde arhinencefalie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -150885,7 +153932,7 @@
     <Disorder id="20231">
       <OrphaCode>268961</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=268961</ExpertLink>
-      <Name lang="nl">Geïsoleerde focale corticale dysplasie type I</Name>
+      <Name lang="nl">GeÃ¯soleerde focale corticale dysplasie type I</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -151230,7 +154277,7 @@
     <Disorder id="20249">
       <OrphaCode>269221</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=269221</ExpertLink>
-      <Name lang="nl">Geïsoleerde bilaterale hypoplasie van cerebellaire hemisfeer</Name>
+      <Name lang="nl">GeÃ¯soleerde bilaterale hypoplasie van cerebellaire hemisfeer</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -151294,7 +154341,7 @@
     <Disorder id="20248">
       <OrphaCode>269218</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=269218</ExpertLink>
-      <Name lang="nl">Geïsoleerde unilaterale hypoplasie van cerebellaire hemisfeer</Name>
+      <Name lang="nl">GeÃ¯soleerde unilaterale hypoplasie van cerebellaire hemisfeer</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -151390,7 +154437,7 @@
     <Disorder id="3036">
       <OrphaCode>3454</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3454</ExpertLink>
-      <Name lang="nl">Intellectuele achterstand - ontwikkelingsachterstand - contracturen-syndroom</Name>
+      <Name lang="nl">Syndroom van Wieacker-Wolff</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -151520,7 +154567,7 @@
     <Disorder id="20243">
       <OrphaCode>269203</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=269203</ExpertLink>
-      <Name lang="nl">Geïsoleerde cerebellaire vermis-agenesie</Name>
+      <Name lang="nl">GeÃ¯soleerde cerebellaire vermis-agenesie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -151616,7 +154663,7 @@
     <Disorder id="20247">
       <OrphaCode>269215</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=269215</ExpertLink>
-      <Name lang="nl">Geïsoleerde Dandy-Walker malformatie zonder hydrocefalus</Name>
+      <Name lang="nl">GeÃ¯soleerde Dandy-Walker malformatie zonder hydrocefalus</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -151648,7 +154695,7 @@
     <Disorder id="20246">
       <OrphaCode>269212</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=269212</ExpertLink>
-      <Name lang="nl">Geïsoleerde Dandy-Walker malformatie met hydrocefalus</Name>
+      <Name lang="nl">GeÃ¯soleerde Dandy-Walker malformatie met hydrocefalus</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -151680,7 +154727,7 @@
     <Disorder id="20245">
       <OrphaCode>269209</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=269209</ExpertLink>
-      <Name lang="nl">Geïsoleerde partiële cerebellaire vermis-agenesie</Name>
+      <Name lang="nl">GeÃ¯soleerde partiÃ«le cerebellaire vermis-agenesie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -151712,7 +154759,7 @@
     <Disorder id="20244">
       <OrphaCode>269206</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=269206</ExpertLink>
-      <Name lang="nl">Geïsoleerde totale cerebellaire vermis-agenesie</Name>
+      <Name lang="nl">GeÃ¯soleerde totale cerebellaire vermis-agenesie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -151790,6 +154837,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2853">
+      <OrphaCode>3181</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3181</ExpertLink>
+      <Name lang="nl">Deformiteit van Sprengel</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17962">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="20452">
       <OrphaCode>280302</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=280302</ExpertLink>
@@ -151874,7 +154953,7 @@
     <Disorder id="20454">
       <OrphaCode>280325</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=280325</ExpertLink>
-      <Name lang="nl">Distale deletie 12p</Name>
+      <Name lang="nl">Distale deletie 12p-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -152085,7 +155164,7 @@
     <Disorder id="20463">
       <OrphaCode>280379</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=280379</ExpertLink>
-      <Name lang="nl">Erytropoëtische uroporfyrie geassocieerd met myeloïde maligniteiten</Name>
+      <Name lang="nl">ErytropoÃ«tische uroporfyrie geassocieerd met myeloÃ¯de maligniteiten</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -152247,7 +155326,7 @@
     <Disorder id="2857">
       <OrphaCode>3186</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3186</ExpertLink>
-      <Name lang="nl">Holoprosencefalie - radiale, cardiale en renale anomalieën-syndroom</Name>
+      <Name lang="nl">Holoprosencefalie - radiale, cardiale en renale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -152396,7 +155475,7 @@
     <Disorder id="20458">
       <OrphaCode>280356</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=280356</ExpertLink>
-      <Name lang="nl">PLIN1-gerelateerde familiale partiële lipodystrofie</Name>
+      <Name lang="nl">PLIN1-gerelateerde familiale partiÃ«le lipodystrofie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -152543,7 +155622,7 @@
     <Disorder id="20470">
       <OrphaCode>280406</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=280406</ExpertLink>
-      <Name lang="nl">Familiaal steroïdresistent nefrotisch syndroom met sensorineurale doofheid</Name>
+      <Name lang="nl">Familiaal steroÃ¯dresistent nefrotisch syndroom met sensorineurale doofheid</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -153507,7 +156586,7 @@
     <Disorder id="20419">
       <OrphaCode>279934</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=279934</ExpertLink>
-      <Name lang="nl">Mitochondriaal DNA-depletiesyndroom, hepatocerebrale vorm door DGUOK-deficiëntie</Name>
+      <Name lang="nl">Mitochondriaal DNA-depletiesyndroom, hepatocerebrale vorm door DGUOK-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -153605,7 +156684,7 @@
     <Disorder id="20431">
       <OrphaCode>280142</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=280142</ExpertLink>
-      <Name lang="nl">Ernstige gecombineerde immuundeficiëntie door LCK-deficiëntie</Name>
+      <Name lang="nl">Ernstige gecombineerde immuundeficiÃ«ntie door LCK-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -153752,7 +156831,7 @@
     <Disorder id="20430">
       <OrphaCode>280133</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=280133</ExpertLink>
-      <Name lang="nl">Complementcomponent 3-deficiëntie</Name>
+      <Name lang="nl">Complementcomponent 3-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -154677,7 +157756,7 @@
     <Disorder id="20385">
       <OrphaCode>276580</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=276580</ExpertLink>
-      <Name lang="nl">Autosomaal dominant hyperinsulinisme door Kir6.2-deficiëntie</Name>
+      <Name lang="nl">Autosomaal dominant hyperinsulinisme door Kir6.2-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -154758,7 +157837,7 @@
     <Disorder id="20384">
       <OrphaCode>276575</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=276575</ExpertLink>
-      <Name lang="nl">Autosomaal dominant hyperinsulinisme door SUR1-deficiëntie</Name>
+      <Name lang="nl">Autosomaal dominant hyperinsulinisme door SUR1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -154787,6 +157866,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="20387">
+      <OrphaCode>276598</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=276598</ExpertLink>
+      <Name lang="nl">Diazoxideresistent focaal hyperinsulinisme door SUR1-deficiÃ«ntie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="9525">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25965">
+            <Name lang="nl">Not yet validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="2914">
       <OrphaCode>3262</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3262</ExpertLink>
@@ -154836,38 +157947,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="20387">
-      <OrphaCode>276598</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=276598</ExpertLink>
-      <Name lang="nl">Diazoxideresistent focaal hyperinsulinisme door SUR1-deficiëntie</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="9525">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="20389">
       <OrphaCode>276608</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=276608</ExpertLink>
@@ -154903,7 +157982,7 @@
     <Disorder id="2916">
       <OrphaCode>3265</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3265</ExpertLink>
-      <Name lang="nl">Geïsoleerde humeroradiale synostose</Name>
+      <Name lang="nl">GeÃ¯soleerde humeroradiale synostose</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -154952,7 +158031,7 @@
     <Disorder id="20388">
       <OrphaCode>276603</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=276603</ExpertLink>
-      <Name lang="nl">Diazoxideresistent focaal hyperinsulinisme door Kir6.2-deficiëntie</Name>
+      <Name lang="nl">Diazoxideresistent focaal hyperinsulinisme door Kir6.2-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -154984,7 +158063,7 @@
     <Disorder id="2917">
       <OrphaCode>3266</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3266</ExpertLink>
-      <Name lang="nl">Geïsoleerde humeroradio-ulnaire synostose</Name>
+      <Name lang="nl">GeÃ¯soleerde humeroradio-ulnaire synostose</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -155244,7 +158323,7 @@
     <Disorder id="2927">
       <OrphaCode>425</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=425</ExpertLink>
-      <Name lang="nl">Apolipoproteïne A-I-deficiëntie</Name>
+      <Name lang="nl">ApolipoproteÃ¯ne A-I-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -155474,7 +158553,7 @@
     <Disorder id="2934">
       <OrphaCode>3294</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3294</ExpertLink>
-      <Name lang="nl">Anomalieën van extensorpezen van vinger</Name>
+      <Name lang="nl">AnomalieÃ«n van extensorpezen van vinger</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -155813,7 +158892,7 @@
     <Disorder id="20414">
       <OrphaCode>279914</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=279914</ExpertLink>
-      <Name lang="nl">Intermediaire uveïtis</Name>
+      <Name lang="nl">Intermediaire uveÃ¯tis</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -155891,6 +158970,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="2882">
+      <OrphaCode>3225</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3225</ExpertLink>
+      <Name lang="nl">Gehoorverlies - familiale insensitiviteit van speekselklier voor aldosteron-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17850">
+          <Source>2280149[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>2.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17851">
+          <Source>2280149[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="20354">
       <OrphaCode>276193</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=276193</ExpertLink>
@@ -155992,7 +159120,7 @@
     <Disorder id="2881">
       <OrphaCode>3224</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3224</ExpertLink>
-      <Name lang="nl">Doofheid - genitale anomalieën - metacarpale en metatarsale synostose-syndroom</Name>
+      <Name lang="nl">Doofheid - genitale anomalieÃ«n - metacarpale en metatarsale synostose-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -156331,7 +159459,7 @@
     <Disorder id="2895">
       <OrphaCode>3236</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3236</ExpertLink>
-      <Name lang="nl">Conductieve doofheid - ptosis - skeletanomalieën-syndroom</Name>
+      <Name lang="nl">Conductieve doofheid - ptosis - skeletanomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -156755,7 +159883,7 @@
     <Disorder id="2903">
       <OrphaCode>3246</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3246</ExpertLink>
-      <Name lang="nl">Symfalangisme met meervoudige anomalieën van handen en voeten</Name>
+      <Name lang="nl">Symfalangisme met meervoudige anomalieÃ«n van handen en voeten</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -156966,7 +160094,7 @@
     <Disorder id="2905">
       <OrphaCode>3248</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3248</ExpertLink>
-      <Name lang="nl">Geïsoleerd distaal symfalangisme</Name>
+      <Name lang="nl">GeÃ¯soleerd distaal symfalangisme</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -157128,7 +160256,7 @@
     <Disorder id="20383">
       <OrphaCode>276556</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=276556</ExpertLink>
-      <Name lang="nl">Hyperinsulinisme door UCP2-deficiëntie</Name>
+      <Name lang="nl">Hyperinsulinisme door UCP2-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -157324,7 +160452,7 @@
     <Disorder id="3280">
       <OrphaCode>911</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=911</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door ZAP70-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door ZAP70-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -157356,7 +160484,7 @@
     <Disorder id="3282">
       <OrphaCode>3325</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3325</ExpertLink>
-      <Name lang="nl">Heparinegeïnduceerde trombocytopenie</Name>
+      <Name lang="nl">HeparinegeÃ¯nduceerde trombocytopenie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -157388,7 +160516,7 @@
     <Disorder id="3294">
       <OrphaCode>746</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=746</ExpertLink>
-      <Name lang="nl">Deficiëntie van mitochondriaal trifunctioneel proteïne</Name>
+      <Name lang="nl">DeficiÃ«ntie van mitochondriaal trifunctioneel proteÃ¯ne</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -157537,7 +160665,7 @@
     <Disorder id="3271">
       <OrphaCode>2089</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2089</ExpertLink>
-      <Name lang="nl">Glycogeenstapelingsziekte door hepatische glycogeensynthasedeficiëntie</Name>
+      <Name lang="nl">Glycogeenstapelingsziekte door hepatische glycogeensynthasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -157586,7 +160714,7 @@
     <Disorder id="3264">
       <OrphaCode>412</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=412</ExpertLink>
-      <Name lang="nl">Dysbètalipoproteïnemie</Name>
+      <Name lang="nl">DysbÃ¨talipoproteÃ¯nemie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -157637,7 +160765,7 @@
     <Disorder id="3267">
       <OrphaCode>743</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=743</ExpertLink>
-      <Name lang="nl">Ernstige erfelijke trombofilie door congenitale proteïne S-deficiëntie</Name>
+      <Name lang="nl">Ernstige erfelijke trombofilie door congenitale proteÃ¯ne S-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -157688,7 +160816,7 @@
     <Disorder id="3266">
       <OrphaCode>424</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=424</ExpertLink>
-      <Name lang="nl">Familiale hyperthyreoïdie door mutaties in TSH-receptor</Name>
+      <Name lang="nl">Familiale hyperthyreoÃ¯die door mutaties in TSH-receptor</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -157737,7 +160865,7 @@
     <Disorder id="3277">
       <OrphaCode>325</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=325</ExpertLink>
-      <Name lang="nl">Congenitale factor II-deficiëntie</Name>
+      <Name lang="nl">Congenitale factor II-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -157818,7 +160946,7 @@
     <Disorder id="3279">
       <OrphaCode>572</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=572</ExpertLink>
-      <Name lang="nl">Immuundeficiëntie door verstoorde expressie van MHC klasse II</Name>
+      <Name lang="nl">ImmuundeficiÃ«ntie door verstoorde expressie van MHC klasse II</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -157956,7 +161084,7 @@
     <Disorder id="3316">
       <OrphaCode>158</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=158</ExpertLink>
-      <Name lang="nl">Systemische primaire carnitinedeficiëntie</Name>
+      <Name lang="nl">Systemische primaire carnitinedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -158102,7 +161230,7 @@
     <Disorder id="3313">
       <OrphaCode>2056</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2056</ExpertLink>
-      <Name lang="nl">Essentiële fructosurie</Name>
+      <Name lang="nl">EssentiÃ«le fructosurie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -158236,7 +161364,7 @@
     <Disorder id="18494">
       <OrphaCode>206428</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=206428</ExpertLink>
-      <Name lang="nl">Deficiëntie van hypoxanthine-guanine-fosforibosyltransferase</Name>
+      <Name lang="nl">DeficiÃ«ntie van hypoxanthine-guanine-fosforibosyltransferase</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -158268,7 +161396,7 @@
     <Disorder id="3321">
       <OrphaCode>1945</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1945</ExpertLink>
-      <Name lang="nl">Rolandische epilepsie</Name>
+      <Name lang="nl">Zelflimiterende epilepsie met centrotemporale pieken</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -158319,7 +161447,7 @@
     <Disorder id="3298">
       <OrphaCode>832</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=832</ExpertLink>
-      <Name lang="nl">Deficiëntie van succinyl-CoA:3-oxozuur-CoA-transferase</Name>
+      <Name lang="nl">DeficiÃ«ntie van succinyl-CoA:3-oxozuur-CoA-transferase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -158368,7 +161496,7 @@
     <Disorder id="3297">
       <OrphaCode>6</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=6</ExpertLink>
-      <Name lang="nl">Deficiëntie van 3-methylcrotonyl-CoA-carboxylase</Name>
+      <Name lang="nl">DeficiÃ«ntie van 3-methylcrotonyl-CoA-carboxylase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -158584,7 +161712,7 @@
     <Disorder id="3304">
       <OrphaCode>712</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=712</ExpertLink>
-      <Name lang="nl">Hemolytische anemie door deficiëntie van glucofosfaatisomerase</Name>
+      <Name lang="nl">Hemolytische anemie door deficiÃ«ntie van glucofosfaatisomerase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -159449,7 +162577,7 @@
     <Disorder id="3214">
       <OrphaCode>1655</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1655</ExpertLink>
-      <Name lang="nl">Mülleriaanse derivaten - lymfangiëctasie - polydactylie-syndroom</Name>
+      <Name lang="nl">MÃ¼lleriaanse derivaten - lymfangiÃ«ctasie - polydactylie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -159889,6 +163017,57 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="3258">
+      <OrphaCode>229</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=229</ExpertLink>
+      <Name lang="nl">Familiale aortadissectie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17842">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17843">
+          <Source>28722992[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.4</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="3256">
       <OrphaCode>777</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=777</ExpertLink>
@@ -159924,7 +163103,7 @@
     <Disorder id="3257">
       <OrphaCode>766</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=766</ExpertLink>
-      <Name lang="nl">Hemolytische anemie door deficiëntie van pyruvaatkinase in rode bloedcellen</Name>
+      <Name lang="nl">Hemolytische anemie door deficiÃ«ntie van pyruvaatkinase in rode bloedcellen</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -160107,7 +163286,7 @@
     <Disorder id="18531">
       <OrphaCode>206599</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=206599</ExpertLink>
-      <Name lang="nl">Geïsoleerde asymptomatische verhoging van creatinefosfokinase</Name>
+      <Name lang="nl">GeÃ¯soleerde asymptomatische verhoging van creatinefosfokinase</Name>
       <DisorderType id="21408">
         <Name lang="nl">Biologische anomalie</Name>
       </DisorderType>
@@ -160139,7 +163318,7 @@
     <Disorder id="3233">
       <OrphaCode>3206</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3206</ExpertLink>
-      <Name lang="nl">Syndroom van Stüve-Wiedemann</Name>
+      <Name lang="nl">Syndroom van StÃ¼ve-Wiedemann</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -160450,38 +163629,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="3245">
-      <OrphaCode>144</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=144</ExpertLink>
-      <Name lang="nl">Syndroom van Lynch</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="4358">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="18540">
       <OrphaCode>206647</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=206647</ExpertLink>
@@ -160723,6 +163870,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="3245">
+      <OrphaCode>144</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=144</ExpertLink>
+      <Name lang="nl">Syndroom van Lynch</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="4358">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="3244">
       <OrphaCode>110</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=110</ExpertLink>
@@ -160812,6 +163991,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="3164">
+      <OrphaCode>3095</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3095</ExpertLink>
+      <Name lang="nl">Atypisch syndroom van Rett</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17866">
+          <Source>32984552[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="3167">
       <OrphaCode>2326</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2326</ExpertLink>
@@ -161158,7 +164369,7 @@
     <Disorder id="3149">
       <OrphaCode>2015</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2015</ExpertLink>
-      <Name lang="nl">Gespleten gehemelte - kleine gestalte - vertebrale anomalieën-syndroom</Name>
+      <Name lang="nl">Gespleten gehemelte - kleine gestalte - vertebrale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -161305,7 +164516,7 @@
     <Disorder id="3143">
       <OrphaCode>2349</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2349</ExpertLink>
-      <Name lang="nl">Musculaire pseudohypertrofie - hypothyreoïdie-syndroom</Name>
+      <Name lang="nl">Musculaire pseudohypertrofie - hypothyreoÃ¯die-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -161556,7 +164767,7 @@
     <Disorder id="3191">
       <OrphaCode>1101</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1101</ExpertLink>
-      <Name lang="nl">Anoftalmie - megalocornea - cardiopathie - skeletale anomalieën-syndroom</Name>
+      <Name lang="nl">Anoftalmie - megalocornea - cardiopathie - skeletale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -161654,7 +164865,7 @@
     <Disorder id="18613">
       <OrphaCode>208650</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=208650</ExpertLink>
-      <Name lang="nl">Cryopyrine-geassocieerd periodiek syndroom</Name>
+      <Name lang="nl">NLRP3-geassocieerde auto-inflammatoire ziekte</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -161683,10 +164894,42 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="3188">
+      <OrphaCode>1779</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1779</ExpertLink>
+      <Name lang="nl">Dysmorfie - gespleten verhemelte - slappe huid</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17854">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="3187">
       <OrphaCode>1272</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1272</ExpertLink>
-      <Name lang="nl">Syndroom van Aymé-Gripp</Name>
+      <Name lang="nl">Syndroom van AymÃ©-Gripp</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -161882,7 +165125,7 @@
     <Disorder id="3181">
       <OrphaCode>1134</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1134</ExpertLink>
-      <Name lang="nl">Geïsoleerde arrhinie</Name>
+      <Name lang="nl">GeÃ¯soleerde arrhinie</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -162029,12 +165272,12 @@
     <Disorder id="3173">
       <OrphaCode>2963</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2963</ExpertLink>
-      <Name lang="nl">Progeroïd syndroom, Petty-type</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
+      <Name lang="nl">ProgeroÃ¯d syndroom, Petty-type</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="12821">
@@ -162531,6 +165774,57 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="3075">
+      <OrphaCode>1759</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1759</ExpertLink>
+      <Name lang="nl">Thoraco-abdominale enterische duplicatie</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17844">
+          <Source>34890978[PMID]</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.4</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17845">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="18682">
       <OrphaCode>210110</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=210110</ExpertLink>
@@ -162759,38 +166053,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="18681">
-      <OrphaCode>209989</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=209989</ExpertLink>
-      <Name lang="nl">Niet-papillair overgangscelcarcinoom van blaas</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="8694">
-          <Source>European Medicines Agency 2009[INST]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
-          </PrevalenceClass>
-          <ValMoy>37.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="3128">
       <OrphaCode>1459</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1459</ExpertLink>
@@ -163139,7 +166401,7 @@
     <Disorder id="18674">
       <OrphaCode>209959</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=209959</ExpertLink>
-      <Name lang="nl">Faco-anafylactische uveïtis</Name>
+      <Name lang="nl">Faco-anafylactische uveÃ¯tis</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -163499,7 +166761,7 @@
     <Disorder id="18667">
       <OrphaCode>209908</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=209908</ExpertLink>
-      <Name lang="nl">Geïsoleerde spraakapraxie op kinderleeftijd</Name>
+      <Name lang="nl">GeÃ¯soleerde spraakapraxie op kinderleeftijd</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -163597,7 +166859,7 @@
     <Disorder id="18665">
       <OrphaCode>209902</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=209902</ExpertLink>
-      <Name lang="nl">Hypercholesterolemie door deficiëntie van cholesterol-7-alfa-hydroxylase</Name>
+      <Name lang="nl">Hypercholesterolemie door deficiÃ«ntie van cholesterol-7-alfa-hydroxylase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -163825,7 +167087,7 @@
     <Disorder id="18668">
       <OrphaCode>209916</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=209916</ExpertLink>
-      <Name lang="nl">Extraskeletaal myxoïd chondrosarcoom</Name>
+      <Name lang="nl">Extraskeletaal myxoÃ¯d chondrosarcoom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -163906,7 +167168,7 @@
     <Disorder id="18656">
       <OrphaCode>209370</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=209370</ExpertLink>
-      <Name lang="nl">Ernstige neonataal optredende encefalopathie met microcefalie</Name>
+      <Name lang="nl">MECP2-gerelateerde ernstige neonatale encefalopathie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -164085,7 +167347,7 @@
     <Disorder id="18692">
       <OrphaCode>210272</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=210272</ExpertLink>
-      <Name lang="nl">Mal de débarquement</Name>
+      <Name lang="nl">Mal de dÃ©barquement</Name>
       <DisorderType id="21422">
         <Name lang="nl">Klinisch syndroom</Name>
       </DisorderType>
@@ -165529,7 +168791,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="3">
         <Prevalence id="4676">
           <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
@@ -165549,6 +168811,44 @@
             <Name lang="nl">Not yet validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17826">
+          <Source>24244780[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.09</ValMoy>
+          <PrevalenceGeographic id="25307">
+            <Name lang="nl">Sudan</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17827">
+          <Source>24244780[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.2</ValMoy>
+          <PrevalenceGeographic id="24824">
+            <Name lang="nl">Mauritania</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="3536">
@@ -165703,7 +169003,7 @@
     <Disorder id="3551">
       <OrphaCode>656</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=656</ExpertLink>
-      <Name lang="nl">Genetisch steroïdresistent nefrotisch syndroom</Name>
+      <Name lang="nl">Hereditair steroÃ¯dresistent nefrotisch syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -166250,7 +169550,7 @@
     <Disorder id="3559">
       <OrphaCode>2968</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2968</ExpertLink>
-      <Name lang="nl">Deficiëntie van leukocytenadhesie</Name>
+      <Name lang="nl">DeficiÃ«ntie van leukocytenadhesie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -166450,7 +169750,7 @@
     <Disorder id="3555">
       <OrphaCode>5</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=5</ExpertLink>
-      <Name lang="nl">Lange keten 3-hydroxyacyl-CoA-dehydrogenasedeficiëntie</Name>
+      <Name lang="nl">Lange keten 3-hydroxyacyl-CoA-dehydrogenasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -166691,7 +169991,7 @@
     <Disorder id="3565">
       <OrphaCode>85</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85</ExpertLink>
-      <Name lang="nl">Congenitale dyserytropoëtische anemie</Name>
+      <Name lang="nl">Congenitale dyserytropoÃ«tische anemie</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -166778,7 +170078,7 @@
     <Disorder id="3564">
       <OrphaCode>25</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=25</ExpertLink>
-      <Name lang="nl">Glutaryl-CoA-dehydrogenasedeficiëntie</Name>
+      <Name lang="nl">Glutaryl-CoA-dehydrogenasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -167183,7 +170483,7 @@
     <Disorder id="18741">
       <OrphaCode>213500</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=213500</ExpertLink>
-      <Name lang="nl">Ovariumkanker</Name>
+      <Name lang="nl">Zeldzame ovariumkanker</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -167380,7 +170680,7 @@
     <Disorder id="18743">
       <OrphaCode>213512</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=213512</ExpertLink>
-      <Name lang="nl">Maligne mengtumor van Müller van ovarium</Name>
+      <Name lang="nl">Maligne mengtumor van MÃ¼ller van ovarium</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -168002,7 +171302,7 @@
     <Disorder id="3570">
       <OrphaCode>42</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=42</ExpertLink>
-      <Name lang="nl">Middellange keten acyl-CoA-dehydrogenasedeficiëntie</Name>
+      <Name lang="nl">Middellange keten acyl-CoA-dehydrogenasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -168011,7 +171311,7 @@
       </DisorderGroup>
       <PrevalenceList count="19">
         <Prevalence id="4743">
-          <Source>Haute Autorité de Santé 2011[INST]</Source>
+          <Source>Haute AutoritÃ© de SantÃ© 2011[INST]</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -168826,7 +172126,7 @@
     <Disorder id="3577">
       <OrphaCode>2066</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2066</ExpertLink>
-      <Name lang="nl">Deficiëntie van gamma-aminoboterzuurtransaminase</Name>
+      <Name lang="nl">DeficiÃ«ntie van gamma-aminoboterzuurtransaminase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -170919,247 +174219,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="3469">
-      <OrphaCode>1572</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1572</ExpertLink>
-      <Name lang="nl">Gewone variabele immuundeficiëntie</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="12">
-        <Prevalence id="4619">
-          <Source>[EXPERT]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>4.0</ValMoy>
-          <PrevalenceGeographic id="23851">
-            <Name lang="nl">Specifieke populatie</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="4620">
-          <Source>22288591[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>2.3</ValMoy>
-          <PrevalenceGeographic id="24936">
-            <Name lang="nl">Netherlands</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="4621">
-          <Source>22288591[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.98</ValMoy>
-          <PrevalenceGeographic id="24369">
-            <Name lang="nl">France</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="4622">
-          <Source>22288591[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.66</ValMoy>
-          <PrevalenceGeographic id="25293">
-            <Name lang="nl">Spain</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="4623">
-          <Source>22288591[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.87</ValMoy>
-          <PrevalenceGeographic id="24936">
-            <Name lang="nl">Netherlands</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="4624">
-          <Source>22288591[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.6</ValMoy>
-          <PrevalenceGeographic id="25475">
-            <Name lang="nl">United Kingdom</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="4625">
-          <Source>22288591[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.72</ValMoy>
-          <PrevalenceGeographic id="24607">
-            <Name lang="nl">Italy</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="4626">
-          <Source>22288591[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.52</ValMoy>
-          <PrevalenceGeographic id="24418">
-            <Name lang="nl">Germany</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="4627">
-          <Source>22288591[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.1</ValMoy>
-          <PrevalenceGeographic id="25426">
-            <Name lang="nl">Turkey</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="4628">
-          <Source>22288591[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.073</ValMoy>
-          <PrevalenceGeographic id="25083">
-            <Name lang="nl">Poland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="4629">
-          <Source>9314356[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.77</ValMoy>
-          <PrevalenceGeographic id="23949">
-            <Name lang="nl">Australia</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="4630">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="3468">
       <OrphaCode>3261</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3261</ExpertLink>
@@ -171221,7 +174280,7 @@
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="4631">
-          <Source>ORPHANET</Source>
+          <Source>18780370[PMID]_28328139[PMID]_38161545[PMID]_34964966[PMID]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
           </PrevalenceType>
@@ -171229,7 +174288,7 @@
             <Name lang="nl">Geval(len)</Name>
           </PrevalenceQualification>
           <PrevalenceClass/>
-          <ValMoy>30.0</ValMoy>
+          <ValMoy>32.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -171238,7 +174297,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="4632">
-          <Source>ORPHANET</Source>
+          <Source>18780370[PMID]_28328139[PMID]_38161545[PMID]_34964966[PMID]_ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -172295,7 +175354,7 @@
     <Disorder id="3482">
       <OrphaCode>747</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=747</ExpertLink>
-      <Name lang="nl">Auto-immune pulmonale alveolaire proteïnose</Name>
+      <Name lang="nl">Auto-immune pulmonale alveolaire proteÃ¯nose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -172546,7 +175605,7 @@
     <Disorder id="3489">
       <OrphaCode>3269</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3269</ExpertLink>
-      <Name lang="nl">Geïsoleerde radio-ulnaire synostose</Name>
+      <Name lang="nl">GeÃ¯soleerde radio-ulnaire synostose</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -172644,7 +175703,7 @@
     <Disorder id="3491">
       <OrphaCode>3309</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3309</ExpertLink>
-      <Name lang="nl">Tetrasomie 5p</Name>
+      <Name lang="nl">Tetrasomie 5p-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -173082,7 +176141,7 @@
     <Disorder id="18789">
       <OrphaCode>216718</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=216718</ExpertLink>
-      <Name lang="nl">Geïsoleerde congenitaal ongecorrigeerde transpositie van grote slagaders</Name>
+      <Name lang="nl">GeÃ¯soleerde congenitaal ongecorrigeerde transpositie van grote slagaders</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -173737,7 +176796,7 @@
     <Disorder id="3506">
       <OrphaCode>361</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=361</ExpertLink>
-      <Name lang="nl">Familiale glucocorticoïddeficiëntie</Name>
+      <Name lang="nl">Familiale glucocorticoÃ¯ddeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -174685,7 +177744,7 @@
     <Disorder id="3401">
       <OrphaCode>3162</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3162</ExpertLink>
-      <Name lang="nl">Syndroom van Sézary</Name>
+      <Name lang="nl">Syndroom van SÃ©zary</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -174806,7 +177865,7 @@
     <Disorder id="18823">
       <OrphaCode>217080</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=217080</ExpertLink>
-      <Name lang="nl">Pulmonale fungale infecties bij risicopatiënten</Name>
+      <Name lang="nl">Pulmonale fungale infecties bij risicopatiÃ«nten</Name>
       <DisorderType id="21429">
         <Name lang="nl">Particulaire klinische situatie binnen een ziekte of syndroom</Name>
       </DisorderType>
@@ -175174,7 +178233,7 @@
     <Disorder id="18818">
       <OrphaCode>217059</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=217059</ExpertLink>
-      <Name lang="nl">Geïsoleerde horlogeglasnagel</Name>
+      <Name lang="nl">GeÃ¯soleerde horlogeglasnagel</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -175432,7 +178491,7 @@
     <Disorder id="18845">
       <OrphaCode>217330</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=217330</ExpertLink>
-      <Name lang="nl">REN-gerelateerde autosomaal dominante tubulo-interstitiële nierziekte</Name>
+      <Name lang="nl">REN-gerelateerde autosomaal dominante tubulo-interstitiÃ«le nierziekte</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -176198,7 +179257,7 @@
     <Disorder id="18860">
       <OrphaCode>217557</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=217557</ExpertLink>
-      <Name lang="nl">Pulmonale interstitiële glycogenose</Name>
+      <Name lang="nl">Pulmonale interstitiÃ«le glycogenose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -176262,7 +179321,7 @@
     <Disorder id="18862">
       <OrphaCode>217563</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=217563</ExpertLink>
-      <Name lang="nl">Neonatale acute ademnood door SP-B-deficiëntie</Name>
+      <Name lang="nl">Neonataal acuut ademhalingsnoodsyndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -176806,7 +179865,7 @@
     <Disorder id="18853">
       <OrphaCode>217390</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=217390</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie als gevolg van DOCK8-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie als gevolg van DOCK8-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -177066,7 +180125,7 @@
     <Disorder id="18849">
       <OrphaCode>217371</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=217371</ExpertLink>
-      <Name lang="nl">Acuut infantiel leverfalen door synthesedefect van mtDNA-gecodeerde proteïnen</Name>
+      <Name lang="nl">Acuut infantiel leverfalen door synthesedefect van mtDNA-gecodeerde proteÃ¯nen</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -177215,7 +180274,7 @@
     <Disorder id="18851">
       <OrphaCode>217382</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=217382</ExpertLink>
-      <Name lang="nl">Neurodegeneratief syndroom door deficiëntie van cerebraal folaattransport</Name>
+      <Name lang="nl">Neurodegeneratief syndroom door deficiÃ«ntie van cerebraal folaattransport</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -177579,7 +180638,7 @@
     <Disorder id="3445">
       <OrphaCode>439</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=439</ExpertLink>
-      <Name lang="nl">Geïsoleerde rechterventrikelhypoplasie</Name>
+      <Name lang="nl">GeÃ¯soleerde rechterventrikelhypoplasie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -177611,7 +180670,7 @@
     <Disorder id="3444">
       <OrphaCode>422</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=422</ExpertLink>
-      <Name lang="nl">Idiopathische/erfelijke pulmonale arteriële hypertensie</Name>
+      <Name lang="nl">Idiopathische/erfelijke pulmonale arteriÃ«le hypertensie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -177808,7 +180867,7 @@
     <Disorder id="3443">
       <OrphaCode>2041</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2041</ExpertLink>
-      <Name lang="nl">Coronaire arteriële fistel</Name>
+      <Name lang="nl">Coronaire arteriÃ«le fistel</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -177891,7 +180950,7 @@
     <Disorder id="3336">
       <OrphaCode>331</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=331</ExpertLink>
-      <Name lang="nl">Congenitale factor XIII-deficiëntie</Name>
+      <Name lang="nl">Congenitale factor XIII-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -177942,7 +181001,7 @@
     <Disorder id="3343">
       <OrphaCode>159</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=159</ExpertLink>
-      <Name lang="nl">Deficiëntie van carnitine-acylcarnitine translocase</Name>
+      <Name lang="nl">DeficiÃ«ntie van carnitine-acylcarnitine translocase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -178093,7 +181152,7 @@
     <Disorder id="3331">
       <OrphaCode>335</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=335</ExpertLink>
-      <Name lang="nl">Congenitale deficiëntie van fibrinogeen</Name>
+      <Name lang="nl">Congenitale deficiÃ«ntie van fibrinogeen</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -178125,7 +181184,7 @@
     <Disorder id="3335">
       <OrphaCode>79</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79</ExpertLink>
-      <Name lang="nl">Congenitale deficiëntie van alfa2-antiplasmine</Name>
+      <Name lang="nl">Congenitale deficiÃ«ntie van alfa2-antiplasmine</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -178174,7 +181233,7 @@
     <Disorder id="18885">
       <OrphaCode>217656</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=217656</ExpertLink>
-      <Name lang="nl">Erfelijke geïsoleerde aritmogene cardiomyopathie</Name>
+      <Name lang="nl">Erfelijke geÃ¯soleerde aritmogene cardiomyopathie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -178610,7 +181669,7 @@
     <Disorder id="3359">
       <OrphaCode>332</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=332</ExpertLink>
-      <Name lang="nl">Congenitale deficiëntie van intrinsieke factor</Name>
+      <Name lang="nl">Congenitale deficiÃ«ntie van intrinsieke factor</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -178659,7 +181718,7 @@
     <Disorder id="18910">
       <OrphaCode>220448</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=220448</ExpertLink>
-      <Name lang="nl">Macrotrombocytopenie met mitralisklepinsufficiëntie</Name>
+      <Name lang="nl">Macrotrombocytopenie met mitralisklepinsufficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -178810,7 +181869,7 @@
     <Disorder id="3351">
       <OrphaCode>2170</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2170</ExpertLink>
-      <Name lang="nl">Deficiëntie van methylcobalamine type cblG</Name>
+      <Name lang="nl">DeficiÃ«ntie van methylcobalamine type cblG</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -179025,7 +182084,7 @@
     <Disorder id="3370">
       <OrphaCode>927</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=927</ExpertLink>
-      <Name lang="nl">Hyperammoniëmie door deficiëntie van N-acetylglutamaatsynthetase</Name>
+      <Name lang="nl">HyperammoniÃ«mie door deficiÃ«ntie van N-acetylglutamaatsynthetase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -179074,7 +182133,7 @@
     <Disorder id="3374">
       <OrphaCode>2880</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2880</ExpertLink>
-      <Name lang="nl">Deficiëntie van fosfo-enolpyruvaat-carboxykinase</Name>
+      <Name lang="nl">DeficiÃ«ntie van fosfo-enolpyruvaat-carboxykinase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -179155,7 +182214,7 @@
     <Disorder id="18913">
       <OrphaCode>220465</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=220465</ExpertLink>
-      <Name lang="nl">Syndroom van Laron met immuundeficiëntie</Name>
+      <Name lang="nl">Syndroom van Laron met immuundeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -179434,7 +182493,7 @@
     <Disorder id="3366">
       <OrphaCode>470</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=470</ExpertLink>
-      <Name lang="nl">Lysinurische proteïne-intolerantie</Name>
+      <Name lang="nl">Lysinurische proteÃ¯ne-intolerantie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -180144,7 +183203,7 @@
     <Disorder id="3391">
       <OrphaCode>1578</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1578</ExpertLink>
-      <Name lang="nl">Deficiëntie van pterine-4-alfa-carbinolaminedehydratase</Name>
+      <Name lang="nl">DeficiÃ«ntie van pterine-4-alfa-carbinolaminedehydratase</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -180193,7 +183252,7 @@
     <Disorder id="3377">
       <OrphaCode>3208</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3208</ExpertLink>
-      <Name lang="nl">Geïsoleerde succinaat-CoQ-reductasedeficiëntie</Name>
+      <Name lang="nl">GeÃ¯soleerde succinaat-CoQ-reductasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -180291,7 +183350,7 @@
     <Disorder id="3376">
       <OrphaCode>24</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=24</ExpertLink>
-      <Name lang="nl">Fumarasedeficiëntie</Name>
+      <Name lang="nl">FumarasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -180585,7 +183644,7 @@
     <Disorder id="3383">
       <OrphaCode>745</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=745</ExpertLink>
-      <Name lang="nl">Ernstige erfelijke trombofilie als gevolg van congenitale proteïne C-deficiëntie</Name>
+      <Name lang="nl">Ernstige erfelijke trombofilie als gevolg van congenitale proteÃ¯ne C-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -181011,7 +184070,7 @@
     <Disorder id="18947">
       <OrphaCode>221139</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=221139</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie met facio-oculoskeletale anomalieën</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie met facio-oculoskeletale anomalieÃ«n</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -181109,7 +184168,7 @@
     <Disorder id="18949">
       <OrphaCode>221145</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=221145</ExpertLink>
-      <Name lang="nl">Cutis laxa met ernstige pulmonale, gastro-intestinale en urinaire anomalieën</Name>
+      <Name lang="nl">Cutis laxa met ernstige pulmonale, gastro-intestinale en urinaire anomalieÃ«n</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -181158,7 +184217,7 @@
     <Disorder id="19062">
       <OrphaCode>228003</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228003</ExpertLink>
-      <Name lang="nl">Ernstige gecombineerde immuundeficiëntie als gevolg van CORO1A-deficiëntie</Name>
+      <Name lang="nl">Ernstige gecombineerde immuundeficiÃ«ntie als gevolg van CORO1A-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -181611,7 +184670,7 @@
     <Disorder id="19071">
       <OrphaCode>228123</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228123</ExpertLink>
-      <Name lang="nl">Coccidioïdomycose</Name>
+      <Name lang="nl">CoccidioÃ¯domycose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -183031,7 +186090,7 @@
     <Disorder id="19029">
       <OrphaCode>226292</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=226292</ExpertLink>
-      <Name lang="nl">Permanente congenitale hypothyreoïdie</Name>
+      <Name lang="nl">Permanente congenitale hypothyreoÃ¯die</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -183241,7 +186300,7 @@
     <Disorder id="19031">
       <OrphaCode>226298</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=226298</ExpertLink>
-      <Name lang="nl">Centrale congenitale hypothyreoïdie</Name>
+      <Name lang="nl">Centrale congenitale hypothyreoÃ¯die</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -183356,7 +186415,7 @@
     <Disorder id="19030">
       <OrphaCode>226295</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=226295</ExpertLink>
-      <Name lang="nl">Primaire congenitale hypothyreoïdie</Name>
+      <Name lang="nl">Primaire congenitale hypothyreoÃ¯die</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -183978,7 +187037,7 @@
     <Disorder id="19033">
       <OrphaCode>226307</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=226307</ExpertLink>
-      <Name lang="nl">Hypothyreoïdie door deficiëntie van transcriptiefactoren betrokken bij ontwikkeling of functie van hypofyse</Name>
+      <Name lang="nl">HypothyreoÃ¯die door deficiÃ«ntie van transcriptiefactoren betrokken bij ontwikkeling of functie van hypofyse</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -184846,7 +187905,7 @@
     <Disorder id="3713">
       <OrphaCode>2542</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2542</ExpertLink>
-      <Name lang="nl">Geïsoleerde microftalmie - anoftalmie - coloboom</Name>
+      <Name lang="nl">GeÃ¯soleerde microftalmie - anoftalmie - coloboom</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -185243,7 +188302,7 @@
     <Disorder id="19131">
       <OrphaCode>228423</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228423</ExpertLink>
-      <Name lang="nl">GATA2-deficiëntie-spectrum</Name>
+      <Name lang="nl">GATA2-deficiÃ«ntie-spectrum</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -185292,7 +188351,7 @@
     <Disorder id="3705">
       <OrphaCode>521</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=521</ExpertLink>
-      <Name lang="nl">Chronische myeloïde leukemie</Name>
+      <Name lang="nl">Chronische myeloÃ¯de leukemie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -185449,7 +188508,7 @@
     <Disorder id="3704">
       <OrphaCode>132</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=132</ExpertLink>
-      <Name lang="nl">Hereditaire deficiëntie van butyrylcholinesterase</Name>
+      <Name lang="nl">Hereditaire deficiÃ«ntie van butyrylcholinesterase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -185482,8 +188541,8 @@
       <OrphaCode>1172</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1172</ExpertLink>
       <Name lang="nl">Autosomaal recessieve cerebellaire ataxie</Name>
-      <DisorderType id="36561">
-        <Name lang="nl">Categorie</Name>
+      <DisorderType id="21436">
+        <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
       <DisorderGroup id="36540">
         <Name lang="nl">Groep van aandoeningen</Name>
@@ -185589,7 +188648,7 @@
     <Disorder id="19134">
       <OrphaCode>229717</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=229717</ExpertLink>
-      <Name lang="nl">Geïsoleerde agammaglobulinemie</Name>
+      <Name lang="nl">Niet-syndromale agammaglobulinemie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -185621,7 +188680,7 @@
     <Disorder id="19132">
       <OrphaCode>228426</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228426</ExpertLink>
-      <Name lang="nl">Syndromale multisystemische auto-immuunziekte door Itch-deficiëntie</Name>
+      <Name lang="nl">Syndromale multisystemische auto-immuunziekte door Itch-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -185670,7 +188729,7 @@
     <Disorder id="3709">
       <OrphaCode>2345</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2345</ExpertLink>
-      <Name lang="nl">Geïsoleerd syndroom van Klippel-Feil</Name>
+      <Name lang="nl">GeÃ¯soleerd syndroom van Klippel-Feil</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -185851,7 +188910,7 @@
     <Disorder id="19121">
       <OrphaCode>228390</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228390</ExpertLink>
-      <Name lang="nl">Frontonasale dysplasie - alopecie - genitale anomalieën-syndroom</Name>
+      <Name lang="nl">Frontonasale dysplasie - alopecie - genitale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -185900,7 +188959,7 @@
     <Disorder id="19127">
       <OrphaCode>228410</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228410</ExpertLink>
-      <Name lang="nl">Hartanomalieën - kleine gestalte - gewrichtshypermobiliteit - faciale dysmorfie-syndroom</Name>
+      <Name lang="nl">HartanomalieÃ«n - kleine gestalte - gewrichtshypermobiliteit - faciale dysmorfie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -186331,6 +189390,104 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="19106">
+      <OrphaCode>228337</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228337</ExpertLink>
+      <Name lang="nl">CLN10-ziekte</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17949">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>11.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17950">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="19105">
+      <OrphaCode>228329</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228329</ExpertLink>
+      <Name lang="nl">CLN1-ziekte</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17847">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>200.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17848">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="19096">
       <OrphaCode>228290</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228290</ExpertLink>
@@ -186430,7 +189587,7 @@
     <Disorder id="19099">
       <OrphaCode>228302</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228302</ExpertLink>
-      <Name lang="nl">Carnitinepalmitoyltransferase II-deficiëntie, myopathische vorm</Name>
+      <Name lang="nl">Carnitinepalmitoyltransferase II-deficiÃ«ntie, myopathische vorm</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -186479,7 +189636,7 @@
     <Disorder id="19100">
       <OrphaCode>228305</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228305</ExpertLink>
-      <Name lang="nl">Carnitinepalmitoyltransferase II-deficiëntie, ernstige infantiele vorm</Name>
+      <Name lang="nl">Carnitinepalmitoyltransferase II-deficiÃ«ntie, ernstige infantiele vorm</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -186528,7 +189685,7 @@
     <Disorder id="19101">
       <OrphaCode>228308</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228308</ExpertLink>
-      <Name lang="nl">Carnitinepalmitoyltransferase II-deficiëntie, neonatale vorm</Name>
+      <Name lang="nl">Carnitinepalmitoyltransferase II-deficiÃ«ntie, neonatale vorm</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -186933,7 +190090,7 @@
     <Disorder id="19081">
       <OrphaCode>228190</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228190</ExpertLink>
-      <Name lang="nl">Persisterende ductus arteriosus - bicuspide aortaklep - handanomalieën-syndroom</Name>
+      <Name lang="nl">Persisterende ductus arteriosus - bicuspide aortaklep - handanomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -187038,7 +190195,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="4">
         <Prevalence id="4827">
           <Source>ORPHANET_9718354[PMID]_11001917[PMID]_23479567[PMID]</Source>
           <PrevalenceType id="23669">
@@ -187059,7 +190216,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="11040">
-          <Source>9718354[PMID]_11001917[PMID]_23479567[PMID]_Pr Loïc GARÇON_Dr Véronique PICARD[EXPERT]</Source>
+          <Source>9718354[PMID]_11001917[PMID]_23479567[PMID]_Pr LoÃ¯c GARÃON_Dr VÃ©ronique PICARD[EXPERT]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
           </PrevalenceType>
@@ -187075,6 +190232,44 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17739">
+          <Source>39400415[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.7</ValMoy>
+          <PrevalenceGeographic id="24264">
+            <Name lang="nl">Denmark</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17740">
+          <Source>31308777[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.1</ValMoy>
+          <PrevalenceGeographic id="23809">
+            <Name lang="nl">Noord-Amerika</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="19087">
@@ -187242,7 +190437,7 @@
     <Disorder id="19075">
       <OrphaCode>228165</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228165</ExpertLink>
-      <Name lang="nl">Concentrische sclerose van Baló</Name>
+      <Name lang="nl">Concentrische sclerose van BalÃ³</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -187274,7 +190469,7 @@
     <Disorder id="3651">
       <OrphaCode>306</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=306</ExpertLink>
-      <Name lang="nl">Goedaardige familiale infantiele epilepsie</Name>
+      <Name lang="nl">Zelflimiterende infantiele epilepsie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -187338,7 +190533,7 @@
     <Disorder id="3652">
       <OrphaCode>328</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=328</ExpertLink>
-      <Name lang="nl">Congenitale factor X-deficiëntie</Name>
+      <Name lang="nl">Congenitale factor X-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -187632,7 +190827,7 @@
     <Disorder id="19198">
       <OrphaCode>231531</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=231531</ExpertLink>
-      <Name lang="nl">Syndroom van Hermansky-Pudlak door deficiëntie van BLOC-1</Name>
+      <Name lang="nl">Syndroom van Hermansky-Pudlak door deficiÃ«ntie van BLOC-1</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -187681,7 +190876,7 @@
     <Disorder id="19196">
       <OrphaCode>231512</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=231512</ExpertLink>
-      <Name lang="nl">Syndroom van Hermansky-Pudlak door deficiëntie van BLOC-2</Name>
+      <Name lang="nl">Syndroom van Hermansky-Pudlak door deficiÃ«ntie van BLOC-2</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -187853,7 +191048,7 @@
     <Disorder id="19195">
       <OrphaCode>231500</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=231500</ExpertLink>
-      <Name lang="nl">Syndroom van Hermansky-Pudlak door deficiëntie van BLOC-3</Name>
+      <Name lang="nl">Syndroom van Hermansky-Pudlak door deficiÃ«ntie van BLOC-3</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -187949,7 +191144,7 @@
     <Disorder id="19190">
       <OrphaCode>231445</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=231445</ExpertLink>
-      <Name lang="nl">Paraparetische variant van syndroom van Guillain-Barré</Name>
+      <Name lang="nl">Paraparetische variant van syndroom van Guillain-BarrÃ©</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -188360,7 +191555,7 @@
     <Disorder id="19182">
       <OrphaCode>231393</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=231393</ExpertLink>
-      <Name lang="nl">Bèta-thalassemie - X-gebonden trombocytopenie-syndroom</Name>
+      <Name lang="nl">BÃ¨ta-thalassemie - X-gebonden trombocytopenie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -188551,7 +191746,7 @@
     <Disorder id="19177">
       <OrphaCode>231249</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=231249</ExpertLink>
-      <Name lang="nl">Hemoglobine E - bèta-thalassemie-syndroom</Name>
+      <Name lang="nl">Hemoglobine E - bÃ¨ta-thalassemie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -188583,7 +191778,7 @@
     <Disorder id="19176">
       <OrphaCode>231242</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=231242</ExpertLink>
-      <Name lang="nl">Hemoglobine C - bèta-thalassemie-syndroom</Name>
+      <Name lang="nl">Hemoglobine C - bÃ¨ta-thalassemie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -188666,7 +191861,7 @@
     <Disorder id="19175">
       <OrphaCode>231237</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=231237</ExpertLink>
-      <Name lang="nl">Delta-bèta-thalassemie</Name>
+      <Name lang="nl">Delta-bÃ¨ta-thalassemie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -188698,7 +191893,7 @@
     <Disorder id="19173">
       <OrphaCode>231226</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=231226</ExpertLink>
-      <Name lang="nl">Dominante bèta-thalassemie</Name>
+      <Name lang="nl">Dominante bÃ¨ta-thalassemie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -189185,7 +192380,7 @@
     <Disorder id="19165">
       <OrphaCode>231154</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=231154</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie als gevolg van partiële RAG1-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie als gevolg van partiÃ«le RAG1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -189368,7 +192563,7 @@
     <Disorder id="19152">
       <OrphaCode>231080</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=231080</ExpertLink>
-      <Name lang="nl">Hooggradige dysplasie bij patiënten met Barrett-oesofagus</Name>
+      <Name lang="nl">Hooggradige dysplasie bij patiÃ«nten met Barrett-oesofagus</Name>
       <DisorderType id="21429">
         <Name lang="nl">Particulaire klinische situatie binnen een ziekte of syndroom</Name>
       </DisorderType>
@@ -189400,7 +192595,7 @@
     <Disorder id="19153">
       <OrphaCode>231108</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=231108</ExpertLink>
-      <Name lang="nl">Syndroom van predispositie voor rhabdoïde tumor</Name>
+      <Name lang="nl">Syndroom van predispositie voor rhabdoÃ¯de tumor</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -189449,7 +192644,7 @@
     <Disorder id="3600">
       <OrphaCode>405</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=405</ExpertLink>
-      <Name lang="nl">Familiale hypocalciurische hypercalciëmie</Name>
+      <Name lang="nl">Familiale hypocalciurische hypercalciÃ«mie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -189481,7 +192676,7 @@
     <Disorder id="19154">
       <OrphaCode>231111</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=231111</ExpertLink>
-      <Name lang="nl">Medicatiegeïnduceerde lupus erythematosus</Name>
+      <Name lang="nl">MedicatiegeÃ¯nduceerde lupus erythematosus</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -189577,7 +192772,7 @@
     <Disorder id="3599">
       <OrphaCode>3318</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3318</ExpertLink>
-      <Name lang="nl">Essentiële trombocytemie</Name>
+      <Name lang="nl">EssentiÃ«le trombocytemie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -189989,7 +193184,7 @@
     <Disorder id="3590">
       <OrphaCode>82</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=82</ExpertLink>
-      <Name lang="nl">Erfelijke trombofilie als gevolg van congenitale antitrombinedeficiëntie</Name>
+      <Name lang="nl">Erfelijke trombofilie als gevolg van congenitale antitrombinedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -190070,7 +193265,7 @@
     <Disorder id="3586">
       <OrphaCode>519</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=519</ExpertLink>
-      <Name lang="nl">Acute myeloïde leukemie</Name>
+      <Name lang="nl">Acute myeloÃ¯de leukemie</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -190572,7 +193767,7 @@
     <Disorder id="4043">
       <OrphaCode>1900</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1900</ExpertLink>
-      <Name lang="nl">Kyfoscoliotisch syndroom van Ehlers-Danlos door lysylhydroxylase 1-deficiëntie</Name>
+      <Name lang="nl">Kyfoscoliotisch syndroom van Ehlers-Danlos door lysylhydroxylase 1-deficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -190736,7 +193931,7 @@
     <Disorder id="19215">
       <OrphaCode>231742</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=231742</ExpertLink>
-      <Name lang="nl">Epibulbair lipodermoïd - preauriculair aanhangsel - polythelie-syndroom</Name>
+      <Name lang="nl">Epibulbair lipodermoÃ¯d - preauriculair aanhangsel - polythelie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -190883,7 +194078,7 @@
     <Disorder id="19213">
       <OrphaCode>231720</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=231720</ExpertLink>
-      <Name lang="nl">Niet-verworven gecombineerde deficiëntie van hypofysehormonen - sensorineuraal gehoorverlies - afwijkingen van wervelkolom-syndroom</Name>
+      <Name lang="nl">Niet-verworven gecombineerde deficiÃ«ntie van hypofysehormonen - sensorineuraal gehoorverlies - afwijkingen van wervelkolom-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -191022,26 +194217,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="4942">
-          <Source>[EXPERT]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>1.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
+      <PrevalenceList count="1">
         <Prevalence id="4943">
           <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
@@ -191057,8 +194233,8 @@
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
       </PrevalenceList>
@@ -191136,7 +194312,7 @@
     <Disorder id="4058">
       <OrphaCode>1084</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1084</ExpertLink>
-      <Name lang="nl">Geïsoleerde lissencefalie type 1 zonder bekende genetische defecten</Name>
+      <Name lang="nl">GeÃ¯soleerde lissencefalie type 1 zonder bekende genetische defecten</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -191200,7 +194376,7 @@
     <Disorder id="4057">
       <OrphaCode>452</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=452</ExpertLink>
-      <Name lang="nl">X-gebonden lissencefalie met abnormale genitaliën</Name>
+      <Name lang="nl">X-gebonden lissencefalie met abnormale genitaliÃ«n</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -191526,7 +194702,7 @@
     <Disorder id="19269">
       <OrphaCode>238505</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=238505</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door deficiëntie van CD27</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door deficiÃ«ntie van CD27</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -191803,7 +194979,7 @@
     <Disorder id="19279">
       <OrphaCode>238583</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=238583</ExpertLink>
-      <Name lang="nl">Hyperfenylalaninemie door deficiëntie van tetrahydrobiopterine</Name>
+      <Name lang="nl">Hyperfenylalaninemie door deficiÃ«ntie van tetrahydrobiopterine</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -192067,7 +195243,7 @@
     <Disorder id="19286">
       <OrphaCode>238624</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=238624</ExpertLink>
-      <Name lang="nl">Idiopathische intracraniële hypertensie</Name>
+      <Name lang="nl">Idiopathische intracraniÃ«le hypertensie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -192212,7 +195388,7 @@
     <Disorder id="19293">
       <OrphaCode>238670</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=238670</ExpertLink>
-      <Name lang="nl">Geïsoleerde deficiëntie van thyrotropinevrijmakend hormoon</Name>
+      <Name lang="nl">GeÃ¯soleerde deficiÃ«ntie van thyrotropinevrijmakend hormoon</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -192244,7 +195420,7 @@
     <Disorder id="19292">
       <OrphaCode>238666</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=238666</ExpertLink>
-      <Name lang="nl">Geïsoleerd congenitaal hypogonadotroop hypogonadisme</Name>
+      <Name lang="nl">GeÃ¯soleerd congenitaal hypogonadotroop hypogonadisme</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -192649,7 +195825,7 @@
     <Disorder id="22001">
       <OrphaCode>331226</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=331226</ExpertLink>
-      <Name lang="nl">Susceptibiliteit voor infectie door TYK2-deficiëntie</Name>
+      <Name lang="nl">Susceptibiliteit voor infectie door TYK2-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -192698,7 +195874,7 @@
     <Disorder id="22003">
       <OrphaCode>331235</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=331235</ExpertLink>
-      <Name lang="nl">Selectieve IgM-deficiëntie</Name>
+      <Name lang="nl">Selectieve IgM-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -192730,7 +195906,7 @@
     <Disorder id="21992">
       <OrphaCode>331176</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=331176</ExpertLink>
-      <Name lang="nl">Ernstige congenitale neutropenie door G6PC3-deficiëntie</Name>
+      <Name lang="nl">Ernstige congenitale neutropenie door G6PC3-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -192779,7 +195955,7 @@
     <Disorder id="21994">
       <OrphaCode>331187</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=331187</ExpertLink>
-      <Name lang="nl">Immuundeficiëntie door MASP-2-deficiëntie</Name>
+      <Name lang="nl">ImmuundeficiÃ«ntie door MASP-2-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -192828,7 +196004,7 @@
     <Disorder id="21995">
       <OrphaCode>331190</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=331190</ExpertLink>
-      <Name lang="nl">Immuundeficiëntie door ficolin3-deficiëntie</Name>
+      <Name lang="nl">ImmuundeficiÃ«ntie door ficolin3-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -192877,7 +196053,7 @@
     <Disorder id="21997">
       <OrphaCode>331206</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=331206</ExpertLink>
-      <Name lang="nl">Ernstige gecombineerde immuundeficiëntie door volledige RAG1/2-deficiëntie</Name>
+      <Name lang="nl">Ernstige gecombineerde immuundeficiÃ«ntie door volledige RAG1/2-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -192960,7 +196136,7 @@
     <Disorder id="21955">
       <OrphaCode>330001</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=330001</ExpertLink>
-      <Name lang="nl">Wild-type ATTR-amyloïdose</Name>
+      <Name lang="nl">Wild-type ATTR-amyloÃ¯dose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -193177,7 +196353,7 @@
     <Disorder id="21962">
       <OrphaCode>330032</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=330032</ExpertLink>
-      <Name lang="nl">Lepore-hemoglobine - bèta-thalassemie-syndroom</Name>
+      <Name lang="nl">Lepore-hemoglobine - bÃ¨ta-thalassemie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -193503,7 +196679,7 @@
     <Disorder id="21941">
       <OrphaCode>329813</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=329813</ExpertLink>
-      <Name lang="nl">Mozaïsche genoomwijde paternale uniparentale disomie</Name>
+      <Name lang="nl">MozaÃ¯sche genoomwijde paternale uniparentale disomie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -193601,7 +196777,7 @@
     <Disorder id="21943">
       <OrphaCode>329883</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=329883</ExpertLink>
-      <Name lang="nl">Niet-hypoproteïnemische hypertrofische gastropathie</Name>
+      <Name lang="nl">Niet-hypoproteÃ¯nemische hypertrofische gastropathie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -193731,7 +196907,7 @@
     <Disorder id="21939">
       <OrphaCode>329481</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=329481</ExpertLink>
-      <Name lang="nl">Lipoproteïne-glomerulopathie</Name>
+      <Name lang="nl">LipoproteÃ¯ne-glomerulopathie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -193829,7 +197005,7 @@
     <Disorder id="21949">
       <OrphaCode>329942</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=329942</ExpertLink>
-      <Name lang="nl">Voorbijgaande neonatale meervoudige acyl-CoA-dehydrogenasedeficiëntie</Name>
+      <Name lang="nl">Voorbijgaande neonatale meervoudige acyl-CoA-dehydrogenasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -194036,7 +197212,7 @@
     <Disorder id="21925">
       <OrphaCode>329314</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=329314</ExpertLink>
-      <Name lang="nl">Meervoudig mitochondriaal DNA-deletiesyndroom door DGUOK-deficiëntie met aanvang op volwassen leeftijd</Name>
+      <Name lang="nl">Meervoudig mitochondriaal DNA-deletiesyndroom door DGUOK-deficiÃ«ntie met aanvang op volwassen leeftijd</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -194114,59 +197290,10 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="21927">
-      <OrphaCode>329324</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=329324</ExpertLink>
-      <Name lang="nl">Invers syndroom van Klippel-Trenaunay</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="10173">
-          <Source>17341861[PMID]_23000147[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Geval(len)/Gezinnen</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Geval(len)</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>15.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10174">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="21922">
       <OrphaCode>329284</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=329284</ExpertLink>
-      <Name lang="nl">Neurodegeneratie geassocieerd met bèta-propellerproteïne</Name>
+      <Name lang="nl">Neurodegeneratie geassocieerd met bÃ¨ta-propellerproteÃ¯ne</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -194475,7 +197602,7 @@
     <Disorder id="21911">
       <OrphaCode>329228</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=329228</ExpertLink>
-      <Name lang="nl">Microcefale primordiale dwerggroei door ZNF335-deficiëntie</Name>
+      <Name lang="nl">Microcefale primordiale dwerggroei door ZNF335-deficiÃ«ntie</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -194869,7 +197996,7 @@
     <Disorder id="21916">
       <OrphaCode>329249</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=329249</ExpertLink>
-      <Name lang="nl">Ernstig obesitas-insulineresistentiesyndroom door SH2B1-deficiëntie met vroege aanvang</Name>
+      <Name lang="nl">Ernstig obesitas-insulineresistentiesyndroom door SH2B1-deficiÃ«ntie met vroege aanvang</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -194918,7 +198045,7 @@
     <Disorder id="21914">
       <OrphaCode>329242</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=329242</ExpertLink>
-      <Name lang="nl">Congenitale chronische diarree met proteïneverliezende enteropathie</Name>
+      <Name lang="nl">Congenitale chronische diarree met proteÃ¯neverliezende enteropathie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -194967,7 +198094,7 @@
     <Disorder id="21913">
       <OrphaCode>329235</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=329235</ExpertLink>
-      <Name lang="nl">X-gebonden centrale congenitale hypothyreoïdie met laat optredende testesvergroting</Name>
+      <Name lang="nl">X-gebonden centrale congenitale hypothyreoÃ¯die met laat optredende testesvergroting</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -195016,7 +198143,7 @@
     <Disorder id="21903">
       <OrphaCode>329173</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=329173</ExpertLink>
-      <Name lang="nl">Auto-inflammatoir syndroom met pyogene bacteriële infectie en amylopectinose</Name>
+      <Name lang="nl">Auto-inflammatoir syndroom met pyogene bacteriÃ«le infectie en amylopectinose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -195065,7 +198192,7 @@
     <Disorder id="4511">
       <OrphaCode>329</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=329</ExpertLink>
-      <Name lang="nl">Congenitale factor XI-deficiëntie</Name>
+      <Name lang="nl">Congenitale factor XI-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -195202,10 +198329,74 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="21833">
+      <OrphaCode>325124</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=325124</ExpertLink>
+      <Name lang="nl">Testiculaire agenesie</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17838">
+          <Source>21853106[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>2.5</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="21838">
+      <OrphaCode>325345</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=325345</ExpertLink>
+      <Name lang="nl">46,XY ovotesticulaire geslachtsontwikkelingsstoornis</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17945">
+          <Source>29285340[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.3</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="21817">
       <OrphaCode>324964</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=324964</ExpertLink>
-      <Name lang="nl">Chronische niet-bacteriële osteomyelitis/Chronische terugkerende multifocale osteomyelitis</Name>
+      <Name lang="nl">Chronische niet-bacteriÃ«le osteomyelitis/Chronische terugkerende multifocale osteomyelitis</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -195354,7 +198545,7 @@
     <Disorder id="21801">
       <OrphaCode>324718</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=324718</ExpertLink>
-      <Name lang="nl">ABètaA21G-amyloïdose</Name>
+      <Name lang="nl">ABÃ¨taA21G-amyloÃ¯dose</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -195403,7 +198594,7 @@
     <Disorder id="21800">
       <OrphaCode>324713</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=324713</ExpertLink>
-      <Name lang="nl">ABèta-amyloïdose, Italiaans type</Name>
+      <Name lang="nl">ABÃ¨ta-amyloÃ¯dose, Italiaans type</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -195501,7 +198692,7 @@
     <Disorder id="21802">
       <OrphaCode>324723</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=324723</ExpertLink>
-      <Name lang="nl">ABèta-amyloïdose, Arctisch type</Name>
+      <Name lang="nl">ABÃ¨ta-amyloÃ¯dose, Arctisch type</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -195550,7 +198741,7 @@
     <Disorder id="21797">
       <OrphaCode>324648</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=324648</ExpertLink>
-      <Name lang="nl">Invasieve niet-tyfoïde salmonellose</Name>
+      <Name lang="nl">Invasieve niet-tyfoÃ¯de salmonellose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -195631,7 +198822,7 @@
     <Disorder id="21799">
       <OrphaCode>324708</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=324708</ExpertLink>
-      <Name lang="nl">ABèta-amyloïdose, Iowa-type</Name>
+      <Name lang="nl">ABÃ¨ta-amyloÃ¯dose, Iowa-type</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -195680,7 +198871,7 @@
     <Disorder id="21798">
       <OrphaCode>324703</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=324703</ExpertLink>
-      <Name lang="nl">ABètaL34V-amyloïdose</Name>
+      <Name lang="nl">ABÃ¨taL34V-amyloÃ¯dose</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -196374,7 +199565,7 @@
     <Disorder id="21787">
       <OrphaCode>324575</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=324575</ExpertLink>
-      <Name lang="nl">Hyperinsulinisme door HNF1A-deficiëntie</Name>
+      <Name lang="nl">Hyperinsulinisme door HNF1A-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -196521,7 +199712,7 @@
     <Disorder id="21782">
       <OrphaCode>324530</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=324530</ExpertLink>
-      <Name lang="nl">Auto-inflammatie - PLCG2-geassocieerde antilichaamdeficiëntie - immuundisregulatie</Name>
+      <Name lang="nl">Auto-inflammatie - PLCG2-geassocieerde antilichaamdeficiÃ«ntie - immuundisregulatie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -196570,7 +199761,7 @@
     <Disorder id="21783">
       <OrphaCode>324535</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=324535</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 11</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 11</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -196619,7 +199810,7 @@
     <Disorder id="21781">
       <OrphaCode>324525</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=324525</ExpertLink>
-      <Name lang="nl">Hypertrofische cardiomyopathie met nieranomalieën door mutatie van mitochondriaal DNA</Name>
+      <Name lang="nl">Hypertrofische cardiomyopathie met nieranomalieÃ«n door mutatie van mitochondriaal DNA</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -197190,7 +200381,7 @@
     <Disorder id="21761">
       <OrphaCode>324294</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=324294</ExpertLink>
-      <Name lang="nl">T-cel-immuundeficiëntie met epidermodysplasia verruciformis</Name>
+      <Name lang="nl">T-cel-immuundeficiÃ«ntie met epidermodysplasia verruciformis</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -197288,7 +200479,7 @@
     <Disorder id="21758">
       <OrphaCode>324262</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=324262</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve congenitale cerebellaire ataxie door MGLUR1-deficiëntie</Name>
+      <Name lang="nl">Autosomaal recessieve congenitale cerebellaire ataxie door MGLUR1-deficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -197925,7 +201116,7 @@
     <Disorder id="21670">
       <OrphaCode>319543</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319543</ExpertLink>
-      <Name lang="nl">Autosomaal dominante mendeliaanse gevoeligheid voor mycobacteriële ziekten door een partiële deficiëntie</Name>
+      <Name lang="nl">Autosomaal dominante mendeliaanse gevoeligheid voor mycobacteriÃ«le ziekten door een partiÃ«le deficiÃ«ntie</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -197957,7 +201148,7 @@
     <Disorder id="21671">
       <OrphaCode>319547</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319547</ExpertLink>
-      <Name lang="nl">Mendeliaanse gevoeligheid voor mycobacteriële ziekten door volledige IFNgammaR2-deficiëntie</Name>
+      <Name lang="nl">Mendeliaanse gevoeligheid voor mycobacteriÃ«le ziekten door volledige IFNgammaR2-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -198006,7 +201197,7 @@
     <Disorder id="21668">
       <OrphaCode>319535</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319535</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve mendeliaanse gevoeligheid voor mycobacteriële ziekten door een volledige deficiëntie</Name>
+      <Name lang="nl">Autosomaal recessieve mendeliaanse gevoeligheid voor mycobacteriÃ«le ziekten door een volledige deficiÃ«ntie</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -198038,7 +201229,7 @@
     <Disorder id="21669">
       <OrphaCode>319539</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319539</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve mendeliaanse gevoeligheid voor mycobacteriële ziekten door een partiële deficiëntie</Name>
+      <Name lang="nl">Autosomaal recessieve mendeliaanse gevoeligheid voor mycobacteriÃ«le ziekten door een partiÃ«le deficiÃ«ntie</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -198070,7 +201261,7 @@
     <Disorder id="21666">
       <OrphaCode>319519</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319519</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 14</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 14</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -198119,7 +201310,7 @@
     <Disorder id="21667">
       <OrphaCode>319524</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319524</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 15</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 15</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -198168,7 +201359,7 @@
     <Disorder id="21664">
       <OrphaCode>319509</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319509</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 9</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 9</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -198217,7 +201408,7 @@
     <Disorder id="21665">
       <OrphaCode>319514</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319514</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 13</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 13</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -198266,7 +201457,7 @@
     <Disorder id="21678">
       <OrphaCode>319589</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319589</ExpertLink>
-      <Name lang="nl">Autosomaal dominante Mendeliaanse gevoeligheid voor mycobacteriële ziekten door partiële IFNgammaR2-deficiëntie</Name>
+      <Name lang="nl">Autosomaal dominante Mendeliaanse gevoeligheid voor mycobacteriÃ«le ziekten door partiÃ«le IFNgammaR2-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -198315,7 +201506,7 @@
     <Disorder id="21679">
       <OrphaCode>319595</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319595</ExpertLink>
-      <Name lang="nl">Mendeliaanse gevoeligheid voor mycobacteriële ziekten door partiële STAT1-deficiëntie</Name>
+      <Name lang="nl">Mendeliaanse gevoeligheid voor mycobacteriÃ«le ziekten door partiÃ«le STAT1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -198364,7 +201555,7 @@
     <Disorder id="21676">
       <OrphaCode>319574</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319574</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve Mendeliaanse gevoeligheid voor mycobacteriële ziekten door partiële IFNgammaR2-deficiëntie</Name>
+      <Name lang="nl">Autosomaal recessieve Mendeliaanse gevoeligheid voor mycobacteriÃ«le ziekten door partiÃ«le IFNgammaR2-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -198413,7 +201604,7 @@
     <Disorder id="21677">
       <OrphaCode>319581</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319581</ExpertLink>
-      <Name lang="nl">Autosomaal dominante Mendeliaanse gevoeligheid voor mycobacteriële ziekten door partiële IFNgammaR1-deficiëntie</Name>
+      <Name lang="nl">Autosomaal dominante Mendeliaanse gevoeligheid voor mycobacteriÃ«le ziekten door partiÃ«le IFNgammaR1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -198462,7 +201653,7 @@
     <Disorder id="21674">
       <OrphaCode>319563</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319563</ExpertLink>
-      <Name lang="nl">Mendeliaanse gevoeligheid voor mycobacteriële ziekten door volledige ISG15-deficiëntie</Name>
+      <Name lang="nl">Mendeliaanse gevoeligheid voor mycobacteriÃ«le ziekten door volledige ISG15-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -198511,7 +201702,7 @@
     <Disorder id="21675">
       <OrphaCode>319569</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319569</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve Mendeliaanse gevoeligheid voor mycobacteriële ziekten door partiële IFNgammaR1-deficiëntie</Name>
+      <Name lang="nl">Autosomaal recessieve Mendeliaanse gevoeligheid voor mycobacteriÃ«le ziekten door partiÃ«le IFNgammaR1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -198560,7 +201751,7 @@
     <Disorder id="21672">
       <OrphaCode>319552</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319552</ExpertLink>
-      <Name lang="nl">Mendeliaanse gevoeligheid voor mycobacteriële ziekten door volledige IL12RB1-deficiëntie</Name>
+      <Name lang="nl">Mendeliaanse gevoeligheid voor mycobacteriÃ«le ziekten door volledige IL12RB1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -198609,7 +201800,7 @@
     <Disorder id="21673">
       <OrphaCode>319558</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319558</ExpertLink>
-      <Name lang="nl">Mendeliaanse gevoeligheid voor mycobacteriële ziekten door volledige IL12B-deficiëntie</Name>
+      <Name lang="nl">Mendeliaanse gevoeligheid voor mycobacteriÃ«le ziekten door volledige IL12B-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -198851,108 +202042,10 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="21683">
-      <OrphaCode>319623</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319623</ExpertLink>
-      <Name lang="nl">X-gebonden Mendeliaanse gevoeligheid voor mycobacteriële ziekten door CYBB-deficiëntie</Name>
-      <DisorderType id="21443">
-        <Name lang="nl">Etiologisch subtype</Name>
-      </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="nl">Subtype van aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="13334">
-          <Source>21278736[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Geval(len)/Gezinnen</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Geval(len)</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>7.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="13335">
-          <Source>ORPHANET_21278736[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
-    <Disorder id="21682">
-      <OrphaCode>319612</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319612</ExpertLink>
-      <Name lang="nl">X-gebonden Mendeliaanse gevoeligheid voor mycobacteriële ziekten door IKBKG-deficiëntie</Name>
-      <DisorderType id="21443">
-        <Name lang="nl">Etiologisch subtype</Name>
-      </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="nl">Subtype van aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="10078">
-          <Source>25453225[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Geval(len)/Gezinnen</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Geval(len)</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>6.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10079">
-          <Source>ORPHANET_25453225[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="21681">
       <OrphaCode>319605</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319605</ExpertLink>
-      <Name lang="nl">X-gebonden Mendeliaanse gevoeligheid voor mycobacteriële ziekten</Name>
+      <Name lang="nl">X-gebonden Mendeliaanse gevoeligheid voor mycobacteriÃ«le ziekten</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -199001,7 +202094,7 @@
     <Disorder id="21680">
       <OrphaCode>319600</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319600</ExpertLink>
-      <Name lang="nl">Mendeliaanse gevoeligheid voor mycobacteriële ziekten door partiële IRF8-deficiëntie</Name>
+      <Name lang="nl">Mendeliaanse gevoeligheid voor mycobacteriÃ«le ziekten door partiÃ«le IRF8-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -199455,7 +202548,7 @@
     <Disorder id="21663">
       <OrphaCode>319504</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=319504</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 8</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 8</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -199866,7 +202959,7 @@
     <Disorder id="21581">
       <OrphaCode>317428</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=317428</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door ORAI1-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door ORAI1-deficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -199915,7 +203008,7 @@
     <Disorder id="21580">
       <OrphaCode>317425</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=317425</ExpertLink>
-      <Name lang="nl">Ernstige gecombineerde immuundeficiëntie door DNA-PKcs-deficiëntie</Name>
+      <Name lang="nl">Ernstige gecombineerde immuundeficiÃ«ntie door DNA-PKcs-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -199964,7 +203057,7 @@
     <Disorder id="21582">
       <OrphaCode>317430</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=317430</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door STIM1-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door STIM1-deficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -200094,7 +203187,7 @@
     <Disorder id="21549">
       <OrphaCode>315311</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=315311</ExpertLink>
-      <Name lang="nl">Klassieke congenitale adrenale hyperplasie door deficiëntie van 21-hydroxylase, eenvoudige viriliserende vorm</Name>
+      <Name lang="nl">Klassieke congenitale adrenale hyperplasie door deficiÃ«ntie van 21-hydroxylase, eenvoudige viriliserende vorm</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -200126,7 +203219,7 @@
     <Disorder id="21548">
       <OrphaCode>315306</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=315306</ExpertLink>
-      <Name lang="nl">Klassieke congenitale adrenale hyperplasie door deficiëntie van 21-hydroxylase, vorm met zoutverlies</Name>
+      <Name lang="nl">Klassieke congenitale adrenale hyperplasie door deficiÃ«ntie van 21-hydroxylase, vorm met zoutverlies</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -200275,7 +203368,7 @@
     <Disorder id="21545">
       <OrphaCode>314970</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314970</ExpertLink>
-      <Name lang="nl">Lymfoïd hypereosinofiel syndroom</Name>
+      <Name lang="nl">LymfoÃ¯d hypereosinofiel syndroom</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -200435,7 +203528,7 @@
     <Disorder id="21517">
       <OrphaCode>314701</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314701</ExpertLink>
-      <Name lang="nl">Primaire systemische amyloïdose</Name>
+      <Name lang="nl">Primaire systemische amyloÃ¯dose</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -200565,7 +203658,7 @@
     <Disorder id="21515">
       <OrphaCode>314689</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314689</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door STK4-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door STK4-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -200646,7 +203739,7 @@
     <Disorder id="21509">
       <OrphaCode>314652</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314652</ExpertLink>
-      <Name lang="nl">Variant ABèta2M-amyloïdose</Name>
+      <Name lang="nl">Variant ABÃ¨ta2M-amyloÃ¯dose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -200891,7 +203984,7 @@
     <Disorder id="21507">
       <OrphaCode>314637</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314637</ExpertLink>
-      <Name lang="nl">Mitochondriale hypertrofische cardiomyopathie met lactaatacidose door MTO1-deficiëntie</Name>
+      <Name lang="nl">Mitochondriale hypertrofische cardiomyopathie met lactaatacidose door MTO1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -200989,7 +204082,7 @@
     <Disorder id="21532">
       <OrphaCode>314802</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314802</ExpertLink>
-      <Name lang="nl">Kleine gestalte door partiële GHR-deficiëntie</Name>
+      <Name lang="nl">Kleine gestalte door partiÃ«le GHR-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -201021,7 +204114,7 @@
     <Disorder id="21533">
       <OrphaCode>314811</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314811</ExpertLink>
-      <Name lang="nl">Kleine gestalte door GHSR-deficiëntie</Name>
+      <Name lang="nl">Kleine gestalte door GHSR-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -201119,7 +204212,7 @@
     <Disorder id="21528">
       <OrphaCode>314777</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314777</ExpertLink>
-      <Name lang="nl">Familiaal geïsoleerd hypofyseadenoom</Name>
+      <Name lang="nl">Familiaal geÃ¯soleerd hypofyseadenoom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -201200,7 +204293,7 @@
     <Disorder id="21520">
       <OrphaCode>314718</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314718</ExpertLink>
-      <Name lang="nl">Letaal arteriopathiesyndroom door fibuline-4-deficiëntie</Name>
+      <Name lang="nl">Letaal arteriopathiesyndroom door fibuline-4-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -201249,7 +204342,7 @@
     <Disorder id="21521">
       <OrphaCode>314721</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314721</ExpertLink>
-      <Name lang="nl">Atypische dentinedysplasie door SMOC2-deficiëntie</Name>
+      <Name lang="nl">Atypische dentinedysplasie door SMOC2-deficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -201491,6 +204584,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="22495">
+      <OrphaCode>370396</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=370396</ExpertLink>
+      <Name lang="nl">Kleincellig carcinoom van ovarium</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17856">
+          <Source>29731803[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>300.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17857">
+          <Source>29731803[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="22491">
       <OrphaCode>370348</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=370348</ExpertLink>
@@ -202185,7 +205327,7 @@
     <Disorder id="22467">
       <OrphaCode>370026</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=370026</ExpertLink>
-      <Name lang="nl">Acute myeloïde leukemie met t(8;16)(p11;p13) translocatie</Name>
+      <Name lang="nl">Acute myeloÃ¯de leukemie met t(8;16)(p11;p13) translocatie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -202841,7 +205983,7 @@
     <Disorder id="22449">
       <OrphaCode>369929</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=369929</ExpertLink>
-      <Name lang="nl">Primair hyperaldosteronisme - insulten - neurologische anomalieën-syndroom</Name>
+      <Name lang="nl">Primair hyperaldosteronisme - insulten - neurologische anomalieÃ«n-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -203233,7 +206375,7 @@
     <Disorder id="22456">
       <OrphaCode>369979</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=369979</ExpertLink>
-      <Name lang="nl">Hyperfalangie van vingers - teenanomalieën - ernstige pectus excavatum-syndroom</Name>
+      <Name lang="nl">Hyperfalangie van vingers - teenanomalieÃ«n - ernstige pectus excavatum-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -203282,7 +206424,7 @@
     <Disorder id="22459">
       <OrphaCode>369992</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=369992</ExpertLink>
-      <Name lang="nl">Ernstige dermatitis - meervoudige allergieën - metabole aftakeling-syndroom</Name>
+      <Name lang="nl">Ernstige dermatitis - meervoudige allergieÃ«n - metabole aftakeling-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -203395,7 +206537,7 @@
     <Disorder id="22463">
       <OrphaCode>370010</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=370010</ExpertLink>
-      <Name lang="nl">Intellectuele achterstand - faciale dysmorfie - handanomalieën-syndroom</Name>
+      <Name lang="nl">Intellectuele achterstand - faciale dysmorfie - handanomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -203444,7 +206586,7 @@
     <Disorder id="22433">
       <OrphaCode>369837</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=369837</ExpertLink>
-      <Name lang="nl">Intellectuele achterstand - insulten - hypofosfatasie - oftalmische-skeletale anomalieën-syndroom</Name>
+      <Name lang="nl">Intellectuele achterstand - insulten - hypofosfatasie - oftalmische-skeletale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -203640,7 +206782,7 @@
     <Disorder id="22438">
       <OrphaCode>369861</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=369861</ExpertLink>
-      <Name lang="nl">Congenitale sideroblastische anemie - B-cel-immuundeficiëntie - periodieke koorts - ontwikkelingsachterstand-syndroom</Name>
+      <Name lang="nl">Congenitale sideroblastische anemie - B-cel-immuundeficiÃ«ntie - periodieke koorts - ontwikkelingsachterstand-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -203738,7 +206880,7 @@
     <Disorder id="22440">
       <OrphaCode>369873</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=369873</ExpertLink>
-      <Name lang="nl">Obesitas door SIM1-deficiëntie</Name>
+      <Name lang="nl">Obesitas door SIM1-deficiÃ«ntie</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -203851,7 +206993,7 @@
     <Disorder id="22443">
       <OrphaCode>369891</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=369891</ExpertLink>
-      <Name lang="nl">Ontwikkelingsachterstand - faciale dysmorfie-syndroom door MED13L-deficiëntie</Name>
+      <Name lang="nl">Ontwikkelingsachterstand - faciale dysmorfie-syndroom door MED13L-deficiÃ«ntie</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -203900,7 +207042,7 @@
     <Disorder id="22445">
       <OrphaCode>369897</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=369897</ExpertLink>
-      <Name lang="nl">Mitochondriaal DNA-depletiesyndroom, encefalomyopathische vorm met variabele craniofaciale anomalieën</Name>
+      <Name lang="nl">Mitochondriaal DNA-depletiesyndroom, encefalomyopathische vorm met variabele craniofaciale anomalieÃ«n</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -203949,7 +207091,7 @@
     <Disorder id="22447">
       <OrphaCode>369913</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=369913</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 17</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 17</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -204245,16 +207387,16 @@
     <Disorder id="5014">
       <OrphaCode>1048</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1048</ExpertLink>
-      <Name lang="nl">Geïsoleerde anencefalie/exencefalie</Name>
+      <Name lang="nl">GeÃ¯soleerde anencefalie/exencefalie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="7">
+      <PrevalenceList count="9">
         <Prevalence id="4974">
-          <Source>[EXPERT]</Source>
+          <Source>EUROCAT European surveillance of congenital anomalies [REG] _ORPHANET_[EXPERT]</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -204264,7 +207406,7 @@
           <PrevalenceClass id="23732">
             <Name lang="nl">1-5 / 10 000</Name>
           </PrevalenceClass>
-          <ValMoy>35.0</ValMoy>
+          <ValMoy>4.22</ValMoy>
           <PrevalenceGeographic id="23795">
             <Name lang="nl">Europa</Name>
           </PrevalenceGeographic>
@@ -204348,8 +207490,8 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="4979">
-          <Source>16858850[PMID]</Source>
+        <Prevalence id="4980">
+          <Source>17245510[PMID]</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -204359,28 +207501,66 @@
           <PrevalenceClass id="23732">
             <Name lang="nl">1-5 / 10 000</Name>
           </PrevalenceClass>
-          <ValMoy>26.0</ValMoy>
-          <PrevalenceGeographic id="25377">
-            <Name lang="nl">Thailand</Name>
+          <ValMoy>58.0</ValMoy>
+          <PrevalenceGeographic id="25244">
+            <Name lang="nl">Singapore</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="4980">
-          <Source>17245510[PMID]</Source>
+        <Prevalence id="17743">
+          <Source>34887455[PMID]_ORPHANET</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
           <PrevalenceQualification id="23711">
             <Name lang="nl">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
+          <PrevalenceClass id="23767">
+            <Name lang="nl">&gt;1 / 1000</Name>
           </PrevalenceClass>
-          <ValMoy>58.0</ValMoy>
-          <PrevalenceGeographic id="25244">
-            <Name lang="nl">Singapore</Name>
+          <ValMoy>1.4</ValMoy>
+          <PrevalenceGeographic id="23788">
+            <Name lang="nl">Afrika</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17744">
+          <Source>36253858[PMID]</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23753">
+            <Name lang="nl">6-9 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>8.6</ValMoy>
+          <PrevalenceGeographic id="23949">
+            <Name lang="nl">Australia</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17745">
+          <Source>36253858[PMID]</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>5.1</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
@@ -204442,7 +207622,7 @@
     <Disorder id="5013">
       <OrphaCode>823</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=823</ExpertLink>
-      <Name lang="nl">Geïsoleerde spina bifida</Name>
+      <Name lang="nl">GeÃ¯soleerde spina bifida</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -205153,8 +208333,8 @@
       <OrphaCode>363746</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=363746</ExpertLink>
       <Name lang="nl">Syndroom van Balint</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21422">
+        <Name lang="nl">Klinisch syndroom</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
@@ -205216,7 +208396,7 @@
     <Disorder id="22346">
       <OrphaCode>363727</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=363727</ExpertLink>
-      <Name lang="nl">X-gebonden dyserytropoëtische anemie met abnormale bloedplaatjes en neutropenie</Name>
+      <Name lang="nl">X-gebonden dyserytropoÃ«tische anemie met abnormale bloedplaatjes en neutropenie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -205917,7 +209097,7 @@
     <Disorder id="22303">
       <OrphaCode>363432</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=363432</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve congenitale cerebellaire ataxie door GRID2-deficiëntie</Name>
+      <Name lang="nl">Autosomaal recessieve congenitale cerebellaire ataxie door GRID2-deficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -206113,7 +209293,7 @@
     <Disorder id="22278">
       <OrphaCode>363203</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=363203</ExpertLink>
-      <Name lang="nl">Ringchromosoom</Name>
+      <Name lang="nl">Ringchromosoom-syndroom</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -206243,7 +209423,7 @@
     <Disorder id="22331">
       <OrphaCode>363649</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=363649</ExpertLink>
-      <Name lang="nl">Mandibulaire hypoplasie - doofheid - progeroïde kenmerken - lipodystrofie-syndroom</Name>
+      <Name lang="nl">Mandibulaire hypoplasie - doofheid - progeroÃ¯de kenmerken - lipodystrofie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -206373,7 +209553,7 @@
     <Disorder id="22334">
       <OrphaCode>363665</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=363665</ExpertLink>
-      <Name lang="nl">Acro-osteolyse - keloïdachtige laesies - vroegtijdige veroudering-syndroom</Name>
+      <Name lang="nl">Acro-osteolyse - keloÃ¯dachtige laesies - vroegtijdige veroudering-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -207909,7 +211089,7 @@
     <Disorder id="22220">
       <OrphaCode>357329</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=357329</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door IL21R-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door IL21R-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -208007,7 +211187,7 @@
     <Disorder id="22219">
       <OrphaCode>357237</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=357237</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door CARD11-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door CARD11-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -208134,55 +211314,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="22188">
-      <OrphaCode>356947</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=356947</ExpertLink>
-      <Name lang="nl">3q26q27-microdeletiesyndroom</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="10305">
-          <Source>23357683[PMID]_24055528[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Geval(len)/Gezinnen</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Geval(len)</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>4.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10306">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="22189">
       <OrphaCode>356961</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=356961</ExpertLink>
@@ -208235,7 +211366,7 @@
     <Disorder id="22195">
       <OrphaCode>357008</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=357008</ExpertLink>
-      <Name lang="nl">Hemolytisch-uremisch syndroom met DGKE-deficiëntie</Name>
+      <Name lang="nl">Hemolytisch-uremisch syndroom met DGKE-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -209247,7 +212378,7 @@
     <Disorder id="22105">
       <OrphaCode>352712</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=352712</ExpertLink>
-      <Name lang="nl">Faciale dysmorfie - immuundeficiëntie - livedo - kleine gestalte-syndroom</Name>
+      <Name lang="nl">Faciale dysmorfie - immuundeficiÃ«ntie - livedo - kleine gestalte-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -209345,7 +212476,7 @@
     <Disorder id="22107">
       <OrphaCode>352723</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=352723</ExpertLink>
-      <Name lang="nl">Verzwakt syndroom van Chédiak-Higashi</Name>
+      <Name lang="nl">Verzwakt syndroom van ChÃ©diak-Higashi</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -209394,7 +212525,7 @@
     <Disorder id="22096">
       <OrphaCode>352665</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=352665</ExpertLink>
-      <Name lang="nl">Neurologische ontwikkelingsstoornis - craniofaciale dysmorfie - hartdefect - skeletanomalieën-syndroom door 9q21.3-microdeletie</Name>
+      <Name lang="nl">Neurologische ontwikkelingsstoornis - craniofaciale dysmorfie - hartdefect - skeletanomalieÃ«n-syndroom door 9q21.3-microdeletie</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -209641,7 +212772,7 @@
     <Disorder id="22120">
       <OrphaCode>353220</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=353220</ExpertLink>
-      <Name lang="nl">Familiale primaire gelokaliseerde cutane amyloïdose</Name>
+      <Name lang="nl">Familiale primaire gelokaliseerde cutane amyloÃ¯dose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -209786,7 +212917,7 @@
     <Disorder id="22136">
       <OrphaCode>353320</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=353320</ExpertLink>
-      <Name lang="nl">Pyruvaatcarboxylasedeficiëntie, goedaardig type</Name>
+      <Name lang="nl">PyruvaatcarboxylasedeficiÃ«ntie, goedaardig type</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -209867,7 +212998,7 @@
     <Disorder id="22134">
       <OrphaCode>353308</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=353308</ExpertLink>
-      <Name lang="nl">Pyruvaatcarboxylasedeficiëntie, infantiel type</Name>
+      <Name lang="nl">PyruvaatcarboxylasedeficiÃ«ntie, infantiel type</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -209899,7 +213030,7 @@
     <Disorder id="22135">
       <OrphaCode>353314</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=353314</ExpertLink>
-      <Name lang="nl">Pyruvaatcarboxylasedeficiëntie, ernstig neonataal type</Name>
+      <Name lang="nl">PyruvaatcarboxylasedeficiÃ«ntie, ernstig neonataal type</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -209980,7 +213111,7 @@
     <Disorder id="22129">
       <OrphaCode>353284</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=353284</ExpertLink>
-      <Name lang="nl">Syndroom van Rubinstein-Taybi door haploinsufficiëntie van EP300</Name>
+      <Name lang="nl">Syndroom van Rubinstein-Taybi door haploinsufficiÃ«ntie van EP300</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -210274,7 +213405,7 @@
     <Disorder id="22078">
       <OrphaCode>352563</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=352563</ExpertLink>
-      <Name lang="nl">Infantiele hypertrofische cardiomyopathie door MRPL44-deficiëntie</Name>
+      <Name lang="nl">Infantiele hypertrofische cardiomyopathie door MRPL44-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -210470,7 +213601,7 @@
     <Disorder id="22069">
       <OrphaCode>352490</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=352490</ExpertLink>
-      <Name lang="nl">Autismespectrumstoornis door AUTS2-deficiëntie</Name>
+      <Name lang="nl">Autismespectrumstoornis door AUTS2-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -210864,7 +213995,7 @@
     <Disorder id="20898">
       <OrphaCode>293978</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=293978</ExpertLink>
-      <Name lang="nl">Disfunctie van adenohypofyse - variabele immuundeficiëntie-syndroom</Name>
+      <Name lang="nl">Disfunctie van adenohypofyse - variabele immuundeficiÃ«ntie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -210962,7 +214093,7 @@
     <Disorder id="20894">
       <OrphaCode>293955</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=293955</ExpertLink>
-      <Name lang="nl">Encefalopathie in de kindertijd door deficiëntie van thiaminepyrofosfokinase</Name>
+      <Name lang="nl">Encefalopathie in de kindertijd door deficiÃ«ntie van thiaminepyrofosfokinase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -211354,7 +214485,7 @@
     <Disorder id="20875">
       <OrphaCode>293825</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=293825</ExpertLink>
-      <Name lang="nl">Congenitale dyserytropoëtische anemie type IV</Name>
+      <Name lang="nl">Congenitale dyserytropoÃ«tische anemie type IV</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -211435,7 +214566,7 @@
     <Disorder id="20871">
       <OrphaCode>293807</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=293807</ExpertLink>
-      <Name lang="nl">Ketaminegeïnduceerde galdilatatie</Name>
+      <Name lang="nl">KetaminegeÃ¯nduceerde galdilatatie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -211597,7 +214728,7 @@
     <Disorder id="20937">
       <OrphaCode>294975</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=294975</ExpertLink>
-      <Name lang="nl">Geïsoleerde congenitale afwezigheid van bovenarm en onderarm met hand aanwezig</Name>
+      <Name lang="nl">GeÃ¯soleerde congenitale afwezigheid van bovenarm en onderarm met hand aanwezig</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -211680,7 +214811,7 @@
     <Disorder id="20935">
       <OrphaCode>294971</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=294971</ExpertLink>
-      <Name lang="nl">Geïsoleerde tetra-amelie</Name>
+      <Name lang="nl">GeÃ¯soleerde tetra-amelie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -211761,7 +214892,7 @@
     <Disorder id="20771">
       <OrphaCode>289877</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=289877</ExpertLink>
-      <Name lang="nl">Transiënte hyperammoniëmie van neonaat</Name>
+      <Name lang="nl">TransiÃ«nte hyperammoniÃ«mie van neonaat</Name>
       <DisorderType id="21429">
         <Name lang="nl">Particulaire klinische situatie binnen een ziekte of syndroom</Name>
       </DisorderType>
@@ -212004,7 +215135,7 @@
     <Disorder id="20739">
       <OrphaCode>289548</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=289548</ExpertLink>
-      <Name lang="nl">Overgeërfde geïsoleerde adrenale insufficiëntie door CYP11A1-deficiëntie</Name>
+      <Name lang="nl">OvergeÃ«rfde geÃ¯soleerde adrenale insufficiÃ«ntie door CYP11A1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -212068,7 +215199,7 @@
     <Disorder id="20749">
       <OrphaCode>289601</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=289601</ExpertLink>
-      <Name lang="nl">Erfelijke arteriële en articulaire meervoudige calcificatie-syndroom</Name>
+      <Name lang="nl">Erfelijke arteriÃ«le en articulaire meervoudige calcificatie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -212723,7 +215854,7 @@
     <Disorder id="5543">
       <OrphaCode>428</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=428</ExpertLink>
-      <Name lang="nl">Autosomaal dominante hypocalciëmie</Name>
+      <Name lang="nl">Autosomaal dominante hypocalciÃ«mie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -212793,7 +215924,7 @@
     <Disorder id="20841">
       <OrphaCode>293181</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=293181</ExpertLink>
-      <Name lang="nl">Maligne migrerende partiële epileptische aanvallen op jonge leeftijd</Name>
+      <Name lang="nl">Epilepsie bij zuigeling met migrerende focale insulten</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -212912,7 +216043,7 @@
     <Disorder id="5545">
       <OrphaCode>2207</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2207</ExpertLink>
-      <Name lang="nl">Familiale primaire hyperparathyreoïdie</Name>
+      <Name lang="nl">Familiale primaire hyperparathyreoÃ¯die</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -213097,7 +216228,7 @@
     <Disorder id="20844">
       <OrphaCode>293202</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=293202</ExpertLink>
-      <Name lang="nl">Epithelioïd sarcoom</Name>
+      <Name lang="nl">EpithelioÃ¯d sarcoom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -213333,7 +216464,7 @@
     <Disorder id="5520">
       <OrphaCode>2394</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2394</ExpertLink>
-      <Name lang="nl">Pyruvaatdehydrogenase E3-deficiëntie</Name>
+      <Name lang="nl">Pyruvaatdehydrogenase E3-deficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -213382,7 +216513,7 @@
     <Disorder id="5527">
       <OrphaCode>2356</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2356</ExpertLink>
-      <Name lang="nl">Arachnoïdale cyste</Name>
+      <Name lang="nl">ArachnoÃ¯dale cyste</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -214094,7 +217225,7 @@
     <Disorder id="20609">
       <OrphaCode>284417</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=284417</ExpertLink>
-      <Name lang="nl">Deficiëntie van fosfoserine-aminotransferase, infantiele/juveniele vorm</Name>
+      <Name lang="nl">DeficiÃ«ntie van fosfoserine-aminotransferase, infantiele/juveniele vorm</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -214126,7 +217257,7 @@
     <Disorder id="20610">
       <OrphaCode>284426</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=284426</ExpertLink>
-      <Name lang="nl">Glycogeenstapelingsziekte door deficiëntie van lactaatdehydrogenase M-subeenheid</Name>
+      <Name lang="nl">Glycogeenstapelingsziekte door deficiÃ«ntie van lactaatdehydrogenase M-subeenheid</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -214158,7 +217289,7 @@
     <Disorder id="20611">
       <OrphaCode>284435</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=284435</ExpertLink>
-      <Name lang="nl">Glycogeenstapelingsziekte door lactaatdehydrogenase H-subeenheiddeficiëntie</Name>
+      <Name lang="nl">Glycogeenstapelingsziekte door lactaatdehydrogenase H-subeenheiddeficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -214431,7 +217562,7 @@
     <Disorder id="20707">
       <OrphaCode>289290</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=289290</ExpertLink>
-      <Name lang="nl">Encefalopathie met hypermethioninemie door deficiëntie van adenosinekinase</Name>
+      <Name lang="nl">Encefalopathie met hypermethioninemie door deficiÃ«ntie van adenosinekinase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -214527,7 +217658,7 @@
     <Disorder id="20709">
       <OrphaCode>289307</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=289307</ExpertLink>
-      <Name lang="nl">Ontwikkelingsachterstand door methylmalonaat-semialdehydedehydrogenasedeficiëntie</Name>
+      <Name lang="nl">Ontwikkelingsachterstand door methylmalonaat-semialdehydedehydrogenasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -214691,7 +217822,7 @@
     <Disorder id="20734">
       <OrphaCode>289522</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=289522</ExpertLink>
-      <Name lang="nl">Microtriplicatie 11q24.1</Name>
+      <Name lang="nl">Microtriplicatie 11q24.1-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -214741,11 +217872,11 @@
       <OrphaCode>289513</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=289513</ExpertLink>
       <Name lang="nl">12q15q21.1-microdeletiesyndroom</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
+      <DisorderType id="21443">
+        <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="13367">
@@ -214789,7 +217920,7 @@
     <Disorder id="20723">
       <OrphaCode>289465</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=289465</ExpertLink>
-      <Name lang="nl">Geïsoleerde congenitale adermatoglyfie</Name>
+      <Name lang="nl">GeÃ¯soleerde congenitale adermatoglyfie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -214821,7 +217952,7 @@
     <Disorder id="20721">
       <OrphaCode>289390</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=289390</ExpertLink>
-      <Name lang="nl">Primair syndroom van Sjögren</Name>
+      <Name lang="nl">Primair syndroom van SjÃ¶gren</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -215245,7 +218376,7 @@
     <Disorder id="20702">
       <OrphaCode>289157</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=289157</ExpertLink>
-      <Name lang="nl">Hypocalciëmische vitamine D-afhankelijke rachitis</Name>
+      <Name lang="nl">HypocalciÃ«mische vitamine D-afhankelijke rachitis</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -215277,7 +218408,7 @@
     <Disorder id="20518">
       <OrphaCode>280921</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=280921</ExpertLink>
-      <Name lang="nl">Idiopathische panuveïtis</Name>
+      <Name lang="nl">Idiopathische panuveÃ¯tis</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -215366,7 +218497,7 @@
     <Disorder id="20515">
       <OrphaCode>280898</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=280898</ExpertLink>
-      <Name lang="nl">Panuveïtis</Name>
+      <Name lang="nl">PanuveÃ¯tis</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -215398,7 +218529,7 @@
     <Disorder id="20514">
       <OrphaCode>280892</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=280892</ExpertLink>
-      <Name lang="nl">Posterieure uveïtis</Name>
+      <Name lang="nl">Posterieure uveÃ¯tis</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -215430,7 +218561,7 @@
     <Disorder id="20513">
       <OrphaCode>280886</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=280886</ExpertLink>
-      <Name lang="nl">Anterieure uveïtis</Name>
+      <Name lang="nl">Anterieure uveÃ¯tis</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -215634,7 +218765,7 @@
     <Disorder id="20524">
       <OrphaCode>281085</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=281085</ExpertLink>
-      <Name lang="nl">Overgeërfde ichthyosis syndromale vorm</Name>
+      <Name lang="nl">OvergeÃ«rfde ichthyosis syndromale vorm</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -215666,7 +218797,7 @@
     <Disorder id="20523">
       <OrphaCode>281082</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=281082</ExpertLink>
-      <Name lang="nl">Overgeërfde ichthyosis niet-syndromale vorm</Name>
+      <Name lang="nl">OvergeÃ«rfde ichthyosis niet-syndromale vorm</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -215975,7 +219106,7 @@
     <Disorder id="20486">
       <OrphaCode>280633</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=280633</ExpertLink>
-      <Name lang="nl">Multipele congenitale anomalieën - hypotonie - insulten-syndroom</Name>
+      <Name lang="nl">Multipele congenitale anomalieÃ«n - hypotonie - insulten-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -216563,7 +219694,7 @@
     <Disorder id="20499">
       <OrphaCode>280774</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=280774</ExpertLink>
-      <Name lang="nl">Gegeneraliseerde essentiële teleangiëctasie</Name>
+      <Name lang="nl">Gegeneraliseerde essentiÃ«le teleangiÃ«ctasie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -216595,7 +219726,7 @@
     <Disorder id="20578">
       <OrphaCode>284149</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=284149</ExpertLink>
-      <Name lang="nl">Craniosynostose - dentale anomalieën</Name>
+      <Name lang="nl">Craniosynostose - dentale anomalieÃ«n</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -217015,7 +220146,7 @@
     <Disorder id="20592">
       <OrphaCode>284282</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=284282</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve cerebellaire ataxie - epilepsie - intellectuele achterstand-syndroom door WWOX-deficiëntie</Name>
+      <Name lang="nl">Autosomaal recessieve cerebellaire ataxie - epilepsie - intellectuele achterstand-syndroom door WWOX-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -217343,7 +220474,7 @@
     <Disorder id="20556">
       <OrphaCode>282166</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=282166</ExpertLink>
-      <Name lang="nl">Overgeërfde ziekte van Creutzfeldt-Jakob</Name>
+      <Name lang="nl">OvergeÃ«rfde ziekte van Creutzfeldt-Jakob</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -217522,7 +220653,7 @@
     <Disorder id="21468">
       <OrphaCode>314017</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314017</ExpertLink>
-      <Name lang="nl">Idiopathische lineaire interstitiële keratitis</Name>
+      <Name lang="nl">Idiopathische lineaire interstitiÃ«le keratitis</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -217801,7 +220932,7 @@
     <Disorder id="21461">
       <OrphaCode>313892</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=313892</ExpertLink>
-      <Name lang="nl">Ontwikkelings- en spraakachterstand door SOX5-deficiëntie</Name>
+      <Name lang="nl">Ontwikkelings- en spraakachterstand door SOX5-deficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -217997,7 +221128,7 @@
     <Disorder id="21457">
       <OrphaCode>313846</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=313846</ExpertLink>
-      <Name lang="nl">Familiale cutane teleangiëctasie en orofaryngeale kankerpredispositiesyndroom</Name>
+      <Name lang="nl">Familiale cutane teleangiÃ«ctasie en orofaryngeale kankerpredispositiesyndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -218127,7 +221258,7 @@
     <Disorder id="21453">
       <OrphaCode>313808</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=313808</ExpertLink>
-      <Name lang="nl">Erfelijke diffuse leuko-encefalopathie met axonale sferoïden en gepigmenteerde glia</Name>
+      <Name lang="nl">Erfelijke diffuse leuko-encefalopathie met axonale sferoÃ¯den en gepigmenteerde glia</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -218551,7 +221682,7 @@
     <Disorder id="21499">
       <OrphaCode>314588</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314588</ExpertLink>
-      <Name lang="nl">Distale triplicatie 15q</Name>
+      <Name lang="nl">Distale triplicatie 15q-syndroom</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -218747,7 +221878,7 @@
     <Disorder id="21494">
       <OrphaCode>314555</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314555</ExpertLink>
-      <Name lang="nl">Faciale dysmorfie - oculaire anomalieën - osteopenie - intellectuele achterstand - dentale anomalieën-syndroom</Name>
+      <Name lang="nl">Faciale dysmorfie - oculaire anomalieÃ«n - osteopenie - intellectuele achterstand - dentale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -219299,7 +222430,7 @@
     <Disorder id="21477">
       <OrphaCode>314376</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314376</ExpertLink>
-      <Name lang="nl">Intestinale obstructie bij neonaat door gyanylaatcyclase 2C-deficiëntie</Name>
+      <Name lang="nl">Intestinale obstructie bij neonaat door gyanylaatcyclase 2C-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -219495,7 +222626,7 @@
     <Disorder id="21474">
       <OrphaCode>314041</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314041</ExpertLink>
-      <Name lang="nl">Marfanoïde habitus - liesbreuk - gevorderde botleeftijd-syndroom</Name>
+      <Name lang="nl">MarfanoÃ¯de habitus - liesbreuk - gevorderde botleeftijd-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -219544,7 +222675,7 @@
     <Disorder id="21475">
       <OrphaCode>314051</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=314051</ExpertLink>
-      <Name lang="nl">Leuko-encefalopathie - anomalieën van thalamus en hersenstam - hoog lactaatgehalte-syndroom</Name>
+      <Name lang="nl">Leuko-encefalopathie - anomalieÃ«n van thalamus en hersenstam - hoog lactaatgehalte-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -219853,7 +222984,7 @@
     <Disorder id="21306">
       <OrphaCode>308386</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=308386</ExpertLink>
-      <Name lang="nl">Sulfietoxidasedeficiëntie door molybdeen-cofactordeficiëntie type A</Name>
+      <Name lang="nl">SulfietoxidasedeficiÃ«ntie door molybdeen-cofactordeficiÃ«ntie type A</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -219885,7 +223016,7 @@
     <Disorder id="21310">
       <OrphaCode>308410</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=308410</ExpertLink>
-      <Name lang="nl">Autisme - epilepsie-syndroom door deficiëntie van vertakte keten-ketozuurdehydrogenasekinase</Name>
+      <Name lang="nl">Autisme - epilepsie-syndroom door deficiÃ«ntie van vertakte keten-ketozuurdehydrogenasekinase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -219934,7 +223065,7 @@
     <Disorder id="21311">
       <OrphaCode>308425</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=308425</ExpertLink>
-      <Name lang="nl">Methylmalonacidurie door methylmalonyl-CoA-epimerasedeficiëntie</Name>
+      <Name lang="nl">Methylmalonacidurie door methylmalonyl-CoA-epimerasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -219983,7 +223114,7 @@
     <Disorder id="21283">
       <OrphaCode>307766</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=307766</ExpertLink>
-      <Name lang="nl">Gekruld haar-acrale keratodermie-cariës-syndroom</Name>
+      <Name lang="nl">Gekruld haar-acrale keratodermie-cariÃ«s-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -220081,7 +223212,7 @@
     <Disorder id="21342">
       <OrphaCode>309111</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=309111</ExpertLink>
-      <Name lang="nl">Gecombineerde deficiëntie van pancreatisch lipase-colipase</Name>
+      <Name lang="nl">Gecombineerde deficiÃ«ntie van pancreatisch lipase-colipase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -220130,7 +223261,7 @@
     <Disorder id="21340">
       <OrphaCode>309031</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=309031</ExpertLink>
-      <Name lang="nl">Deficiëntie van pancreatisch triacylglycerollipase</Name>
+      <Name lang="nl">DeficiÃ«ntie van pancreatisch triacylglycerollipase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -220181,7 +223312,7 @@
     <Disorder id="21341">
       <OrphaCode>309108</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=309108</ExpertLink>
-      <Name lang="nl">Deficiëntie van pancreatisch colipase</Name>
+      <Name lang="nl">DeficiÃ«ntie van pancreatisch colipase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -220230,7 +223361,7 @@
     <Disorder id="21338">
       <OrphaCode>309025</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=309025</ExpertLink>
-      <Name lang="nl">Deficiëntie van mevalonaatkinase</Name>
+      <Name lang="nl">DeficiÃ«ntie van mevalonaatkinase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -220279,7 +223410,7 @@
     <Disorder id="21336">
       <OrphaCode>309015</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=309015</ExpertLink>
-      <Name lang="nl">Familiale deficiëntie van lipoproteïnelipase</Name>
+      <Name lang="nl">Familiale deficiÃ«ntie van lipoproteÃ¯nelipase</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -220330,7 +223461,7 @@
     <Disorder id="21337">
       <OrphaCode>309020</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=309020</ExpertLink>
-      <Name lang="nl">Familiale deficiëntie van apolipoproteïne C-II</Name>
+      <Name lang="nl">Familiale deficiÃ«ntie van apolipoproteÃ¯ne C-II</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -220492,7 +223623,7 @@
     <Disorder id="21321">
       <OrphaCode>308552</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=308552</ExpertLink>
-      <Name lang="nl">Glycogeenstapelingsziekte door zure-maltasedeficiëntie, infantiele aanvang</Name>
+      <Name lang="nl">Glycogeenstapelingsziekte door zure-maltasedeficiÃ«ntie, infantiele aanvang</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -221304,7 +224435,7 @@
     <Disorder id="21351">
       <OrphaCode>309147</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=309147</ExpertLink>
-      <Name lang="nl">Hyper-bèta-alaninemie</Name>
+      <Name lang="nl">Hyper-bÃ¨ta-alaninemie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -221404,7 +224535,7 @@
     <Disorder id="21128">
       <OrphaCode>300547</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=300547</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve infantiele hypercalciëmie</Name>
+      <Name lang="nl">Autosomaal recessieve infantiele hypercalciÃ«mie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -221699,59 +224830,10 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="21134">
-      <OrphaCode>300576</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=300576</ExpertLink>
-      <Name lang="nl">Oligodontie - kankerpredispositie-syndroom</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="9859">
-          <Source>15042511[PMID]_21416598[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Geval(len)/Gezinnen</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23725">
-            <Name lang="nl">Familie/Gezinnen</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>2.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="9860">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="21120">
       <OrphaCode>300496</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=300496</ExpertLink>
-      <Name lang="nl">Multipele congenitale anomalieën - hypotonie - insulten-syndroom type 2</Name>
+      <Name lang="nl">Multipele congenitale anomalieÃ«n - hypotonie - insulten-syndroom type 2</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -221800,7 +224882,7 @@
     <Disorder id="21121">
       <OrphaCode>300501</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=300501</ExpertLink>
-      <Name lang="nl">Pijnlijke orbitale en systemische neurofibromen - marfanoïde habitus-syndroom</Name>
+      <Name lang="nl">Pijnlijke orbitale en systemische neurofibromen - marfanoÃ¯de habitus-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -222567,7 +225649,7 @@
     <Disorder id="21212">
       <OrphaCode>306431</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=306431</ExpertLink>
-      <Name lang="nl">Imuundeficiëntie met anti-interferon-gamma auto-antilichamen met aanvang op volwassen leeftijd</Name>
+      <Name lang="nl">ImuundeficiÃ«ntie met anti-interferon-gamma auto-antilichamen met aanvang op volwassen leeftijd</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -222599,7 +225681,7 @@
     <Disorder id="21230">
       <OrphaCode>306550</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=306550</ExpertLink>
-      <Name lang="nl">FADD-gerelateerde immuundeficiëntie</Name>
+      <Name lang="nl">FADD-gerelateerde immuundeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -222827,7 +225909,7 @@
     <Disorder id="21225">
       <OrphaCode>306527</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=306527</ExpertLink>
-      <Name lang="nl">Geïsoleerde erfelijke congenitale facialisparalyse</Name>
+      <Name lang="nl">GeÃ¯soleerde erfelijke congenitale facialisparalyse</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -222876,7 +225958,7 @@
     <Disorder id="21222">
       <OrphaCode>306516</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=306516</ExpertLink>
-      <Name lang="nl">Primaire hypomagnesiëmie met hypercalciurie en nefrocalcinose</Name>
+      <Name lang="nl">Primaire hypomagnesiÃ«mie met hypercalciurie en nefrocalcinose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -222975,11 +226057,11 @@
       <OrphaCode>306498</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=306498</ExpertLink>
       <Name lang="nl">PTEN-hamartoom-tumorsyndroom</Name>
-      <DisorderType id="21436">
-        <Name lang="nl">Group of phenomes</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
       </DisorderType>
-      <DisorderGroup id="36540">
-        <Name lang="nl">Groep van aandoeningen</Name>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="9872">
@@ -223006,7 +226088,7 @@
     <Disorder id="21219">
       <OrphaCode>306504</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=306504</ExpertLink>
-      <Name lang="nl">Interstitiële longziekte - nefrotisch syndroom - epidermolysis bullosa-syndroom</Name>
+      <Name lang="nl">InterstitiÃ«le longziekte - nefrotisch syndroom - epidermolysis bullosa-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -223217,7 +226299,7 @@
     <Disorder id="21100">
       <OrphaCode>300179</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=300179</ExpertLink>
-      <Name lang="nl">Kyfoscoliotisch syndroom van Ehlers-Danlos door FKBP22-deficiëntie</Name>
+      <Name lang="nl">Kyfoscoliotisch syndroom van Ehlers-Danlos door FKBP22-deficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -223511,7 +226593,7 @@
     <Disorder id="21104">
       <OrphaCode>300284</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=300284</ExpertLink>
-      <Name lang="nl">Aandoening van bindweefsel door lysylhydroxylase 3-deficiëntie</Name>
+      <Name lang="nl">Aandoening van bindweefsel door lysylhydroxylase 3-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -223560,7 +226642,7 @@
     <Disorder id="21105">
       <OrphaCode>300293</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=300293</ExpertLink>
-      <Name lang="nl">Transiënte infantiele hypertriglyceridemie en hepatosteatose</Name>
+      <Name lang="nl">TransiÃ«nte infantiele hypertriglyceridemie en hepatosteatose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -224214,7 +227296,7 @@
     <Disorder id="21117">
       <OrphaCode>300382</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=300382</ExpertLink>
-      <Name lang="nl">Progeroïd en marfanoïd uiterlijk - lipodystrofie-syndroom</Name>
+      <Name lang="nl">ProgeroÃ¯d en marfanoÃ¯d uiterlijk - lipodystrofie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -224312,7 +227394,7 @@
     <Disorder id="21115">
       <OrphaCode>300359</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=300359</ExpertLink>
-      <Name lang="nl">PLCG2-geassocieerde antilichaamdeficiëntie en immuundisregulatie</Name>
+      <Name lang="nl">PLCG2-geassocieerde antilichaamdeficiÃ«ntie en immuundisregulatie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -225338,42 +228420,10 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="6519">
-      <OrphaCode>639</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=639</ExpertLink>
-      <Name lang="nl">Polyneuropathie geassocieerd met IgM monoklonale gammopathie met anti-MAG</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="5025">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="6520">
       <OrphaCode>662</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=662</ExpertLink>
-      <Name lang="nl">Gelenagelsyndroom</Name>
+      <Name lang="nl">Lymfoedeem met gele nagels</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -225535,7 +228585,7 @@
     <Disorder id="23678">
       <OrphaCode>456328</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=456328</ExpertLink>
-      <Name lang="nl">X-gebonden myotubulaire myopathie - abnormale genitaliën-syndroom</Name>
+      <Name lang="nl">X-gebonden myotubulaire myopathie - abnormale genitaliÃ«n-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -225814,7 +228864,7 @@
     <Disorder id="23658">
       <OrphaCode>454723</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=454723</ExpertLink>
-      <Name lang="nl">Endometrioïd carcinoom van ovarium</Name>
+      <Name lang="nl">EndometrioÃ¯d carcinoom van ovarium</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -225945,42 +228995,10 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="23663">
-      <OrphaCode>454821</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=454821</ExpertLink>
-      <Name lang="nl">Pleomorf adenoom van speekselklier</Name>
-      <DisorderType id="21457">
-        <Name lang="nl">Histopathologisch subtype</Name>
-      </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="nl">Subtype van aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="12114">
-          <Source>World Health Organization 2005[INST]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>2.725</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="23661">
       <OrphaCode>454750</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=454750</ExpertLink>
-      <Name lang="nl">Geïsoleerde tracheo-oesofageale fistel</Name>
+      <Name lang="nl">GeÃ¯soleerde tracheo-oesofageale fistel</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -226167,7 +229185,7 @@
     <Disorder id="23648">
       <OrphaCode>453521</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=453521</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve cerebellaire ataxie als gevolg van CWF19L1-deficiëntie</Name>
+      <Name lang="nl">Autosomaal recessieve cerebellaire ataxie als gevolg van CWF19L1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -226216,7 +229234,7 @@
     <Disorder id="23655">
       <OrphaCode>454710</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=454710</ExpertLink>
-      <Name lang="nl">Anti-p200-pemfigoïd</Name>
+      <Name lang="nl">Anti-p200-pemfigoÃ¯d</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -226427,7 +229445,7 @@
     <Disorder id="23645">
       <OrphaCode>453499</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=453499</ExpertLink>
-      <Name lang="nl">Neurologische ontwikkelingsstoornis - craniofaciale dysmorfie - hartdefect - skeletanomalieën-syndroom</Name>
+      <Name lang="nl">Neurologische ontwikkelingsstoornis - craniofaciale dysmorfie - hartdefect - skeletanomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -226476,7 +229494,7 @@
     <Disorder id="23646">
       <OrphaCode>453504</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=453504</ExpertLink>
-      <Name lang="nl">Neurologische ontwikkelingsstoornis - craniofaciale dysmorfie - hartdefect - skeletanomalieën-syndroom door een puntmutatie</Name>
+      <Name lang="nl">Neurologische ontwikkelingsstoornis - craniofaciale dysmorfie - hartdefect - skeletanomalieÃ«n-syndroom door een puntmutatie</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -226684,38 +229702,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="23616">
-      <OrphaCode>449291</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=449291</ExpertLink>
-      <Name lang="nl">Symptomatische vorm van fragiele-X-syndroom bij vrouwelijke dragers</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="12169">
-          <Source>ORPHANET_19642710[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="23619">
       <OrphaCode>449400</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=449400</ExpertLink>
@@ -226962,7 +229948,7 @@
     <Disorder id="23565">
       <OrphaCode>448264</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=448264</ExpertLink>
-      <Name lang="nl">Geïsoleerde focale niet-epidermolytische palmoplantaire keratodermie</Name>
+      <Name lang="nl">GeÃ¯soleerde focale niet-epidermolytische palmoplantaire keratodermie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -227307,7 +230293,7 @@
     <Disorder id="23562">
       <OrphaCode>448237</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=448237</ExpertLink>
-      <Name lang="nl">Ziekte door zika-virus</Name>
+      <Name lang="nl">Ziekte door zikavirus</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -227505,7 +230491,7 @@
     <Disorder id="23553">
       <OrphaCode>447954</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=447954</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 25</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 25</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -227750,7 +230736,7 @@
     <Disorder id="23771">
       <OrphaCode>459061</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=459061</ExpertLink>
-      <Name lang="nl">Craniofaciale dysplasie - kleine gestalte - ectodermale anomalieën - intellectuele achterstand-syndroom</Name>
+      <Name lang="nl">Craniofaciale dysplasie - kleine gestalte - ectodermale anomalieÃ«n - intellectuele achterstand-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -228860,7 +231846,7 @@
     <Disorder id="23703">
       <OrphaCode>457185</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=457185</ExpertLink>
-      <Name lang="nl">Neonatale encefalomyopathie - cardiomyopathie - ademnood-syndroom</Name>
+      <Name lang="nl">Neonatale encefalomyopathie - cardiomyopathie - ademhalingsnood-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -228909,7 +231895,7 @@
     <Disorder id="23697">
       <OrphaCode>457083</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=457083</ExpertLink>
-      <Name lang="nl">Geïsoleerde splenogonadale fusie</Name>
+      <Name lang="nl">GeÃ¯soleerde splenogonadale fusie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -229039,7 +232025,7 @@
     <Disorder id="23709">
       <OrphaCode>457223</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=457223</ExpertLink>
-      <Name lang="nl">Syndromale sensorineurale doofheid door gecombineerde oxidatieve fosforylatiedeficiëntie</Name>
+      <Name lang="nl">Syndromale sensorineurale doofheid door gecombineerde oxidatieve fosforylatiedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -229088,7 +232074,7 @@
     <Disorder id="23708">
       <OrphaCode>457212</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=457212</ExpertLink>
-      <Name lang="nl">Progressieve essentiële tremor - spraakstoornis - faciale dysmorfie - intellectuele achterstand - gedragsstoornis-syndroom</Name>
+      <Name lang="nl">Progressieve essentiÃ«le tremor - spraakstoornis - faciale dysmorfie - intellectuele achterstand - gedragsstoornis-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -229137,7 +232123,7 @@
     <Disorder id="23705">
       <OrphaCode>457193</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=457193</ExpertLink>
-      <Name lang="nl">KAT6-gerelateerd intellectuele achterstand - craniofaciale anomalieën - hartdefecten-syndroom</Name>
+      <Name lang="nl">KAT6-gerelateerd intellectuele achterstand - craniofaciale anomalieÃ«n - hartdefecten-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -230363,7 +233349,7 @@
     <Disorder id="24151">
       <OrphaCode>466650</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=466650</ExpertLink>
-      <Name lang="nl">Maligne hyperthermie geïnduceerd door lichaamsbeweging</Name>
+      <Name lang="nl">Maligne hyperthermie geÃ¯nduceerd door lichaamsbeweging</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -230395,7 +233381,7 @@
     <Disorder id="24185">
       <OrphaCode>466962</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=466962</ExpertLink>
-      <Name lang="nl">SMARCA4-deficiënt sarcoom van thorax</Name>
+      <Name lang="nl">SMARCA4-deficiÃ«nt sarcoom van thorax</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -231179,7 +234165,7 @@
     <Disorder id="24102">
       <OrphaCode>466026</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=466026</ExpertLink>
-      <Name lang="nl">Deficiëntie van glucose-6-fosfaatdehydrogenase klasse 1</Name>
+      <Name lang="nl">DeficiÃ«ntie van glucose-6-fosfaatdehydrogenase klasse 1</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -231260,7 +234246,7 @@
     <Disorder id="24223">
       <OrphaCode>468631</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=468631</ExpertLink>
-      <Name lang="nl">Microcefale corticale malformaties - kleine gestalte door RTTN-deficiëntie</Name>
+      <Name lang="nl">Microcefale corticale malformaties - kleine gestalte door RTTN-deficiÃ«ntie</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -231554,7 +234540,7 @@
     <Disorder id="24231">
       <OrphaCode>468666</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=468666</ExpertLink>
-      <Name lang="nl">Geïsoleerde gegeneraliseerde anhidrose met normale zweetklieren</Name>
+      <Name lang="nl">GeÃ¯soleerde gegeneraliseerde anhidrose met normale zweetklieren</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -232745,7 +235731,7 @@
     <Disorder id="22842">
       <OrphaCode>401859</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=401859</ExpertLink>
-      <Name lang="nl">Liponzuursynthasedeficiëntie</Name>
+      <Name lang="nl">LiponzuursynthasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -232794,7 +235780,7 @@
     <Disorder id="22843">
       <OrphaCode>401862</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=401862</ExpertLink>
-      <Name lang="nl">Lipoyltransferase 1-deficiëntie</Name>
+      <Name lang="nl">Lipoyltransferase 1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -233307,11 +236293,11 @@
       <OrphaCode>401911</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=401911</ExpertLink>
       <Name lang="nl">AXIN2-gerelateerde geattenueerde familiale adenomateuze polyposis</Name>
-      <DisorderType id="21450">
-        <Name lang="nl">Klinisch subtype</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
       </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="nl">Subtype van aandoening</Name>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="11119">
@@ -233551,7 +236537,7 @@
     <Disorder id="22859">
       <OrphaCode>401959</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=401959</ExpertLink>
-      <Name lang="nl">Partiële agenesie van corpus callosum - hypoplasie van vermis cerebelli met cysten in fossa posterior-syndroom</Name>
+      <Name lang="nl">PartiÃ«le agenesie van corpus callosum - hypoplasie van vermis cerebelli met cysten in fossa posterior-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -233649,7 +236635,7 @@
     <Disorder id="22857">
       <OrphaCode>401948</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=401948</ExpertLink>
-      <Name lang="nl">Hyperammoniëmische encefalopathie door deficiëntie van koolzuuranhydrase VA</Name>
+      <Name lang="nl">HyperammoniÃ«mische encefalopathie door deficiÃ«ntie van koolzuuranhydrase VA</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -233796,7 +236782,7 @@
     <Disorder id="22862">
       <OrphaCode>401979</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=401979</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve spondylometafysaire dysplasie, Mégarbané-type</Name>
+      <Name lang="nl">Autosomaal recessieve spondylometafysaire dysplasie, MÃ©garbanÃ©-type</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -233992,7 +236978,7 @@
     <Disorder id="22865">
       <OrphaCode>401996</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=401996</ExpertLink>
-      <Name lang="nl">Interstitiële nefritis met karyomegalie</Name>
+      <Name lang="nl">InterstitiÃ«le nefritis met karyomegalie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -234038,6 +237024,68 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="22871">
+      <OrphaCode>402020</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=402020</ExpertLink>
+      <Name lang="nl">Acute myeloÃ¯de leukemie met inv3(q21;q26.2) of t(3;3)(q21;q26.2)</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="18011">
+          <Source>36951163[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>0.02</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="22869">
+      <OrphaCode>402014</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=402014</ExpertLink>
+      <Name lang="nl">Acute myeloÃ¯de leukemie met t(6;9)(p23;q34)</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17910">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.02</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="22875">
       <OrphaCode>402035</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=402035</ExpertLink>
@@ -234269,7 +237317,7 @@
     <Disorder id="22927">
       <OrphaCode>404473</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=404473</ExpertLink>
-      <Name lang="nl">Ernstige intellectuele achterstand - progressieve spastische diplegie-syndroom</Name>
+      <Name lang="nl">Intellectuele achterstand - perifere spasticiteit - exsudatieve vitreoretinopathie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -234641,55 +237689,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="22919">
-      <OrphaCode>404440</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=404440</ExpertLink>
-      <Name lang="nl">Intellectuele achterstand - faciale dysmorfie-syndroom door SETD5-haploinsufficiëntie</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="10779">
-          <Source>24680889[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Geval(len)/Gezinnen</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Geval(len)</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>7.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10780">
-          <Source>ORPHANET_24680889[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="22939">
       <OrphaCode>404560</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=404560</ExpertLink>
@@ -234725,7 +237724,7 @@
     <Disorder id="22938">
       <OrphaCode>404553</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=404553</ExpertLink>
-      <Name lang="nl">Adenosinedeaminase 2-deficiëntie</Name>
+      <Name lang="nl">DeficiÃ«ntie van adenosinedeaminase 2</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -234823,7 +237822,7 @@
     <Disorder id="22935">
       <OrphaCode>404521</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=404521</ExpertLink>
-      <Name lang="nl">Spinale spieratrofie met respiratoire insufficiëntie type 2</Name>
+      <Name lang="nl">Spinale spieratrofie met ademhalingsnood type 2</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -234872,7 +237871,7 @@
     <Disorder id="22932">
       <OrphaCode>404507</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=404507</ExpertLink>
-      <Name lang="nl">Chondromyxoïd fibroom</Name>
+      <Name lang="nl">ChondromyxoÃ¯d fibroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -234921,7 +237920,7 @@
     <Disorder id="22931">
       <OrphaCode>404499</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=404499</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve cerebellaire ataxie - epilepsie - intellectuele achterstand-syndroom door RUBCN-deficiëntie</Name>
+      <Name lang="nl">Autosomaal recessieve cerebellaire ataxie - epilepsie - intellectuele achterstand-syndroom door RUBCN-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -234970,7 +237969,7 @@
     <Disorder id="22930">
       <OrphaCode>404493</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=404493</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve cerebellaire ataxie - epilepsie - intellectuele achterstand-syndroom door TUD-deficiëntie</Name>
+      <Name lang="nl">Autosomaal recessieve cerebellaire ataxie - epilepsie - intellectuele achterstand-syndroom door TUD-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -235411,7 +238410,7 @@
     <Disorder id="23032">
       <OrphaCode>411712</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=411712</ExpertLink>
-      <Name lang="nl">Maternale riboflavinedeficiëntie</Name>
+      <Name lang="nl">Maternale riboflavinedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -235460,7 +238459,7 @@
     <Disorder id="23034">
       <OrphaCode>411788</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=411788</ExpertLink>
-      <Name lang="nl">Familiale geïsoleerde trichomegalie</Name>
+      <Name lang="nl">Familiale geÃ¯soleerde trichomegalie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -235607,7 +238606,7 @@
     <Disorder id="23038">
       <OrphaCode>412022</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=412022</ExpertLink>
-      <Name lang="nl">Faciale dysmorfie - lensdislocatie - anomalieën van voorste oogsegment - spontane filtratieblaasjes-syndroom</Name>
+      <Name lang="nl">Faciale dysmorfie - lensdislocatie - anomalieÃ«n van voorste oogsegment - spontane filtratieblaasjes-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -235822,7 +238821,7 @@
     <Disorder id="23030">
       <OrphaCode>411703</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=411703</ExpertLink>
-      <Name lang="nl">Pulmonale niet-tuberculeuze mycobacteriële infectie</Name>
+      <Name lang="nl">Pulmonale niet-tuberculeuze mycobacteriÃ«le infectie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -235967,7 +238966,7 @@
     <Disorder id="22641">
       <OrphaCode>391677</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=391677</ExpertLink>
-      <Name lang="nl">Kleine gestalte - optische atrofie - Pelger-Huëtanomalie-syndroom</Name>
+      <Name lang="nl">Kleine gestalte - opticusatrofie - anomalie van Pelger-HuÃ«t-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -238385,7 +241384,7 @@
     <Disorder id="22715">
       <OrphaCode>397973</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=397973</ExpertLink>
-      <Name lang="nl">Intellectuele achterstand - obesitas - prognathie - oog- en huidanomalieën-syndroom</Name>
+      <Name lang="nl">Intellectuele achterstand - obesitas - prognathie - oog- en huidanomalieÃ«n-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -238483,7 +241482,7 @@
     <Disorder id="22713">
       <OrphaCode>397964</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=397964</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door MALT1-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door MALT1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -238532,7 +241531,7 @@
     <Disorder id="22712">
       <OrphaCode>397959</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=397959</ExpertLink>
-      <Name lang="nl">TCR-alfa-bèta-positieve T-celdeficiëntie</Name>
+      <Name lang="nl">TCR-alfa-bÃ¨ta-positieve T-celdeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -238924,7 +241923,7 @@
     <Disorder id="22702">
       <OrphaCode>397787</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=397787</ExpertLink>
-      <Name lang="nl">Ernstige gecombineerde immuundeficiëntie door IKK2-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door IKK2-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -239022,7 +242021,7 @@
     <Disorder id="22701">
       <OrphaCode>397758</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=397758</ExpertLink>
-      <Name lang="nl">Retinadystrofie met disfunctie van inwendige retina en anomalieën van ganglioncellen</Name>
+      <Name lang="nl">Retinadystrofie met disfunctie van inwendige retina en anomalieÃ«n van ganglioncellen</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -239169,7 +242168,7 @@
     <Disorder id="22696">
       <OrphaCode>397725</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=397725</ExpertLink>
-      <Name lang="nl">COASY-proteïnegeassocieerde neurodegeneratie</Name>
+      <Name lang="nl">COASY-proteÃ¯negeassocieerde neurodegeneratie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -239316,7 +242315,7 @@
     <Disorder id="22695">
       <OrphaCode>397715</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=397715</ExpertLink>
-      <Name lang="nl">Syndroom van Joubert met asfyxiërende thoracale dystrofie van Jeune</Name>
+      <Name lang="nl">Syndroom van Joubert met asfyxiÃ«rende thoracale dystrofie van Jeune</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -239365,7 +242364,7 @@
     <Disorder id="22692">
       <OrphaCode>397692</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=397692</ExpertLink>
-      <Name lang="nl">Erfelijke geïsoleerde aplastische anemie</Name>
+      <Name lang="nl">Erfelijke geÃ¯soleerde aplastische anemie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -239394,59 +242393,10 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="22693">
-      <OrphaCode>397695</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=397695</ExpertLink>
-      <Name lang="nl">3q27.3-microdeletiesyndroom</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="10986">
-          <Source>24133203[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Geval(len)/Gezinnen</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Geval(len)</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>7.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10987">
-          <Source>ORPHANET_24133203[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="22690">
       <OrphaCode>397623</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=397623</ExpertLink>
-      <Name lang="nl">Kleine gestalte - gehoorgangatresie - mandibulaire hypoplasie - skeletanomalieën-syndroom</Name>
+      <Name lang="nl">Kleine gestalte - gehoorgangatresie - mandibulaire hypoplasie - skeletanomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -239527,7 +242477,7 @@
     <Disorder id="22688">
       <OrphaCode>397615</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=397615</ExpertLink>
-      <Name lang="nl">Obesitas door CEP19-deficiëntie</Name>
+      <Name lang="nl">Obesitas door CEP19-deficiÃ«ntie</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -239626,11 +242576,11 @@
       <OrphaCode>397596</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=397596</ExpertLink>
       <Name lang="nl">Geactiveerd PI3K-delta-syndroom</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21436">
+        <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36540">
+        <Name lang="nl">Groep van aandoeningen</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="10970">
@@ -239674,7 +242624,7 @@
     <Disorder id="22684">
       <OrphaCode>397593</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=397593</ExpertLink>
-      <Name lang="nl">Ernstige neonatale lactaatacidose door deficiëntie van NFS1-ISD11-complex</Name>
+      <Name lang="nl">Ernstige neonatale lactaatacidose door deficiÃ«ntie van NFS1-ISD11-complex</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -239772,7 +242722,7 @@
     <Disorder id="22686">
       <OrphaCode>397606</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=397606</ExpertLink>
-      <Name lang="nl">PrP systemische amyloïdose</Name>
+      <Name lang="nl">PrP systemische amyloÃ¯dose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -240582,7 +243532,7 @@
     <Disorder id="22749">
       <OrphaCode>399103</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=399103</ExpertLink>
-      <Name lang="nl">Distale nebuline myopathie</Name>
+      <Name lang="nl">Distale nebulinemyopathie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -242067,7 +245017,7 @@
     <Disorder id="22720">
       <OrphaCode>398069</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=398069</ExpertLink>
-      <Name lang="nl">MAGEL2-gerelateerd Prader-Willi-achtig syndroom</Name>
+      <Name lang="nl">Syndroom van Schaaf-Yang</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -242076,7 +245026,7 @@
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="11063">
-          <Source>27195816[PMID]</Source>
+          <Source>33570896[PMID]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
           </PrevalenceType>
@@ -242084,7 +245034,7 @@
             <Name lang="nl">Geval(len)</Name>
           </PrevalenceQualification>
           <PrevalenceClass/>
-          <ValMoy>28.0</ValMoy>
+          <ValMoy>250.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -242459,7 +245409,7 @@
     <Disorder id="23310">
       <OrphaCode>435660</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=435660</ExpertLink>
-      <Name lang="nl">LIPE-gerelateerde familiale partiële lipodystrofie</Name>
+      <Name lang="nl">LIPE-gerelateerde familiale partiÃ«le lipodystrofie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -242508,7 +245458,7 @@
     <Disorder id="23309">
       <OrphaCode>435651</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=435651</ExpertLink>
-      <Name lang="nl">CIDEC-gerelateerde familiale partiële lipodystrofie</Name>
+      <Name lang="nl">CIDEC-gerelateerde familiale partiÃ«le lipodystrofie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -242802,7 +245752,7 @@
     <Disorder id="23322">
       <OrphaCode>435953</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=435953</ExpertLink>
-      <Name lang="nl">Progeroïde kenmerken - vatbaarheid voor hepatocellulair carcinoom-syndroom</Name>
+      <Name lang="nl">ProgeroÃ¯de kenmerken - vatbaarheid voor hepatocellulair carcinoom-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -243194,7 +246144,7 @@
     <Disorder id="23329">
       <OrphaCode>436159</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=436159</ExpertLink>
-      <Name lang="nl">Auto-immuun lymfoproliferatief syndroom door CTLA4-haploinsufficiëntie</Name>
+      <Name lang="nl">Auto-immuun lymfoproliferatief syndroom door CTLA4-haploinsufficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -243390,7 +246340,7 @@
     <Disorder id="23332">
       <OrphaCode>436174</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=436174</ExpertLink>
-      <Name lang="nl">Cataract - deficiëntie van groeihormoon - sensorische neuropathie - sensorineuraal gehoorverlies - skeletdysplasie-syndroom</Name>
+      <Name lang="nl">Cataract - deficiÃ«ntie van groeihormoon - sensorische neuropathie - sensorineuraal gehoorverlies - skeletdysplasie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -243586,7 +246536,7 @@
     <Disorder id="23351">
       <OrphaCode>437552</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=437552</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve primaire immuundeficiëntie met defecte spontane natuurlijke killercel-cytotoxiciteit</Name>
+      <Name lang="nl">Autosomaal recessieve primaire immuundeficiÃ«ntie met defecte spontane natuurlijke killercel-cytotoxiciteit</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -243635,7 +246585,7 @@
     <Disorder id="23367">
       <OrphaCode>438178</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=438178</ExpertLink>
-      <Name lang="nl">Deficiëntie van vetzuur-acyl-CoA-reductase 1</Name>
+      <Name lang="nl">DeficiÃ«ntie van vetzuur-acyl-CoA-reductase 1</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -243880,7 +246830,7 @@
     <Disorder id="23361">
       <OrphaCode>438075</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=438075</ExpertLink>
-      <Name lang="nl">Ketoacidose als gevolg van monocarboxylaattransporter 1-deficiëntie</Name>
+      <Name lang="nl">Ketoacidose als gevolg van monocarboxylaattransporter 1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -244189,7 +247139,7 @@
     <Disorder id="23383">
       <OrphaCode>439232</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=439232</ExpertLink>
-      <Name lang="nl">AApoAIV-amyloïdose</Name>
+      <Name lang="nl">AApoAIV-amyloÃ¯dose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -244238,7 +247188,7 @@
     <Disorder id="23380">
       <OrphaCode>439212</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=439212</ExpertLink>
-      <Name lang="nl">Vroeg beginnende myopathie - areflexie - ademnood - dysfagie-syndroom</Name>
+      <Name lang="nl">Vroeg beginnende myopathie - areflexie - ademhalingsnood - dysfagie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -244368,7 +247318,7 @@
     <Disorder id="23376">
       <OrphaCode>439167</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=439167</ExpertLink>
-      <Name lang="nl">Placentale insufficiëntie</Name>
+      <Name lang="nl">Placentale insufficiÃ«ntie</Name>
       <DisorderType id="21422">
         <Name lang="nl">Klinisch syndroom</Name>
       </DisorderType>
@@ -244400,7 +247350,7 @@
     <Disorder id="23391">
       <OrphaCode>439822</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=439822</ExpertLink>
-      <Name lang="nl">Syndroom door PDE4D-haploinsufficiëntie</Name>
+      <Name lang="nl">Syndroom door PDE4D-haploinsufficiÃ«ntie</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -244449,7 +247399,7 @@
     <Disorder id="23385">
       <OrphaCode>439254</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=439254</ExpertLink>
-      <Name lang="nl">ITM2B-amyloïdose</Name>
+      <Name lang="nl">ITM2B-amyloÃ¯dose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -244677,7 +247627,7 @@
     <Disorder id="23412">
       <OrphaCode>440713</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=440713</ExpertLink>
-      <Name lang="nl">Geïsoleerde sedoheptulokinasedeficiëntie</Name>
+      <Name lang="nl">GeÃ¯soleerde sedoheptulokinasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -244775,7 +247725,7 @@
     <Disorder id="23415">
       <OrphaCode>440731</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=440731</ExpertLink>
-      <Name lang="nl">L-ferritinedeficiëntie</Name>
+      <Name lang="nl">L-ferritinedeficiÃ«ntie</Name>
       <DisorderType id="21408">
         <Name lang="nl">Biologische anomalie</Name>
       </DisorderType>
@@ -244824,7 +247774,7 @@
     <Disorder id="23411">
       <OrphaCode>440706</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=440706</ExpertLink>
-      <Name lang="nl">Ribose-5-P isomerase-deficiëntie</Name>
+      <Name lang="nl">Ribose-5-P isomerase-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -244870,6 +247820,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="23416">
+      <OrphaCode>440987</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=440987</ExpertLink>
+      <Name lang="nl">GeÃ¯soleerde agenesie van galblaas</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="18061">
+          <Source>23337680[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>25.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="23439">
       <OrphaCode>443084</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=443084</ExpertLink>
@@ -244986,7 +247968,7 @@
     <Disorder id="23424">
       <OrphaCode>442582</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=442582</ExpertLink>
-      <Name lang="nl">AH-amyloïdose</Name>
+      <Name lang="nl">AH-amyloÃ¯dose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -245035,7 +248017,7 @@
     <Disorder id="23451">
       <OrphaCode>443197</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=443197</ExpertLink>
-      <Name lang="nl">X-gebonden erytropoëtische protoporfyrie</Name>
+      <Name lang="nl">X-gebonden erytropoÃ«tische protoporfyrie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -245084,7 +248066,7 @@
     <Disorder id="8026">
       <OrphaCode>3008</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3008</ExpertLink>
-      <Name lang="nl">Deficiëntie van pyruvaatcarboxylase</Name>
+      <Name lang="nl">DeficiÃ«ntie van pyruvaatcarboxylase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -245196,6 +248178,70 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="23449">
+      <OrphaCode>443180</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=443180</ExpertLink>
+      <Name lang="nl">Spontane intracraniÃ«le hypotensie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17946">
+          <Source>32644492[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>5.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="23448">
+      <OrphaCode>443173</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=443173</ExpertLink>
+      <Name lang="nl">Postpartumpsychose</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17877">
+          <Source>31335024[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>4.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="8030">
       <OrphaCode>298</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=298</ExpertLink>
@@ -245301,7 +248347,7 @@
     <Disorder id="23453">
       <OrphaCode>443236</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=443236</ExpertLink>
-      <Name lang="nl">Posturale orthostatische tachycardie-syndroom door NET-deficiëntie</Name>
+      <Name lang="nl">Posturale orthostatische tachycardie-syndroom door NET-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -245401,7 +248447,7 @@
     <Disorder id="8029">
       <OrphaCode>854</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=854</ExpertLink>
-      <Name lang="nl">Primitieve poortadertrombose</Name>
+      <Name lang="nl">Niet-maligne en niet-cirrotische poortadertrombose</Name>
       <DisorderType id="21422">
         <Name lang="nl">Klinisch syndroom</Name>
       </DisorderType>
@@ -245556,7 +248602,7 @@
     <Disorder id="23440">
       <OrphaCode>443087</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=443087</ExpertLink>
-      <Name lang="nl">46,XY-geslachtsontwikkelingsstoornis door testiculaire deficiëntie van 17,20-desmolase</Name>
+      <Name lang="nl">46,XY-geslachtsontwikkelingsstoornis door testiculaire deficiÃ«ntie van 17,20-desmolase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -245602,6 +248648,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="23447">
+      <OrphaCode>443167</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=443167</ExpertLink>
+      <Name lang="nl">NUT-middellijncarcinoom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17891">
+          <Source>35957893[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>310.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17892">
+          <Source>35957893[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>2.0E-4</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="8022">
       <OrphaCode>130</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=130</ExpertLink>
@@ -245645,7 +248740,7 @@
           </PrevalenceClass>
           <ValMoy>75.0</ValMoy>
           <PrevalenceGeographic id="23830">
-            <Name lang="nl">Zuid-Oost Azië</Name>
+            <Name lang="nl">Zuid-Oost AziÃ«</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25965">
             <Name lang="nl">Not yet validated</Name>
@@ -245656,7 +248751,7 @@
     <Disorder id="8023">
       <OrphaCode>277</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=277</ExpertLink>
-      <Name lang="nl">Ernstige gecombineerde immuundeficiëntie door deficiëntie van adenosinedeaminase</Name>
+      <Name lang="nl">Ernstige gecombineerde immuundeficiÃ«ntie door deficiÃ«ntie van adenosinedeaminase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -245954,7 +249049,7 @@
     <Disorder id="23481">
       <OrphaCode>444092</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=444092</ExpertLink>
-      <Name lang="nl">Auto-immune interstitiële longziekte - artritis-syndroom</Name>
+      <Name lang="nl">Auto-immune interstitiÃ«le longziekte - artritis-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -246199,7 +249294,7 @@
     <Disorder id="23475">
       <OrphaCode>444048</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=444048</ExpertLink>
-      <Name lang="nl">46,XX ovariële dysgenesie - kleine gestalte-syndroom</Name>
+      <Name lang="nl">46,XX ovariÃ«le dysgenesie - kleine gestalte-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -246248,7 +249343,7 @@
     <Disorder id="23474">
       <OrphaCode>444013</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=444013</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 23</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 23</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -246493,7 +249588,7 @@
     <Disorder id="23490">
       <OrphaCode>444463</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=444463</ExpertLink>
-      <Name lang="nl">Auto-immune hemolytische anemie - auto-immune trombocytopenie - primaire immuundeficiëntie-syndroom door TPP2-deficiëntie</Name>
+      <Name lang="nl">Auto-immune hemolytische anemie - auto-immune trombocytopenie - primaire immuundeficiÃ«ntie-syndroom door TPP2-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -246593,7 +249688,7 @@
     <Disorder id="23489">
       <OrphaCode>444458</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=444458</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 24</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 24</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -246642,7 +249737,7 @@
     <Disorder id="23519">
       <OrphaCode>445110</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=445110</ExpertLink>
-      <Name lang="nl">Limb-girdle-spierdystrofie als gevolg van POMK-deficiëntie</Name>
+      <Name lang="nl">Limb-girdle-spierdystrofie als gevolg van POMK-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -246789,7 +249884,7 @@
     <Disorder id="23515">
       <OrphaCode>445018</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=445018</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door LRBA-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door LRBA-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -246838,7 +249933,7 @@
     <Disorder id="23533">
       <OrphaCode>447731</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=447731</ExpertLink>
-      <Name lang="nl">NIK-deficiëntie</Name>
+      <Name lang="nl">NIK-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -246887,7 +249982,7 @@
     <Disorder id="23534">
       <OrphaCode>447737</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=447737</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door DOCK2-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door DOCK2-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -247098,7 +250193,7 @@
     <Disorder id="23546">
       <OrphaCode>447795</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=447795</ExpertLink>
-      <Name lang="nl">Lipoyltransferase 2-deficiëntie</Name>
+      <Name lang="nl">Lipoyltransferase 2-deficiÃ«ntie</Name>
       <DisorderType id="21408">
         <Name lang="nl">Biologische anomalie</Name>
       </DisorderType>
@@ -247130,7 +250225,7 @@
     <Disorder id="23543">
       <OrphaCode>447784</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=447784</ExpertLink>
-      <Name lang="nl">Mitochondriale pyruvaat-carrier-deficiëntie</Name>
+      <Name lang="nl">Mitochondriale pyruvaat-carrier-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -247375,7 +250470,7 @@
     <Disorder id="23040">
       <OrphaCode>412057</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=412057</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve cerebellaire ataxie door STUB1-deficiëntie</Name>
+      <Name lang="nl">Autosomaal recessieve cerebellaire ataxie door STUB1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -247424,7 +250519,7 @@
     <Disorder id="23043">
       <OrphaCode>412181</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=412181</ExpertLink>
-      <Name lang="nl">Epidermolysis bullosa simplex door BP230-deficiëntie</Name>
+      <Name lang="nl">Epidermolysis bullosa simplex door BP230-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -247522,7 +250617,7 @@
     <Disorder id="23044">
       <OrphaCode>412189</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=412189</ExpertLink>
-      <Name lang="nl">Epidermolysis bullosa simplex door exofiline-5-deficiëntie</Name>
+      <Name lang="nl">Epidermolysis bullosa simplex door exofiline-5-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -249130,7 +252225,7 @@
     <Disorder id="23120">
       <OrphaCode>420702</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=420702</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve ernstige congenitale neutropenie door CSF3R-deficiëntie</Name>
+      <Name lang="nl">Autosomaal recessieve ernstige congenitale neutropenie door CSF3R-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -249179,7 +252274,7 @@
     <Disorder id="23121">
       <OrphaCode>420728</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=420728</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 20</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 20</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -249228,7 +252323,7 @@
     <Disorder id="23122">
       <OrphaCode>420733</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=420733</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 21</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 21</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -249407,7 +252502,7 @@
     <Disorder id="23106">
       <OrphaCode>420429</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=420429</ExpertLink>
-      <Name lang="nl">Glycogeenstapelingsziekte door zure-maltasedeficiëntie, late aanvang</Name>
+      <Name lang="nl">Glycogeenstapelingsziekte door zure-maltasedeficiÃ«ntie, late aanvang</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -249439,7 +252534,7 @@
     <Disorder id="23116">
       <OrphaCode>420584</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=420584</ExpertLink>
-      <Name lang="nl">Postaxiale polydactylie - anomalieën van adenohypofyse - faciale dysmorfie-syndroom</Name>
+      <Name lang="nl">Postaxiale polydactylie - anomalieÃ«n van adenohypofyse - faciale dysmorfie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -249488,7 +252583,7 @@
     <Disorder id="23119">
       <OrphaCode>420699</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=420699</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve ernstige congenitale neutropenie door CXCR2-deficiëntie</Name>
+      <Name lang="nl">Autosomaal recessieve ernstige congenitale neutropenie door CXCR2-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -249635,7 +252730,7 @@
     <Disorder id="23115">
       <OrphaCode>420573</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=420573</ExpertLink>
-      <Name lang="nl">Ernstige gecombineerde immuundeficiëntie als gevolg van CTPS1-deficiëntie</Name>
+      <Name lang="nl">Ernstige gecombineerde immuundeficiÃ«ntie als gevolg van CTPS1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -249684,7 +252779,7 @@
     <Disorder id="23114">
       <OrphaCode>420566</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=420566</ExpertLink>
-      <Name lang="nl">Bloedingsstoornis door CalDAG-GEFI-deficiëntie</Name>
+      <Name lang="nl">Bloedingsstoornis door CalDAG-GEFI-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -249733,7 +252828,7 @@
     <Disorder id="23158">
       <OrphaCode>423461</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=423461</ExpertLink>
-      <Name lang="nl">Mucolipidose type III alfa/bèta</Name>
+      <Name lang="nl">Mucolipidose type III alfa/bÃ¨ta</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -249846,7 +252941,7 @@
     <Disorder id="23154">
       <OrphaCode>423384</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=423384</ExpertLink>
-      <Name lang="nl">Ernstige congenitale neutropenie door JAGN1-deficiëntie</Name>
+      <Name lang="nl">Ernstige congenitale neutropenie door JAGN1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -249993,7 +253088,7 @@
     <Disorder id="23160">
       <OrphaCode>423479</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=423479</ExpertLink>
-      <Name lang="nl">X-gebonden intellectuele achterstand - spasticiteit van ledemaat - retinadystrofie - deficiëntie van arginine-vasopressine-syndroom</Name>
+      <Name lang="nl">X-gebonden intellectuele achterstand - spasticiteit van ledemaat - retinadystrofie - deficiÃ«ntie van arginine-vasopressine-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -256983,7 +260078,7 @@
     <Disorder id="23249">
       <OrphaCode>431361</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=431361</ExpertLink>
-      <Name lang="nl">Progressieve encefalopathie met leukodystrofie door DECR-deficiëntie</Name>
+      <Name lang="nl">Progressieve encefalopathie met leukodystrofie door DECR-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -257294,7 +260389,7 @@
     <Disorder id="23233">
       <OrphaCode>431149</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=431149</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door OX40-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door OX40-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -257343,7 +260438,7 @@
     <Disorder id="23235">
       <OrphaCode>431166</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=431166</ExpertLink>
-      <Name lang="nl">Primaire immuundeficiëntie met virale infectie na mazelen-bof-rodehond-vaccinatie</Name>
+      <Name lang="nl">Primaire immuundeficiÃ«ntie met virale infectie na mazelen-bof-rodehond-vaccinatie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -257620,7 +260715,7 @@
     <Disorder id="26293">
       <OrphaCode>504523</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=504523</ExpertLink>
-      <Name lang="nl">Ernstige gecombineerde immuundeficiëntie door LAT-deficiëntie</Name>
+      <Name lang="nl">Ernstige gecombineerde immuundeficiÃ«ntie door LAT-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -257669,7 +260764,7 @@
     <Disorder id="26294">
       <OrphaCode>504530</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=504530</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door Moesin-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door Moesin-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -257718,7 +260813,7 @@
     <Disorder id="8768">
       <OrphaCode>26793</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=26793</ExpertLink>
-      <Name lang="nl">Zeer lange keten acyl-CoA-dehydrogenasedeficiëntie</Name>
+      <Name lang="nl">Zeer lange keten acyl-CoA-dehydrogenasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -258229,7 +261324,7 @@
     <Disorder id="8781">
       <OrphaCode>30391</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=30391</ExpertLink>
-      <Name lang="nl">Geïsoleerde biliaire atresie</Name>
+      <Name lang="nl">GeÃ¯soleerde biliaire atresie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -258584,7 +261679,7 @@
     <Disorder id="8740">
       <OrphaCode>320</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=320</ExpertLink>
-      <Name lang="nl">Schijnbare overmaat aan mineralocorticoïd</Name>
+      <Name lang="nl">Schijnbare overmaat aan mineralocorticoÃ¯d</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -258665,7 +261760,7 @@
     <Disorder id="8743">
       <OrphaCode>230</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=230</ExpertLink>
-      <Name lang="nl">Deficiëntie van dopamine-bèta-hydroxylase</Name>
+      <Name lang="nl">DeficiÃ«ntie van dopamine-bÃ¨ta-hydroxylase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -258714,7 +261809,7 @@
     <Disorder id="8736">
       <OrphaCode>725</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=725</ExpertLink>
-      <Name lang="nl">Continue piekgolven tijdens de slaap</Name>
+      <Name lang="nl">Ontwikkelings- en epileptische encefalopathie met activatie van piekgolven tijdens de slaap</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -260305,7 +263400,7 @@
     <Disorder id="8746">
       <OrphaCode>748</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=748</ExpertLink>
-      <Name lang="nl">Mendeliaanse gevoeligheid voor mycobacteriële ziekten</Name>
+      <Name lang="nl">Mendeliaanse gevoeligheid voor mycobacteriÃ«le ziekten</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -260416,7 +263511,7 @@
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="5359">
-          <Source>25809233[PMID]</Source>
+          <Source>25809233[PMID]_38517523[PMID]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
           </PrevalenceType>
@@ -260424,7 +263519,7 @@
             <Name lang="nl">Familie/Gezinnen</Name>
           </PrevalenceQualification>
           <PrevalenceClass/>
-          <ValMoy>18.0</ValMoy>
+          <ValMoy>36.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -260556,7 +263651,7 @@
     <Disorder id="26354">
       <OrphaCode>505395</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=505395</ExpertLink>
-      <Name lang="nl">Disfunctie van diafragma geïnduceerd door kunstmatige beademing</Name>
+      <Name lang="nl">Disfunctie van diafragma geÃ¯nduceerd door kunstmatige beademing</Name>
       <DisorderType id="21429">
         <Name lang="nl">Particulaire klinische situatie binnen een ziekte of syndroom</Name>
       </DisorderType>
@@ -260588,7 +263683,7 @@
     <Disorder id="8755">
       <OrphaCode>25968</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=25968</ExpertLink>
-      <Name lang="nl">Goedaardige occipitale epilepsie</Name>
+      <Name lang="nl">Zelflimiterende occipitale epilepsie in de kindertijd</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -260709,7 +263804,7 @@
     <Disorder id="8767">
       <OrphaCode>26792</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=26792</ExpertLink>
-      <Name lang="nl">Korte keten acyl-CoA-dehydrogenasedeficiëntie</Name>
+      <Name lang="nl">Korte keten acyl-CoA-dehydrogenasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -260760,7 +263855,7 @@
     <Disorder id="8766">
       <OrphaCode>26791</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=26791</ExpertLink>
-      <Name lang="nl">Meervoudige acyl-CoA-dehydrogenasedeficiëntie</Name>
+      <Name lang="nl">Meervoudige acyl-CoA-dehydrogenasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -260978,55 +264073,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="8718">
-      <OrphaCode>266</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=266</ExpertLink>
-      <Name lang="nl">Autosomaal dominante limb-girdle-spierdystrofie type 1A</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="5297">
-          <Source>21336781[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Geval(len)/Gezinnen</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23725">
-            <Name lang="nl">Familie/Gezinnen</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>4.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="5298">
-          <Source>ORPHANET_21336781[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="8716">
       <OrphaCode>353</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=353</ExpertLink>
@@ -261183,7 +264229,7 @@
     <Disorder id="8715">
       <OrphaCode>119</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=119</ExpertLink>
-      <Name lang="nl">Bèta-sarcoglycaan-gerelateerde limb-girdle-spierdystrofie R4</Name>
+      <Name lang="nl">BÃ¨ta-sarcoglycaan-gerelateerde limb-girdle-spierdystrofie R4</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -261285,7 +264331,7 @@
     <Disorder id="26326">
       <OrphaCode>505227</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=505227</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door GINS1-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door GINS1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -261334,7 +264380,7 @@
     <Disorder id="26327">
       <OrphaCode>505237</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=505237</ExpertLink>
-      <Name lang="nl">Vroeg aanvangende insulten - distale ledemaatanomalieën - faciale dysmorfie - globale ontwikkelingsachterstand-syndroom</Name>
+      <Name lang="nl">Vroeg aanvangende insulten - distale ledemaatanomalieÃ«n - faciale dysmorfie - globale ontwikkelingsachterstand-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -261901,7 +264947,7 @@
     <Disorder id="26330">
       <OrphaCode>505248</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=505248</ExpertLink>
-      <Name lang="nl">Mucopolysacharidose-achtig syndroom met congenitale hartdefecten en hematopoëtische stoornissen</Name>
+      <Name lang="nl">Mucopolysacharidose-achtig syndroom met congenitale hartdefecten en hematopoÃ«tische stoornissen</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -262150,7 +265196,7 @@
     <Disorder id="26576">
       <OrphaCode>508533</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=508533</ExpertLink>
-      <Name lang="nl">Skeletdysplasie - T-cel-immuundeficiëntie - ontwikkelingsachterstand-syndroom</Name>
+      <Name lang="nl">Skeletdysplasie - T-cel-immuundeficiÃ«ntie - ontwikkelingsachterstand-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -262199,7 +265245,7 @@
     <Disorder id="26578">
       <OrphaCode>508542</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=508542</ExpertLink>
-      <Name lang="nl">Congenitaal progressief beenmergfalen - B-cel-immuundeficiëntie - skeletdysplasie-syndroom</Name>
+      <Name lang="nl">Congenitaal progressief beenmergfalen - B-cel-immuundeficiÃ«ntie - skeletdysplasie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -262248,7 +265294,7 @@
     <Disorder id="26573">
       <OrphaCode>508512</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=508512</ExpertLink>
-      <Name lang="nl">Intra-uteriene groeirestrictie - congenitale multipele café-au-lait vlekken - verhoogde uitwisseling van zusterchromatiden-syndroom</Name>
+      <Name lang="nl">Intra-uteriene groeirestrictie - congenitale multipele cafÃ©-au-lait vlekken - verhoogde uitwisseling van zusterchromatiden-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -262346,7 +265392,7 @@
     <Disorder id="26574">
       <OrphaCode>508523</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=508523</ExpertLink>
-      <Name lang="nl">Hyperfenylalaninemie door DNAJC12-deficiëntie</Name>
+      <Name lang="nl">Hyperfenylalaninemie door DNAJC12-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -262542,7 +265588,7 @@
     <Disorder id="26570">
       <OrphaCode>508498</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=508498</ExpertLink>
-      <Name lang="nl">Intellectuele achterstand - hartanomalieën - kleine gestalte - gewrichtslaxiteit-syndroom</Name>
+      <Name lang="nl">Intellectuele achterstand - hartanomalieÃ«n - kleine gestalte - gewrichtslaxiteit-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -262591,7 +265637,7 @@
     <Disorder id="26390">
       <OrphaCode>505652</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=505652</ExpertLink>
-      <Name lang="nl">CDKL5-deficiëntiestoornis</Name>
+      <Name lang="nl">CDKL5-deficiÃ«ntiestoornis</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -263268,7 +266314,7 @@
     <Disorder id="25843">
       <OrphaCode>496693</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=496693</ExpertLink>
-      <Name lang="nl">Omphalocele - hernia diafragmatica - cardiovasculaire anomalieën - radiale straal defect-syndroom</Name>
+      <Name lang="nl">Omfalocele - hernia diaphragmatica - cardiovasculaire anomalieÃ«n - radiale straal defect-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -263415,7 +266461,7 @@
     <Disorder id="25849">
       <OrphaCode>496790</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=496790</ExpertLink>
-      <Name lang="nl">Oculaire anomalieën - axonale neuropathie - ontwikkelingsachterstand-syndroom</Name>
+      <Name lang="nl">Oculaire anomalieÃ«n - axonale neuropathie - ontwikkelingsachterstand-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -263513,7 +266559,7 @@
     <Disorder id="25675">
       <OrphaCode>494439</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=494439</ExpertLink>
-      <Name lang="nl">Retinitis pigmentosa - gehoorverlies - hypothyreoïdie - vroegtijdige veroudering - faciale dysmorfie-syndroom</Name>
+      <Name lang="nl">Retinitis pigmentosa - gehoorverlies - hypothyreoÃ¯die - vroegtijdige veroudering - faciale dysmorfie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -263562,7 +266608,7 @@
     <Disorder id="25672">
       <OrphaCode>494424</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=494424</ExpertLink>
-      <Name lang="nl">Extracraniële halsslagader-aneurysma</Name>
+      <Name lang="nl">ExtracraniÃ«le halsslagader-aneurysma</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -263738,6 +266784,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="25670">
+      <OrphaCode>494418</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=494418</ExpertLink>
+      <Name lang="nl">Vulvacarcinoom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="18035">
+          <Source>37531169[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.86</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="25683">
       <OrphaCode>494547</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=494547</ExpertLink>
@@ -264845,7 +267923,7 @@
     <Disorder id="8537">
       <OrphaCode>76</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=76</ExpertLink>
-      <Name lang="nl">Strongyloïdiase</Name>
+      <Name lang="nl">StrongyloÃ¯diase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -265139,7 +268217,7 @@
     <Disorder id="25995">
       <OrphaCode>500095</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=500095</ExpertLink>
-      <Name lang="nl">Grote gestalte - intellectuele achterstand - renale anomalieën-syndroom</Name>
+      <Name lang="nl">Grote gestalte - intellectuele achterstand - renale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -265269,7 +268347,7 @@
     <Disorder id="8566">
       <OrphaCode>123</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=123</ExpertLink>
-      <Name lang="nl">Syndroom van Björnstad</Name>
+      <Name lang="nl">Syndroom van BjÃ¶rnstad</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -265450,7 +268528,7 @@
     <Disorder id="8562">
       <OrphaCode>318</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=318</ExpertLink>
-      <Name lang="nl">Acute erytroïde leukemie</Name>
+      <Name lang="nl">Acute erytroÃ¯de leukemie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -265696,38 +268774,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="8572">
-      <OrphaCode>202</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=202</ExpertLink>
-      <Name lang="nl">Syndroom van Crandall</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="5131">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="8571">
       <OrphaCode>170</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=170</ExpertLink>
@@ -266859,7 +269905,7 @@
     <Disorder id="26080">
       <OrphaCode>502444</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=502444</ExpertLink>
-      <Name lang="nl">Alkalisch ceramidase 3-deficiëntie</Name>
+      <Name lang="nl">Alkalisch ceramidase 3-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -266908,7 +269954,7 @@
     <Disorder id="8670">
       <OrphaCode>91</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=91</ExpertLink>
-      <Name lang="nl">Aromatasedeficiëntie</Name>
+      <Name lang="nl">AromatasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -267006,7 +270052,7 @@
     <Disorder id="8665">
       <OrphaCode>873</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=873</ExpertLink>
-      <Name lang="nl">Desmoïde tumor</Name>
+      <Name lang="nl">DesmoÃ¯de tumor</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -267174,7 +270220,7 @@
     <Disorder id="8663">
       <OrphaCode>703</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=703</ExpertLink>
-      <Name lang="nl">Bulleus pemfigoïd</Name>
+      <Name lang="nl">Bulleus pemfigoÃ¯d</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -267559,7 +270605,7 @@
     <Disorder id="25864">
       <OrphaCode>497623</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=497623</ExpertLink>
-      <Name lang="nl">C12ORF65-gerelateerde gecombineerde oxidatieve fosforylatiedeficiëntie</Name>
+      <Name lang="nl">C12ORF65-gerelateerde gecombineerde oxidatieve fosforylatiedeficiÃ«ntie</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -267654,6 +270700,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="25865">
+      <OrphaCode>497737</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=497737</ExpertLink>
+      <Name lang="nl">Epidermolytische naevus</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17933">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23767">
+            <Name lang="nl">&gt;1 / 1000</Name>
+          </PrevalenceClass>
+          <ValMoy>100.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="25866">
       <OrphaCode>497757</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=497757</ExpertLink>
@@ -267755,7 +270833,7 @@
     <Disorder id="8650">
       <OrphaCode>530</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=530</ExpertLink>
-      <Name lang="nl">Lipoïdproteïnose</Name>
+      <Name lang="nl">LipoÃ¯dproteÃ¯nose</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -268196,7 +271274,7 @@
     <Disorder id="8691">
       <OrphaCode>465</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=465</ExpertLink>
-      <Name lang="nl">Congenitale deficiëntie van plasminogeenactivator-inhibitor type 1</Name>
+      <Name lang="nl">Congenitale deficiÃ«ntie van plasminogeenactivator-inhibitor type 1</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -268674,7 +271752,7 @@
     <Disorder id="8680">
       <OrphaCode>467</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=467</ExpertLink>
-      <Name lang="nl">Niet-verworven gecombineerde hypofysehormoondeficiëntie</Name>
+      <Name lang="nl">Niet-verworven gecombineerde hypofysehormoondeficiÃ«ntie</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -269302,7 +272380,7 @@
     <Disorder id="8672">
       <OrphaCode>786</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=786</ExpertLink>
-      <Name lang="nl">Gegeneraliseerde glucocorticoïdresistentie-syndroom</Name>
+      <Name lang="nl">Gegeneraliseerde glucocorticoÃ¯dresistentie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -270765,7 +273843,7 @@
     <Disorder id="8627">
       <OrphaCode>122</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=122</ExpertLink>
-      <Name lang="nl">Syndroom van Birt-Hogg-Dubé</Name>
+      <Name lang="nl">Syndroom van Birt-Hogg-DubÃ©</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -270797,7 +273875,7 @@
     <Disorder id="8624">
       <OrphaCode>38</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=38</ExpertLink>
-      <Name lang="nl">Acrokerato-elastoïdosis van Costa</Name>
+      <Name lang="nl">Acrokerato-elastoÃ¯dosis van Costa</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -270910,7 +273988,7 @@
     <Disorder id="8618">
       <OrphaCode>658</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=658</ExpertLink>
-      <Name lang="nl">Niet-histamine-geïnduceerd angio-oedeem</Name>
+      <Name lang="nl">Niet-histamine-geÃ¯nduceerd angio-oedeem</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -272246,7 +275324,7 @@
     <Disorder id="25256">
       <OrphaCode>482606</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=482606</ExpertLink>
-      <Name lang="nl">X-gebonden keloïde littekenvorming - verminderde gewrichtsmobiliteit - verhoogde papilexcavatie-syndroom</Name>
+      <Name lang="nl">X-gebonden keloÃ¯de littekenvorming - verminderde gewrichtsmobiliteit - verhoogde papilexcavatie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -272544,7 +275622,7 @@
     <Disorder id="25229">
       <OrphaCode>480898</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=480898</ExpertLink>
-      <Name lang="nl">Algehele ontwikkelingsachterstand - visuele anomalieën - progressieve cerebellaire atrofie - truncale hypotonie-syndroom</Name>
+      <Name lang="nl">Algehele ontwikkelingsachterstand - visuele anomalieÃ«n - progressieve cerebellaire atrofie - truncale hypotonie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -272674,7 +275752,7 @@
     <Disorder id="25219">
       <OrphaCode>480556</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=480556</ExpertLink>
-      <Name lang="nl">Geïsoleerde neonatale scleroserende cholangitis</Name>
+      <Name lang="nl">GeÃ¯soleerde neonatale scleroserende cholangitis</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -272981,7 +276059,7 @@
     <Disorder id="25240">
       <OrphaCode>481665</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=481665</ExpertLink>
-      <Name lang="nl">UPS18-deficiëntie</Name>
+      <Name lang="nl">UPS18-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -273324,7 +276402,7 @@
     <Disorder id="25213">
       <OrphaCode>480528</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=480528</ExpertLink>
-      <Name lang="nl">Letaal hydranencefalie - diafragmatische hernia-syndroom</Name>
+      <Name lang="nl">Letaal hydranencefalie - hernia diaphragmatica-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -273370,15 +276448,47 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="25212">
+      <OrphaCode>480524</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=480524</ExpertLink>
+      <Name lang="nl">Idiopathische peliosis hepatis</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="18060">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="25215">
       <OrphaCode>480536</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=480536</ExpertLink>
       <Name lang="nl">MSH3-gerelateerde geattenueerde familiale adenomateuze polyposis</Name>
-      <DisorderType id="21450">
-        <Name lang="nl">Klinisch subtype</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
       </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="nl">Subtype van aandoening</Name>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="13151">
@@ -273419,6 +276529,70 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="25214">
+      <OrphaCode>480531</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=480531</ExpertLink>
+      <Name lang="nl">Congenitale portosystemische shunt</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17909">
+          <Source>29243189[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>3.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="25208">
+      <OrphaCode>480501</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=480501</ExpertLink>
+      <Name lang="nl">Choledochuscyste</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17983">
+          <Source>32491694[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="25211">
       <OrphaCode>480520</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=480520</ExpertLink>
@@ -273451,6 +276625,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="25210">
+      <OrphaCode>480512</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=480512</ExpertLink>
+      <Name lang="nl">Idiopathische ductopenie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17969">
+          <Source>32337312[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>100.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17970">
+          <Source>32337312[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="25159">
       <OrphaCode>477814</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=477814</ExpertLink>
@@ -273535,7 +276758,7 @@
     <Disorder id="25153">
       <OrphaCode>477787</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=477787</ExpertLink>
-      <Name lang="nl">Bloedingsziekte geassocieerd met deficiëntie van cytosolisch fosfolipase-A2-alfa</Name>
+      <Name lang="nl">Bloedingsziekte geassocieerd met deficiÃ«ntie van cytosolisch fosfolipase-A2-alfa</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -273584,7 +276807,7 @@
     <Disorder id="25166">
       <OrphaCode>478029</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=478029</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 29</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 29</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -273633,7 +276856,7 @@
     <Disorder id="25167">
       <OrphaCode>478042</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=478042</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 30</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 30</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -273682,7 +276905,7 @@
     <Disorder id="25164">
       <OrphaCode>477993</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=477993</ExpertLink>
-      <Name lang="nl">Anomalieën gehemelte - ver uit elkaar staande tanden - faciale dysmorfie - ontwikkelingsachterstand-syndroom</Name>
+      <Name lang="nl">AnomalieÃ«n gehemelte - ver uit elkaar staande tanden - faciale dysmorfie - ontwikkelingsachterstand-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -273731,7 +276954,7 @@
     <Disorder id="25162">
       <OrphaCode>477857</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=477857</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve Mendeliaanse gevoeligheid voor mycobacteriële ziekten door volledige deficiëntie van RORgamma-receptor</Name>
+      <Name lang="nl">Mendeliaanse gevoeligheid voor mycobacteriÃ«le ziekten door volledige deficiÃ«ntie van RORgamma-receptor</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -274074,7 +277297,7 @@
     <Disorder id="25139">
       <OrphaCode>477684</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=477684</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 26</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 26</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -274253,7 +277476,7 @@
     <Disorder id="25150">
       <OrphaCode>477774</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=477774</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 27</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 27</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -274351,7 +277574,7 @@
     <Disorder id="25089">
       <OrphaCode>476113</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=476113</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door TFRC-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door TFRC-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -274400,7 +277623,7 @@
     <Disorder id="25093">
       <OrphaCode>476126</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=476126</ExpertLink>
-      <Name lang="nl">Micrognathie - terugkerende infecties - gedragsstoornissen - milde intellectuele achterstand-syndroom</Name>
+      <Name lang="nl">Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -274743,7 +277966,7 @@
     <Disorder id="25408">
       <OrphaCode>488618</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=488618</ExpertLink>
-      <Name lang="nl">Transketolasedeficiëntie</Name>
+      <Name lang="nl">TransketolasedeficiÃ«ntie</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -274890,7 +278113,7 @@
     <Disorder id="25411">
       <OrphaCode>488635</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=488635</ExpertLink>
-      <Name lang="nl">Epilepsie met vroege aanvang - intellectuele achterstand - hersenanomalieën-syndroom</Name>
+      <Name lang="nl">Epilepsie met vroege aanvang - intellectuele achterstand - hersenanomalieÃ«n-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -275429,7 +278652,7 @@
     <Disorder id="25389">
       <OrphaCode>488191</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=488191</ExpertLink>
-      <Name lang="nl">Vrouwelijke infertiliteit door meiotisch arrest van oöcyt</Name>
+      <Name lang="nl">Vrouwelijke infertiliteit door meiotisch arrest van oÃ¶cyt</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -275738,7 +278961,7 @@
     <Disorder id="9291">
       <OrphaCode>31202</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=31202</ExpertLink>
-      <Name lang="nl">Melioïdose</Name>
+      <Name lang="nl">MelioÃ¯dose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -275857,7 +279080,7 @@
     <Disorder id="9284">
       <OrphaCode>31043</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=31043</ExpertLink>
-      <Name lang="nl">Primaire hypomagnesiëmie met hypercalciurie en nefrocalcinose zonder ernstige oculaire betrokkenheid</Name>
+      <Name lang="nl">Primaire hypomagnesiÃ«mie met hypercalciurie en nefrocalcinose zonder ernstige oculaire betrokkenheid</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -275938,7 +279161,7 @@
     <Disorder id="9282">
       <OrphaCode>30924</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=30924</ExpertLink>
-      <Name lang="nl">Primaire hypomagnesiëmie met secundaire hypocalciëmie</Name>
+      <Name lang="nl">Primaire hypomagnesiÃ«mie met secundaire hypocalciÃ«mie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -275987,7 +279210,7 @@
     <Disorder id="9283">
       <OrphaCode>30925</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=30925</ExpertLink>
-      <Name lang="nl">Hereditaire deficiëntie van arginine-vasopressine</Name>
+      <Name lang="nl">Hereditaire deficiÃ«ntie van arginine-vasopressine</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -276166,7 +279389,7 @@
     <Disorder id="11000">
       <OrphaCode>71278</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=71278</ExpertLink>
-      <Name lang="nl">Congenitale dysgenesie van hersenen door deficiëntie van glutaminesynthetase</Name>
+      <Name lang="nl">Congenitale dysgenesie van hersenen door deficiÃ«ntie van glutaminesynthetase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -276426,7 +279649,7 @@
     <Disorder id="10997">
       <OrphaCode>71275</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=71275</ExpertLink>
-      <Name lang="nl">Rh-deficiëntiesyndroom</Name>
+      <Name lang="nl">Rh-deficiÃ«ntiesyndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -276507,7 +279730,7 @@
     <Disorder id="10999">
       <OrphaCode>71277</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=71277</ExpertLink>
-      <Name lang="nl">Klassiek glucosetransporter type 1-deficiëntie-syndroom</Name>
+      <Name lang="nl">Klassiek glucosetransporter type 1-deficiÃ«ntie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -276596,7 +279819,7 @@
     <Disorder id="10987">
       <OrphaCode>71212</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=71212</ExpertLink>
-      <Name lang="nl">Hyperinsulinisme door deficiëntie van korte-keten-3-hydroxylacyl-CoA-dehydrogenase</Name>
+      <Name lang="nl">Hyperinsulinisme door deficiÃ«ntie van korte-keten-3-hydroxylacyl-CoA-dehydrogenase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -277481,7 +280704,7 @@
     <Disorder id="10963">
       <OrphaCode>70592</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=70592</ExpertLink>
-      <Name lang="nl">Immuundeficiëntie door deficiëntie van interleukine 1-receptorgeassocieerd kinase 4</Name>
+      <Name lang="nl">Tijdelijke predispositie voor invasieve pyogene bacteriÃ«le infectie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -277626,7 +280849,7 @@
     <Disorder id="10964">
       <OrphaCode>70593</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=70593</ExpertLink>
-      <Name lang="nl">Immuundeficiëntie door selectieve deficiëntie van antipolysacharide-antilichaam</Name>
+      <Name lang="nl">ImmuundeficiÃ«ntie door selectieve deficiÃ«ntie van antipolysacharide-antilichaam</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -277658,7 +280881,7 @@
     <Disorder id="10965">
       <OrphaCode>70594</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=70594</ExpertLink>
-      <Name lang="nl">Doparesponsieve dystonie als gevolg van sepiapterinereductasedeficiëntie</Name>
+      <Name lang="nl">Doparesponsieve dystonie als gevolg van sepiapterinereductasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -277707,7 +280930,7 @@
     <Disorder id="10954">
       <OrphaCode>70578</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=70578</ExpertLink>
-      <Name lang="nl">Acuut ademnoodsyndroom bij volwassenen</Name>
+      <Name lang="nl">Acuut ademhalingsnoodsyndroom bij volwassenen</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -279159,7 +282382,7 @@
     <Disorder id="10936">
       <OrphaCode>69735</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=69735</ExpertLink>
-      <Name lang="nl">Hypotrichose - lymfoedeem - teleangiëctasie - renaal defect-syndroom</Name>
+      <Name lang="nl">Hypotrichose - lymfoedeem - teleangiÃ«ctasie - renaal defect-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -279598,7 +282821,7 @@
     <Disorder id="10922">
       <OrphaCode>69088</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=69088</ExpertLink>
-      <Name lang="nl">Anhidrotische ectodermale dysplasie - immuundeficiëntie - osteopetrose - lymfoedeem-syndroom</Name>
+      <Name lang="nl">Anhidrotische ectodermale dysplasie - immuundeficiÃ«ntie - osteopetrose - lymfoedeem-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -279843,7 +283066,7 @@
     <Disorder id="10913">
       <OrphaCode>69077</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=69077</ExpertLink>
-      <Name lang="nl">Rhabdoïde tumor</Name>
+      <Name lang="nl">RhabdoÃ¯de tumor</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -280013,7 +283236,7 @@
     <Disorder id="10910">
       <OrphaCode>69061</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=69061</ExpertLink>
-      <Name lang="nl">Idiopathisch steroïdgevoelig nefrotisch syndroom</Name>
+      <Name lang="nl">Idiopathisch steroÃ¯dgevoelig nefrotisch syndroom</Name>
       <DisorderType id="21422">
         <Name lang="nl">Klinisch syndroom</Name>
       </DisorderType>
@@ -280239,7 +283462,7 @@
     <Disorder id="10904">
       <OrphaCode>67044</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=67044</ExpertLink>
-      <Name lang="nl">Trombocytopenie met congenitale dyserytropoëtische anemie</Name>
+      <Name lang="nl">Trombocytopenie met congenitale dyserytropoÃ«tische anemie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -280288,7 +283511,7 @@
     <Disorder id="10905">
       <OrphaCode>67045</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=67045</ExpertLink>
-      <Name lang="nl">X-gebonden intellectuele achterstand met geïsoleerde groeihormoondeficiëntie</Name>
+      <Name lang="nl">X-gebonden intellectuele achterstand met geÃ¯soleerde groeihormoondeficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -280450,7 +283673,7 @@
     <Disorder id="10901">
       <OrphaCode>67041</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=67041</ExpertLink>
-      <Name lang="nl">Hyaluronidasedeficiëntie</Name>
+      <Name lang="nl">HyaluronidasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -280530,6 +283753,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="10896">
+      <OrphaCode>66662</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=66662</ExpertLink>
+      <Name lang="nl">Extracutaan mastocytoom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18082">
+          <Source>34233110[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>7.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18083">
+          <Source>34233110[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="10897">
       <OrphaCode>67036</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=67036</ExpertLink>
@@ -280695,7 +283967,7 @@
     <Disorder id="10891">
       <OrphaCode>66633</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=66633</ExpertLink>
-      <Name lang="nl">Sensorineuraal gehoorverlies - vroege vergrijzing - essentiële tremor-syndroom</Name>
+      <Name lang="nl">Sensorineuraal gehoorverlies - vroege vergrijzing - essentiÃ«le tremor-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -280891,7 +284163,7 @@
     <Disorder id="10886">
       <OrphaCode>66628</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=66628</ExpertLink>
-      <Name lang="nl">Obesitas door congenitale deficiëntie van leptine</Name>
+      <Name lang="nl">Obesitas door congenitale deficiÃ«ntie van leptine</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -281284,11 +284556,11 @@
       <OrphaCode>65285</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=65285</ExpertLink>
       <Name lang="nl">Ziekte van Lhermitte-Duclos</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="5909">
@@ -281332,7 +284604,7 @@
     <Disorder id="10869">
       <OrphaCode>65287</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=65287</ExpertLink>
-      <Name lang="nl">Deficiëntie van bèta-ureïdopropionase</Name>
+      <Name lang="nl">DeficiÃ«ntie van bÃ¨ta-ureÃ¯dopropionase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -281494,7 +284766,7 @@
     <Disorder id="10873">
       <OrphaCode>65683</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=65683</ExpertLink>
-      <Name lang="nl">Geïsoleerde focale corticale dysplasie</Name>
+      <Name lang="nl">GeÃ¯soleerde focale corticale dysplasie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -281869,7 +285141,7 @@
     <Disorder id="10849">
       <OrphaCode>64745</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=64745</ExpertLink>
-      <Name lang="nl">Pruritische urticariële papels en plaques bij zwangerschap</Name>
+      <Name lang="nl">Pruritische urticariÃ«le papels en plaques bij zwangerschap</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -282029,7 +285301,7 @@
     <Disorder id="28329">
       <OrphaCode>562509</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=562509</ExpertLink>
-      <Name lang="nl">Heem-oxygenase-1-deficiëntie</Name>
+      <Name lang="nl">Heem-oxygenase-1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -282469,6 +285741,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="10839">
+      <OrphaCode>64722</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=64722</ExpertLink>
+      <Name lang="nl">Granulomateuze mastitis</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="18084">
+          <Source>38304866[PMID]</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>2.4</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="10838">
       <OrphaCode>64720</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=64720</ExpertLink>
@@ -282833,7 +286137,7 @@
     <Disorder id="10816">
       <OrphaCode>63259</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=63259</ExpertLink>
-      <Name lang="nl">Iniëncefalie</Name>
+      <Name lang="nl">IniÃ«ncefalie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -283623,14 +286927,14 @@
     <Disorder id="10802">
       <OrphaCode>60033</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=60033</ExpertLink>
-      <Name lang="nl">Idiopathische bronchiëctasie</Name>
+      <Name lang="nl">Idiopathische bronchiÃ«ctasie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="3">
         <Prevalence id="5857">
           <Source>9787927[PMID]</Source>
           <PrevalenceType id="23676">
@@ -283669,6 +286973,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="18075">
+          <Source>9787927[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>29.0</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="nl">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="10788">
@@ -284002,7 +287325,7 @@
     <Disorder id="10798">
       <OrphaCode>60026</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=60026</ExpertLink>
-      <Name lang="nl">Pulmonale nodulaire lymfoïdhyperplasie</Name>
+      <Name lang="nl">Pulmonale nodulaire lymfoÃ¯dhyperplasie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -284034,7 +287357,7 @@
     <Disorder id="28399">
       <OrphaCode>564178</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=564178</ExpertLink>
-      <Name lang="nl">Primaire hypomagnesiëmie - refractaire insulten - intellectuele achterstand-syndroom</Name>
+      <Name lang="nl">Primaire hypomagnesiÃ«mie - refractaire insulten - intellectuele achterstand-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -284213,7 +287536,7 @@
     <Disorder id="10774">
       <OrphaCode>57196</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=57196</ExpertLink>
-      <Name lang="nl">Mediale condenserende osteïtis van clavicula</Name>
+      <Name lang="nl">Mediale condenserende osteÃ¯tis van clavicula</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -284524,7 +287847,7 @@
     <Disorder id="10782">
       <OrphaCode>59135</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=59135</ExpertLink>
-      <Name lang="nl">Distale myopathie met vroege aanvang, Laing-type</Name>
+      <Name lang="nl">Distale myopathie, Laing-type</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -286083,7 +289406,7 @@
     <Disorder id="28453">
       <OrphaCode>565909</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=565909</ExpertLink>
-      <Name lang="nl">Calpaïne-3-gerelateerde limb-girdle-spierdystrofie D4</Name>
+      <Name lang="nl">CalpaÃ¯ne-3-gerelateerde limb-girdle-spierdystrofie D4</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -286132,7 +289455,7 @@
     <Disorder id="11259">
       <OrphaCode>79233</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79233</ExpertLink>
-      <Name lang="nl">Partiële deficiëntie van hypoxanthine-guanine-fosforibosyltransferase</Name>
+      <Name lang="nl">PartiÃ«le deficiÃ«ntie van hypoxanthine-guanine-fosforibosyltransferase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -286213,7 +289536,7 @@
     <Disorder id="11263">
       <OrphaCode>79237</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79237</ExpertLink>
-      <Name lang="nl">Galactokinasedeficiëntie</Name>
+      <Name lang="nl">GalactokinasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -286245,7 +289568,7 @@
     <Disorder id="28477">
       <OrphaCode>566067</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=566067</ExpertLink>
-      <Name lang="nl">CEBPE-geassocieerd auto-inflammatie - immuundeficiëntie - neutrofieldisfunctie-syndroom</Name>
+      <Name lang="nl">CEBPE-geassocieerd auto-inflammatie - immuundeficiÃ«ntie - neutrofieldisfunctie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -286466,7 +289789,7 @@
     <Disorder id="28443">
       <OrphaCode>565624</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=565624</ExpertLink>
-      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiëntie type 39</Name>
+      <Name lang="nl">Gecombineerde oxidatieve fosforylatiedeficiÃ«ntie type 39</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -286516,11 +289839,11 @@
       <OrphaCode>565612</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=565612</ExpertLink>
       <Name lang="nl">Primaire cardiomyovasculopathie door depositie van triglyceriden</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21443">
+        <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="16298">
@@ -286628,7 +289951,7 @@
     <Disorder id="11183">
       <OrphaCode>79157</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79157</ExpertLink>
-      <Name lang="nl">2-methylbutyryl-CoA-dehydrogenasedeficiëntie</Name>
+      <Name lang="nl">2-methylbutyryl-CoA-dehydrogenasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -286677,7 +290000,7 @@
     <Disorder id="11182">
       <OrphaCode>79156</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79156</ExpertLink>
-      <Name lang="nl">Epileptische aanvallen - intellectuele achterstand als gevolg van hydroxylysinurie-syndroom</Name>
+      <Name lang="nl">Epileptische aanvallen - intellectuele achterstand door hydroxylysinurie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -287082,7 +290405,7 @@
     <Disorder id="11170">
       <OrphaCode>79144</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79144</ExpertLink>
-      <Name lang="nl">Geïsoleerde congenitale onychodysplasie</Name>
+      <Name lang="nl">GeÃ¯soleerde congenitale onychodysplasie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -287114,7 +290437,7 @@
     <Disorder id="11169">
       <OrphaCode>79143</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79143</ExpertLink>
-      <Name lang="nl">Geïsoleerde congenitale anonychie</Name>
+      <Name lang="nl">GeÃ¯soleerde congenitale anonychie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -287163,7 +290486,7 @@
     <Disorder id="11198">
       <OrphaCode>79172</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79172</ExpertLink>
-      <Name lang="nl">Creatinedeficiëntiesyndroom</Name>
+      <Name lang="nl">CreatinedeficiÃ«ntiesyndroom</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -287259,7 +290582,7 @@
     <Disorder id="11185">
       <OrphaCode>79159</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79159</ExpertLink>
-      <Name lang="nl">Deficiëntie van isobutyryl-CoA-dehydrogenase</Name>
+      <Name lang="nl">DeficiÃ«ntie van isobutyryl-CoA-dehydrogenase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -287300,7 +290623,7 @@
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="6261">
-          <Source>12325076[PMID]</Source>
+          <Source>12325076[PMID]_[EXPERT]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
           </PrevalenceType>
@@ -287308,7 +290631,7 @@
             <Name lang="nl">Geval(len)</Name>
           </PrevalenceQualification>
           <PrevalenceClass/>
-          <ValMoy>2.0</ValMoy>
+          <ValMoy>15.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -287340,7 +290663,7 @@
     <Disorder id="28493">
       <OrphaCode>566231</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=566231</ExpertLink>
-      <Name lang="nl">Resistentie tegen thyroïdhormoon door een mutatie in thyroïdhormoonreceptor-alfa</Name>
+      <Name lang="nl">Resistentie tegen thyroÃ¯dhormoon door een mutatie in thyroÃ¯dhormoonreceptor-alfa</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -287438,7 +290761,7 @@
     <Disorder id="28494">
       <OrphaCode>566243</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=566243</ExpertLink>
-      <Name lang="nl">Resistentie tegen thyroïdhormoon door een mutatie in thyroïdhormoonreceptor-bèta</Name>
+      <Name lang="nl">Resistentie tegen thyroÃ¯dhormoon door een mutatie in thyroÃ¯dhormoonreceptor-bÃ¨ta</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -287527,7 +290850,7 @@
     <Disorder id="11151">
       <OrphaCode>79118</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79118</ExpertLink>
-      <Name lang="nl">Neonatale diabetes - congenitale hypothyreoïdie - congenitaal glaucoom - hepatische fibrose - polycystische nieren</Name>
+      <Name lang="nl">Neonatale diabetes - congenitale hypothyreoÃ¯die - congenitaal glaucoom - hepatische fibrose - polycystische nieren</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -287689,7 +291012,7 @@
     <Disorder id="11141">
       <OrphaCode>79099</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79099</ExpertLink>
-      <Name lang="nl">Interstitiële granulomateuze dermatitis met artritis</Name>
+      <Name lang="nl">InterstitiÃ«le granulomateuze dermatitis met artritis</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -288000,7 +291323,7 @@
     <Disorder id="28482">
       <OrphaCode>566175</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=566175</ExpertLink>
-      <Name lang="nl">Hyperactivatie van complementsysteem - angiopathische trombose - proteïneverliezende enteropathie-syndroom</Name>
+      <Name lang="nl">Hyperactivatie van complementsysteem - angiopathische trombose - proteÃ¯neverliezende enteropathie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -288765,7 +292088,7 @@
     <Disorder id="11152">
       <OrphaCode>79124</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79124</ExpertLink>
-      <Name lang="nl">Hepatische veno-occlusieve ziekte - immuundeficiëntie-syndroom</Name>
+      <Name lang="nl">Hepatische veno-occlusieve ziekte - immuundeficiÃ«ntie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -288814,7 +292137,7 @@
     <Disorder id="11153">
       <OrphaCode>79126</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79126</ExpertLink>
-      <Name lang="nl">Acute interstitiële pneumonie</Name>
+      <Name lang="nl">Acute interstitiÃ«le pneumonie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -288846,7 +292169,7 @@
     <Disorder id="11154">
       <OrphaCode>79127</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79127</ExpertLink>
-      <Name lang="nl">Respiratoire bronchiolitis - interstitiële longziekte-syndroom</Name>
+      <Name lang="nl">Respiratoire bronchiolitis - interstitiÃ«le longziekte-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -288878,7 +292201,7 @@
     <Disorder id="11155">
       <OrphaCode>79128</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79128</ExpertLink>
-      <Name lang="nl">Lymfoïde interstitiële pneumonie</Name>
+      <Name lang="nl">LymfoÃ¯de interstitiÃ«le pneumonie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -288910,7 +292233,7 @@
     <Disorder id="11106">
       <OrphaCode>77293</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=77293</ExpertLink>
-      <Name lang="nl">Chronische viscerale deficiëntie van zure sfingomyelinase</Name>
+      <Name lang="nl">Chronische viscerale deficiÃ«ntie van zure sfingomyelinase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -289042,7 +292365,7 @@
     <Disorder id="11105">
       <OrphaCode>77292</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=77292</ExpertLink>
-      <Name lang="nl">Infantiele neuroviscerale deficiëntie van zure sfingomyelinase</Name>
+      <Name lang="nl">Infantiele neuroviscerale deficiÃ«ntie van zure sfingomyelinase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -289272,7 +292595,7 @@
     <Disorder id="28585">
       <OrphaCode>567502</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=567502</ExpertLink>
-      <Name lang="nl">B-cel-immuundeficiëntie - ledemaatanomalieën - urogenitale malformaties-syndroom</Name>
+      <Name lang="nl">B-cel-immuundeficiÃ«ntie - ledemaatanomalieÃ«n - urogenitale malformaties-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -289370,7 +292693,7 @@
     <Disorder id="11113">
       <OrphaCode>77301</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=77301</ExpertLink>
-      <Name lang="nl">Monosomie 9q22.3</Name>
+      <Name lang="nl">Monosomie 9q22.3-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -289451,7 +292774,7 @@
     <Disorder id="28590">
       <OrphaCode>567548</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=567548</ExpertLink>
-      <Name lang="nl">Idiopathisch steroïdresistent nefrotisch syndroom</Name>
+      <Name lang="nl">Idiopathisch steroÃ¯dresistent nefrotisch syndroom</Name>
       <DisorderType id="21422">
         <Name lang="nl">Klinisch syndroom</Name>
       </DisorderType>
@@ -289502,7 +292825,7 @@
     <Disorder id="28589">
       <OrphaCode>567546</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=567546</ExpertLink>
-      <Name lang="nl">Idiopathisch steroïdsensitief nefrotisch syndroom met secundaire steroïdresistentie</Name>
+      <Name lang="nl">Idiopathisch steroÃ¯dsensitief nefrotisch syndroom met secundaire steroÃ¯dresistentie</Name>
       <DisorderType id="21422">
         <Name lang="nl">Klinisch syndroom</Name>
       </DisorderType>
@@ -289566,7 +292889,7 @@
     <Disorder id="11127">
       <OrphaCode>79083</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79083</ExpertLink>
-      <Name lang="nl">PPARG-gerelateerde familiale partiële lipodystrofie</Name>
+      <Name lang="nl">PPARG-gerelateerde familiale partiÃ«le lipodystrofie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -289696,7 +293019,7 @@
     <Disorder id="11131">
       <OrphaCode>79087</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79087</ExpertLink>
-      <Name lang="nl">Verworven partiële lipodystrofie</Name>
+      <Name lang="nl">Verworven partiÃ«le lipodystrofie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -289798,7 +293121,7 @@
     <Disorder id="11129">
       <OrphaCode>79085</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79085</ExpertLink>
-      <Name lang="nl">AKT2-gerelateerde familiale partiële lipodystrofie</Name>
+      <Name lang="nl">AKT2-gerelateerde familiale partiÃ«le lipodystrofie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -289847,7 +293170,7 @@
     <Disorder id="11128">
       <OrphaCode>79084</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79084</ExpertLink>
-      <Name lang="nl">Familiale partiële lipodystrofie, Köbberling-type</Name>
+      <Name lang="nl">Familiale partiÃ«le lipodystrofie, KÃ¶bberling-type</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -290220,7 +293543,7 @@
     <Disorder id="11076">
       <OrphaCode>75377</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=75377</ExpertLink>
-      <Name lang="nl">Centrale areolaire choroïdale dystrofie</Name>
+      <Name lang="nl">Centrale areolaire choroÃ¯dale dystrofie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -290320,7 +293643,7 @@
     <Disorder id="11078">
       <OrphaCode>75381</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=75381</ExpertLink>
-      <Name lang="nl">Cystoïde maculadystrofie</Name>
+      <Name lang="nl">CystoÃ¯de maculadystrofie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -290499,7 +293822,7 @@
     <Disorder id="11081">
       <OrphaCode>75391</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=75391</ExpertLink>
-      <Name lang="nl">Primaire immuundeficiëntie met deficiëntie van natuurlijke killercellen en adrenale insufficiëntie</Name>
+      <Name lang="nl">Primaire immuundeficiÃ«ntie met deficiÃ«ntie van natuurlijke killercellen en adrenale insufficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -291430,7 +294753,7 @@
     <Disorder id="11043">
       <OrphaCode>73260</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=73260</ExpertLink>
-      <Name lang="nl">Paracoccidioïdomycose</Name>
+      <Name lang="nl">ParacoccidioÃ¯domycose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -291462,7 +294785,7 @@
     <Disorder id="11040">
       <OrphaCode>73246</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=73246</ExpertLink>
-      <Name lang="nl">Viscerale neuropathie - hersenanomalieën - faciale dysmorfie - ontwikkelingsachterstand-syndroom</Name>
+      <Name lang="nl">Viscerale neuropathie - hersenanomalieÃ«n - faciale dysmorfie - ontwikkelingsachterstand-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -291641,7 +294964,7 @@
     <Disorder id="11048">
       <OrphaCode>73272</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=73272</ExpertLink>
-      <Name lang="nl">Groeiachterstand door deficiëntie van insulineachtige groeifactor I</Name>
+      <Name lang="nl">Groeiachterstand door deficiÃ«ntie van insulineachtige groeifactor I</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -291722,7 +295045,7 @@
     <Disorder id="11071">
       <OrphaCode>75326</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=75326</ExpertLink>
-      <Name lang="nl">Familiale geïsoleerde retinale arteriële tortuositeit</Name>
+      <Name lang="nl">Familiale geÃ¯soleerde retinale arteriÃ«le tortuositeit</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -291820,7 +295143,7 @@
     <Disorder id="11069">
       <OrphaCode>75249</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=75249</ExpertLink>
-      <Name lang="nl">Familiale geïsoleerde restrictieve cardiomyopathie</Name>
+      <Name lang="nl">Familiale geÃ¯soleerde restrictieve cardiomyopathie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -292019,6 +295342,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="11012">
+      <OrphaCode>71290</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=71290</ExpertLink>
+      <Name lang="nl">Familiale bloedplaatjesstoornis met geassocieerde myeloÃ¯de maligniteit</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18085">
+          <Source>39822584[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>259.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18086">
+          <Source>39822584[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="28612">
       <OrphaCode>568062</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=568062</ExpertLink>
@@ -292135,7 +295507,7 @@
     <Disorder id="28611">
       <OrphaCode>568056</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=568056</ExpertLink>
-      <Name lang="nl">Wratten - immuundeficiëntie - lymfoedeem - anogenitale dysplasie-syndroom</Name>
+      <Name lang="nl">Wratten - immuundeficiÃ«ntie - lymfoedeem - anogenitale dysplasie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -292265,7 +295637,7 @@
     <Disorder id="11020">
       <OrphaCode>71526</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=71526</ExpertLink>
-      <Name lang="nl">Obesitas door deficiëntie van pro-opiomelanocortine</Name>
+      <Name lang="nl">Obesitas door deficiÃ«ntie van pro-opiomelanocortine</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -292314,7 +295686,7 @@
     <Disorder id="11021">
       <OrphaCode>71528</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=71528</ExpertLink>
-      <Name lang="nl">Obesitas door deficiëntie van prohormoonconvertase I</Name>
+      <Name lang="nl">Obesitas door deficiÃ«ntie van prohormoonconvertase I</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -292363,7 +295735,7 @@
     <Disorder id="11022">
       <OrphaCode>71529</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=71529</ExpertLink>
-      <Name lang="nl">Obesitas door deficiëntie van melanocortine 4-receptor</Name>
+      <Name lang="nl">Obesitas door deficiÃ«ntie van melanocortine 4-receptor</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -292414,7 +295786,7 @@
     <Disorder id="28622">
       <OrphaCode>569164</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=569164</ExpertLink>
-      <Name lang="nl">Angiomatoïde fibreus histiocytoom</Name>
+      <Name lang="nl">AngiomatoÃ¯de fibreus histiocytoom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -292853,7 +296225,7 @@
     <Disorder id="11038">
       <OrphaCode>73230</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=73230</ExpertLink>
-      <Name lang="nl">Ossificatieanomalieën - psychomotorische ontwikkelingsachterstand-syndroom</Name>
+      <Name lang="nl">OssificatieanomalieÃ«n - psychomotorische ontwikkelingsachterstand-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -292902,7 +296274,7 @@
     <Disorder id="11033">
       <OrphaCode>73217</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=73217</ExpertLink>
-      <Name lang="nl">Mülleriaanse aplasie</Name>
+      <Name lang="nl">MÃ¼lleriaanse aplasie</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -293134,7 +296506,7 @@
     <Disorder id="27672">
       <OrphaCode>530849</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=530849</ExpertLink>
-      <Name lang="nl">Familiale apolipoproteïne A5-deficiëntie</Name>
+      <Name lang="nl">Familiale apolipoproteÃ¯ne A5-deficiÃ«ntie</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -293587,7 +296959,7 @@
     <Disorder id="10441">
       <OrphaCode>37202</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=37202</ExpertLink>
-      <Name lang="nl">Interstitiële cystitis</Name>
+      <Name lang="nl">InterstitiÃ«le cystitis</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -293725,7 +297097,7 @@
     <Disorder id="10438">
       <OrphaCode>36913</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=36913</ExpertLink>
-      <Name lang="nl">Auto-immune hypoparathyreoïdie</Name>
+      <Name lang="nl">Auto-immune hypoparathyreoÃ¯die</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -294059,7 +297431,7 @@
     <Disorder id="10394">
       <OrphaCode>35705</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=35705</ExpertLink>
-      <Name lang="nl">Neurometabole stoornis door deficiëntie van serine</Name>
+      <Name lang="nl">Neurometabole stoornis door deficiÃ«ntie van serine</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -294140,7 +297512,7 @@
     <Disorder id="10393">
       <OrphaCode>35704</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=35704</ExpertLink>
-      <Name lang="nl">L-Arginine:glycine-amidinotransferasedeficiëntie</Name>
+      <Name lang="nl">L-Arginine:glycine-amidinotransferasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -294272,7 +297644,7 @@
     <Disorder id="10397">
       <OrphaCode>35708</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=35708</ExpertLink>
-      <Name lang="nl">Deficiëntie van aromatisch L-aminozuur-decarboxylase</Name>
+      <Name lang="nl">DeficiÃ«ntie van aromatisch L-aminozuur-decarboxylase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -294353,7 +297725,7 @@
     <Disorder id="10391">
       <OrphaCode>35701</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=35701</ExpertLink>
-      <Name lang="nl">3-hydroxy-3-methylglutaryl-CoA-synthasedeficiëntie</Name>
+      <Name lang="nl">3-hydroxy-3-methylglutaryl-CoA-synthasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -294653,7 +298025,7 @@
     <Disorder id="10380">
       <OrphaCode>35656</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=35656</ExpertLink>
-      <Name lang="nl">Deficiëntie van co-enzym Q10</Name>
+      <Name lang="nl">DeficiÃ«ntie van co-enzym Q10</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -294783,7 +298155,7 @@
     <Disorder id="10373">
       <OrphaCode>35122</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=35122</ExpertLink>
-      <Name lang="nl">Congenitale deficiëntie van sucrase-isomaltase</Name>
+      <Name lang="nl">Congenitale deficiÃ«ntie van sucrase-isomaltase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -294815,7 +298187,7 @@
     <Disorder id="10372">
       <OrphaCode>35121</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=35121</ExpertLink>
-      <Name lang="nl">Lysosomale zure fosfatasedeficiëntie</Name>
+      <Name lang="nl">Lysosomale zure fosfatasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -294847,7 +298219,7 @@
     <Disorder id="10424">
       <OrphaCode>36387</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=36387</ExpertLink>
-      <Name lang="nl">Gegeneraliseerde epilepsie met febriele aanvallen plus</Name>
+      <Name lang="nl">Genetische epilepsie met koortsstuipen plus</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -294943,7 +298315,7 @@
     <Disorder id="10428">
       <OrphaCode>36412</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=36412</ExpertLink>
-      <Name lang="nl">Hypocomplementemische urticariële vasculitis</Name>
+      <Name lang="nl">Hypocomplementemische urticariÃ«le vasculitis</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -295107,7 +298479,7 @@
     <Disorder id="10409">
       <OrphaCode>36234</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=36234</ExpertLink>
-      <Name lang="nl">Bacteriële toxischeshocksyndroom</Name>
+      <Name lang="nl">BacteriÃ«le toxischeshocksyndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -296389,7 +299761,7 @@
     <Disorder id="10403">
       <OrphaCode>35878</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=35878</ExpertLink>
-      <Name lang="nl">Hyperinsulinisme - hyperammoniëmie-syndroom</Name>
+      <Name lang="nl">Hyperinsulinisme - hyperammoniÃ«mie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -296421,7 +299793,7 @@
     <Disorder id="10402">
       <OrphaCode>35858</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=35858</ExpertLink>
-      <Name lang="nl">Syndroom van Imerslund-Gräsbeck</Name>
+      <Name lang="nl">Syndroom van Imerslund-GrÃ¤sbeck</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -296430,7 +299802,7 @@
       </DisorderGroup>
       <PrevalenceList count="4">
         <Prevalence id="5542">
-          <Source>Pr Ralph GRÄSBECK[EXPERT]</Source>
+          <Source>Pr Ralph GRÃSBECK[EXPERT]</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -296449,7 +299821,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="5543">
-          <Source>Pr Ralph GRÄSBECK[EXPERT]</Source>
+          <Source>Pr Ralph GRÃSBECK[EXPERT]</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -296487,7 +299859,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="17514">
-          <Source>Pr Ralph GRÄSBECK[EXPERT]_ORPHANET</Source>
+          <Source>Pr Ralph GRÃSBECK[EXPERT]_ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -296510,7 +299882,7 @@
     <Disorder id="10405">
       <OrphaCode>35909</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=35909</ExpertLink>
-      <Name lang="nl">Gecombineerde deficiëntie van factor V en factor VIII</Name>
+      <Name lang="nl">Gecombineerde deficiÃ«ntie van factor V en factor VIII</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -296561,7 +299933,7 @@
     <Disorder id="10404">
       <OrphaCode>35889</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=35889</ExpertLink>
-      <Name lang="nl">Acute intoxicatie door opioïd</Name>
+      <Name lang="nl">Acute intoxicatie door opioÃ¯d</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -296593,7 +299965,7 @@
     <Disorder id="10407">
       <OrphaCode>36204</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=36204</ExpertLink>
-      <Name lang="nl">Intestinale lymfangiëctasie</Name>
+      <Name lang="nl">Intestinale lymfangiÃ«ctasie</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -296657,7 +300029,7 @@
     <Disorder id="10327">
       <OrphaCode>33572</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=33572</ExpertLink>
-      <Name lang="nl">Deficiëntie van 5-oxoprolinase</Name>
+      <Name lang="nl">DeficiÃ«ntie van 5-oxoprolinase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -296927,7 +300299,7 @@
     <Disorder id="27792">
       <OrphaCode>535458</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=535458</ExpertLink>
-      <Name lang="nl">Familiale GPIHBP1-deficiëntie</Name>
+      <Name lang="nl">Familiale GPIHBP1-deficiÃ«ntie</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -297110,7 +300482,7 @@
     <Disorder id="10329">
       <OrphaCode>33574</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=33574</ExpertLink>
-      <Name lang="nl">Deficiëntie van glutamaat-cysteïneligase</Name>
+      <Name lang="nl">DeficiÃ«ntie van glutamaat-cysteÃ¯neligase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -297159,7 +300531,7 @@
     <Disorder id="10328">
       <OrphaCode>33573</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=33573</ExpertLink>
-      <Name lang="nl">Deficiëntie van gamma-glutamyltranspeptidase</Name>
+      <Name lang="nl">DeficiÃ«ntie van gamma-glutamyltranspeptidase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -297208,7 +300580,7 @@
     <Disorder id="10310">
       <OrphaCode>33110</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=33110</ExpertLink>
-      <Name lang="nl">Autosomale agammaglobulinemie</Name>
+      <Name lang="nl">Autosomale niet-syndromale agammaglobulinemie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -297538,7 +300910,7 @@
     <Disorder id="27791">
       <OrphaCode>535453</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=535453</ExpertLink>
-      <Name lang="nl">Familiale lipase-maturatiefactor 1-deficiëntie</Name>
+      <Name lang="nl">Familiale lipase-maturatiefactor 1-deficiÃ«ntie</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -298245,7 +301617,7 @@
     <Disorder id="10313">
       <OrphaCode>33226</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=33226</ExpertLink>
-      <Name lang="nl">Macroglobulinemie van Waldenström</Name>
+      <Name lang="nl">Macroglobulinemie van WaldenstrÃ¶m</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -298491,7 +301863,7 @@
     <Disorder id="10366">
       <OrphaCode>35078</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=35078</ExpertLink>
-      <Name lang="nl">Ernstige gecombineerde T-B+ immuundeficiëntie als gevolg van JAK3-deficiëntie</Name>
+      <Name lang="nl">Ernstige gecombineerde T-B+ immuundeficiÃ«ntie als gevolg van JAK3-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -298523,7 +301895,7 @@
     <Disorder id="10360">
       <OrphaCode>35062</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=35062</ExpertLink>
-      <Name lang="nl">Ernstige gedissemineerde infectie door cytomegalovirus bij immuuncompetente patiënten</Name>
+      <Name lang="nl">Ernstige gedissemineerde infectie door cytomegalovirus bij immuuncompetente patiÃ«nten</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -298555,7 +301927,7 @@
     <Disorder id="10342">
       <OrphaCode>34520</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=34520</ExpertLink>
-      <Name lang="nl">Congenitale spierdystrofie met deficiëntie van integrine alfa-7</Name>
+      <Name lang="nl">Congenitale spierdystrofie met deficiÃ«ntie van integrine alfa-7</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -298823,7 +302195,7 @@
     <Disorder id="10349">
       <OrphaCode>34592</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=34592</ExpertLink>
-      <Name lang="nl">Immuundeficiëntie door verstoorde expressie van MHC klasse I</Name>
+      <Name lang="nl">ImmuundeficiÃ«ntie door verstoorde expressie van MHC klasse I</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -298872,7 +302244,7 @@
     <Disorder id="10346">
       <OrphaCode>34528</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=34528</ExpertLink>
-      <Name lang="nl">Autosomaal dominante primaire hypomagnesiëmie met hypocalciurie</Name>
+      <Name lang="nl">Autosomaal dominante primaire hypomagnesiÃ«mie met hypocalciurie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -299734,7 +303106,7 @@
     <Disorder id="10699">
       <OrphaCode>52503</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=52503</ExpertLink>
-      <Name lang="nl">X-gebonden creatinetransporterdeficiëntie</Name>
+      <Name lang="nl">X-gebonden creatinetransporterdeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -300502,7 +303874,7 @@
     <Disorder id="10706">
       <OrphaCode>52901</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=52901</ExpertLink>
-      <Name lang="nl">Geïsoleerde deficiëntie van follikelstimulerend hormoon</Name>
+      <Name lang="nl">GeÃ¯soleerde deficiÃ«ntie van follikelstimulerend hormoon</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -300585,7 +303957,7 @@
     <Disorder id="27945">
       <OrphaCode>538756</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=538756</ExpertLink>
-      <Name lang="nl">Familiale multipele discoïde fibromen</Name>
+      <Name lang="nl">Familiale multipele discoÃ¯de fibromen</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -300896,7 +304268,7 @@
     <Disorder id="27964">
       <OrphaCode>538934</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=538934</ExpertLink>
-      <Name lang="nl">X-gebonden lymfoproliferatieve ziekte door XIAP-deficiëntie</Name>
+      <Name lang="nl">X-gebonden lymfoproliferatieve ziekte door XIAP-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -300994,7 +304366,7 @@
     <Disorder id="27963">
       <OrphaCode>538931</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=538931</ExpertLink>
-      <Name lang="nl">X-gebonden lymfoproliferatieve ziekte door SAP-deficiëntie</Name>
+      <Name lang="nl">X-gebonden lymfoproliferatieve ziekte door SAP-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -301143,12 +304515,12 @@
     <Disorder id="10742">
       <OrphaCode>53719</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=53719</ExpertLink>
-      <Name lang="nl">Syndroom van Wyburn-Mason</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
+      <Name lang="nl">Cerebrofaciaal arterioveneus metamerisch syndroom type 2</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="5784">
@@ -301811,7 +305183,7 @@
     <Disorder id="27968">
       <OrphaCode>538958</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=538958</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door CD70-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door CD70-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -301909,7 +305281,7 @@
     <Disorder id="27969">
       <OrphaCode>538963</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=538963</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door ITK-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door ITK-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -302088,7 +305460,7 @@
     <Disorder id="10648">
       <OrphaCode>50809</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=50809</ExpertLink>
-      <Name lang="nl">Talo-patello-scafoïdosteolyse</Name>
+      <Name lang="nl">Talo-patello-scafoÃ¯dosteolyse</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -302235,7 +305607,7 @@
     <Disorder id="10651">
       <OrphaCode>50812</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=50812</ExpertLink>
-      <Name lang="nl">Zellweger-achtig syndroom zonder peroxisomale anomalieën</Name>
+      <Name lang="nl">Zellweger-achtig syndroom zonder peroxisomale anomalieÃ«n</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -302489,7 +305861,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="3">
+      <PrevalenceList count="4">
         <Prevalence id="5695">
           <Source>European Medicines Agency[INST]</Source>
           <PrevalenceType id="23669">
@@ -302547,6 +305919,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17742">
+          <Source>International Agency for Research on Cancer[INST]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>3.0E-4</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="10665">
@@ -302601,7 +305992,7 @@
     <Disorder id="10664">
       <OrphaCode>50944</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=50944</ExpertLink>
-      <Name lang="nl">Syndroom van Schöpf-Schulz-Passarge</Name>
+      <Name lang="nl">Syndroom van SchÃ¶pf-Schulz-Passarge</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -302799,7 +306190,7 @@
     <Disorder id="10687">
       <OrphaCode>52054</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=52054</ExpertLink>
-      <Name lang="nl">Craniosynostose - intracraniële calcificaties-syndroom</Name>
+      <Name lang="nl">Craniosynostose - intracraniÃ«le calcificaties-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -302997,7 +306388,7 @@
     <Disorder id="10675">
       <OrphaCode>51608</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=51608</ExpertLink>
-      <Name lang="nl">Gegeneraliseerde arteriële calcificatie in de kinderjaren</Name>
+      <Name lang="nl">Gegeneraliseerde arteriÃ«le calcificatie in de kinderjaren</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -303244,7 +306635,7 @@
     <Disorder id="10677">
       <OrphaCode>51890</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=51890</ExpertLink>
-      <Name lang="nl">Syndroom van Kómár</Name>
+      <Name lang="nl">Syndroom van KÃ³mÃ¡r</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -303295,7 +306686,7 @@
     <Disorder id="28037">
       <OrphaCode>542306</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=542306</ExpertLink>
-      <Name lang="nl">Intellectuele achterstand - hartaritmie-syndroom door GNB5-deficiëntie</Name>
+      <Name lang="nl">Intellectuele achterstand - hartaritmie-syndroom door GNB5-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -303344,7 +306735,7 @@
     <Disorder id="28036">
       <OrphaCode>542301</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=542301</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door CARMIL2-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door CARMIL2-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -303819,7 +307210,7 @@
     <Disorder id="28055">
       <OrphaCode>542643</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=542643</ExpertLink>
-      <Name lang="nl">Livedoïde vasculopathie</Name>
+      <Name lang="nl">LivedoÃ¯de vasculopathie</Name>
       <DisorderType id="21422">
         <Name lang="nl">Klinisch syndroom</Name>
       </DisorderType>
@@ -304084,7 +307475,7 @@
     <Disorder id="10579">
       <OrphaCode>43115</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=43115</ExpertLink>
-      <Name lang="nl">Erfelijke myopathie met lactaatacidose door ISCU-deficiëntie</Name>
+      <Name lang="nl">Erfelijke myopathie met lactaatacidose door ISCU-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -304411,7 +307802,7 @@
     <Disorder id="28056">
       <OrphaCode>542657</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=542657</ExpertLink>
-      <Name lang="nl">Geïsoleerde hyperchlorhidrose</Name>
+      <Name lang="nl">GeÃ¯soleerde hyperchlorhidrose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -304998,7 +308389,7 @@
     <Disorder id="10596">
       <OrphaCode>46485</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=46485</ExpertLink>
-      <Name lang="nl">Superficiële pemfigus</Name>
+      <Name lang="nl">SuperficiÃ«le pemfigus</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -305030,7 +308421,7 @@
     <Disorder id="10597">
       <OrphaCode>46486</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=46486</ExpertLink>
-      <Name lang="nl">Slijmvliespemfigoïd</Name>
+      <Name lang="nl">SlijmvliespemfigoÃ¯d</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -305419,7 +308810,7 @@
     <Disorder id="10601">
       <OrphaCode>46532</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=46532</ExpertLink>
-      <Name lang="nl">Hereditaire persistentie van foetaal hemoglobine - bèta-thalassemie-syndroom</Name>
+      <Name lang="nl">Hereditaire persistentie van foetaal hemoglobine - bÃ¨ta-thalassemie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -305857,7 +309248,7 @@
     <Disorder id="28083">
       <OrphaCode>544488</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=544488</ExpertLink>
-      <Name lang="nl">Algehele ontwikkelingsachterstand - alopecie - macrocefalie - faciale dysmorfie - structurele hersenanomalieën-syndroom</Name>
+      <Name lang="nl">Algehele ontwikkelingsachterstand - alopecie - macrocefalie - faciale dysmorfie - structurele hersenanomalieÃ«n-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -306217,7 +309608,7 @@
     <Disorder id="28103">
       <OrphaCode>555402</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=555402</ExpertLink>
-      <Name lang="nl">NAD(P)HX-dehydratasedeficiëntie</Name>
+      <Name lang="nl">NAD(P)HX-dehydratasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -306298,7 +309689,7 @@
     <Disorder id="28104">
       <OrphaCode>555407</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=555407</ExpertLink>
-      <Name lang="nl">NAD(P)HX-epimerasedeficiëntie</Name>
+      <Name lang="nl">NAD(P)HX-epimerasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -306669,7 +310060,7 @@
     <Disorder id="28142">
       <OrphaCode>557064</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=557064</ExpertLink>
-      <Name lang="nl">Neonatale epileptische encefalopathie door glutaminasedeficiëntie</Name>
+      <Name lang="nl">Neonatale epileptische encefalopathie door glutaminasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -306718,7 +310109,7 @@
     <Disorder id="28141">
       <OrphaCode>557056</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=557056</ExpertLink>
-      <Name lang="nl">Spastische ataxie-dysartrie door glutaminasedeficiëntie</Name>
+      <Name lang="nl">Spastische ataxie-dysartrie door glutaminasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -306816,7 +310207,7 @@
     <Disorder id="11956">
       <OrphaCode>90065</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90065</ExpertLink>
-      <Name lang="nl">Verworven aneurysmale subarachnoïdale hemorragie</Name>
+      <Name lang="nl">Verworven aneurysmale subarachnoÃ¯dale hemorragie</Name>
       <DisorderType id="21429">
         <Name lang="nl">Particulaire klinische situatie binnen een ziekte of syndroom</Name>
       </DisorderType>
@@ -306880,7 +310271,7 @@
     <Disorder id="11959">
       <OrphaCode>90068</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90068</ExpertLink>
-      <Name lang="nl">Cocaïne-intoxicatie</Name>
+      <Name lang="nl">CocaÃ¯ne-intoxicatie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -306912,7 +310303,7 @@
     <Disorder id="11952">
       <OrphaCode>90061</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90061</ExpertLink>
-      <Name lang="nl">Niet-infectieuze posterieure uveïtis</Name>
+      <Name lang="nl">Niet-infectieuze posterieure uveÃ¯tis</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -307025,7 +310416,7 @@
     <Disorder id="11955">
       <OrphaCode>90064</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90064</ExpertLink>
-      <Name lang="nl">Acute perifere arteriële occlusie</Name>
+      <Name lang="nl">Acute perifere arteriÃ«le occlusie</Name>
       <DisorderType id="21429">
         <Name lang="nl">Particulaire klinische situatie binnen een ziekte of syndroom</Name>
       </DisorderType>
@@ -307234,7 +310625,7 @@
     <Disorder id="11943">
       <OrphaCode>90052</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90052</ExpertLink>
-      <Name lang="nl">Terugkerende hepatitis C-virus-geïnduceerde leverziekte bij levertransplantaatrecipiënten</Name>
+      <Name lang="nl">Terugkerende hepatitis C-virus-geÃ¯nduceerde leverziekte bij levertransplantaatrecipiÃ«nten</Name>
       <DisorderType id="21429">
         <Name lang="nl">Particulaire klinische situatie binnen een ziekte of syndroom</Name>
       </DisorderType>
@@ -307298,7 +310689,7 @@
     <Disorder id="11937">
       <OrphaCode>90041</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90041</ExpertLink>
-      <Name lang="nl">Syndroom van Gaisböck</Name>
+      <Name lang="nl">Syndroom van GaisbÃ¶ck</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -307362,7 +310753,7 @@
     <Disorder id="11939">
       <OrphaCode>90044</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90044</ExpertLink>
-      <Name lang="nl">Familiale pseudohyperkaliëmie</Name>
+      <Name lang="nl">Familiale pseudohyperkaliÃ«mie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -307541,7 +310932,7 @@
     <Disorder id="11944">
       <OrphaCode>90053</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90053</ExpertLink>
-      <Name lang="nl">Complicaties na hematopoëtische stamceltransplantatie</Name>
+      <Name lang="nl">Complicaties na hematopoÃ«tische stamceltransplantatie</Name>
       <DisorderType id="21429">
         <Name lang="nl">Particulaire klinische situatie binnen een ziekte of syndroom</Name>
       </DisorderType>
@@ -307654,7 +311045,7 @@
     <Disorder id="11925">
       <OrphaCode>90023</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90023</ExpertLink>
-      <Name lang="nl">Primair immuundeficiëntiesyndroom door P14/LAMTOR2-deficiëntie</Name>
+      <Name lang="nl">Primair immuundeficiÃ«ntiesyndroom door P14/LAMTOR2-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -307752,7 +311143,7 @@
     <Disorder id="11934">
       <OrphaCode>90037</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90037</ExpertLink>
-      <Name lang="nl">Medicatiegeïnduceerde auto-immune hemolytische anemie</Name>
+      <Name lang="nl">MedicatiegeÃ¯nduceerde auto-immune hemolytische anemie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -307899,7 +311290,7 @@
     <Disorder id="11930">
       <OrphaCode>90031</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90031</ExpertLink>
-      <Name lang="nl">Niet-sferocytische hemolytische anemie door deficiëntie van hexokinase</Name>
+      <Name lang="nl">Niet-sferocytische hemolytische anemie door deficiÃ«ntie van hexokinase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -308031,7 +311422,7 @@
     <Disorder id="11929">
       <OrphaCode>90030</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90030</ExpertLink>
-      <Name lang="nl">Hemolytische anemie door deficiëntie van glutathionreductase</Name>
+      <Name lang="nl">Hemolytische anemie door deficiÃ«ntie van glutathionreductase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -308759,7 +312150,7 @@
     <Disorder id="12030">
       <OrphaCode>90362</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90362</ExpertLink>
-      <Name lang="nl">Primaire intestinale lymfangiëctasie</Name>
+      <Name lang="nl">Primaire intestinale lymfangiÃ«ctasie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -309208,7 +312599,7 @@
     <Disorder id="12005">
       <OrphaCode>90308</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90308</ExpertLink>
-      <Name lang="nl">Syndroom van Klippel-Trénaunay</Name>
+      <Name lang="nl">Syndroom van Klippel-TrÃ©naunay</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -309308,14 +312699,14 @@
     <Disorder id="11995">
       <OrphaCode>90281</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90281</ExpertLink>
-      <Name lang="nl">Discoïde lupus erythematosus</Name>
+      <Name lang="nl">DiscoÃ¯de lupus erythematosus</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="3">
         <Prevalence id="10707">
           <Source>19289752[PMID]</Source>
           <PrevalenceType id="23676">
@@ -309354,6 +312745,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="18076">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>30.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="11993">
@@ -309941,7 +313351,7 @@
           </PrevalenceClass>
           <ValMoy>5.0</ValMoy>
           <PrevalenceGeographic id="23802">
-            <Name lang="nl">Oceanië</Name>
+            <Name lang="nl">OceaniÃ«</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
@@ -310627,7 +314037,7 @@
     <Disorder id="11817">
       <OrphaCode>88639</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=88639</ExpertLink>
-      <Name lang="nl">Neurodegeneratie door deficiëntie van 3-hydroxyisobutyryl-CoA-hydrolase</Name>
+      <Name lang="nl">Neurodegeneratie door deficiÃ«ntie van 3-hydroxyisobutyryl-CoA-hydrolase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -310725,7 +314135,7 @@
     <Disorder id="11819">
       <OrphaCode>88643</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=88643</ExpertLink>
-      <Name lang="nl">Obesitas - colitis - hypothyreoïdie - cardiale hypertrofie - ontwikkelingsachterstand-syndroom</Name>
+      <Name lang="nl">Obesitas - colitis - hypothyreoÃ¯die - cardiale hypertrofie - ontwikkelingsachterstand-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -310774,7 +314184,7 @@
     <Disorder id="11814">
       <OrphaCode>88635</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=88635</ExpertLink>
-      <Name lang="nl">Vacuolaire myopathie met proteïneaggregaten van sarcoplasmatisch reticulum</Name>
+      <Name lang="nl">Vacuolaire myopathie met proteÃ¯neaggregaten van sarcoplasmatisch reticulum</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -310985,7 +314395,7 @@
     <Disorder id="11807">
       <OrphaCode>88620</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=88620</ExpertLink>
-      <Name lang="nl">Geïsoleerde congenitale anosmie</Name>
+      <Name lang="nl">GeÃ¯soleerde congenitale anosmie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -311083,7 +314493,7 @@
     <Disorder id="11805">
       <OrphaCode>88618</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=88618</ExpertLink>
-      <Name lang="nl">Deficiëntie van S-adenosylhomocysteïnehydrolase</Name>
+      <Name lang="nl">DeficiÃ«ntie van S-adenosylhomocysteÃ¯nehydrolase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -311244,38 +314654,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="11796">
-      <OrphaCode>86923</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86923</ExpertLink>
-      <Name lang="nl">Hereditaire palmoplantaire keratodermie, Gamborg-Nielsen-type</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="6894">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="11793">
       <OrphaCode>86920</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86920</ExpertLink>
@@ -311475,7 +314853,7 @@
     <Disorder id="27340">
       <OrphaCode>522077</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=522077</ExpertLink>
-      <Name lang="nl">Infantiele hypotonie - oculomotorische anomalieën - hyperkinetische bewegingen - ontwikkelingsachterstand-syndroom</Name>
+      <Name lang="nl">Infantiele hypotonie - oculomotorische anomalieÃ«n - hyperkinetische bewegingen - ontwikkelingsachterstand-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -311524,7 +314902,7 @@
     <Disorder id="11786">
       <OrphaCode>86913</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86913</ExpertLink>
-      <Name lang="nl">Myoclonische epilepsie bij niet-progressieve encefalopathieën</Name>
+      <Name lang="nl">Myoclonische epilepsie bij niet-progressieve encefalopathieÃ«n</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -311703,7 +315081,7 @@
     <Disorder id="27332">
       <OrphaCode>521445</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=521445</ExpertLink>
-      <Name lang="nl">Microcefalie - faciale dysmorfie - oculaire anomalieën - multipele congenitale anomalieën-syndroom</Name>
+      <Name lang="nl">Microcefalie - faciale dysmorfie - oculaire anomalieÃ«n - multipele congenitale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -311752,7 +315130,7 @@
     <Disorder id="27331">
       <OrphaCode>521438</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=521438</ExpertLink>
-      <Name lang="nl">Congenitale vertebrale-cardiale-renale anomalieën-syndroom</Name>
+      <Name lang="nl">Congenitale vertebrale-cardiale-renale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -312142,7 +315520,7 @@
     <Disorder id="27323">
       <OrphaCode>521308</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=521308</ExpertLink>
-      <Name lang="nl">Frontonasale dysplasie - bifide neus - anomalieën van bovenste ledematen-syndroom</Name>
+      <Name lang="nl">Frontonasale dysplasie - bifide neus - anomalieÃ«n van bovenste ledematen-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -312419,7 +315797,7 @@
     <Disorder id="11881">
       <OrphaCode>88949</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=88949</ExpertLink>
-      <Name lang="nl">MUC1-gerelateerde autosomaal dominante tubulo-interstitiële nierziekte</Name>
+      <Name lang="nl">MUC1-gerelateerde autosomaal dominante tubulo-interstitiÃ«le nierziekte</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -312508,7 +315886,7 @@
     <Disorder id="11882">
       <OrphaCode>88950</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=88950</ExpertLink>
-      <Name lang="nl">UMOD-gerelateerde autosomaal dominante tubulo-interstitiële nierziekte</Name>
+      <Name lang="nl">UMOD-gerelateerde autosomaal dominante tubulo-interstitiÃ«le nierziekte</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -313176,7 +316554,7 @@
     <Disorder id="12210">
       <OrphaCode>93267</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93267</ExpertLink>
-      <Name lang="nl">Klaverbladschedel - multipele congenitale anomalieën-syndroom</Name>
+      <Name lang="nl">Klaverbladschedel - multipele congenitale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -313787,7 +317165,7 @@
     <Disorder id="27458">
       <OrphaCode>527468</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=527468</ExpertLink>
-      <Name lang="nl">Diafragmatische hernia - korte darm - asplenie-syndroom</Name>
+      <Name lang="nl">Hernia diaphragmatica - korte darm - asplenie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -313887,7 +317265,7 @@
     <Disorder id="12173">
       <OrphaCode>93160</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93160</ExpertLink>
-      <Name lang="nl">Hypocalciëmische vitamine D-resistente rachitis</Name>
+      <Name lang="nl">HypocalciÃ«mische vitamine D-resistente rachitis</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -313919,7 +317297,7 @@
     <Disorder id="12174">
       <OrphaCode>93164</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93164</ExpertLink>
-      <Name lang="nl">Transiënt pseudohypoaldosteronisme</Name>
+      <Name lang="nl">TransiÃ«nt pseudohypoaldosteronisme</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -314017,7 +317395,7 @@
     <Disorder id="12168">
       <OrphaCode>93111</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93111</ExpertLink>
-      <Name lang="nl">HNF1B-gerelateerde autosomaal dominante tubulo-interstitiële nierziekte</Name>
+      <Name lang="nl">HNF1B-gerelateerde autosomaal dominante tubulo-interstitiÃ«le nierziekte</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -314058,7 +317436,7 @@
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="11687">
-          <Source>ORPHANET_Dr Laure-Hélène NOEL[EXPERT]</Source>
+          <Source>ORPHANET_Dr Laure-HÃ©lÃ¨ne NOEL[EXPERT]</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -314164,7 +317542,7 @@
     <Disorder id="12259">
       <OrphaCode>93322</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93322</ExpertLink>
-      <Name lang="nl">Geïsoleerde hemimelie van tibia</Name>
+      <Name lang="nl">GeÃ¯soleerde hemimelie van tibia</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -314215,7 +317593,7 @@
     <Disorder id="12258">
       <OrphaCode>93321</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93321</ExpertLink>
-      <Name lang="nl">Geïsoleerde hemimelie van radius</Name>
+      <Name lang="nl">GeÃ¯soleerde hemimelie van radius</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -314266,7 +317644,7 @@
     <Disorder id="12257">
       <OrphaCode>93320</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93320</ExpertLink>
-      <Name lang="nl">Geïsoleerde hemimelie van ulna</Name>
+      <Name lang="nl">GeÃ¯soleerde hemimelie van ulna</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -314298,7 +317676,7 @@
     <Disorder id="12260">
       <OrphaCode>93323</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93323</ExpertLink>
-      <Name lang="nl">Geïsoleerde hemimelie van fibula</Name>
+      <Name lang="nl">GeÃ¯soleerde hemimelie van fibula</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -315491,7 +318869,7 @@
     <Disorder id="12074">
       <OrphaCode>90673</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90673</ExpertLink>
-      <Name lang="nl">Hypothyreoïdie door mutaties in TSH-receptor</Name>
+      <Name lang="nl">HypothyreoÃ¯die door mutaties in TSH-receptor</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -315523,7 +318901,7 @@
     <Disorder id="12075">
       <OrphaCode>90674</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90674</ExpertLink>
-      <Name lang="nl">Geïsoleerde deficiëntie van thyroïdstimulerend hormoon</Name>
+      <Name lang="nl">GeÃ¯soleerde deficiÃ«ntie van thyroÃ¯dstimulerend hormoon</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -315797,7 +319175,7 @@
     <Disorder id="12095">
       <OrphaCode>90791</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90791</ExpertLink>
-      <Name lang="nl">Congenitale adrenale hyperplasie door deficiëntie van 3-bèta-hydroxysteroïdedehydrogenase</Name>
+      <Name lang="nl">Congenitale adrenale hyperplasie door deficiÃ«ntie van 3-bÃ¨ta-hydroxysteroÃ¯dedehydrogenase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -315846,7 +319224,7 @@
     <Disorder id="12094">
       <OrphaCode>90790</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90790</ExpertLink>
-      <Name lang="nl">Congenitale lipoïde adrenale hyperplasie door STAR-deficiëntie</Name>
+      <Name lang="nl">Congenitale lipoÃ¯de adrenale hyperplasie door STAR-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -316511,7 +319889,7 @@
     <Disorder id="27609">
       <OrphaCode>529665</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=529665</ExpertLink>
-      <Name lang="nl">Neurologische ontwikkelingsachterstand - insulten - oftalmische anomalieën - osteopenie - cerebellaire atrofie-syndroom</Name>
+      <Name lang="nl">Neurologische ontwikkelingsachterstand - insulten - oftalmische anomalieÃ«n - osteopenie - cerebellaire atrofie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -316673,7 +320051,7 @@
     <Disorder id="12139">
       <OrphaCode>91396</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=91396</ExpertLink>
-      <Name lang="nl">Geïsoleerde cryptoftalmie</Name>
+      <Name lang="nl">GeÃ¯soleerde cryptoftalmie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -316911,7 +320289,7 @@
     <Disorder id="12140">
       <OrphaCode>91397</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=91397</ExpertLink>
-      <Name lang="nl">Geïsoleerde ankyloblepharon filiforme adnatum</Name>
+      <Name lang="nl">GeÃ¯soleerde ankyloblepharon filiforme adnatum</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -317334,7 +320712,7 @@
     <Disorder id="12158">
       <OrphaCode>91500</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=91500</ExpertLink>
-      <Name lang="nl">Tubulo-interstitiële nefritis en uveïtis-syndroom</Name>
+      <Name lang="nl">Tubulo-interstitiÃ«le nefritis en uveÃ¯tis-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -317415,7 +320793,7 @@
     <Disorder id="12147">
       <OrphaCode>91481</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=91481</ExpertLink>
-      <Name lang="nl">Ringdermoïd van cornea</Name>
+      <Name lang="nl">RingdermoÃ¯d van cornea</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -317464,7 +320842,7 @@
     <Disorder id="12146">
       <OrphaCode>91416</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=91416</ExpertLink>
-      <Name lang="nl">Geïsoleerde congenitale alacrimie</Name>
+      <Name lang="nl">GeÃ¯soleerde congenitale alacrimie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -317528,7 +320906,7 @@
     <Disorder id="12104">
       <OrphaCode>91127</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=91127</ExpertLink>
-      <Name lang="nl">Adenovirusinfectie bij immunogecompromitteerde patiënten</Name>
+      <Name lang="nl">Adenovirusinfectie bij immunogecompromitteerde patiÃ«nten</Name>
       <DisorderType id="21429">
         <Name lang="nl">Particulaire klinische situatie binnen een ziekte of syndroom</Name>
       </DisorderType>
@@ -317707,7 +321085,7 @@
     <Disorder id="12096">
       <OrphaCode>90793</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90793</ExpertLink>
-      <Name lang="nl">Congenitale adrenale hyperplasie door deficiëntie van 17-alfa-hydroxylase</Name>
+      <Name lang="nl">Congenitale adrenale hyperplasie door deficiÃ«ntie van 17-alfa-hydroxylase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -317739,7 +321117,7 @@
     <Disorder id="12097">
       <OrphaCode>90794</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90794</ExpertLink>
-      <Name lang="nl">Klassieke congenitale adrenale hyperplasie door deficiëntie van 21-hydroxylase</Name>
+      <Name lang="nl">Klassieke congenitale adrenale hyperplasie door deficiÃ«ntie van 21-hydroxylase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -317961,7 +321339,7 @@
     <Disorder id="12098">
       <OrphaCode>90795</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90795</ExpertLink>
-      <Name lang="nl">Congenitale adrenale hyperplasie door deficiëntie van 11-bèta-hydroxylase</Name>
+      <Name lang="nl">Congenitale adrenale hyperplasie door deficiÃ«ntie van 11-bÃ¨ta-hydroxylase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -318012,7 +321390,7 @@
     <Disorder id="12099">
       <OrphaCode>90796</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90796</ExpertLink>
-      <Name lang="nl">46,XY-geslachtsontwikkelingsstoornis door geïsoleerde deficiëntie van 17,20-lyase</Name>
+      <Name lang="nl">46,XY-geslachtsontwikkelingsstoornis door geÃ¯soleerde deficiÃ«ntie van 17,20-lyase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -318061,7 +321439,7 @@
     <Disorder id="12100">
       <OrphaCode>90797</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90797</ExpertLink>
-      <Name lang="nl">Partiële androgeeninsensitiviteitssyndroom</Name>
+      <Name lang="nl">PartiÃ«le androgeeninsensitiviteitssyndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -318341,7 +321719,7 @@
     <Disorder id="12124">
       <OrphaCode>91350</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=91350</ExpertLink>
-      <Name lang="nl">Hypofysedeficiëntie door gespleten cysten van Rathke</Name>
+      <Name lang="nl">HypofysedeficiÃ«ntie door gespleten cysten van Rathke</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -318422,7 +321800,7 @@
     <Disorder id="12112">
       <OrphaCode>91135</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=91135</ExpertLink>
-      <Name lang="nl">Hyperlaxiteit van huid door deficiëntie van vitamine K-afhankelijke stollingsfactor</Name>
+      <Name lang="nl">Hyperlaxiteit van huid door deficiÃ«ntie van vitamine K-afhankelijke stollingsfactor</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -318522,7 +321900,7 @@
     <Disorder id="12114">
       <OrphaCode>91137</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=91137</ExpertLink>
-      <Name lang="nl">Immunotactoïde of fibrillaire glomerulopathie</Name>
+      <Name lang="nl">ImmunotactoÃ¯de of fibrillaire glomerulopathie</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -319320,7 +322698,7 @@
     <Disorder id="11437">
       <OrphaCode>79411</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79411</ExpertLink>
-      <Name lang="nl">Spontaan genezende dystrofische epidermolysis bullosa</Name>
+      <Name lang="nl">Zelfhelende dystrofische epidermolysis bullosa</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -319937,7 +323315,7 @@
     <Disorder id="11471">
       <OrphaCode>79445</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79445</ExpertLink>
-      <Name lang="nl">Pseudopseudohypoparathyreoïdie</Name>
+      <Name lang="nl">PseudopseudohypoparathyreoÃ¯die</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -319969,7 +323347,7 @@
     <Disorder id="11470">
       <OrphaCode>79444</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79444</ExpertLink>
-      <Name lang="nl">Pseudohypoparathyreoïdie type 1C</Name>
+      <Name lang="nl">PseudohypoparathyreoÃ¯die type 1C</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -320001,7 +323379,7 @@
     <Disorder id="11469">
       <OrphaCode>79443</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79443</ExpertLink>
-      <Name lang="nl">Pseudohypoparathyreoïdie type 1A</Name>
+      <Name lang="nl">PseudohypoparathyreoÃ¯die type 1A</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -321144,7 +324522,7 @@
     <Disorder id="11285">
       <OrphaCode>79259</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79259</ExpertLink>
-      <Name lang="nl">Glycogeenstapelingsziekte als gevolg van glucose-6-fosfatasedeficiëntie type 1b</Name>
+      <Name lang="nl">Glycogeenstapelingsziekte als gevolg van glucose-6-fosfatasedeficiÃ«ntie type 1b</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -321320,7 +324698,7 @@
     <Disorder id="11272">
       <OrphaCode>79246</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79246</ExpertLink>
-      <Name lang="nl">Pyruvaatdehydrogenasefosfatasedeficiëntie</Name>
+      <Name lang="nl">PyruvaatdehydrogenasefosfatasedeficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -321384,7 +324762,7 @@
     <Disorder id="11266">
       <OrphaCode>79240</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79240</ExpertLink>
-      <Name lang="nl">Glycogeenstapelingsziekte door fosforylasekinasedeficiëntie in lever en spier</Name>
+      <Name lang="nl">Glycogeenstapelingsziekte door fosforylasekinasedeficiÃ«ntie in lever en spier</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -321416,7 +324794,7 @@
     <Disorder id="11267">
       <OrphaCode>79241</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79241</ExpertLink>
-      <Name lang="nl">Biotinidasedeficiëntie</Name>
+      <Name lang="nl">BiotinidasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -321676,7 +325054,7 @@
     <Disorder id="11264">
       <OrphaCode>79238</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79238</ExpertLink>
-      <Name lang="nl">Galactose-epimerasedeficiëntie</Name>
+      <Name lang="nl">Galactose-epimerasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -321873,7 +325251,7 @@
     <Disorder id="11270">
       <OrphaCode>79244</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79244</ExpertLink>
-      <Name lang="nl">Pyruvaatdehydrogenase E2-deficiëntie</Name>
+      <Name lang="nl">Pyruvaatdehydrogenase E2-deficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -321905,7 +325283,7 @@
     <Disorder id="11268">
       <OrphaCode>79242</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79242</ExpertLink>
-      <Name lang="nl">Deficiëntie van holocarboxylase-synthetase</Name>
+      <Name lang="nl">DeficiÃ«ntie van holocarboxylase-synthetase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -321956,7 +325334,7 @@
     <Disorder id="11269">
       <OrphaCode>79243</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79243</ExpertLink>
-      <Name lang="nl">Pyruvaatdehydrogenase E1-alfa-deficiëntie</Name>
+      <Name lang="nl">Pyruvaatdehydrogenase E1-alfa-deficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -322052,7 +325430,7 @@
     <Disorder id="11319">
       <OrphaCode>79293</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79293</ExpertLink>
-      <Name lang="nl">Familiale LCAT-deficiëntie</Name>
+      <Name lang="nl">Familiale LCAT-deficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -322150,7 +325528,7 @@
     <Disorder id="11304">
       <OrphaCode>79278</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79278</ExpertLink>
-      <Name lang="nl">Autosomale erytropoëtische protoporfyrie</Name>
+      <Name lang="nl">Autosomale erytropoÃ«tische protoporfyrie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -322581,7 +325959,7 @@
     <Disorder id="11305">
       <OrphaCode>79279</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79279</ExpertLink>
-      <Name lang="nl">Deficiëntie van alfa-N-acetylgalactosaminidase type 1</Name>
+      <Name lang="nl">DeficiÃ«ntie van alfa-N-acetylgalactosaminidase type 1</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -322630,7 +326008,7 @@
     <Disorder id="11306">
       <OrphaCode>79280</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79280</ExpertLink>
-      <Name lang="nl">Deficiëntie van alfa-N-acetylgalactosaminidase type 2</Name>
+      <Name lang="nl">DeficiÃ«ntie van alfa-N-acetylgalactosaminidase type 2</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -322679,7 +326057,7 @@
     <Disorder id="11307">
       <OrphaCode>79281</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79281</ExpertLink>
-      <Name lang="nl">Deficiëntie van alfa-N-acetylgalactosaminidase type 3</Name>
+      <Name lang="nl">DeficiÃ«ntie van alfa-N-acetylgalactosaminidase type 3</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -323719,7 +327097,7 @@
     <Disorder id="11303">
       <OrphaCode>79277</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79277</ExpertLink>
-      <Name lang="nl">Congenitale erytropoëtische porfyrie</Name>
+      <Name lang="nl">Congenitale erytropoÃ«tische porfyrie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -324916,7 +328294,7 @@
     <Disorder id="11387">
       <OrphaCode>79361</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79361</ExpertLink>
-      <Name lang="nl">Overgeërfde epidermolysis bullosa</Name>
+      <Name lang="nl">OvergeÃ«rfde epidermolysis bullosa</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -325043,7 +328421,7 @@
     <Disorder id="11377">
       <OrphaCode>79351</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79351</ExpertLink>
-      <Name lang="nl">Deficiëntie van 3-fosfoglyceraatdehydrogenase, infantiele/juveniele vorm</Name>
+      <Name lang="nl">DeficiÃ«ntie van 3-fosfoglyceraatdehydrogenase, infantiele/juveniele vorm</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -325092,7 +328470,7 @@
     <Disorder id="11376">
       <OrphaCode>79350</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79350</ExpertLink>
-      <Name lang="nl">Deficiëntie van 3-fosfoserinefosfatase, infantiele/juveniele vorm</Name>
+      <Name lang="nl">DeficiÃ«ntie van 3-fosfoserinefosfatase, infantiele/juveniele vorm</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -325138,6 +328516,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="11372">
+      <OrphaCode>79346</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79346</ExpertLink>
+      <Name lang="nl">Chondrodysplasia punctata, tibiaal-metacarpaal type</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18087">
+          <Source>2248286[PMID]_14699613[PMID]_25602717[PMID]_36820636[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>12.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18088">
+          <Source>2248286[PMID]_14699613[PMID]_25602717[PMID]_36820636[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="11373">
       <OrphaCode>79347</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79347</ExpertLink>
@@ -325199,7 +328626,7 @@
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="12550">
-          <Source>ORPHANET_Dr BAUJAT Geneviève[EXPERT]</Source>
+          <Source>ORPHANET_Dr BAUJAT GeneviÃ¨ve[EXPERT]</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -325465,7 +328892,7 @@
     <Disorder id="11657">
       <OrphaCode>85199</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85199</ExpertLink>
-      <Name lang="nl">Craniosynostose - anale anomalieën - porokeratose-syndroom</Name>
+      <Name lang="nl">Craniosynostose - anale anomalieÃ«n - porokeratose-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -327638,7 +331065,7 @@
     <Disorder id="11717">
       <OrphaCode>85443</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85443</ExpertLink>
-      <Name lang="nl">AL-amyloïdose</Name>
+      <Name lang="nl">AL-amyloÃ¯dose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -329239,7 +332666,7 @@
     <Disorder id="11719">
       <OrphaCode>85446</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85446</ExpertLink>
-      <Name lang="nl">Wild-type ABèta2M-amyloïdose</Name>
+      <Name lang="nl">Wild-type ABÃ¨ta2M-amyloÃ¯dose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -329271,7 +332698,7 @@
     <Disorder id="11718">
       <OrphaCode>85445</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85445</ExpertLink>
-      <Name lang="nl">AA-amyloïdose</Name>
+      <Name lang="nl">AA-amyloÃ¯dose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -329399,7 +332826,7 @@
     <Disorder id="11725">
       <OrphaCode>85458</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85458</ExpertLink>
-      <Name lang="nl">Cerebrale amyloïdangiopathie</Name>
+      <Name lang="nl">Cerebrale amyloÃ¯dangiopathie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -329595,7 +333022,7 @@
     <Disorder id="11721">
       <OrphaCode>85448</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85448</ExpertLink>
-      <Name lang="nl">AGel-amyloïdose</Name>
+      <Name lang="nl">AGel-amyloÃ¯dose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -329644,7 +333071,7 @@
     <Disorder id="11720">
       <OrphaCode>85447</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85447</ExpertLink>
-      <Name lang="nl">ATTRV30M-amyloïdose</Name>
+      <Name lang="nl">ATTRV30M-amyloÃ¯dose</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -329809,7 +333236,7 @@
     <Disorder id="11723">
       <OrphaCode>85451</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85451</ExpertLink>
-      <Name lang="nl">ATTRV122I-amyloïdose</Name>
+      <Name lang="nl">ATTRV122I-amyloÃ¯dose</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -329841,7 +333268,7 @@
     <Disorder id="11722">
       <OrphaCode>85450</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85450</ExpertLink>
-      <Name lang="nl">Erfelijke amyloïdose met primaire renale betrokkenheid</Name>
+      <Name lang="nl">Erfelijke amyloÃ¯dose met primaire renale betrokkenheid</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -329905,7 +333332,7 @@
     <Disorder id="11733">
       <OrphaCode>86813</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86813</ExpertLink>
-      <Name lang="nl">Helicoïde peripapillaire chorioretinale degeneratie</Name>
+      <Name lang="nl">HelicoÃ¯de peripapillaire chorioretinale degeneratie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -330005,7 +333432,7 @@
     <Disorder id="11728">
       <OrphaCode>86789</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86789</ExpertLink>
-      <Name lang="nl">Geïsoleerde aplasie/hypoplasie van patella</Name>
+      <Name lang="nl">GeÃ¯soleerde aplasie/hypoplasie van patella</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -330333,7 +333760,7 @@
     <Disorder id="11737">
       <OrphaCode>86817</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86817</ExpertLink>
-      <Name lang="nl">Hemolytische anemie door adenylaatkinasedeficiëntie</Name>
+      <Name lang="nl">Hemolytische anemie door adenylaatkinasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -330495,7 +333922,7 @@
     <Disorder id="11750">
       <OrphaCode>86841</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86841</ExpertLink>
-      <Name lang="nl">Myelodysplastisch syndroom geassocieerd met geïsoleerde del(5q) chromosoomabnormaliteit</Name>
+      <Name lang="nl">Myelodysplastisch syndroom geassocieerd met geÃ¯soleerde del(5q) chromosoomabnormaliteit</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -330870,7 +334297,7 @@
     <Disorder id="11755">
       <OrphaCode>86850</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86850</ExpertLink>
-      <Name lang="nl">Myeloïd sarcoom</Name>
+      <Name lang="nl">MyeloÃ¯d sarcoom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -330953,7 +334380,7 @@
     <Disorder id="11753">
       <OrphaCode>86846</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86846</ExpertLink>
-      <Name lang="nl">Therapiegerelateerde acute myeloïde leukemie en myelodysplastisch syndroom</Name>
+      <Name lang="nl">Therapiegerelateerde acute myeloÃ¯de leukemie en myelodysplastisch syndroom</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -330985,7 +334412,7 @@
     <Disorder id="11752">
       <OrphaCode>86845</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86845</ExpertLink>
-      <Name lang="nl">Acute myeloïde leukemie met myelodysplasie-gerelateerde kenmerken</Name>
+      <Name lang="nl">Acute myeloÃ¯de leukemie met myelodysplasie-gerelateerde kenmerken</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -331100,7 +334527,7 @@
     <Disorder id="11764">
       <OrphaCode>86870</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86870</ExpertLink>
-      <Name lang="nl">Blastaire plasmacytoïde dendritische cel-neoplasma</Name>
+      <Name lang="nl">Blastaire plasmacytoÃ¯de dendritische cel-neoplasma</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -332275,38 +335702,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="11544">
-      <OrphaCode>79665</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79665</ExpertLink>
-      <Name lang="nl">Syndroom van Gardner</Name>
-      <DisorderType id="21450">
-        <Name lang="nl">Klinisch subtype</Name>
-      </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="nl">Subtype van aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="6580">
-          <Source>17517313[PMID]_24858982[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>9.1</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="11543">
       <OrphaCode>79651</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79651</ExpertLink>
@@ -332342,7 +335737,7 @@
     <Disorder id="11542">
       <OrphaCode>79644</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79644</ExpertLink>
-      <Name lang="nl">Autosomaal recessief hyperinsulinisme als gevolg van Kir6.2-deficiëntie</Name>
+      <Name lang="nl">Autosomaal recessief hyperinsulinisme als gevolg van Kir6.2-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -332527,7 +335922,7 @@
     <Disorder id="11561">
       <OrphaCode>83316</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=83316</ExpertLink>
-      <Name lang="nl">Pseudotyfus van Californië</Name>
+      <Name lang="nl">Pseudotyfus van CaliforniÃ«</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -333396,7 +336791,7 @@
     <Disorder id="11580">
       <OrphaCode>83471</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=83471</ExpertLink>
-      <Name lang="nl">T-cel-immuundeficiëntie met aplasie van thymus</Name>
+      <Name lang="nl">T-cel-immuundeficiÃ«ntie met aplasie van thymus</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -334009,7 +337404,7 @@
     <Disorder id="27125">
       <OrphaCode>514352</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=514352</ExpertLink>
-      <Name lang="nl">Congenitale brachyoesofagus - intrathoracale maag - vertebrale anomalieën-syndroom</Name>
+      <Name lang="nl">Congenitale brachyoesofagus - intrathoracale maag - vertebrale anomalieÃ«n-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -334205,7 +337600,7 @@
     <Disorder id="11592">
       <OrphaCode>83601</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=83601</ExpertLink>
-      <Name lang="nl">Steroïdresponsieve encefalopathie geassocieerd met auto-immuunthyreoïditis</Name>
+      <Name lang="nl">SteroÃ¯dresponsieve encefalopathie geassocieerd met auto-immuunthyreoÃ¯ditis</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -334916,7 +338311,7 @@
     <Disorder id="11601">
       <OrphaCode>83639</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=83639</ExpertLink>
-      <Name lang="nl">Hypercoagulabiliteit-syndroom door deficiëntie van glycosylfosfatidylinositol</Name>
+      <Name lang="nl">Hypercoagulabiliteit-syndroom door deficiÃ«ntie van glycosylfosfatidylinositol</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -336341,7 +339736,7 @@
     <Disorder id="30615">
       <OrphaCode>603515</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=603515</ExpertLink>
-      <Name lang="nl">Geïsoleerde hypospadie bij vrouw</Name>
+      <Name lang="nl">GeÃ¯soleerde hypospadie bij vrouw</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -336471,7 +339866,7 @@
     <Disorder id="30616">
       <OrphaCode>603684</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=603684</ExpertLink>
-      <Name lang="nl">KLHL7-gerelateerd Bohring-Opitz-achtig en Crisponi/koudegeïnduceerd zweten-achtig overlapsyndroom</Name>
+      <Name lang="nl">KLHL7-gerelateerd Bohring-Opitz-achtig en Crisponi/koudegeÃ¯nduceerd zweten-achtig overlapsyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -337259,7 +340654,7 @@
     <Disorder id="30477">
       <OrphaCode>600691</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=600691</ExpertLink>
-      <Name lang="nl">Gecombineerde deficiëntie van factor VII en factor X</Name>
+      <Name lang="nl">Gecombineerde deficiÃ«ntie van factor VII en factor X</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -337599,7 +340994,7 @@
     <Disorder id="13294">
       <OrphaCode>98277</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98277</ExpertLink>
-      <Name lang="nl">Acute myeloïde leukemie met terugkerende genetische anomalie</Name>
+      <Name lang="nl">Acute myeloÃ¯de leukemie met terugkerende genetische anomalie</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -339332,7 +342727,7 @@
     <Disorder id="12897">
       <OrphaCode>97341</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=97341</ExpertLink>
-      <Name lang="nl">Persisterende placoïde maculopathie</Name>
+      <Name lang="nl">Persisterende placoÃ¯de maculopathie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -339912,7 +343307,7 @@
     <Disorder id="12805">
       <OrphaCode>96181</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=96181</ExpertLink>
-      <Name lang="nl">Maternale uniparentale disomie van chromosoom 6</Name>
+      <Name lang="nl">Maternale uniparentale disomie van chromosoom 6-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -340066,7 +343461,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="13407">
           <Source>7129419[PMID]</Source>
           <PrevalenceType id="23683">
@@ -340086,12 +343481,31 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="18077">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="12812">
       <OrphaCode>96188</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=96188</ExpertLink>
-      <Name lang="nl">Maternale uniparentale disomie van chromosoom 22</Name>
+      <Name lang="nl">Maternale uniparentale disomie van chromosoom 22-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -340140,7 +343554,7 @@
     <Disorder id="12811">
       <OrphaCode>96187</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=96187</ExpertLink>
-      <Name lang="nl">Maternale uniparentale disomie van chromosoom 21</Name>
+      <Name lang="nl">Maternale uniparentale disomie van chromosoom 21-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -340189,7 +343603,7 @@
     <Disorder id="12810">
       <OrphaCode>96186</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=96186</ExpertLink>
-      <Name lang="nl">Maternale uniparentale disomie van chromosoom 20</Name>
+      <Name lang="nl">Maternale uniparentale disomie van chromosoom 20-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -340287,7 +343701,7 @@
     <Disorder id="12816">
       <OrphaCode>96192</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=96192</ExpertLink>
-      <Name lang="nl">Paternale uniparentale disomie van chromosoom 7</Name>
+      <Name lang="nl">Paternale uniparentale disomie van chromosoom 7-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -340589,7 +344003,7 @@
     <Disorder id="12860">
       <OrphaCode>97234</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=97234</ExpertLink>
-      <Name lang="nl">Glycogeenstapelingsziekte door deficiëntie van fosfoglyceraatmutase</Name>
+      <Name lang="nl">Glycogeenstapelingsziekte door deficiÃ«ntie van fosfoglyceraatmutase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -340635,6 +344049,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="12861">
+      <OrphaCode>97238</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=97238</ExpertLink>
+      <Name lang="nl">Rippling-spierziekte</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18080">
+          <Source>7936247[PMID]_9537420[PMID]_11001938[PMID]_11756609[PMID]_12939441[PMID]_15668980[PMID]_16247063[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>59.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18081">
+          <Source>7936247[PMID]_9537420[PMID]_11001938[PMID]_11756609[PMID]_12939441[PMID]_15668980[PMID]_16247063[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="12862">
       <OrphaCode>97239</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=97239</ExpertLink>
@@ -340736,7 +344199,7 @@
     <Disorder id="12856">
       <OrphaCode>97229</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=97229</ExpertLink>
-      <Name lang="nl">Deficiëntie van riboflavinetransporter</Name>
+      <Name lang="nl">DeficiÃ«ntie van riboflavinetransporter</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -340934,7 +344397,7 @@
     <Disorder id="12942">
       <OrphaCode>97678</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=97678</ExpertLink>
-      <Name lang="nl">Maternale uniparentale disomie chromosoom 13</Name>
+      <Name lang="nl">Maternale uniparentale disomie van chromosoom 13-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -340983,7 +344446,7 @@
     <Disorder id="12935">
       <OrphaCode>97593</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=97593</ExpertLink>
-      <Name lang="nl">Pseudohypoparathyreoïdie</Name>
+      <Name lang="nl">PseudohypoparathyreoÃ¯die</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -341062,7 +344525,7 @@
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="11689">
-          <Source>ORPHANET_Dr Laure-Hélène NOEL[EXPERT]</Source>
+          <Source>ORPHANET_Dr Laure-HÃ©lÃ¨ne NOEL[EXPERT]</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -341094,7 +344557,7 @@
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="11688">
-          <Source>ORPHANET_Dr Laure-Hélène NOEL[EXPERT]</Source>
+          <Source>ORPHANET_Dr Laure-HÃ©lÃ¨ne NOEL[EXPERT]</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -341166,7 +344629,7 @@
     <Disorder id="12662">
       <OrphaCode>95707</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=95707</ExpertLink>
-      <Name lang="nl">Idiopathische geïsoleerde micropenis</Name>
+      <Name lang="nl">Idiopathische geÃ¯soleerde micropenis</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -341300,7 +344763,7 @@
     <Disorder id="12670">
       <OrphaCode>95715</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=95715</ExpertLink>
-      <Name lang="nl">Congenitale hypothyreoïdie door transplacentale passage van TSH-bindende inhiberende antilichamen</Name>
+      <Name lang="nl">Congenitale hypothyreoÃ¯die door transplacentale passage van TSH-bindende inhiberende antilichamen</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -341434,7 +344897,7 @@
     <Disorder id="12669">
       <OrphaCode>95714</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=95714</ExpertLink>
-      <Name lang="nl">Pimaire congenitale hypothyreoïdie zonder schildklierontwikkelingsanomalie</Name>
+      <Name lang="nl">Pimaire congenitale hypothyreoÃ¯die zonder schildklierontwikkelingsanomalie</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -341466,7 +344929,7 @@
     <Disorder id="12666">
       <OrphaCode>95711</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=95711</ExpertLink>
-      <Name lang="nl">Congenitale hypothyreoïdie door ontwikkelingsanomalie</Name>
+      <Name lang="nl">Congenitale hypothyreoÃ¯die door ontwikkelingsanomalie</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -341562,7 +345025,7 @@
     <Disorder id="12655">
       <OrphaCode>95700</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=95700</ExpertLink>
-      <Name lang="nl">Familiale adrenale hypoplasie met afwezig hypofysair luteïniserend hormoon</Name>
+      <Name lang="nl">Familiale adrenale hypoplasie met afwezig hypofysair luteÃ¯niserend hormoon</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -341611,7 +345074,7 @@
     <Disorder id="12654">
       <OrphaCode>95699</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=95699</ExpertLink>
-      <Name lang="nl">Congenitale adrenale hyperplasie door deficiëntie van cytochroom P450-oxidoreductase</Name>
+      <Name lang="nl">Congenitale adrenale hyperplasie door deficiÃ«ntie van cytochroom P450-oxidoreductase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -341662,7 +345125,7 @@
     <Disorder id="12650">
       <OrphaCode>95626</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=95626</ExpertLink>
-      <Name lang="nl">Verworven deficiëntie van arginine-vasopressine</Name>
+      <Name lang="nl">Verworven deficiÃ«ntie van arginine-vasopressine</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -341758,7 +345221,7 @@
     <Disorder id="12618">
       <OrphaCode>95494</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=95494</ExpertLink>
-      <Name lang="nl">Gecombineerde hypofysehormoondeficiënties, genetische vormen</Name>
+      <Name lang="nl">Gecombineerde hypofysehormoondeficiÃ«nties, genetische vormen</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -342028,7 +345491,7 @@
     <Disorder id="12580">
       <OrphaCode>95159</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=95159</ExpertLink>
-      <Name lang="nl">Hepato-erytropoëtische porfyrie</Name>
+      <Name lang="nl">Hepato-erytropoÃ«tische porfyrie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -342177,7 +345640,7 @@
     <Disorder id="12584">
       <OrphaCode>95409</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=95409</ExpertLink>
-      <Name lang="nl">Acute adrenale insufficiëntie</Name>
+      <Name lang="nl">Acute adrenale insufficiÃ«ntie</Name>
       <DisorderType id="21422">
         <Name lang="nl">Klinisch syndroom</Name>
       </DisorderType>
@@ -342644,7 +346107,7 @@
     <Disorder id="12547">
       <OrphaCode>94066</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=94066</ExpertLink>
-      <Name lang="nl">Ernstige intellectuele achterstand - epilepsie - anale anomalieën - distale falangeale hypoplasie-syndroom</Name>
+      <Name lang="nl">Ernstige intellectuele achterstand - epilepsie - anale anomalieÃ«n - distale falangeale hypoplasie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -342955,7 +346418,7 @@
     <Disorder id="12559">
       <OrphaCode>94090</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=94090</ExpertLink>
-      <Name lang="nl">Pseudohypoparathyreoïdie type 2</Name>
+      <Name lang="nl">PseudohypoparathyreoÃ¯die type 2</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -342987,7 +346450,7 @@
     <Disorder id="12558">
       <OrphaCode>94089</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=94089</ExpertLink>
-      <Name lang="nl">Pseudohypoparathyreoïdie type 1B</Name>
+      <Name lang="nl">PseudohypoparathyreoÃ¯die type 1B</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -343296,7 +346759,7 @@
     <Disorder id="12792">
       <OrphaCode>96168</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=96168</ExpertLink>
-      <Name lang="nl">Monosomie 13q34</Name>
+      <Name lang="nl">Monosomie 13q34-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -343379,7 +346842,7 @@
     <Disorder id="12772">
       <OrphaCode>96148</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=96148</ExpertLink>
-      <Name lang="nl">Distale deletie 10q</Name>
+      <Name lang="nl">Distale deletie 10q-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -343477,7 +346940,7 @@
     <Disorder id="12749">
       <OrphaCode>96125</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=96125</ExpertLink>
-      <Name lang="nl">Distale deletie 6p</Name>
+      <Name lang="nl">Distale deletie 6p-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -343575,7 +347038,7 @@
     <Disorder id="12726">
       <OrphaCode>96102</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=96102</ExpertLink>
-      <Name lang="nl">Distale duplicatie 10q</Name>
+      <Name lang="nl">Distale duplicatie 10q-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -343673,7 +347136,7 @@
     <Disorder id="12716">
       <OrphaCode>96092</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=96092</ExpertLink>
-      <Name lang="nl">8p geïnverteerde duplicatie/deletie-syndroom</Name>
+      <Name lang="nl">8p geÃ¯nverteerde duplicatie/deletie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -343787,10 +347250,157 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="12692">
+      <OrphaCode>96068</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=96068</ExpertLink>
+      <Name lang="nl">MozaÃ¯ektrisomie 22-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17748">
+          <Source>38540405[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>39.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17749">
+          <Source>38540405[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="12683">
+      <OrphaCode>96059</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=96059</ExpertLink>
+      <Name lang="nl">MozaÃ¯ektrisomie 4-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17903">
+          <Source>26789019[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>7.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17904">
+          <Source>26789019[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="12684">
+      <OrphaCode>96060</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=96060</ExpertLink>
+      <Name lang="nl">MozaÃ¯ektrisomie 5-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17750">
+          <Source>28653809[PMID]_33218416[PMID]_33411590[PMID]_32820524[PMID]_29141250[PMID]_30998911[PMID]_19664845[PMID]_1386985[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>8.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17751">
+          <Source>28653809[PMID]_33218416[PMID]_33411590[PMID]_32820524[PMID]_29141250[PMID]_30998911[PMID]_19664845[PMID]_1386985[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="12685">
       <OrphaCode>96061</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=96061</ExpertLink>
-      <Name lang="nl">Mozaïektrisomie 8</Name>
+      <Name lang="nl">MozaÃ¯ektrisomie 8-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -343819,10 +347429,59 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="12687">
+      <OrphaCode>96063</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=96063</ExpertLink>
+      <Name lang="nl">MozaÃ¯ektrisomie 10-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17746">
+          <Source>30081864[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>7.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17747">
+          <Source>30081864[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="12672">
       <OrphaCode>95717</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=95717</ExpertLink>
-      <Name lang="nl">Idiopathische congenitale hypothyreoïdie</Name>
+      <Name lang="nl">Idiopathische congenitale hypothyreoÃ¯die</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -343918,7 +347577,7 @@
     <Disorder id="12679">
       <OrphaCode>96055</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=96055</ExpertLink>
-      <Name lang="nl">Tetrasomie 21</Name>
+      <Name lang="nl">Tetrasomie 21-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -344276,7 +347935,7 @@
     <Disorder id="29864">
       <OrphaCode>597743</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=597743</ExpertLink>
-      <Name lang="nl">SETD2-gerelateerd syndroom van microcefalie - ernstige intellectuele achterstand - multipele congenitale anomalieën</Name>
+      <Name lang="nl">SETD2-gerelateerd syndroom van microcefalie - ernstige intellectuele achterstand - multipele congenitale anomalieÃ«n</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -344625,7 +348284,7 @@
     <Disorder id="12403">
       <OrphaCode>93561</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93561</ExpertLink>
-      <Name lang="nl">ALys-amyloïdose</Name>
+      <Name lang="nl">ALys-amyloÃ¯dose</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -345826,7 +349485,7 @@
     <Disorder id="29929">
       <OrphaCode>599490</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=599490</ExpertLink>
-      <Name lang="nl">Verworven deficiëntie van factor V</Name>
+      <Name lang="nl">Verworven deficiÃ«ntie van factor V</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -345962,7 +349621,7 @@
     <Disorder id="29930">
       <OrphaCode>599495</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=599495</ExpertLink>
-      <Name lang="nl">Verworven deficiëntie van factor VII</Name>
+      <Name lang="nl">Verworven deficiÃ«ntie van factor VII</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -346011,7 +349670,7 @@
     <Disorder id="29931">
       <OrphaCode>599501</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=599501</ExpertLink>
-      <Name lang="nl">Verworven deficiëntie van factor X</Name>
+      <Name lang="nl">Verworven deficiÃ«ntie van factor X</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -346060,7 +349719,7 @@
     <Disorder id="29932">
       <OrphaCode>599507</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=599507</ExpertLink>
-      <Name lang="nl">Verworven deficiëntie van factor XI</Name>
+      <Name lang="nl">Verworven deficiÃ«ntie van factor XI</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -346109,7 +349768,7 @@
     <Disorder id="29933">
       <OrphaCode>599513</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=599513</ExpertLink>
-      <Name lang="nl">Verworven deficiëntie van factor XIII</Name>
+      <Name lang="nl">Verworven deficiÃ«ntie van factor XIII</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -346467,7 +350126,7 @@
     <Disorder id="12300">
       <OrphaCode>93372</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93372</ExpertLink>
-      <Name lang="nl">Familiale hypocalciurische hypercalciëmie type 1</Name>
+      <Name lang="nl">Familiale hypocalciurische hypercalciÃ«mie type 1</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -347486,7 +351145,7 @@
     <Disorder id="12488">
       <OrphaCode>93928</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93928</ExpertLink>
-      <Name lang="nl">Geïsoleerde epispadie</Name>
+      <Name lang="nl">GeÃ¯soleerde epispadie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -347928,7 +351587,7 @@
     <Disorder id="29725">
       <OrphaCode>595133</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=595133</ExpertLink>
-      <Name lang="nl">Neoplasma van perivasculaire epithelioïde cellen</Name>
+      <Name lang="nl">Neoplasma van perivasculaire epithelioÃ¯de cellen</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -348279,7 +351938,7 @@
           </PrevalenceClass>
           <ValMoy>1200.0</ValMoy>
           <PrevalenceGeographic id="23830">
-            <Name lang="nl">Zuid-Oost Azië</Name>
+            <Name lang="nl">Zuid-Oost AziÃ«</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25965">
             <Name lang="nl">Not yet validated</Name>
@@ -348817,7 +352476,7 @@
     <Disorder id="29784">
       <OrphaCode>596759</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=596759</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door Rela-haploinsufficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door RELA-haploinsufficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -348930,7 +352589,7 @@
     <Disorder id="29788">
       <OrphaCode>596937</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=596937</ExpertLink>
-      <Name lang="nl">Porto-sinusoïdale vasculaire aandoening</Name>
+      <Name lang="nl">Porto-sinusoÃ¯dale vasculaire aandoening</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -350079,7 +353738,7 @@
     <Disorder id="29565">
       <OrphaCode>592570</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=592570</ExpertLink>
-      <Name lang="nl">TRAF7-geassocieerd hartdefect - digitale anomalieën - faciale dysmorfie - motorische achterstand en spraakachterstand-syndroom</Name>
+      <Name lang="nl">TRAF7-geassocieerd hartdefect - digitale anomalieÃ«n - faciale dysmorfie - motorische achterstand en spraakachterstand-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -350209,7 +353868,7 @@
     <Disorder id="29460">
       <OrphaCode>590539</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=590539</ExpertLink>
-      <Name lang="nl">Geïsoleerd melanotisch schwannoom</Name>
+      <Name lang="nl">GeÃ¯soleerd melanotisch schwannoom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -350653,7 +354312,7 @@
     <Disorder id="29446">
       <OrphaCode>589856</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=589856</ExpertLink>
-      <Name lang="nl">Choane atresie - athelie - hypothyreoïdie - vertraagde puberteit - kleine gestalte-syndroom</Name>
+      <Name lang="nl">Choane atresie - athelie - hypothyreoÃ¯die - vertraagde puberteit - kleine gestalte-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -351815,7 +355474,7 @@
     <Disorder id="14304">
       <OrphaCode>99731</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99731</ExpertLink>
-      <Name lang="nl">Geïsoleerde sulfietoxidasedeficiëntie</Name>
+      <Name lang="nl">GeÃ¯soleerde sulfietoxidasedeficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -352068,7 +355727,7 @@
           </PrevalenceClass>
           <ValMoy>274.0</ValMoy>
           <PrevalenceGeographic id="23830">
-            <Name lang="nl">Zuid-Oost Azië</Name>
+            <Name lang="nl">Zuid-Oost AziÃ«</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
@@ -352144,7 +355803,7 @@
           </PrevalenceClass>
           <ValMoy>15.0</ValMoy>
           <PrevalenceGeographic id="23802">
-            <Name lang="nl">Oceanië</Name>
+            <Name lang="nl">OceaniÃ«</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
@@ -352225,7 +355884,7 @@
     <Disorder id="13832">
       <OrphaCode>98815</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98815</ExpertLink>
-      <Name lang="nl">Goedaardige occipitale epilepsie in de kindertijd, Panayiotopoulos-type</Name>
+      <Name lang="nl">Zelflimiterende epilepsie met autonome insulten</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -352257,7 +355916,7 @@
     <Disorder id="13830">
       <OrphaCode>98813</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98813</ExpertLink>
-      <Name lang="nl">Hypohidrotische ectodermale dysplasie met immuundeficiëntie</Name>
+      <Name lang="nl">Hypohidrotische ectodermale dysplasie met immuundeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -352308,7 +355967,7 @@
     <Disorder id="13828">
       <OrphaCode>98811</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98811</ExpertLink>
-      <Name lang="nl">Paroxysmale inspanningsgeïnduceerde dyskinesie</Name>
+      <Name lang="nl">Paroxysmale inspanningsgeÃ¯nduceerde dyskinesie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -352598,7 +356257,7 @@
     <Disorder id="13848">
       <OrphaCode>98831</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98831</ExpertLink>
-      <Name lang="nl">Acute myeloïde leukemie met 11q23-anomalieën</Name>
+      <Name lang="nl">Acute myeloÃ¯de leukemie met 11q23-anomalieÃ«n</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -352630,7 +356289,7 @@
     <Disorder id="13849">
       <OrphaCode>98832</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98832</ExpertLink>
-      <Name lang="nl">Acute myeloïde leukemie met minimale differentiatie</Name>
+      <Name lang="nl">Acute myeloÃ¯de leukemie met minimale differentiatie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -352662,7 +356321,7 @@
     <Disorder id="13846">
       <OrphaCode>98829</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98829</ExpertLink>
-      <Name lang="nl">Acute myeloïde leukemie met abnormale beenmergeosinofielen inv(16)(p13q22) of t(16;16)(p13;q22)</Name>
+      <Name lang="nl">Acute myeloÃ¯de leukemie met abnormale beenmergeosinofielen inv(16)(p13q22) of t(16;16)(p13;q22)</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -352809,7 +356468,7 @@
     <Disorder id="13841">
       <OrphaCode>98824</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98824</ExpertLink>
-      <Name lang="nl">Atypische chronische myeloïde leukemie</Name>
+      <Name lang="nl">Atypische chronische myeloÃ¯de leukemie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -353116,7 +356775,7 @@
     <Disorder id="13859">
       <OrphaCode>98842</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98842</ExpertLink>
-      <Name lang="nl">Lymfomatoïde papulose</Name>
+      <Name lang="nl">LymfomatoÃ¯de papulose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -353180,7 +356839,7 @@
     <Disorder id="29437">
       <OrphaCode>589608</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=589608</ExpertLink>
-      <Name lang="nl">Lineaire hypopigmentatie en craniofaciale asymmetrie met acrale, oculaire en cerebrale anomalieën</Name>
+      <Name lang="nl">Lineaire hypopigmentatie en craniofaciale asymmetrie met acrale, oculaire en cerebrale anomalieÃ«n</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -353312,14 +356971,14 @@
     <Disorder id="13886">
       <OrphaCode>98869</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98869</ExpertLink>
-      <Name lang="nl">Congenitale dyserytropoëtische anemie type I</Name>
+      <Name lang="nl">Congenitale dyserytropoÃ«tische anemie type I</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="4">
         <Prevalence id="7574">
           <Source>20665989[PMID]_[EXPERT]</Source>
           <PrevalenceType id="23669">
@@ -353358,6 +357017,42 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17897">
+          <Source>32518175[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.5</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17898">
+          <Source>30836435[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>300.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="29438">
@@ -353412,7 +357107,7 @@
     <Disorder id="13887">
       <OrphaCode>98870</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98870</ExpertLink>
-      <Name lang="nl">Congenitale dyserytropoëtische anemie type III</Name>
+      <Name lang="nl">Congenitale dyserytropoÃ«tische anemie type III</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -353540,7 +357235,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="7572">
-          <Source>20301609[PMID]_Association Française contre les Myopathies[Patient organisation]</Source>
+          <Source>20301609[PMID]_Association FranÃ§aise contre les Myopathies[Patient organisation]</Source>
           <PrevalenceType id="23683">
             <Name lang="nl">Geboorteprevalentie</Name>
           </PrevalenceType>
@@ -353559,7 +357254,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="7573">
-          <Source>20301609[PMID]_Association Française contre les Myopathies[Patient organisation]</Source>
+          <Source>20301609[PMID]_Association FranÃ§aise contre les Myopathies[Patient organisation]</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -353680,7 +357375,7 @@
     <Disorder id="29434">
       <OrphaCode>589542</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=589542</ExpertLink>
-      <Name lang="nl">Myeloïd/lymfoïd neoplasma geassocieerd met JAK2-herschikking</Name>
+      <Name lang="nl">MyeloÃ¯d/lymfoÃ¯d neoplasma geassocieerd met JAK2-herschikking</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -355923,14 +359618,14 @@
     <Disorder id="13890">
       <OrphaCode>98873</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98873</ExpertLink>
-      <Name lang="nl">Congenitale dyserytropoëtische anemie type II</Name>
+      <Name lang="nl">Congenitale dyserytropoÃ«tische anemie type II</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="7578">
           <Source>20665989[PMID]</Source>
           <PrevalenceType id="23669">
@@ -355950,6 +359645,23 @@
             <Name lang="nl">Not yet validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="18089">
+          <Source>20665989[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>377.0</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="nl">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="13895">
@@ -359123,7 +362835,7 @@
     <Disorder id="13937">
       <OrphaCode>98920</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98920</ExpertLink>
-      <Name lang="nl">Spinale spieratrofie met respiratoire insufficiëntie type 1</Name>
+      <Name lang="nl">Spinale spieratrofie met ademhalingsnood type 1</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -359272,7 +362984,7 @@
     <Disorder id="13967">
       <OrphaCode>98950</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98950</ExpertLink>
-      <Name lang="nl">Partiële cryptoftalmie</Name>
+      <Name lang="nl">PartiÃ«le cryptoftalmie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -359581,7 +363293,7 @@
     <Disorder id="13978">
       <OrphaCode>98961</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98961</ExpertLink>
-      <Name lang="nl">Corneadystrofie van Reis-Bücklers</Name>
+      <Name lang="nl">Corneadystrofie van Reis-BÃ¼cklers</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -359777,7 +363489,7 @@
     <Disorder id="13989">
       <OrphaCode>98972</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98972</ExpertLink>
-      <Name lang="nl">Centrale troebele dystrofie van François</Name>
+      <Name lang="nl">Centrale troebele dystrofie van FranÃ§ois</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -360607,7 +364319,7 @@
     <Disorder id="29204">
       <OrphaCode>585867</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=585867</ExpertLink>
-      <Name lang="nl">Acute myeloïde leukemie met t(9;22)(q34.1;q11.2)</Name>
+      <Name lang="nl">Acute myeloÃ¯de leukemie met t(9;22)(q34.1;q11.2)</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -360741,7 +364453,7 @@
     <Disorder id="29214">
       <OrphaCode>585936</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=585936</ExpertLink>
-      <Name lang="nl">B-lymfoblastische leukemie/lymfoom met hyperdiploïdie</Name>
+      <Name lang="nl">B-lymfoblastische leukemie/lymfoom met hyperdiploÃ¯die</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -360792,7 +364504,7 @@
     <Disorder id="29215">
       <OrphaCode>585942</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=585942</ExpertLink>
-      <Name lang="nl">B-lymfoblastische leukemie/lymfoom met hypodiploïdie</Name>
+      <Name lang="nl">B-lymfoblastische leukemie/lymfoom met hypodiploÃ¯die</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -361066,7 +364778,7 @@
           </PrevalenceClass>
           <ValMoy>0.0</ValMoy>
           <PrevalenceGeographic id="23837">
-            <Name lang="nl">West-Azië</Name>
+            <Name lang="nl">West-AziÃ«</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
@@ -362048,7 +365760,7 @@
     <Disorder id="13693">
       <OrphaCode>98676</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98676</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve geïsoleerde opticusatrofie</Name>
+      <Name lang="nl">Autosomaal recessieve geÃ¯soleerde opticusatrofie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -362387,10 +366099,59 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="29040">
+      <OrphaCode>583595</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=583595</ExpertLink>
+      <Name lang="nl">DeficiÃ«ntie van reactiepad voor biosynthese van serine, infantiele/juveniele vorm</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17988">
+          <Source>8758134[PMID]_26960553[PMID]_28135894[PMID]_36308023[PMID]_26610677[PMID]_17436247[PMID]_29269105[PMID]_34089226[PMID]_26610677[PMID]_9222972[PMID]_25080166[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>23.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17989">
+          <Source>8758134[PMID]_26960553[PMID]_28135894[PMID]_36308023[PMID]_26610677[PMID]_17436247[PMID]_29269105[PMID]_34089226[PMID]_26610677[PMID]_9222972[PMID]_25080166[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="29050">
       <OrphaCode>583856</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=583856</ExpertLink>
-      <Name lang="nl">Geïsoleerde trombose van vena splenica</Name>
+      <Name lang="nl">GeÃ¯soleerde trombose van vena splenica</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -362441,7 +366202,7 @@
     <Disorder id="29051">
       <OrphaCode>583861</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=583861</ExpertLink>
-      <Name lang="nl">Geïsoleerde trombose van vena mesenterica</Name>
+      <Name lang="nl">GeÃ¯soleerde trombose van vena mesenterica</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -362530,7 +366291,7 @@
     <Disorder id="13732">
       <OrphaCode>98715</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98715</ExpertLink>
-      <Name lang="nl">Uveïtis</Name>
+      <Name lang="nl">UveÃ¯tis</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -363162,7 +366923,7 @@
     <Disorder id="13781">
       <OrphaCode>98764</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98764</ExpertLink>
-      <Name lang="nl">Spinocerebellaire ataxie type 27</Name>
+      <Name lang="nl">Spinocerebellaire ataxie type 27A</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -363832,6 +367593,87 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="28932">
+      <OrphaCode>580940</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=580940</ExpertLink>
+      <Name lang="nl">QRICH1-gerelateerd intellectuele achterstand - chondrodysplasie-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18005">
+          <Source>28692176[PMID]_30281152[PMID]_33009816[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>9.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18006">
+          <Source>28692176[PMID]_30281152[PMID]_33009816[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="28934">
+      <OrphaCode>580951</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=580951</ExpertLink>
+      <Name lang="nl">Puntvormige interne choroÃ¯dopathie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="18024">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="28931">
       <OrphaCode>580933</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=580933</ExpertLink>
@@ -364101,7 +367943,7 @@
     <Disorder id="13323">
       <OrphaCode>98306</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98306</ExpertLink>
-      <Name lang="nl">Familiale partiële lipodystrofie</Name>
+      <Name lang="nl">Familiale partiÃ«le lipodystrofie</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -364130,6 +367972,202 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="28838">
+      <OrphaCode>576074</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=576074</ExpertLink>
+      <Name lang="nl">Midden-Oosten respiratoir syndroom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17921">
+          <Source>World Health Organization 2024[INST]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>2613.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17922">
+          <Source>World Health Organization 2024[INST]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="28856">
+      <OrphaCode>576379</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=576379</ExpertLink>
+      <Name lang="nl">Iatrogene ziekte van Creutzfeldt-Jakob</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18020">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>516.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18021">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="28852">
+      <OrphaCode>576349</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=576349</ExpertLink>
+      <Name lang="nl">NLRC4-gerelateerd familiaal auto-inflammatoir syndroom door koude</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17952">
+          <Source>29496273[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>26.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17953">
+          <Source>29496273[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="28855">
+      <OrphaCode>576370</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=576370</ExpertLink>
+      <Name lang="nl">Variant van ziekte van Creutzfeldt-Jakob</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17979">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>233.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17980">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="28850">
       <OrphaCode>576278</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=576278</ExpertLink>
@@ -364150,7 +368188,7 @@
             <Name lang="nl">Geval(len)</Name>
           </PrevalenceQualification>
           <PrevalenceClass/>
-          <ValMoy>171.0</ValMoy>
+          <ValMoy>667.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -364214,7 +368252,7 @@
     <Disorder id="28824">
       <OrphaCode>574957</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=574957</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve mendeliaanse gevoeligheid voor mycobacteriële ziekten door partiële JAK1-deficiëntie</Name>
+      <Name lang="nl">Mendeliaanse gevoeligheid voor mycobacteriÃ«le ziekten door partiÃ«le JAK1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -364246,7 +368284,7 @@
     <Disorder id="28823">
       <OrphaCode>574918</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=574918</ExpertLink>
-      <Name lang="nl">Predispositie voor ernstige virale infectie door IRF7-deficiëntie</Name>
+      <Name lang="nl">Predispositie voor ernstige virale infectie door IRF7-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -364544,7 +368582,7 @@
     <Disorder id="28746">
       <OrphaCode>572428</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=572428</ExpertLink>
-      <Name lang="nl">Pulmonale alveolaire proteïnose met infantiele aanvang - hypogammaglobulinemie</Name>
+      <Name lang="nl">Pulmonale alveolaire proteÃ¯nose met infantiele aanvang - hypogammaglobulinemie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -364593,7 +368631,7 @@
     <Disorder id="13451">
       <OrphaCode>98434</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98434</ExpertLink>
-      <Name lang="nl">Hereditaire gecombineerde deficiëntie van vitamine K-afhankelijke stollingsfactoren</Name>
+      <Name lang="nl">Hereditaire gecombineerde deficiÃ«ntie van vitamine K-afhankelijke stollingsfactoren</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -364602,15 +368640,15 @@
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="7452">
-          <Source>20630065[PMID]</Source>
+          <Source>39496305[PMID]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
           </PrevalenceType>
-          <PrevalenceQualification id="23725">
-            <Name lang="nl">Familie/Gezinnen</Name>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
           </PrevalenceQualification>
           <PrevalenceClass/>
-          <ValMoy>30.0</ValMoy>
+          <ValMoy>272.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -364642,7 +368680,7 @@
     <Disorder id="28754">
       <OrphaCode>572543</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=572543</ExpertLink>
-      <Name lang="nl">RFVT2-gerelateerde riboflavinetransporterdeficiëntie</Name>
+      <Name lang="nl">RFVT2-gerelateerde riboflavinetransporterdeficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -364674,7 +368712,7 @@
     <Disorder id="28755">
       <OrphaCode>572550</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=572550</ExpertLink>
-      <Name lang="nl">RFVT3-gerelateerde riboflavinetransporterdeficiëntie</Name>
+      <Name lang="nl">RFVT3-gerelateerde riboflavinetransporterdeficiÃ«ntie</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -364706,7 +368744,7 @@
     <Disorder id="28766">
       <OrphaCode>572773</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=572773</ExpertLink>
-      <Name lang="nl">Microcefalie - kleine gestalte - ledemaatanomalieën-syndroom</Name>
+      <Name lang="nl">Microcefalie - kleine gestalte - ledemaatanomalieÃ«n-syndroom</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -364755,7 +368793,7 @@
     <Disorder id="28767">
       <OrphaCode>572798</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=572798</ExpertLink>
-      <Name lang="nl">WARS2-gerelateerde gecombineerde oxidatieve fosforylatiedeficiëntie</Name>
+      <Name lang="nl">WARS2-gerelateerde gecombineerde oxidatieve fosforylatiedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -364804,7 +368842,7 @@
     <Disorder id="28764">
       <OrphaCode>572761</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=572761</ExpertLink>
-      <Name lang="nl">DONSON-gerelateerd microcefalie - kleine gestalte - ledemaatanomalieën-spectrum</Name>
+      <Name lang="nl">DONSON-gerelateerd microcefalie - kleine gestalte - ledemaatanomalieÃ«n-spectrum</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -365136,7 +369174,7 @@
     <Disorder id="28677">
       <OrphaCode>570491</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=570491</ExpertLink>
-      <Name lang="nl">QRSL1-gerelateerde gecombineerde oxidatieve fosforylatiedeficiëntie</Name>
+      <Name lang="nl">QRSL1-gerelateerde gecombineerde oxidatieve fosforylatiedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -365302,7 +369340,7 @@
     <Disorder id="28673">
       <OrphaCode>570422</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=570422</ExpertLink>
-      <Name lang="nl">Deficiëntie van galactosemutarotase</Name>
+      <Name lang="nl">DeficiÃ«ntie van galactosemutarotase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -366005,7 +370043,7 @@
     <Disorder id="14986">
       <OrphaCode>103910</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=103910</ExpertLink>
-      <Name lang="nl">Congenitale enterocyt-heparansulfaatdeficiëntie</Name>
+      <Name lang="nl">Congenitale enterocyt-heparansulfaatdeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -366103,7 +370141,7 @@
     <Disorder id="14985">
       <OrphaCode>103909</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=103909</ExpertLink>
-      <Name lang="nl">Trehalasedeficiëntie</Name>
+      <Name lang="nl">TrehalasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -366154,7 +370192,7 @@
     <Disorder id="14983">
       <OrphaCode>103907</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=103907</ExpertLink>
-      <Name lang="nl">Chronische diarree door deficiëntie van glucoamylase</Name>
+      <Name lang="nl">Chronische diarree door deficiÃ«ntie van glucoamylase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -366186,7 +370224,7 @@
     <Disorder id="14981">
       <OrphaCode>102724</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=102724</ExpertLink>
-      <Name lang="nl">Acute myeloïde leukemie met t(8;21)(q22;q22) translocatie</Name>
+      <Name lang="nl">Acute myeloÃ¯de leukemie met t(8;21)(q22;q22) translocatie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -366218,7 +370256,7 @@
     <Disorder id="14933">
       <OrphaCode>101997</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=101997</ExpertLink>
-      <Name lang="nl">Primaire immuundeficiëntie</Name>
+      <Name lang="nl">Primaire immuundeficiÃ«ntie</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -366548,7 +370586,7 @@
     <Disorder id="14895">
       <OrphaCode>101959</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=101959</ExpertLink>
-      <Name lang="nl">Chronische primaire adrenale insufficiëntie</Name>
+      <Name lang="nl">Chronische primaire adrenale insufficiÃ«ntie</Name>
       <DisorderType id="36561">
         <Name lang="nl">Categorie</Name>
       </DisorderType>
@@ -366873,6 +370911,125 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="32058">
+      <OrphaCode>664912</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=664912</ExpertLink>
+      <Name lang="nl">Neonatale trombose van vena renalis</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="3">
+        <Prevalence id="17895">
+          <Source>10653328[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.11</ValMoy>
+          <PrevalenceGeographic id="24418">
+            <Name lang="nl">Germany</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17896">
+          <Source>35372933[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.13</ValMoy>
+          <PrevalenceGeographic id="24124">
+            <Name lang="nl">Canada</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18065">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="32056">
+      <OrphaCode>664787</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=664787</ExpertLink>
+      <Name lang="nl">Syndroom van Nicolau</Name>
+      <DisorderType id="21422">
+        <Name lang="nl">Klinisch syndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18038">
+          <Source>32679363[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>240.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18039">
+          <Source>32679363[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14841">
       <OrphaCode>101330</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=101330</ExpertLink>
@@ -366962,6 +371119,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="32057">
+      <OrphaCode>664901</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=664901</ExpertLink>
+      <Name lang="nl">Trofisch syndroom van nervus trigeminus</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17981">
+          <Source>29931799[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>200.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17982">
+          <Source>29931799[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14796">
       <OrphaCode>101085</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=101085</ExpertLink>
@@ -367064,6 +371270,57 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="32008">
+      <OrphaCode>662376</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=662376</ExpertLink>
+      <Name lang="nl">Duplicatie van maag</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17941">
+          <Source>18558208[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.7</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17942">
+          <Source>18558208[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.7</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14793">
       <OrphaCode>101082</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=101082</ExpertLink>
@@ -367128,6 +371385,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="32005">
+      <OrphaCode>662240</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=662240</ExpertLink>
+      <Name lang="nl">Syndroom van Frey</Name>
+      <DisorderType id="21422">
+        <Name lang="nl">Klinisch syndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18012">
+          <Source>35182195[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>121.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18013">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14788">
       <OrphaCode>101077</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=101077</ExpertLink>
@@ -367226,6 +371532,251 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="32004">
+      <OrphaCode>662234</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=662234</ExpertLink>
+      <Name lang="nl">Neurologische ontwikkelingsachterstand - congenitale hartdefecten - intellectuele achterstand-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18009">
+          <Source>39431794[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>35.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18010">
+          <Source>39431794[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="32007">
+      <OrphaCode>662367</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=662367</ExpertLink>
+      <Name lang="nl">NESCAV-syndroom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18040">
+          <Source>21376300[PMID]_25253658[PMID]_25265257[PMID]_26125038[PMID]_26354034[PMID]_27034427[PMID]_26486474[PMID]_30385166[PMID]_31805580[PMID]_32096284[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>45.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18041">
+          <Source>21376300[PMID]_25253658[PMID]_25265257[PMID]_26125038[PMID]_26354034[PMID]_27034427[PMID]_26486474[PMID]_30385166[PMID]_31805580[PMID]_32096284[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="32006">
+      <OrphaCode>662255</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=662255</ExpertLink>
+      <Name lang="nl">Syndroom van Grisel</Name>
+      <DisorderType id="21422">
+        <Name lang="nl">Klinisch syndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17917">
+          <Source>33274097[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>173.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17918">
+          <Source>33274097[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="32001">
+      <OrphaCode>662216</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=662216</ExpertLink>
+      <Name lang="nl">Mucopolysacharidose type 10</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18036">
+          <Source>34916232[PMID]_35959767[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>6.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18037">
+          <Source>34916232[PMID]_35959767[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="32000">
+      <OrphaCode>662207</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=662207</ExpertLink>
+      <Name lang="nl">Neurologische ontwikkelingsachterstand - hersenmalformaties - skeletdefecten - intellectuele achterstand-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18022">
+          <Source>29938792[PMID]_32335897[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>6.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18023">
+          <Source>29938792[PMID]_32335897[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14786">
       <OrphaCode>101075</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=101075</ExpertLink>
@@ -367764,7 +372315,7 @@
     <Disorder id="14739">
       <OrphaCode>101028</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=101028</ExpertLink>
-      <Name lang="nl">Transaldolasedeficiëntie</Name>
+      <Name lang="nl">TransaldolasedeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -367985,7 +372536,7 @@
     <Disorder id="14689">
       <OrphaCode>100978</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100978</ExpertLink>
-      <Name lang="nl">Klaverbladschedel - asfyxiërende thoracale dysplasie-syndroom</Name>
+      <Name lang="nl">Klaverbladschedel - asfyxiÃ«rende thoracale dysplasie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -368323,6 +372874,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="32182">
+      <OrphaCode>686999</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=686999</ExpertLink>
+      <Name lang="nl">Lipodystrofie - demyeliniserende perifere sensorimotorische neuropathie-syndroom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18018">
+          <Source>37919452[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>7.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18019">
+          <Source>37919452[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14708">
       <OrphaCode>100997</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100997</ExpertLink>
@@ -368470,6 +373070,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="32179">
+      <OrphaCode>686495</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=686495</ExpertLink>
+      <Name lang="nl">MADD-gerelateerd ontwikkelingsachterstand - endocriene disfunctie - hypohemoglobinemie-syndroom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18031">
+          <Source>32761064[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>14.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18032">
+          <Source>32761064[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14707">
       <OrphaCode>100996</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100996</ExpertLink>
@@ -368519,6 +373168,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="32177">
+      <OrphaCode>686488</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=686488</ExpertLink>
+      <Name lang="nl">RNU4-2-gerelateerde neurologische ontwikkelingsstoornis - faciale dysmorfie - wittestofafwijkingen - kleine gestalte-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18033">
+          <Source>38859706[PMID]_38821540[PMID]_38991538[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>189.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18034">
+          <Source>38859706[PMID]_38821540[PMID]_38991538[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14704">
       <OrphaCode>100993</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100993</ExpertLink>
@@ -368568,6 +373266,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="32176">
+      <OrphaCode>686482</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=686482</ExpertLink>
+      <Name lang="nl">BPTF-gerelateerd intellectuele achterstand - faciale dysmorfie - skeletanomalieÃ«n-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18056">
+          <Source>28942966[PMID]_33522091[PMID]_30633344[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>49.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18057">
+          <Source>28942966[PMID]_33522091[PMID]_30633344[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14705">
       <OrphaCode>100994</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100994</ExpertLink>
@@ -369629,7 +374376,7 @@
     <Disorder id="14678">
       <OrphaCode>100924</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100924</ExpertLink>
-      <Name lang="nl">Porfyrie door deficiëntie van ALA-dehydratase</Name>
+      <Name lang="nl">Porfyrie door deficiÃ«ntie van ALA-dehydratase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -369838,7 +374585,7 @@
     <Disorder id="14630">
       <OrphaCode>100057</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100057</ExpertLink>
-      <Name lang="nl">Angio-oedeem geïnduceerd door renine-angiotensine-aldosteronsysteemblokker</Name>
+      <Name lang="nl">Angio-oedeem geÃ¯nduceerd door renine-angiotensine-aldosteronsysteemblokker</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -369867,6 +374614,202 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="32231">
+      <OrphaCode>692173</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=692173</ExpertLink>
+      <Name lang="nl">Neurologisch ontwikkelingssyndroom van Marbach-Schaaf</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17943">
+          <Source>33833410[PMID]_35789103[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>13.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17944">
+          <Source>33833410[PMID]_35789103[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="32238">
+      <OrphaCode>692812</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=692812</ExpertLink>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie - bronchiÃ«ctasie - kankerpredispositie-syndroom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17858">
+          <Source>35596857[PMID]_25512081[PMID]_38194689[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23725">
+            <Name lang="nl">Familie/Gezinnen</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>37.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17859">
+          <Source>35596857[PMID]_25512081[PMID]_38194689[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="32236">
+      <OrphaCode>692305</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=692305</ExpertLink>
+      <Name lang="nl">Cardiomyovasculopathie met depositie van triglyceriden</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17893">
+          <Source>40155256[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>991.0</ValMoy>
+          <PrevalenceGeographic id="24621">
+            <Name lang="nl">Japan</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17894">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="32237">
+      <OrphaCode>692790</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=692790</ExpertLink>
+      <Name lang="nl">ATP6AP1-CDG</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18025">
+          <Source>27231034[PMID]_32395412[PMID]_35732497[PMID]_29396028[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>17.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18026">
+          <Source>27231034[PMID]_32395412[PMID]_35732497[PMID]_29396028[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14643">
       <OrphaCode>100070</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100070</ExpertLink>
@@ -370042,7 +374985,7 @@
     <Disorder id="14644">
       <OrphaCode>100071</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100071</ExpertLink>
-      <Name lang="nl">Mozaïektrisomie 3</Name>
+      <Name lang="nl">MozaÃ¯ektrisomie 3-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -370152,6 +375095,104 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="32193">
+      <OrphaCode>688581</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=688581</ExpertLink>
+      <Name lang="nl">Hypoplasie van middengezicht - gehoorstoornis - elliptocytose - nefrocalcinose-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17899">
+          <Source>27811305[PMID]_28089922[PMID]_29193635[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>6.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17900">
+          <Source>27811305[PMID]_28089922[PMID]_29193635[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="32194">
+      <OrphaCode>688594</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=688594</ExpertLink>
+      <Name lang="nl">Gecombineerde immuundeficiÃ«ntie door RELB-deficiÃ«ntie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17975">
+          <Source>39231201[PMID]_26385063[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>5.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17976">
+          <Source>39231201[PMID]_26385063[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14595">
       <OrphaCode>100022</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100022</ExpertLink>
@@ -370184,6 +375225,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="32195">
+      <OrphaCode>688642</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=688642</ExpertLink>
+      <Name lang="nl">Syndroom van Turnpenny-Fry</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17967">
+          <Source>34750959[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>14.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17968">
+          <Source>34750959[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14594">
       <OrphaCode>100021</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100021</ExpertLink>
@@ -370265,6 +375355,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="32197">
+      <OrphaCode>688649</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=688649</ExpertLink>
+      <Name lang="nl">GeÃ¯soleerde hyperplasie van bijniermerg</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17977">
+          <Source>36896586[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>66.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17978">
+          <Source>36896586[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14599">
       <OrphaCode>100026</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100026</ExpertLink>
@@ -370363,6 +375502,251 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="32208">
+      <OrphaCode>689234</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=689234</ExpertLink>
+      <Name lang="nl">RNASEH2B-gerelateerde hereditaire spastische paraplegie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17997">
+          <Source>15908569[PMID]_25243380[PMID]_30826161[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>22.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17998">
+          <Source>15908569[PMID]_25243380[PMID]_30826161[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="32210">
+      <OrphaCode>689397</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=689397</ExpertLink>
+      <Name lang="nl">Neurologisch ontwikkelingssyndroom van Poirier-Bienvenue</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17925">
+          <Source>38037515[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>81.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17926">
+          <Source>38037515[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="32212">
+      <OrphaCode>689408</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=689408</ExpertLink>
+      <Name lang="nl">Syndroom van Shashi-Pena</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17965">
+          <Source>39527683[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>24.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17966">
+          <Source>39527683[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="32215">
+      <OrphaCode>689430</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=689430</ExpertLink>
+      <Name lang="nl">Ameloblastoom van adenoÃ¯d</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17971">
+          <Source>37540485[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>30.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17972">
+          <Source>37540485[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="32214">
+      <OrphaCode>689422</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=689422</ExpertLink>
+      <Name lang="nl">Neurologisch ontwikkelingssyndroom van Okur-Chung</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17915">
+          <Source>38444259[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>48.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17916">
+          <Source>38444259[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14616">
       <OrphaCode>100043</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100043</ExpertLink>
@@ -370559,6 +375943,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="32218">
+      <OrphaCode>689822</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=689822</ExpertLink>
+      <Name lang="nl">Structurele hartdefecten - nieranomalieÃ«n-yndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17973">
+          <Source>28318500[PMID]_34612517[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>11.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17974">
+          <Source>28318500[PMID]_34612517[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14623">
       <OrphaCode>100050</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100050</ExpertLink>
@@ -370711,7 +376144,7 @@
     <Disorder id="14581">
       <OrphaCode>100008</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100008</ExpertLink>
-      <Name lang="nl">ACys-amyloïdose</Name>
+      <Name lang="nl">ACys-amyloÃ¯dose</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -370760,7 +376193,7 @@
     <Disorder id="14579">
       <OrphaCode>100006</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100006</ExpertLink>
-      <Name lang="nl">ABèta-amyloïdose, Nederlands type</Name>
+      <Name lang="nl">ABÃ¨ta-amyloÃ¯dose, Nederlands type</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -370806,6 +376239,57 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31788">
+      <OrphaCode>645749</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=645749</ExpertLink>
+      <Name lang="nl">Congenitale stenose van oesofagus</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17732">
+          <Source>25789088[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23683">
+            <Name lang="nl">Geboorteprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>3.0</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18066">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14568">
       <OrphaCode>99995</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99995</ExpertLink>
@@ -371571,7 +377055,7 @@
     <Disorder id="14549">
       <OrphaCode>99976</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99976</ExpertLink>
-      <Name lang="nl">Adenocarcinoom van oesofagus</Name>
+      <Name lang="nl">Adenocarcinoom van oesofagus en oesofagogastrische overgang</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -372269,7 +377753,7 @@
     <Disorder id="14540">
       <OrphaCode>99967</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99967</ExpertLink>
-      <Name lang="nl">Myxoïd/rondcellig liposarcoom</Name>
+      <Name lang="nl">MyxoÃ¯d/rondcellig liposarcoom</Name>
       <DisorderType id="21457">
         <Name lang="nl">Histopathologisch subtype</Name>
       </DisorderType>
@@ -372320,7 +377804,7 @@
     <Disorder id="14539">
       <OrphaCode>99966</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99966</ExpertLink>
-      <Name lang="nl">Atypische teratoïde rhabdoïde tumor</Name>
+      <Name lang="nl">Atypische teratoÃ¯de rhabdoÃ¯de tumor</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -372417,6 +377901,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31745">
+      <OrphaCode>643503</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=643503</ExpertLink>
+      <Name lang="nl">MarfanoÃ¯de habitus - faciale dysmorfie - skeletafwijking - hartdefect-syndroom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17730">
+          <Source>28288113[PMID]_ 32643838[PMID]_ 30855488[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>13.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17731">
+          <Source>28288113[PMID]_ 32643838[PMID]_ 30855488[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14528">
       <OrphaCode>99955</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99955</ExpertLink>
@@ -372758,6 +378291,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31856">
+      <OrphaCode>648992</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=648992</ExpertLink>
+      <Name lang="nl">Niet-syndromale 'bridging bronchus'</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17873">
+          <Source>32534300[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>17.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17874">
+          <Source>32534300[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14513">
       <OrphaCode>99940</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99940</ExpertLink>
@@ -372839,10 +378421,42 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="14514">
-      <OrphaCode>99941</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99941</ExpertLink>
-      <Name lang="nl">Autosomaal dominante ziekte van Charcot-Marie-Tooth type 2G</Name>
+    <Disorder id="31858">
+      <OrphaCode>649010</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=649010</ExpertLink>
+      <Name lang="nl">Niet-syndromale congenitale atresie van bronchus</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17930">
+          <Source>15366333[PMID]</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="14517">
+      <OrphaCode>99944</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99944</ExpertLink>
+      <Name lang="nl">Autosomaal dominante ziekte van Charcot-Marie-Tooth type 2K</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -372850,16 +378464,16 @@
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
-        <Prevalence id="7872">
-          <Source>3022865[PMID]</Source>
+        <Prevalence id="7874">
+          <Source>18231710[PMID]_19089472[PMID]_20685671[PMID]_21753178[PMID]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
           </PrevalenceType>
-          <PrevalenceQualification id="23725">
-            <Name lang="nl">Familie/Gezinnen</Name>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
           </PrevalenceQualification>
           <PrevalenceClass/>
-          <ValMoy>1.0</ValMoy>
+          <ValMoy>30.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -372867,8 +378481,8 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="7873">
-          <Source>ORPHANET_3022865[PMID]</Source>
+        <Prevalence id="7875">
+          <Source>ORPHANET_18231710[PMID]_19089472[PMID]_20685671[PMID]_21753178[PMID]</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -372888,19 +378502,19 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="14517">
-      <OrphaCode>99944</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99944</ExpertLink>
-      <Name lang="nl">Autosomaal dominante ziekte van Charcot-Marie-Tooth type 2K</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+    <Disorder id="31861">
+      <OrphaCode>649029</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=649029</ExpertLink>
+      <Name lang="nl">GeÃ¯soleerde isomerie van linker bronchus</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
-        <Prevalence id="7874">
-          <Source>18231710[PMID]_19089472[PMID]_20685671[PMID]_21753178[PMID]</Source>
+        <Prevalence id="17934">
+          <Source>33061133[PMID]_16633755[PMID]_36832240[PMID]_32481391[PMID]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Geval(len)/Gezinnen</Name>
           </PrevalenceType>
@@ -372908,7 +378522,7 @@
             <Name lang="nl">Geval(len)</Name>
           </PrevalenceQualification>
           <PrevalenceClass/>
-          <ValMoy>30.0</ValMoy>
+          <ValMoy>4.0</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -372916,8 +378530,8 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="7875">
-          <Source>ORPHANET_18231710[PMID]_19089472[PMID]_20685671[PMID]_21753178[PMID]</Source>
+        <Prevalence id="17935">
+          <Source>33061133[PMID]_16633755[PMID]_36832240[PMID]_32481391[PMID]_ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -373086,6 +378700,106 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31848">
+      <OrphaCode>648684</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=648684</ExpertLink>
+      <Name lang="nl">Occlusie van centrale retinale arterie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17887">
+          <Source>29262124[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>2.2</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18078">
+          <Source>29262124[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>12.1</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31851">
+      <OrphaCode>648919</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=648919</ExpertLink>
+      <Name lang="nl">Idiopathische katatonie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17889">
+          <Source>26243853[PMID]_37138368[PMID]_36649557[PMID]_23051079[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>16.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17890">
+          <Source>26243853[PMID]_37138368[PMID]_36649557[PMID]_23051079[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14511">
       <OrphaCode>99938</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99938</ExpertLink>
@@ -373358,6 +379072,57 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31847">
+      <OrphaCode>648681</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=648681</ExpertLink>
+      <Name lang="nl">Immuungemedieerde scleritis</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17865">
+          <Source>32504648[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>4.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18079">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14491">
       <OrphaCode>99918</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99918</ExpertLink>
@@ -373370,7 +379135,7 @@
       </DisorderGroup>
       <PrevalenceList count="4">
         <Prevalence id="11304">
-          <Source>21976764[PMID]_Dr Lina Gérard[EXPERT]</Source>
+          <Source>21976764[PMID]_Dr Lina GÃ©rard[EXPERT]</Source>
           <PrevalenceType id="23676">
             <Name lang="nl">Jaarlijkse incidentie</Name>
           </PrevalenceType>
@@ -373389,7 +379154,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="11305">
-          <Source>22534148[PMID]_Dr Lina Gérard[EXPERT]</Source>
+          <Source>22534148[PMID]_Dr Lina GÃ©rard[EXPERT]</Source>
           <PrevalenceType id="23676">
             <Name lang="nl">Jaarlijkse incidentie</Name>
           </PrevalenceType>
@@ -373408,7 +379173,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="11306">
-          <Source>17638193[PMID]_Dr Lina Gérard[EXPERT]</Source>
+          <Source>17638193[PMID]_Dr Lina GÃ©rard[EXPERT]</Source>
           <PrevalenceType id="23676">
             <Name lang="nl">Jaarlijkse incidentie</Name>
           </PrevalenceType>
@@ -373450,7 +379215,7 @@
     <Disorder id="14490">
       <OrphaCode>99917</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99917</ExpertLink>
-      <Name lang="nl">Maligne steroïdeproducerende thecaceltumor van ovarium, niet verder gespecifieerd</Name>
+      <Name lang="nl">Maligne steroÃ¯deproducerende thecaceltumor van ovarium, niet verder gespecifieerd</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -373648,7 +379413,7 @@
     <Disorder id="14474">
       <OrphaCode>99901</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99901</ExpertLink>
-      <Name lang="nl">Acyl-CoA-dehydrogenase 9-deficiëntie</Name>
+      <Name lang="nl">Acyl-CoA-dehydrogenase 9-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -373812,7 +379577,7 @@
     <Disorder id="14471">
       <OrphaCode>99898</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99898</ExpertLink>
-      <Name lang="nl">Mendeliaanse gevoeligheid voor mycobacteriële ziekten door volledige IFNgammaR1-deficiëntie</Name>
+      <Name lang="nl">Mendeliaanse gevoeligheid voor mycobacteriÃ«le ziekten door volledige IFNgammaR1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -373861,7 +379626,7 @@
     <Disorder id="14452">
       <OrphaCode>99879</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99879</ExpertLink>
-      <Name lang="nl">Familiale geïsoleerde hyperparathyreoïdie</Name>
+      <Name lang="nl">Familiale geÃ¯soleerde hyperparathyreoÃ¯die</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -373910,7 +379675,7 @@
     <Disorder id="14453">
       <OrphaCode>99880</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99880</ExpertLink>
-      <Name lang="nl">Hyperparathyreoïdie - kaaktumor-syndroom</Name>
+      <Name lang="nl">HyperparathyreoÃ¯die - kaaktumor-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -373991,7 +379756,7 @@
     <Disorder id="14458">
       <OrphaCode>99885</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99885</ExpertLink>
-      <Name lang="nl">Geïsoleerde permanente neonatale diabetes mellitus</Name>
+      <Name lang="nl">GeÃ¯soleerde permanente neonatale diabetes mellitus</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -374156,7 +379921,7 @@
     <Disorder id="14459">
       <OrphaCode>99886</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99886</ExpertLink>
-      <Name lang="nl">Transiënte neonatale diabetes mellitus</Name>
+      <Name lang="nl">TransiÃ«nte neonatale diabetes mellitus</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -374392,7 +380157,7 @@
     <Disorder id="14422">
       <OrphaCode>99849</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99849</ExpertLink>
-      <Name lang="nl">Glycogeenstapelingsziekte door deficiëntie van bèta-enolase in spier</Name>
+      <Name lang="nl">Glycogeenstapelingsziekte door deficiÃ«ntie van bÃ¨ta-enolase in spier</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -374522,7 +380287,7 @@
     <Disorder id="14416">
       <OrphaCode>99843</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99843</ExpertLink>
-      <Name lang="nl">Deficiëntie van leukocytenadhesie type II</Name>
+      <Name lang="nl">DeficiÃ«ntie van leukocytenadhesie type II</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -374571,7 +380336,7 @@
     <Disorder id="14417">
       <OrphaCode>99844</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99844</ExpertLink>
-      <Name lang="nl">Deficiëntie van leukocytenadhesie type III</Name>
+      <Name lang="nl">DeficiÃ«ntie van leukocytenadhesie type III</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -374666,6 +380431,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31897">
+      <OrphaCode>652528</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=652528</ExpertLink>
+      <Name lang="nl">Niet-syndromale accessoire nieren</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18042">
+          <Source>30761238[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>99.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18043">
+          <Source>30761238[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14425">
       <OrphaCode>99852</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99852</ExpertLink>
@@ -375376,7 +381190,7 @@
     <Disorder id="14415">
       <OrphaCode>99842</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99842</ExpertLink>
-      <Name lang="nl">Deficiëntie van leukocytenadhesie type I</Name>
+      <Name lang="nl">DeficiÃ«ntie van leukocytenadhesie type I</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -375405,6 +381219,106 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31883">
+      <OrphaCode>650077</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=650077</ExpertLink>
+      <Name lang="nl">Genetische centrale pubertas praecox bij vrouw</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17883">
+          <Source>38857188[PMID]_26539988[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>7.8</ValMoy>
+          <PrevalenceGeographic id="24663">
+            <Name lang="nl">Korea, Democratic People's Republic of</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17884">
+          <Source>38857188[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>3.0</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="nl">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31985">
+      <OrphaCode>660017</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=660017</ExpertLink>
+      <Name lang="nl">Neurologische ontwikkelingsachterstand - taalstoornis - doparesponsieve dystonie - parkinsonisme-syndroom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18052">
+          <Source>31428396[PMID]_31922365[PMID]_32366965[PMID]_ 33585677[PMID]_28544326[PMID]_29770430[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>15.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18053">
+          <Source>31428396[PMID]_31922365[PMID]_32366965[PMID]_ 33585677[PMID]_28544326[PMID]_29770430[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14385">
       <OrphaCode>99812</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99812</ExpertLink>
@@ -375454,6 +381368,349 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31986">
+      <OrphaCode>660021</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=660021</ExpertLink>
+      <Name lang="nl">Orofaciale schisis - hartanomalieÃ«n - faciale dysmorfie-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17958">
+          <Source>36751037[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>13.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17959">
+          <Source>36751037[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31991">
+      <OrphaCode>661526</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=661526</ExpertLink>
+      <Name lang="nl">MBD4-gerelateerd tumorpredispositiesyndroom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17990">
+          <Source>35460607[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23725">
+            <Name lang="nl">Familie/Gezinnen</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>4.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17991">
+          <Source>30049810[PMID]_31322271[PMID]_35460607[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31990">
+      <OrphaCode>661412</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=661412</ExpertLink>
+      <Name lang="nl">Megaloblastische anemie - immuundeficiÃ«ntie door deficiÃ«ntie van folaattransporter 1</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17992">
+          <Source>36517554[PMID]_36745868[PMID]_32276275[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>5.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17993">
+          <Source>36517554[PMID]_36745868[PMID]_32276275[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31995">
+      <OrphaCode>662179</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=662179</ExpertLink>
+      <Name lang="nl">Microcefalie - gehoorverlies - faciale dysmorfie - intellectuele achterstand-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18014">
+          <Source>32109420[PMID]_35892095[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>3.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18015">
+          <Source>32109420[PMID]_35892095[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31994">
+      <OrphaCode>662175</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=662175</ExpertLink>
+      <Name lang="nl">Macrocefalie - congenitale hartziekte - faciale dysmorfie  - intellectuele achterstand-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17963">
+          <Source>32109420[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>5.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17964">
+          <Source>32109420[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31997">
+      <OrphaCode>662189</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=662189</ExpertLink>
+      <Name lang="nl">Neurodevelopmental disorder-brain malformation-facial dysmorphism-brachydactyly syndrome</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18050">
+          <Source>31079900[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>5.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18051">
+          <Source>31079900[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31996">
+      <OrphaCode>662184</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=662184</ExpertLink>
+      <Name lang="nl">Congenitale spierdystrofie - cataract - intellectuele achterstand-syndroom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17936">
+          <Source>28190456[PMID]_28190459[PMID]_33792664[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>23.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17937">
+          <Source>28190456[PMID]_28190459[PMID]_33792664[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14397">
       <OrphaCode>99824</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99824</ExpertLink>
@@ -375505,6 +381762,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31999">
+      <OrphaCode>662198</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=662198</ExpertLink>
+      <Name lang="nl">Neurologische ontwikkelingsachterstand - intellectuele achterstand - skeletdefecten-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18046">
+          <Source>27545675[PMID]_30887513[PMID]_31236915[PMID]_31670473[PMID]_33728377[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>44.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18047">
+          <Source>27545675[PMID]_30887513[PMID]_31236915[PMID]_31670473[PMID]_33728377[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14398">
       <OrphaCode>99825</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99825</ExpertLink>
@@ -375635,6 +381941,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31972">
+      <OrphaCode>659744</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=659744</ExpertLink>
+      <Name lang="nl">Squameuze neoplasie van oogoppervlak</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17994">
+          <Source>23974890[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.03</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14375">
       <OrphaCode>99802</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99802</ExpertLink>
@@ -375667,6 +382005,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31975">
+      <OrphaCode>659873</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=659873</ExpertLink>
+      <Name lang="nl">Wormiaanse botstructuren - micrognathie - abnormaal gebit - progeroÃ¯de kenmerken-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17927">
+          <Source>30905398[PMID]_37867468[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>3.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17928">
+          <Source>30905398[PMID]_37867468[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14376">
       <OrphaCode>99803</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99803</ExpertLink>
@@ -375765,6 +382152,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31981">
+      <OrphaCode>659904</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=659904</ExpertLink>
+      <Name lang="nl">Multipele congenitale anomalieÃ«n - neurologische ontwikkelingsachterstand - oogafwijkingen-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18007">
+          <Source>29556724[PMID]_33314030[PMID]_ 33824499[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>29.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18008">
+          <Source>29556724[PMID]_33314030[PMID]_ 33824499[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14380">
       <OrphaCode>99807</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99807</ExpertLink>
@@ -375846,6 +382282,270 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31983">
+      <OrphaCode>659975</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=659975</ExpertLink>
+      <Name lang="nl">Sensorineuraal gehoorverlies - spastische quadriplegie - intellectuele achterstand-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18029">
+          <Source>34626583[PMID]_34626583[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>26.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18030">
+          <Source>34626583[PMID]_34626583[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31955">
+      <OrphaCode>659396</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=659396</ExpertLink>
+      <Name lang="nl">Syndroom van Cohen-Gibson</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17907">
+          <Source>34533271[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>12.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17908">
+          <Source>34533271[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31958">
+      <OrphaCode>659609</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=659609</ExpertLink>
+      <Name lang="nl">Faciale dysmorfie - algehele ontwikkelingsachterstand - hypotonie - polymicrogyrie-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="3">
+        <Prevalence id="17984">
+          <Source>35851598[PMID]_30293988[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>15.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17985">
+          <Source>35851598[PMID]_30293988[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23690">
+            <Name lang="nl">Levensprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17986">
+          <Source>35851598[PMID]_30293988[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31957">
+      <OrphaCode>659463</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=659463</ExpertLink>
+      <Name lang="nl">Syndroom van Imagawa-Matsumoto</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17960">
+          <Source>28229514[PMID]_30019515[PMID]_31736240[PMID]_ 39258127[PMID]_38850627[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>15.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17961">
+          <Source>28229514[PMID]_30019515[PMID]_31736240[PMID]_ 39258127[PMID]_38850627[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31963">
+      <OrphaCode>659672</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=659672</ExpertLink>
+      <Name lang="nl">Harderoporfyrie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17923">
+          <Source>6886003[PMID]_6143037[PMID]_16159891[PMID]_21103937[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>6.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17924">
+          <Source>6886003[PMID]_6143037[PMID]_16159891[PMID]_21103937[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14362">
       <OrphaCode>99789</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99789</ExpertLink>
@@ -375878,6 +382578,104 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31961">
+      <OrphaCode>659642</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=659642</ExpertLink>
+      <Name lang="nl">Syndroom van Rauch-Steindl</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17947">
+          <Source>29760529[PMID]_30345613[PMID]_29892088[PMID]_31171569[PMID]_31382906[PMID]_33276791[PMID]_33941880[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>28.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17948">
+          <Source>29760529[PMID]_30345613[PMID]_29892088[PMID]_31171569[PMID]_31382906[PMID]_33276791[PMID]_33941880[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31967">
+      <OrphaCode>659702</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=659702</ExpertLink>
+      <Name lang="nl">Intra-uteriene groeiretardatie - micrognathie - kleine gestalte - faciale dysmorfie - rhizomele verkorting-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17954">
+          <Source>35300924[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>20.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17955">
+          <Source>35300924[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14364">
       <OrphaCode>99791</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99791</ExpertLink>
@@ -375976,6 +382774,155 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31938">
+      <OrphaCode>658584</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=658584</ExpertLink>
+      <Name lang="nl">Syndroom van Rowell</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17956">
+          <Source>22170759[PMID]_32967943[PMID]_32607016[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>73.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17957">
+          <Source>22170759[PMID]_32967943[PMID]_32607016[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31939">
+      <OrphaCode>658590</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=658590</ExpertLink>
+      <Name lang="nl">Sebaceus carcinoom van ooglid</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17905">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17906">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31940">
+      <OrphaCode>658595</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=658595</ExpertLink>
+      <Name lang="nl">DNMT3A-gerelateerde microcefale dwerggroei</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18027">
+          <Source>30478443[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>3.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18028">
+          <Source>30478443[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="14345">
       <OrphaCode>99772</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99772</ExpertLink>
@@ -376043,7 +382990,7 @@
     <Disorder id="14349">
       <OrphaCode>99776</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99776</ExpertLink>
-      <Name lang="nl">Mozaïektrisomie 9</Name>
+      <Name lang="nl">MozaÃ¯ektrisomie 9-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -376631,7 +383578,7 @@
     <Disorder id="31692">
       <OrphaCode>634475</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=634475</ExpertLink>
-      <Name lang="nl">Mozaïek NF2-gerelateerde schwannomatose</Name>
+      <Name lang="nl">MozaÃ¯ek NF2-gerelateerde schwannomatose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -376663,7 +383610,7 @@
     <Disorder id="31693">
       <OrphaCode>634492</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=634492</ExpertLink>
-      <Name lang="nl">Mozaïek schwannomatose</Name>
+      <Name lang="nl">MozaÃ¯ek schwannomatose</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -376733,7 +383680,7 @@
     <Disorder id="31691">
       <OrphaCode>634461</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=634461</ExpertLink>
-      <Name lang="nl">Mozaïek neurofibromatose type 1</Name>
+      <Name lang="nl">MozaÃ¯ek neurofibromatose type 1</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -376784,7 +383731,7 @@
     <Disorder id="31680">
       <OrphaCode>633228</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=633228</ExpertLink>
-      <Name lang="nl">Geïsoleerde proximale femorale focale deficiëntie</Name>
+      <Name lang="nl">GeÃ¯soleerde proximale femorale focale deficiÃ«ntie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -376835,7 +383782,7 @@
     <Disorder id="31705">
       <OrphaCode>637064</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=637064</ExpertLink>
-      <Name lang="nl">Geïsoleerde aplasie van oogzenuw</Name>
+      <Name lang="nl">GeÃ¯soleerde aplasie van oogzenuw</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -376884,7 +383831,7 @@
     <Disorder id="31704">
       <OrphaCode>637061</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=637061</ExpertLink>
-      <Name lang="nl">Geïsoleerde hypoplasie van oogzenuw</Name>
+      <Name lang="nl">GeÃ¯soleerde hypoplasie van oogzenuw</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -376979,6 +383926,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31702">
+      <OrphaCode>637013</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=637013</ExpertLink>
+      <Name lang="nl">SMARCA2-gerelateerd blefarofimose - intellectuele achterstand-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17911">
+          <Source>32694869[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>14.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17912">
+          <Source>32694869[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="31697">
       <OrphaCode>636945</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=636945</ExpertLink>
@@ -377412,7 +384408,7 @@
     <Disorder id="31716">
       <OrphaCode>641368</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=641368</ExpertLink>
-      <Name lang="nl">Autosomaal recessief hyper-IgE-syndroom door ZNF341-deficiëntie</Name>
+      <Name lang="nl">Autosomaal recessief hyper-IgE-syndroom door ZNF341-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -377559,7 +384555,7 @@
     <Disorder id="31713">
       <OrphaCode>641350</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=641350</ExpertLink>
-      <Name lang="nl">Hypofysitis geïnduceerd door immuuntherapie</Name>
+      <Name lang="nl">Hypofysitis geÃ¯nduceerd door immuuntherapie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -377607,6 +384603,268 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31741">
+      <OrphaCode>642965</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=642965</ExpertLink>
+      <Name lang="nl">Autosomaal recessieve ataxie door PEX2-deficiÃ«ntie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17724">
+          <Source>21392394[PMID]_30237433[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>2.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17725">
+          <Source/>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31737">
+      <OrphaCode>642763</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=642763</ExpertLink>
+      <Name lang="nl">Autosomaal dominante intellectuele achterstand - craniofaciale dysmorfie - macrocefalie - hypotonie-syndroom door H1-4-mutatie</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17721">
+          <Source>28475857[PMID]_31400068[PMID]_35154720[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>49.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17722">
+          <Source>28475857[PMID]_31400068[PMID]_35154720[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31736">
+      <OrphaCode>642747</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=642747</ExpertLink>
+      <Name lang="nl">PUM1-gerelateerde cerebellaire ataxie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="3">
+        <Prevalence id="17733">
+          <Source>29474920[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>4.0</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17734">
+          <Source>31422002[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>2.0</ValMoy>
+          <PrevalenceGeographic id="23830">
+            <Name lang="nl">Zuid-Oost AziÃ«</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17735">
+          <Source>29474920[PMID]_31422002 [PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31733">
+      <OrphaCode>642675</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=642675</ExpertLink>
+      <Name lang="nl">CHD8-overgroeisyndroom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17728">
+          <Source>24998929[PMID]_26789910[PMID]_31721432[PMID]_31001818[PMID]_38441608[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>73.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17729">
+          <Source>24998929[PMID]_26789910[PMID]_31721432[PMID]_31001818[PMID]_38441608[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31732">
+      <OrphaCode>642671</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=642671</ExpertLink>
+      <Name lang="nl">Familiaal hyperaldosteronisme type IV</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17726">
+          <Source>38860417[PMID]_35757409[PMID]_39803142[PMID]_38495792[PMID]_25907736[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>17.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17727">
+          <Source>38860417[PMID]_35757409[PMID]_39803142[PMID]_38495792[PMID]_25907736[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="31731">
       <OrphaCode>642099</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=642099</ExpertLink>
@@ -377705,6 +384963,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31658">
+      <OrphaCode>632603</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=632603</ExpertLink>
+      <Name lang="nl">Mesomele dysplasie - digitale anomalieÃ«n - intellectuele achterstand-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17999">
+          <Source>18616733[PMID]_31388108[PMID]_33961779[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>18.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18000">
+          <Source>18616733[PMID]_31388108[PMID]_33961779[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="31660">
       <OrphaCode>633004</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=633004</ExpertLink>
@@ -377835,6 +385142,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31665">
+      <OrphaCode>633035</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=633035</ExpertLink>
+      <Name lang="nl">Intellectuele achterstand - vroeg optredend cataract - microcefalie-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18058">
+          <Source>33632302[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>6.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18059">
+          <Source>33632302[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="31664">
       <OrphaCode>633028</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=633028</ExpertLink>
@@ -377884,6 +385240,104 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31670">
+      <OrphaCode>633099</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=633099</ExpertLink>
+      <Name lang="nl">PAICS-deficiÃ«ntie</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17995">
+          <Source>39726239[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>3.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17996">
+          <Source>39726239[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31668">
+      <OrphaCode>633076</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=633076</ExpertLink>
+      <Name lang="nl">Gespleten ruggenmerg-malformatie, samengesteld type</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18003">
+          <Source>34802216[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>15.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18004">
+          <Source>34802216[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="31322">
       <OrphaCode>615970</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=615970</ExpertLink>
@@ -377916,6 +385370,104 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31320">
+      <OrphaCode>615954</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=615954</ExpertLink>
+      <Name lang="nl">Letaal pontocerebellaire hypoplasie - hypotonie - respiratoire insufficiÃ«ntie-syndroom</Name>
+      <DisorderType id="21422">
+        <Name lang="nl">Klinisch syndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18001">
+          <Source>27640307[PMID]_28549128[PMID]_29053797[PMID]_31727539[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>16.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18002">
+          <Source>27640307[PMID]_28549128[PMID]_29053797[PMID]_31727539[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31321">
+      <OrphaCode>615964</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=615964</ExpertLink>
+      <Name lang="nl">Acute reversibele leuko-encefalopathie met verhoogd alfa-ketoglutaraat in urine</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18054">
+          <Source>38235040[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>7.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18055">
+          <Source>38235040[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="31346">
       <OrphaCode>617408</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=617408</ExpertLink>
@@ -377948,6 +385500,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31347">
+      <OrphaCode>617440</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=617440</ExpertLink>
+      <Name lang="nl">Syndroom van pijnlijke benen en bewegende tenen</Name>
+      <DisorderType id="21422">
+        <Name lang="nl">Klinisch syndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="18048">
+          <Source>39585061[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>144.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="18049">
+          <Source>39585061[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="31340">
       <OrphaCode>617304</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=617304</ExpertLink>
@@ -378047,7 +385648,7 @@
     <Disorder id="31338">
       <OrphaCode>617297</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=617297</ExpertLink>
-      <Name lang="nl">Omgekeerde arteriële perfusie bij tweeling-sequentie</Name>
+      <Name lang="nl">Omgekeerde arteriÃ«le perfusie bij tweeling-sequentie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -378177,7 +385778,7 @@
     <Disorder id="31441">
       <OrphaCode>620368</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=620368</ExpertLink>
-      <Name lang="nl">EGF-gerelateerde primaire hypomagnesiëmie met intellectuele achterstand</Name>
+      <Name lang="nl">EGF-gerelateerde primaire hypomagnesiÃ«mie met intellectuele achterstand</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -378226,7 +385827,7 @@
     <Disorder id="31440">
       <OrphaCode>620363</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=620363</ExpertLink>
-      <Name lang="nl">Primaire hypomagnesiëmie - gegeneraliseerde insulten - intellectuele achterstand - obesitas-syndroom</Name>
+      <Name lang="nl">Primaire hypomagnesiÃ«mie - gegeneraliseerde insulten - intellectuele achterstand - obesitas-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -378403,7 +386004,7 @@
     <Disorder id="31432">
       <OrphaCode>620178</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=620178</ExpertLink>
-      <Name lang="nl">Niet-syndromale bilambdoïde craniosynostose</Name>
+      <Name lang="nl">Niet-syndromale bilambdoÃ¯de craniosynostose</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -378595,7 +386196,7 @@
     <Disorder id="31427">
       <OrphaCode>620113</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=620113</ExpertLink>
-      <Name lang="nl">Niet-syndromale unilambdoïde craniosynostose</Name>
+      <Name lang="nl">Niet-syndromale unilambdoÃ¯de craniosynostose</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -378691,7 +386292,7 @@
     <Disorder id="31472">
       <OrphaCode>624190</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=624190</ExpertLink>
-      <Name lang="nl">Paraneoplastische geïsoleerde encefalitis van hersenstam</Name>
+      <Name lang="nl">Paraneoplastische geÃ¯soleerde encefalitis van hersenstam</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -378927,7 +386528,7 @@
     <Disorder id="31470">
       <OrphaCode>624166</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=624166</ExpertLink>
-      <Name lang="nl">Aspecifieke auto-immune supratentoriële encefalitis met typische antilichamen</Name>
+      <Name lang="nl">Aspecifieke auto-immune supratentoriÃ«le encefalitis met typische antilichamen</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -378959,7 +386560,7 @@
     <Disorder id="31471">
       <OrphaCode>624178</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=624178</ExpertLink>
-      <Name lang="nl">Aspecifieke auto-immune supratentoriële encefalitis zonder typische antilichamen</Name>
+      <Name lang="nl">Aspecifieke auto-immune supratentoriÃ«le encefalitis zonder typische antilichamen</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -379166,6 +386767,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31467">
+      <OrphaCode>623695</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=623695</ExpertLink>
+      <Name lang="nl">MIR140-gerelateerde spondylo-epifysaire dysplasie</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17913">
+          <Source>30804514[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Geval(len)/Gezinnen</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Geval(len)</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>2.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17914">
+          <Source>30804514[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="31460">
       <OrphaCode>622925</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=622925</ExpertLink>
@@ -379218,7 +386868,7 @@
     <Disorder id="31388">
       <OrphaCode>618891</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=618891</ExpertLink>
-      <Name lang="nl">Chronische neuroviscerale deficiëntie van zure sfingomyelinase</Name>
+      <Name lang="nl">Chronische neuroviscerale deficiÃ«ntie van zure sfingomyelinase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -379397,7 +387047,7 @@
     <Disorder id="31417">
       <OrphaCode>619941</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=619941</ExpertLink>
-      <Name lang="nl">Immuundeficiëntie door verstoorde fagocytose en migratie van neutrofielen</Name>
+      <Name lang="nl">Congenitale neutropenie - gecombineerde immuundeficiÃ«ntie door MKL1-deficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -379495,7 +387145,7 @@
     <Disorder id="31419">
       <OrphaCode>619953</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=619953</ExpertLink>
-      <Name lang="nl">Familiale hyperinflammatoire lymfoproliferatieve immuundeficiëntie</Name>
+      <Name lang="nl">Familiale hyperinflammatoire lymfoproliferatieve immuundeficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -379544,7 +387194,7 @@
     <Disorder id="31418">
       <OrphaCode>619948</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=619948</ExpertLink>
-      <Name lang="nl">Vroeg optredende auto-immuniteit - auto-inflammatie - immuundeficiëntie-syndroom door SOCS1-haploinsufficiëntie</Name>
+      <Name lang="nl">Vroeg optredende auto-immuniteit - auto-inflammatie - immuundeficiÃ«ntie-syndroom door SOCS1-haploinsufficiÃ«ntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -379593,7 +387243,7 @@
     <Disorder id="31423">
       <OrphaCode>619979</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=619979</ExpertLink>
-      <Name lang="nl">Ontwikkelingsachterstand - immuundeficiëntie - leuko-encefalopathie - hypohomocysteïnemie-syndroom</Name>
+      <Name lang="nl">Ontwikkelingsachterstand - immuundeficiÃ«ntie - leuko-encefalopathie - hypohomocysteÃ¯nemie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
